data_1put_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1put _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.318 0.58 . . . . 0.0 109.504 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.436 ' O ' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -151.48 159.38 44.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.187 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.536 HG13 ' CD2' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -147.95 125.2 3.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.211 -0.93 . . . . 0.0 109.38 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 99' ' ' VAL . 97.4 t -126.01 129.64 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 108.887 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CD2' ' CG2' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -97.69 154.59 17.48 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.944 -1.097 . . . . 0.0 109.374 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.528 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 5.1 t -123.96 170.19 14.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.446 -0.784 . . . . 0.0 108.977 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.542 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 14.6 p -121.43 162.89 19.65 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.477 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.43 -8.38 13.26 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 120.872 -1.142 . . . . 0.0 109.051 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 4.5 t70 -110.25 -6.06 15.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.114 -0.991 . . . . 0.0 110.316 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.41 -31.75 5.67 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.266 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.56 ' CG2' ' NH1' ' A' ' 13' ' ' ARG . 54.1 m -49.71 114.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.043 -1.269 . . . . 0.0 109.486 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 18.3 ptt180 -130.78 126.05 35.33 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.596 -0.69 . . . . 0.0 109.694 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.56 ' NH1' ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -104.24 125.96 50.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.949 . . . . 0.0 108.714 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -85.83 157.37 20.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.122 -0.986 . . . . 0.0 110.567 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.595 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -167.4 -177.32 3.57 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.698 0.761 . . . . 0.0 109.334 179.153 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.41 106.23 8.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.714 -0.616 . . . . 0.0 109.574 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.523 HG22 ' CD2' ' A' ' 23' ' ' LEU . 78.5 t -81.05 108.71 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.404 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -46.31 172.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.548 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.459 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 75.1 m-20 -83.27 125.19 31.33 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.327 -0.858 . . . . 0.0 109.137 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.81 29.31 8.74 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.521 ' O ' ' CG2' ' A' ' 89' ' ' ILE . 2.1 t -130.58 170.96 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.342 -1.093 . . . . 0.0 109.378 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.506 ' HB2' ' CD1' ' A' ' 89' ' ' ILE . 13.2 t -115.92 146.43 42.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 108.926 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.536 ' CD2' HG13 ' A' ' 3' ' ' VAL . 16.2 mt -47.53 -25.48 1.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.961 -1.087 . . . . 0.0 108.478 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.526 ' CG ' ' N ' ' A' ' 25' ' ' GLN . 24.2 ptt? -71.6 -46.3 59.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.847 . . . . 0.0 108.832 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.526 ' N ' ' CG ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -55.14 -56.54 18.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.144 -0.972 . . . . 0.0 108.805 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 30' ' ' ASN . . . -60.17 -19.25 53.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.3 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.53 ' CB ' ' HB ' ' A' ' 32' ' ' ILE . . . -70.76 -40.07 72.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.847 . . . . 0.0 110.127 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 25' ' ' GLN . 32.6 m -45.65 -33.05 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.181 -0.95 . . . . 0.0 110.366 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 31' ' ' GLY . 3.7 t -107.39 -59.64 1.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 109.815 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.569 ' ND2' ' CD1' ' A' ' 15' ' ' LEU . 47.2 m-20 -38.8 -27.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.342 0.592 . . . . 0.0 109.989 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 107.63 -9.69 38.04 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.634 ' CG2' ' CD2' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -68.29 -13.15 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -1.223 . . . . 0.0 107.913 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.496 ' N ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -49.51 -28.72 5.77 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 178.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -92.15 -30.16 16.1 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.544 ' CG2' ' NH2' ' A' ' 13' ' ' ARG . 3.0 mt -105.83 40.66 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.128 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.58 ' CG1' ' N ' ' A' ' 37' ' ' GLY . 1.3 p -143.16 -151.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.58 ' N ' ' CG1' ' A' ' 36' ' ' VAL . . . -72.0 -159.91 4.39 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -141.5 -53.95 0.46 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.974 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 42' ' ' SER . 15.1 p -63.7 -11.1 23.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.079 -1.013 . . . . 0.0 109.695 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 86' ' ' CYS . . . 85.19 -164.99 39.0 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.499 ' N ' ' SD ' ' A' ' 24' ' ' MET . . . -42.56 -27.43 0.5 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 67.8 p -59.91 168.86 1.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -1.15 . . . . 0.0 109.37 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.451 ' O ' ' SD ' ' A' ' 70' ' ' MET . . . -128.68 71.04 1.39 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -124.71 -10.81 7.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.791 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.522 ' O ' ' CE ' ' A' ' 70' ' ' MET . 1.8 p -111.83 -178.92 3.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.662 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.508 ' HB1' ' NE1' ' A' ' 106' ' ' TRP . . . -133.03 12.89 4.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.181 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.6 p -75.57 -16.15 60.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.448 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.49 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 25.6 p -86.72 41.61 0.96 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.289 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.653 ' CE1' ' O ' ' A' ' 77' ' ' GLU . 26.7 t60 -82.25 64.16 6.78 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 83' ' ' ARG . 12.5 m -80.68 147.22 6.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.55 -1.344 . . . . 0.0 110.076 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.639 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 8.0 m-85 -107.86 106.41 16.68 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.56 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 4.5 t -89.78 166.79 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.791 0.805 . . . . 0.0 112.151 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -64.61 -176.79 0.27 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -100.64 -6.6 24.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 110.28 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.5 1.53 18.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.965 -1.084 . . . . 0.0 110.463 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.619 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 49.5 m-85 -115.14 -20.96 10.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.93 -1.106 . . . . 0.0 110.087 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.56 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -78.36 1.44 21.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.991 -1.068 . . . . 0.0 109.523 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -85.08 -58.62 2.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.673 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.582 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . 3.4 mptt -49.98 -39.93 42.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.569 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -56.68 164.36 2.19 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.136 -0.977 . . . . 0.0 109.412 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 4.8 Cg_exo -59.16 172.14 1.93 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.149 1.899 . . . . 0.0 110.261 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.14 59.39 0.61 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.379 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.05 111.27 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.523 -0.736 . . . . 0.0 109.56 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 63' ' ' ALA . 5.8 m-20 -57.11 -160.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.526 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 21.1 tt0 -85.07 -10.36 56.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -48.28 -67.62 0.26 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -65.63 -12.94 57.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.503 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.526 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 14.5 mt -73.89 -31.92 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.75 -58.58 4.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.526 ' HE3' ' CD2' ' A' ' 84' ' ' LEU . 6.1 ptm -67.95 -27.04 66.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -1.141 . . . . 0.0 109.298 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.521 ' HG ' ' CD1' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -89.99 6.41 42.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.332 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 68' ' ' ILE . 9.7 tp10 -94.62 -30.34 14.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.249 -0.907 . . . . 0.0 109.16 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 74' ' ' VAL . 77.4 m -98.64 15.79 24.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.886 . . . . 0.0 109.233 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.518 ' CG1' HD12 ' A' ' 71' ' ' LEU . 17.1 m -46.27 171.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.474 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.575 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 62.2 m -73.77 -2.14 22.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.739 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.488 ' CA ' ' HD2' ' A' ' 104' ' ' ARG . . . -126.43 -152.52 0.52 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.004 -1.06 . . . . 0.0 109.812 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.653 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.6 pt-20 -112.57 155.72 23.89 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.64 ' CD1' ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -129.54 152.45 49.05 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 117.779 -1.568 . . . . 0.0 111.989 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.53 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 2.5 mmtm -132.67 166.32 29.92 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.53 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 6.2 Cg_exo -54.94 -17.25 13.62 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.254 1.969 . . . . 0.0 110.717 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.42 -31.44 22.88 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 110.644 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.568 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.3 m -60.45 159.55 10.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.889 -1.132 . . . . 0.0 109.578 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.519 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -162.04 139.67 8.65 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.819 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.526 ' CD2' ' HE3' ' A' ' 70' ' ' MET . 1.3 mp -63.0 107.75 1.07 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -43.02 -26.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.878 -179.438 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 28.6 p -86.83 31.76 0.69 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 110.24 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 86' ' ' CYS . 12.3 mt-30 -153.36 24.24 0.54 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.872 -1.143 . . . . 0.0 110.492 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.475 ' CG2' HG13 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -140.63 131.31 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 0.0 109.649 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.524 HG21 ' N ' ' A' ' 90' ' ' MET . 31.1 mm -110.0 148.44 13.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.362 -0.837 . . . . 0.0 109.436 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.537 ' CE ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -103.69 84.95 2.35 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.169 -0.957 . . . . 0.0 109.132 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.533 ' CG2' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -78.03 171.69 11.81 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 91' ' ' THR . 5.5 Cg_exo -59.14 -14.06 22.13 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.104 1.869 . . . . 0.0 110.117 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -69.54 -50.9 40.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 0.0 109.336 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.582 ' CD1' ' CB ' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -83.46 138.96 33.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 109.378 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -145.31 132.14 20.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 0.0 109.632 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.433 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 70.69 37.39 67.22 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.619 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -71.92 147.89 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.408 -1.054 . . . . 0.0 109.522 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.439 ' C ' HD12 ' A' ' 97' ' ' ILE . 5.5 t -114.09 106.68 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.239 -0.913 . . . . 0.0 109.8 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.513 HG23 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -98.0 152.22 4.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -128.07 176.05 7.93 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.922 -1.111 . . . . 0.0 109.807 -179.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.582 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 21.5 t -106.42 146.48 33.09 Favored Pre-proline 0 C--N 1.296 -1.735 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.527 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.627 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 11.6 Cg_exo -52.99 177.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.428 2.086 . . . . 0.0 110.303 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 21.8 t0 -74.77 -22.62 58.67 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -130.87 -167.51 1.85 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 106' ' ' TRP . 50.3 tp60 -139.01 28.19 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.939 -1.101 . . . . 0.0 109.657 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.575 ' CE2' ' OG1' ' A' ' 75' ' ' THR . 8.9 m95 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.515 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.311 0.577 . . . . 0.0 109.581 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.448 ' O ' HG21 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -139.81 161.62 37.11 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.871 . . . . 0.0 109.116 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.535 HG13 ' CD2' ' A' ' 23' ' ' LEU . 1.4 t -150.75 128.43 2.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.27 -0.894 . . . . 0.0 109.683 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.533 ' O ' ' CG2' ' A' ' 99' ' ' VAL . 42.6 t -132.04 164.5 34.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.638 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -137.72 159.56 41.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.073 . . . . 0.0 109.903 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.468 ' O ' HG21 ' A' ' 101' ' ' VAL . 4.0 t -131.2 137.24 56.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.587 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 35.2 t -93.19 171.15 9.12 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.494 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -66.98 -6.05 15.3 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.028 -1.045 . . . . 0.0 109.156 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.35 -2.99 16.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.977 . . . . 0.0 110.219 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.66 17.34 15.12 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.215 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.529 ' OG1' ' CB ' ' A' ' 7' ' ' SER . 69.5 m -49.82 112.97 0.74 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.037 -1.272 . . . . 0.0 109.1 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.07 105.71 16.48 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.564 -0.71 . . . . 0.0 110.325 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.454 ' O ' HG11 ' A' ' 4' ' ' VAL . 22.8 ttm180 -148.33 133.86 18.71 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.465 ' HB3' ' CG2' ' A' ' 4' ' ' VAL . 3.5 mp0 -120.03 179.4 4.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.004 -1.06 . . . . 0.0 110.986 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.503 ' CD2' HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -176.12 -176.03 0.76 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.27 100.0 5.89 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.545 -0.722 . . . . 0.0 109.53 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 90' ' ' MET . 39.5 t -65.51 108.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.352 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -46.55 172.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.42 ' OD2' ' HG3' ' A' ' 92' ' ' PRO . 52.8 m-20 -82.2 125.03 30.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.259 -0.901 . . . . 0.0 109.151 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.04 41.13 6.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' CG1' ' HB3' ' A' ' 25' ' ' GLN . 1.9 t -133.79 162.37 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -1.165 . . . . 0.0 109.414 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.462 ' OG ' ' CD1' ' A' ' 89' ' ' ILE . 46.6 m -98.09 137.08 37.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 108.854 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.535 ' CD2' HG13 ' A' ' 3' ' ' VAL . 6.5 mt -46.29 -26.36 0.79 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.012 -1.055 . . . . 0.0 108.613 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.26 -47.09 45.91 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.503 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -51.96 -51.22 58.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.038 179.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.484 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -60.84 -29.59 69.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 108.821 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.525 ' CB ' ' N ' ' A' ' 33' ' ' TYR . . . -73.02 -25.2 60.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.552 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.57 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 88.4 t -57.07 -42.13 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.069 -1.019 . . . . 0.0 109.385 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.2 t -84.56 -55.08 4.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.401 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 24.5 m-80 -52.92 -18.53 2.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.376 -0.828 . . . . 0.0 109.606 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.89 23.61 57.22 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.503 HD12 ' CD2' ' A' ' 15' ' ' LEU . 1.1 mt -101.33 -25.55 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.272 . . . . 0.0 108.286 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.632 ' CG ' ' N ' ' A' ' 34' ' ' ASP . 2.3 p90 -48.74 -47.17 41.66 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.632 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 34.0 t70 -69.46 -33.08 72.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.517 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 53.5 mt -57.72 -19.28 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.182 -0.949 . . . . 0.0 108.936 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.525 ' CG1' HG12 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -170.03 133.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.442 -0.786 . . . . 0.0 109.377 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' OD1' ' A' ' 38' ' ' ASP . . . 133.86 169.06 11.97 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.483 ' CG ' ' CG2' ' A' ' 47' ' ' THR . 0.2 OUTLIER -161.73 -89.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -1.201 . . . . 0.0 109.824 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 40' ' ' GLY . 13.1 p -50.97 -41.97 59.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.568 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.513 ' N ' ' SG ' ' A' ' 39' ' ' CYS . . . 71.05 -83.9 0.4 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 43' ' ' ALA . . . -70.92 -79.1 0.39 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.461 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 59.8 p -59.71 88.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -1.139 . . . . 0.0 109.813 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.518 ' CB ' ' OE1' ' A' ' 87' ' ' GLN . . . -60.29 99.68 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.481 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.457 ' HA ' ' HG2' ' A' ' 70' ' ' MET . 2.3 m -160.03 22.06 0.17 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.713 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 7.8 p -116.05 -157.89 0.66 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 109.432 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.503 ' HB1' ' NE1' ' A' ' 106' ' ' TRP . . . -147.81 12.8 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.098 -1.001 . . . . 0.0 109.877 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.519 HG21 ' CB ' ' A' ' 106' ' ' TRP . 5.0 p -77.93 -23.74 48.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.997 . . . . 0.0 109.496 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 27.1 p -86.66 42.66 1.02 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 110.312 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.734 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 69.8 t60 -77.85 67.03 3.64 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.427 ' O ' HG21 ' A' ' 50' ' ' VAL . 11.4 m -87.16 147.71 5.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.471 -1.393 . . . . 0.0 110.862 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.734 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 6.8 m-30 -107.26 106.31 16.71 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 122.159 0.981 . . . . 0.0 108.393 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.545 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 9.6 t -90.0 164.46 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.852 0.834 . . . . 0.0 112.431 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -69.0 152.49 45.19 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -77.27 7.49 5.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -0.877 . . . . 0.0 110.619 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.33 -12.52 14.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.778 -1.202 . . . . 0.0 110.046 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.614 ' CD1' ' HA ' ' A' ' 97' ' ' ILE . 80.2 m-85 -111.36 -19.71 12.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 0.0 109.587 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.574 ' CG2' ' ND2' ' A' ' 81' ' ' ASN . 1.9 p -68.78 -12.17 61.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.241 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -88.97 -37.95 14.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.568 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 1.2 mptm? -71.44 -33.14 69.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.165 -0.96 . . . . 0.0 109.487 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -51.91 164.21 0.58 Allowed Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.223 -0.923 . . . . 0.0 109.218 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 5.7 Cg_exo -56.33 -166.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.044 1.829 . . . . 0.0 110.234 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.39 58.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -43.41 107.46 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.455 -0.778 . . . . 0.0 109.355 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' ALA . 4.3 m-20 -56.86 -160.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.613 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.523 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 62.1 tt0 -100.09 -16.95 17.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.489 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 65' ' ' GLU . 2.1 mtp180 -44.74 -61.12 1.7 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.457 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.515 ' OE1' ' CB ' ' A' ' 43' ' ' ALA . 1.2 mt-10 -66.86 -23.63 66.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.523 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 32.2 mm -63.65 -31.87 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.503 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.59 -50.76 47.36 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.457 ' HG2' ' HA ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -65.9 -23.8 66.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -1.145 . . . . 0.0 109.3 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.522 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 5.2 tp -87.76 -10.49 50.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.428 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -76.22 -35.62 58.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.355 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.99 45.07 0.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 0.0 109.363 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 71' ' ' LEU . 10.9 m -82.16 171.05 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 0.0 109.514 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.465 HG22 ' CB ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -57.41 -16.14 8.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.604 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -124.86 -151.23 0.47 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.114 -0.991 . . . . 0.0 110.52 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.576 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 2.2 pm0 -112.59 153.01 28.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.562 ' HG ' ' CB ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -111.22 127.36 55.58 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.803 -1.559 . . . . 0.0 111.672 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 1.9 mptp? -98.61 167.85 10.76 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 2.2 Cg_endo -60.05 -9.73 10.83 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.456 2.104 . . . . 0.0 111.37 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.574 ' ND2' ' CG2' ' A' ' 57' ' ' THR . 0.2 OUTLIER -107.26 4.92 27.1 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.086 -1.009 . . . . 0.0 111.836 -178.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.562 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -88.6 155.95 19.33 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.54 -1.35 . . . . 0.0 109.964 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.49 ' HG2' ' CD1' ' A' ' 88' ' ' ILE . 6.5 ttt180 -162.14 158.05 24.11 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.731 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.523 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 4.1 mp -78.84 106.28 10.74 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 108.648 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 48' ' ' CYS . 20.2 p -48.72 -22.11 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.596 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 26.6 p -81.3 -38.65 26.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.19 -0.944 . . . . 0.0 110.245 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.518 ' OE1' ' CB ' ' A' ' 43' ' ' ALA . 4.0 tp60 -89.47 42.85 1.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.084 -1.01 . . . . 0.0 110.865 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -149.31 146.64 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.889 -1.132 . . . . 0.0 109.534 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 90' ' ' MET . 11.4 mm -115.26 166.98 8.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.391 -0.818 . . . . 0.0 109.229 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.577 ' CE ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -130.13 97.59 4.49 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.213 -0.929 . . . . 0.0 109.462 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.524 ' CG2' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -90.13 172.17 7.46 Favored Pre-proline 0 C--N 1.298 -1.666 0 O-C-N 121.56 -0.713 . . . . 0.0 109.146 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.524 ' HD2' ' CG2' ' A' ' 91' ' ' THR . 3.8 Cg_exo -60.79 -11.03 16.02 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.161 1.907 . . . . 0.0 110.481 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -68.23 -51.1 49.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -0.999 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -78.49 127.45 32.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 109.37 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.31 126.46 33.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.918 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.577 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 78.23 35.28 34.36 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.614 ' HA ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -71.54 133.21 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -1.087 . . . . 0.0 109.541 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.584 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 3.7 t -107.02 108.49 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -99.08 153.55 4.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -126.58 174.07 8.96 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.072 -1.018 . . . . 0.0 109.284 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.614 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 28.8 t -107.59 147.09 34.67 Favored Pre-proline 0 N--CA 1.494 1.725 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.95 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.645 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 8.2 Cg_exo -53.76 -171.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.32 2.013 . . . . 0.0 110.458 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -89.45 -26.66 20.84 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.465 ' CB ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -120.86 -157.96 0.74 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 105' ' ' GLN . 9.7 tt0 -154.97 24.4 0.43 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.001 -1.062 . . . . 0.0 109.586 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.519 ' CB ' HG21 ' A' ' 47' ' ' THR . 24.4 m95 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.715 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.433 ' HB2' ' HE2' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.469 ' O ' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -137.59 165.57 26.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.284 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.535 ' CG1' HD23 ' A' ' 23' ' ' LEU . 6.7 t -154.32 161.64 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.159 -0.963 . . . . 0.0 109.052 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.53 HG11 ' N ' ' A' ' 5' ' ' TYR . 51.9 t -159.46 148.68 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.075 -1.016 . . . . 0.0 109.202 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.636 ' CE1' ' CD2' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -124.68 154.08 41.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.097 -1.002 . . . . 0.0 109.498 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 12' ' ' ARG . 3.0 t -136.71 141.4 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.438 -0.789 . . . . 0.0 110.177 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.557 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 1.5 p -81.52 169.52 17.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -41.87 -89.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.872 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.23 74.95 0.89 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.789 -1.194 . . . . 0.0 109.267 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.23 -105.08 0.37 Allowed Glycine 0 N--CA 1.489 2.208 0 C-N-CA 118.465 -1.826 . . . . 0.0 110.918 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -130.5 -176.09 3.86 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.544 -0.974 . . . . 0.0 109.57 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 5.0 ptp180 -150.98 124.35 8.91 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.291 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.475 ' O ' HG11 ' A' ' 4' ' ' VAL . 50.4 mtt180 -89.27 175.52 7.31 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.497 ' CB ' HG21 ' A' ' 4' ' ' VAL . 9.7 pt20 -134.97 141.11 46.17 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.974 -1.079 . . . . 0.0 110.324 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.636 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -136.69 -176.52 4.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.365 -0.834 . . . . 0.0 109.353 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -126.72 71.43 1.3 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.677 -0.639 . . . . 0.0 109.484 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.521 HG23 ' CD2' ' A' ' 23' ' ' LEU . 61.7 t -54.41 112.9 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.541 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -47.15 174.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 0.0 109.549 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.463 ' OD1' ' HA ' ' A' ' 92' ' ' PRO . 80.9 m-20 -83.66 125.3 31.7 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.359 -0.838 . . . . 0.0 109.192 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.46 19.01 31.2 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.517 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 0.6 OUTLIER -118.13 155.75 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -1.135 . . . . 0.0 109.293 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 23' ' ' LEU . 2.0 m -92.4 135.04 34.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.231 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.535 HD23 ' CG1' ' A' ' 3' ' ' VAL . 16.7 mt -45.27 -35.28 3.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.001 . . . . 0.0 108.968 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.446 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 1.8 tmt? -65.61 -46.24 80.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.263 -0.898 . . . . 0.0 108.976 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.471 ' O ' HG21 ' A' ' 28' ' ' VAL . 4.5 tp-100 -53.75 -52.08 61.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 109.206 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.453 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -63.2 -23.39 67.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.915 . . . . 0.0 109.171 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.527 ' HB3' ' N ' ' A' ' 33' ' ' TYR . . . -68.11 -26.33 65.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.358 -0.839 . . . . 0.0 109.712 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.509 ' CG2' ' N ' ' A' ' 29' ' ' SER . 2.7 m -57.52 -43.62 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.996 -1.065 . . . . 0.0 109.368 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 2.7 t -81.63 -56.26 4.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.329 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.469 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 33.1 m-80 -50.06 -20.8 1.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.446 -0.784 . . . . 0.0 109.372 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' HG22 ' A' ' 35' ' ' ILE . . . 83.55 22.21 56.67 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.53 HG22 ' CD1' ' A' ' 35' ' ' ILE . 1.4 mt -98.63 -31.3 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.208 -1.172 . . . . 0.0 108.848 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -51.64 -36.69 47.12 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.586 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 20.9 t70 -72.22 -35.62 68.93 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.53 ' CD1' HG22 ' A' ' 32' ' ' ILE . 3.7 pt -83.09 5.08 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.958 -1.089 . . . . 0.0 109.423 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 35' ' ' ILE . 0.3 OUTLIER -169.53 120.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.407 ' C ' HG22 ' A' ' 47' ' ' THR . . . 130.36 170.01 12.61 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.521 ' HB2' ' CG2' ' A' ' 47' ' ' THR . 5.0 m-20 -162.31 -59.93 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -1.158 . . . . 0.0 109.795 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.469 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 8.1 p -82.86 9.43 9.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' GLY . . . 57.64 -89.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 40' ' ' GLY . . . -60.63 -124.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.4 ' O ' ' HE2' ' A' ' 70' ' ' MET . 52.7 p -138.48 48.67 1.93 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.16 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' A' ' 39' ' ' CYS . . . -59.78 -93.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.515 ' HA ' ' CB ' ' A' ' 70' ' ' MET . 37.2 t -160.4 60.08 0.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.059 -1.026 . . . . 0.0 109.936 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 70' ' ' MET . 1.7 p -107.5 -171.71 1.93 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.085 -1.01 . . . . 0.0 109.21 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.502 ' HB3' ' N ' ' A' ' 74' ' ' VAL . . . -146.92 20.49 1.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 0.0 109.516 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 38' ' ' ASP . 7.9 t -90.3 -21.94 21.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.765 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 84' ' ' LEU . 21.8 p -87.18 42.55 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.145 -0.972 . . . . 0.0 110.398 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.649 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 44.8 t-80 -81.56 60.92 4.76 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 14.1 m -76.28 149.09 6.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 120.752 -1.218 . . . . 0.0 110.912 -177.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.512 ' CE2' ' CE1' ' A' ' 49' ' ' HIS . 7.7 m-85 -108.21 103.09 12.2 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.552 ' O ' ' ND2' ' A' ' 81' ' ' ASN . 4.3 t -89.15 174.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 121.662 0.744 . . . . 0.0 111.941 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.526 ' O ' ' CG2' ' A' ' 57' ' ' THR . 0.3 OUTLIER -70.41 -175.78 1.09 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -101.3 4.59 41.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.915 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.37 -25.54 10.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.081 -1.012 . . . . 0.0 110.258 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.637 ' CD2' ' CG2' ' A' ' 97' ' ' ILE . 73.8 m-85 -99.69 -17.05 17.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.068 -1.02 . . . . 0.0 109.816 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.542 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 25.1 p -63.87 -43.63 95.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 109.612 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -55.72 -51.77 66.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.904 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.541 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -49.86 -41.8 46.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 109.623 -179.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.542 ' CG1' ' HD2' ' A' ' 61' ' ' PRO . 54.6 t -54.22 142.83 47.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.998 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.542 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 5.2 Cg_exo -55.79 173.43 0.39 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.076 1.851 . . . . 0.0 110.519 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.72 62.52 0.61 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -0.818 . . . . 0.0 109.373 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -38.92 126.52 1.57 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.72 -0.612 . . . . 0.0 109.849 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.528 ' ND2' ' N ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -51.39 -174.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.896 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.491 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 3.9 tp10 -76.86 -10.19 59.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.357 -0.839 . . . . 0.0 109.548 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -58.82 -51.25 70.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.336 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' HG2' ' HE1' ' A' ' 70' ' ' MET . 86.3 mt-10 -72.73 -7.06 48.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.403 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.493 HG23 HD11 ' A' ' 68' ' ' ILE . 15.2 mt -76.65 -36.93 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 0.0 109.556 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.23 -54.1 24.89 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.515 ' CB ' ' HA ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -68.45 -27.06 65.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.287 -1.125 . . . . 0.0 108.779 179.591 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.525 ' CD1' HD12 ' A' ' 78' ' ' LEU . 3.7 tt -83.34 8.13 14.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.144 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 72' ' ' GLU . 4.0 tp10 -100.51 -10.58 20.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.478 ' CB ' ' CB ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -82.24 -13.49 56.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.186 -0.946 . . . . 0.0 109.85 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.649 ' CG2' ' CD2' ' A' ' 49' ' ' HIS . 4.1 m -40.02 137.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.472 -0.768 . . . . 0.0 109.736 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.525 HG22 ' CB ' ' A' ' 104' ' ' ARG . 5.5 m -44.58 -25.3 0.26 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.243 -0.911 . . . . 0.0 109.289 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.531 ' O ' ' CG2' ' A' ' 74' ' ' VAL . . . -116.94 -148.94 0.43 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.629 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.6 OUTLIER -114.51 150.18 35.26 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.646 ' CD1' ' CD2' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -104.13 130.59 51.86 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 117.232 -1.787 . . . . 0.0 111.269 179.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.544 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 0.5 OUTLIER -104.76 166.1 12.09 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.544 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 5.0 Cg_exo -53.79 -26.37 38.59 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.937 1.758 . . . . 0.0 109.931 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.552 ' ND2' ' O ' ' A' ' 52' ' ' VAL . 1.9 t30 -75.41 -35.06 61.08 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 110.128 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.566 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -87.07 165.52 15.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.006 -1.059 . . . . 0.0 109.471 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.525 ' HB3' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -162.33 -162.34 0.81 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.449 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.549 ' O ' ' CD1' ' A' ' 88' ' ' ILE . 1.5 mt -98.04 108.28 20.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.523 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 23.3 t -42.81 -25.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.108 -0.995 . . . . 0.0 110.034 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' LEU . 29.1 p -82.9 -39.35 21.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.987 . . . . 0.0 110.607 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.416 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 0.7 OUTLIER -88.91 27.0 1.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 111.192 -178.524 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.549 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -106.68 149.39 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.654 -1.279 . . . . 0.0 108.902 178.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 88' ' ' ILE . 28.7 mm -128.24 161.61 36.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.93 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.529 ' HE3' ' CG2' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -130.33 95.91 4.02 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.451 -0.781 . . . . 0.0 109.12 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.464 ' OG1' HD11 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -82.38 164.93 45.38 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.545 -0.722 . . . . 0.0 109.586 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.463 ' HA ' ' OD1' ' A' ' 19' ' ' ASP . 4.0 Cg_exo -60.87 -28.49 86.45 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.138 1.892 . . . . 0.0 110.057 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.68 -37.74 85.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.541 ' CD2' ' CB ' ' A' ' 59' ' ' LYS . 4.2 mp -77.41 143.93 38.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.395 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.12 124.35 8.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 109.538 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.573 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 76.53 48.98 8.47 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.637 ' CG2' ' CD2' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -77.07 145.75 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -1.188 . . . . 0.0 108.549 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.482 ' N ' HD11 ' A' ' 97' ' ' ILE . 1.8 t -119.17 113.24 40.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 120.849 -1.157 . . . . 0.0 109.869 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -106.77 144.81 15.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 51' ' ' TYR . 9.2 m-20 -122.28 174.09 7.21 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.113 -0.992 . . . . 0.0 109.527 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.582 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 12.0 t -103.63 147.39 34.16 Favored Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.462 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.584 ' HG3' ' HB3' ' A' ' 49' ' ' HIS . 12.8 Cg_exo -52.59 163.48 1.82 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.413 2.075 . . . . 0.0 110.05 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.521 ' HB3' ' NH2' ' A' ' 104' ' ' ARG . 3.2 m-20 -57.99 -27.37 63.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.013 -1.054 . . . . 0.0 108.751 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.525 ' CB ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -130.67 -163.45 1.32 Allowed 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -152.2 23.38 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.487 ' NE1' ' N ' ' A' ' 75' ' ' THR . 38.0 m95 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.642 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.59 135.64 21.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.274 -0.891 . . . . 0.0 109.177 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.566 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 1.1 t -133.24 123.79 47.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.587 ' CG1' ' CG ' ' A' ' 12' ' ' ARG . 65.9 t -121.82 128.81 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.128 -0.982 . . . . 0.0 108.636 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.641 ' CZ ' ' CD1' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -98.21 153.8 18.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.953 -1.092 . . . . 0.0 109.478 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.527 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 12.0 t -121.52 168.87 13.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.535 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 41.0 t -122.99 161.52 24.09 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.496 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.55 -8.13 12.81 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.089 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -110.66 -3.33 15.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.079 -1.013 . . . . 0.0 110.643 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.68 -23.63 13.12 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.173 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' A' ' 7' ' ' SER . 74.6 m -49.52 112.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.031 -1.276 . . . . 0.0 109.065 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.587 ' CG ' ' CG1' ' A' ' 4' ' ' VAL . 3.6 ttm180 -125.49 117.34 23.43 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.575 -0.703 . . . . 0.0 110.187 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.465 ' CD ' HG12 ' A' ' 32' ' ' ILE . 1.2 ptp180 -108.7 124.95 51.35 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.402 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -91.37 155.55 18.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.018 -1.051 . . . . 0.0 110.569 -178.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.585 HD23 ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -163.02 -176.13 4.72 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.639 0.733 . . . . 0.0 109.169 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -129.37 114.63 16.43 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.5 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.519 ' CG1' ' HB3' ' A' ' 90' ' ' MET . 46.2 t -77.48 110.31 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.49 ' CB ' HG23 ' A' ' 21' ' ' VAL . . . -46.95 172.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 0.0 109.337 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -81.52 124.73 29.73 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.225 -0.922 . . . . 0.0 109.153 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.77 44.25 6.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.49 HG23 ' CB ' ' A' ' 18' ' ' ALA . 1.5 t -133.07 165.57 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.46 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 p -105.87 141.91 36.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.169 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.641 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -48.68 -23.79 1.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.137 -0.977 . . . . 0.0 108.985 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 0.1 OUTLIER -76.83 -43.88 34.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 108.657 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.496 ' O ' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -56.77 -51.15 70.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.374 -0.829 . . . . 0.0 109.259 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.51 -24.51 65.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.0 109.308 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.524 ' CB ' ' N ' ' A' ' 33' ' ' TYR . . . -74.64 -26.45 59.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.323 -0.861 . . . . 0.0 109.927 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.571 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 1.7 m -56.57 -44.15 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.788 -1.195 . . . . 0.0 109.448 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.499 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 3.3 t -80.59 -52.7 7.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.433 -0.792 . . . . 0.0 109.527 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 25.9 m-80 -57.24 -14.58 4.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.832 . . . . 0.0 109.622 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' O ' ' CD1' ' A' ' 35' ' ' ILE . . . 77.33 22.78 69.74 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 27' ' ' ALA . 1.1 mt -100.14 -25.85 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.208 -1.172 . . . . 0.0 108.271 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.617 ' CG ' ' N ' ' A' ' 34' ' ' ASP . 2.1 p90 -48.63 -46.95 40.55 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.617 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 12.5 t70 -66.44 -35.5 80.45 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.534 ' CG2' ' O ' ' A' ' 35' ' ' ILE . 2.6 mp -92.3 40.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.197 -0.939 . . . . 0.0 108.889 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 35' ' ' ILE . 49.1 t -160.88 -93.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.594 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.527 ' CA ' ' HB3' ' A' ' 48' ' ' CYS . . . -84.18 167.82 43.94 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.28 -50.0 1.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -1.129 . . . . 0.0 109.689 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.513 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 16.8 p -65.15 -18.86 65.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 109.537 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 42.98 93.21 0.01 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.61 -140.76 11.06 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.7 p -60.0 161.64 6.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -1.149 . . . . 0.0 109.353 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . . . -59.91 101.3 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.412 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.513 ' HB3' ' CB ' ' A' ' 39' ' ' CYS . 4.6 t -132.93 18.72 4.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.687 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.9 p -168.08 -167.61 0.85 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.943 . . . . 0.0 109.683 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB3' ' CG1' ' A' ' 74' ' ' VAL . . . -135.48 5.54 3.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.331 -0.856 . . . . 0.0 109.331 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -63.07 -28.78 70.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.396 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.527 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 25.1 p -84.25 42.32 0.88 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.449 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.638 ' CE1' ' CD1' ' A' ' 78' ' ' LEU . 28.3 t60 -81.35 64.09 5.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.27 147.33 6.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.569 -1.332 . . . . 0.0 110.061 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 9.6 m-85 -107.03 104.12 13.71 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.558 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 4.6 t -89.41 172.6 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-O 121.948 0.88 . . . . 0.0 112.201 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.6 157.98 30.01 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -81.88 12.57 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.233 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.29 -25.95 9.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.98 -1.075 . . . . 0.0 109.75 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 97' ' ' ILE . 90.8 m-85 -104.49 -17.35 14.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.558 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -66.16 -34.97 79.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.814 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.15 -46.88 72.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.21 -0.931 . . . . 0.0 110.346 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.588 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -49.51 -43.99 45.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.736 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.525 ' CG1' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -100.45 143.24 26.16 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.892 . . . . 0.0 109.259 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.525 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 6.2 Cg_exo -58.15 -179.59 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.811 1.674 . . . . 0.0 109.219 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.472 ' HA ' ' HD3' ' A' ' 83' ' ' ARG . . . -110.29 -105.2 0.37 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.839 -1.163 . . . . 0.0 109.573 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.522 ' HB2' ' CG1' ' A' ' 68' ' ' ILE . . . -111.7 -160.14 0.7 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.071 . . . . 0.0 109.894 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.542 ' O ' ' CG1' ' A' ' 68' ' ' ILE . 12.3 m-20 -137.62 -145.43 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.87 -34.75 9.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.912 -1.117 . . . . 0.0 109.463 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -84.06 -48.37 9.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.903 . . . . 0.0 109.595 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.527 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 15.2 pt-20 -68.79 -27.0 65.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.564 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.542 ' CG1' ' O ' ' A' ' 64' ' ' ASN . 1.3 mt -66.34 -43.25 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.105 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.83 -55.8 21.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -25.61 65.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -1.16 . . . . 0.0 109.398 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.521 HD12 ' CG1' ' A' ' 74' ' ' VAL . 0.2 OUTLIER -87.86 -3.63 58.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.247 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 68' ' ' ILE . 15.0 tp10 -82.47 -26.05 32.99 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.22 -0.925 . . . . 0.0 109.211 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.74 75.77 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.391 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.521 ' CG1' HD12 ' A' ' 71' ' ' LEU . 4.9 m -97.75 174.66 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.925 . . . . 0.0 109.633 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.574 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 18.2 m -74.13 -11.95 60.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.852 . . . . 0.0 109.934 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB1' ' HG2' ' A' ' 104' ' ' ARG . . . -122.42 -151.41 0.48 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.029 -1.045 . . . . 0.0 109.874 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.628 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -112.26 156.13 22.89 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.638 ' CD1' ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -128.62 152.79 47.95 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 117.596 -1.641 . . . . 0.0 112.096 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.557 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 13.7 mmtt -137.52 167.26 21.3 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.557 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 5.8 Cg_exo -54.41 -17.99 13.68 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.17 1.913 . . . . 0.0 110.589 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 52' ' ' VAL . 0.2 OUTLIER -82.62 -33.75 27.81 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.375 -0.828 . . . . 0.0 110.45 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.59 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.1 m -61.7 159.68 13.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.951 -1.093 . . . . 0.0 109.595 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.538 ' CZ ' ' HB3' ' A' ' 83' ' ' ARG . 6.9 mmm-85 -160.4 167.96 26.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.737 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.518 HD11 ' NE2' ' A' ' 87' ' ' GLN . 0.3 OUTLIER -88.44 112.37 22.86 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 24' ' ' MET . 0.3 OUTLIER -65.35 -6.99 11.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.286 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.449 ' SG ' HD21 ' A' ' 84' ' ' LEU . 30.3 p -105.89 13.23 29.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.961 -1.087 . . . . 0.0 110.305 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.518 ' NE2' HD11 ' A' ' 84' ' ' LEU . 2.9 pt20 -139.06 3.28 2.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.796 -1.19 . . . . 0.0 110.399 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.521 HD11 HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -105.08 146.88 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.946 -1.097 . . . . 0.0 109.201 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.505 HG21 ' N ' ' A' ' 90' ' ' MET . 12.1 mm -116.32 158.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.27 -0.894 . . . . 0.0 109.505 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.532 ' CE ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -127.89 95.24 4.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.292 -0.88 . . . . 0.0 109.271 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.514 ' CG2' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -87.62 171.23 10.05 Favored Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.589 -0.694 . . . . 0.0 109.533 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.514 ' HD2' ' CG2' ' A' ' 91' ' ' THR . 3.9 Cg_exo -60.34 -15.17 33.65 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.189 1.926 . . . . 0.0 110.33 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 94' ' ' LEU . 22.3 pt-20 -66.29 -47.88 72.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.234 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.588 ' CD2' ' CB ' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -86.38 152.18 22.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.886 . . . . 0.0 109.23 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -161.42 133.99 6.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.98 . . . . 0.0 110.022 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.585 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 78.41 37.32 27.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.613 ' HA ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -78.22 149.64 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.178 -1.189 . . . . 0.0 109.047 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.44 ' C ' HD12 ' A' ' 97' ' ' ILE . 3.7 t -114.18 110.35 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.061 -1.024 . . . . 0.0 109.884 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.513 HG21 ' CD1' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -102.75 148.72 7.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -126.15 176.63 6.92 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.74 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.571 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 21.6 t -106.02 146.32 32.68 Favored Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.685 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.636 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 10.5 Cg_exo -54.06 -173.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.458 2.105 . . . . 0.0 110.656 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -92.21 -18.01 24.05 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -130.29 -162.36 1.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 106' ' ' TRP . 4.8 tm0? -151.36 22.56 0.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.838 -1.163 . . . . 0.0 109.895 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.574 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 6.5 m95 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.533 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.487 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -138.17 159.52 41.82 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.261 -0.899 . . . . 0.0 109.167 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.526 HG13 ' CG2' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -157.28 130.54 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.23 -0.919 . . . . 0.0 109.659 -179.215 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 13' ' ' ARG . 75.5 t -129.02 140.93 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 109.023 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CE1' ' CD2' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -109.24 156.87 19.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 109.252 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 101' ' ' VAL . 2.7 t -133.28 132.97 58.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.551 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -78.91 -177.37 5.5 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -48.59 162.95 0.08 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.513 ' C ' ' O ' ' A' ' 8' ' ' HIS . 5.1 t0 -29.75 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.032 0.444 . . . . 0.0 110.78 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 8' ' ' HIS . . . -168.47 -95.39 0.1 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.476 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.458 ' O ' HG11 ' A' ' 6' ' ' VAL . 1.4 m -125.37 -175.87 3.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -1.156 . . . . 0.0 109.666 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 11.5 ptt180 -156.69 141.09 16.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.631 -0.668 . . . . 0.0 109.904 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -100.41 174.63 6.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.21 -0.931 . . . . 0.0 108.718 179.266 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -130.38 162.91 28.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.029 -1.044 . . . . 0.0 110.788 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.639 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -175.84 -176.53 0.85 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.627 0.727 . . . . 0.0 109.193 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 1' ' ' SER . 7.3 t0 -132.24 88.59 2.56 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.059 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 90' ' ' MET . 49.4 t -54.24 145.61 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 108.918 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.531 ' CB ' HG23 ' A' ' 21' ' ' VAL . . . -86.42 172.98 9.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 109.662 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.428 ' CG ' ' HG3' ' A' ' 92' ' ' PRO . 78.8 m-20 -80.92 125.75 30.51 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.354 -0.841 . . . . 0.0 108.927 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.38 22.44 34.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.531 HG23 ' CB ' ' A' ' 18' ' ' ALA . 1.9 t -117.16 162.86 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -1.086 . . . . 0.0 108.918 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -100.62 134.92 42.86 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.981 -1.074 . . . . 0.0 108.568 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.637 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -46.64 -25.27 0.68 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.016 -1.052 . . . . 0.0 108.699 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.5 ' CE ' ' HB2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -74.44 -46.69 38.32 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.404 ' HG3' ' OG ' ' A' ' 22' ' ' SER . 2.7 mm-40 -52.23 -54.29 32.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 108.95 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.22 -29.08 63.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 0.0 108.677 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.525 ' HB2' ' CA ' ' A' ' 33' ' ' TYR . . . -67.93 -34.15 76.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -0.809 . . . . 0.0 109.145 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.563 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 88.4 t -52.8 -40.49 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 109.399 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 t -79.95 -48.85 12.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.848 . . . . 0.0 109.402 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.459 ' CB ' HG13 ' A' ' 32' ' ' ILE . 29.1 m-80 -65.62 -6.19 10.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.795 . . . . 0.0 109.68 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 72.09 17.6 77.32 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -95.56 -27.18 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -1.157 . . . . 0.0 108.538 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.563 ' CD1' ' HA ' ' A' ' 28' ' ' VAL . 1.2 p90 -46.96 -45.11 20.59 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.557 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 10.9 t70 -77.31 -29.06 53.46 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 31' ' ' GLY . 20.0 mm -64.86 -10.03 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 37' ' ' GLY . 2.5 p -160.12 -51.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.134 -0.979 . . . . 0.0 109.826 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' TYR . . . -42.9 166.29 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.465 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 13.7 t0 -154.15 -93.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -1.203 . . . . 0.0 109.863 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 42' ' ' SER . 20.8 p -65.49 -9.5 26.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.131 -0.98 . . . . 0.0 109.765 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 86' ' ' CYS . . . 89.59 -167.47 33.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -42.01 -27.09 0.37 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.457 ' O ' ' SG ' ' A' ' 86' ' ' CYS . 19.3 m -59.68 159.57 8.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.136 -1.214 . . . . 0.0 109.286 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.477 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -124.57 74.45 1.33 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.356 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 m -129.6 -2.33 4.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 109.735 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 38' ' ' ASP . 1.4 p -120.96 -169.24 1.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.085 -1.009 . . . . 0.0 109.613 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.495 ' HB1' ' NE1' ' A' ' 106' ' ' TRP . . . -141.83 11.44 2.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.297 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.523 ' OG1' ' CB ' ' A' ' 106' ' ' TRP . 9.5 m -71.54 -21.0 61.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.51 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.523 ' HB2' ' CB ' ' A' ' 85' ' ' CYS . 23.5 p -86.75 42.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.645 ' CE1' ' O ' ' A' ' 77' ' ' GLU . 21.6 t60 -74.47 72.65 1.88 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 10.1 m -81.64 145.41 8.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.285 -1.509 . . . . 0.0 110.728 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.638 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 6.1 m-85 -107.26 99.97 9.46 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.539 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 3.8 t -89.93 172.08 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-O 122.053 0.93 . . . . 0.0 112.461 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -77.39 159.34 29.54 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.18 11.71 5.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.38 -0.825 . . . . 0.0 110.103 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.29 -29.91 7.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.015 -1.053 . . . . 0.0 109.755 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.64 ' CD2' ' CB ' ' A' ' 97' ' ' ILE . 47.2 m-85 -99.53 -18.47 17.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.174 -0.954 . . . . 0.0 109.4 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.539 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -64.16 -14.33 54.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.073 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.85 -36.06 17.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.526 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . 1.9 mptp? -72.88 -32.92 65.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.462 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 57' ' ' THR . 1.3 m -56.18 163.05 2.55 Favored Pre-proline 0 C--N 1.305 -1.344 0 O-C-N 121.222 -0.924 . . . . 0.0 109.455 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 5.8 Cg_exo -58.16 166.47 5.7 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.166 1.911 . . . . 0.0 110.179 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -110.25 60.21 0.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -41.86 164.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.53 -0.731 . . . . 0.0 109.611 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.41 ' O ' HG12 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -94.15 -175.23 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 0.0 109.695 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.518 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 38.2 tt0 -88.13 -17.98 29.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 0.0 109.521 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -46.54 -64.53 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.477 ' OE1' ' CB ' ' A' ' 43' ' ' ALA . 4.7 mt-10 -65.56 -21.29 66.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.433 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.518 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 23.5 mm -65.37 -31.7 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -45.12 -56.42 6.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 57.2 mtt -68.21 -26.79 65.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -1.176 . . . . 0.0 109.106 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -88.11 2.78 51.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.346 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 68' ' ' ILE . 55.7 tt0 -88.15 -30.53 19.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.85 . . . . 0.0 109.008 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -101.95 29.86 4.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.168 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 73' ' ' CYS . 5.3 m -46.07 171.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.593 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.574 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 83.4 m -75.2 -4.22 37.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.786 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.76 -150.71 0.45 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.063 -1.023 . . . . 0.0 109.651 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.645 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -111.85 156.64 21.7 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 179.333 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.636 ' CD1' ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -130.71 153.91 48.49 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.964 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.528 ' HD2' ' CD ' ' A' ' 80' ' ' PRO . 4.5 mmmt -136.88 166.85 24.22 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.528 ' CD ' ' HD2' ' A' ' 79' ' ' LYS . 6.0 Cg_exo -54.68 -17.41 13.19 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.246 1.964 . . . . 0.0 110.697 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.78 -31.66 23.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.615 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.598 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.4 m -61.6 162.83 7.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.965 -1.084 . . . . 0.0 110.307 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.511 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -161.03 -159.08 0.63 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.369 -0.832 . . . . 0.0 109.278 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -110.93 118.54 36.37 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.285 -0.885 . . . . 0.0 108.97 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.528 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 1.8 t -60.79 -19.62 59.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.125 -0.984 . . . . 0.0 108.991 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 17.2 p -110.66 30.16 7.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.426 -0.796 . . . . 0.0 109.973 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.453 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -143.26 9.55 1.66 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.019 -1.051 . . . . 0.0 110.048 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.504 HG21 ' NH2' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -123.35 131.27 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.072 -1.017 . . . . 0.0 109.287 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.528 ' CG2' ' N ' ' A' ' 90' ' ' MET . 13.8 mm -96.29 166.39 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.342 -0.849 . . . . 0.0 109.622 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.531 ' HB3' ' CG1' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.87 90.33 3.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.375 -0.828 . . . . 0.0 109.417 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.409 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -88.2 167.51 19.34 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.382 -0.824 . . . . 0.0 109.336 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.428 ' HG3' ' CG ' ' A' ' 19' ' ' ASP . 3.5 Cg_exo -60.09 -12.84 20.79 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.138 1.892 . . . . 0.0 110.353 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 94' ' ' LEU . 24.9 pt-20 -69.83 -45.87 66.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.589 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 59' ' ' LYS . 1.3 mp -75.98 136.02 40.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.924 . . . . 0.0 109.556 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -139.8 119.89 13.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.59 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 72.78 46.82 28.63 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.64 ' CB ' ' CD2' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -74.96 148.77 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.375 -1.074 . . . . 0.0 109.101 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.454 ' N ' HD13 ' A' ' 97' ' ' ILE . 2.9 t -116.23 106.34 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.11 -0.994 . . . . 0.0 109.443 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.524 HG21 ' CD1' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -104.84 147.14 11.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -126.38 174.27 8.73 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.722 -179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.624 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 40.1 t -108.3 145.79 32.24 Favored Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.093 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.624 ' HD2' ' CG1' ' A' ' 101' ' ' VAL . 8.6 Cg_exo -50.24 177.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.304 2.003 . . . . 0.0 111.031 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.07 -22.87 33.36 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.61 -157.03 0.69 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.436 ' O ' ' C ' ' A' ' 106' ' ' TRP . 20.0 mt-30 -153.36 23.99 0.54 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.953 -1.092 . . . . 0.0 109.728 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.574 ' CE2' ' OG1' ' A' ' 75' ' ' THR . 5.0 m95 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.589 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.361 0.6 . . . . 0.0 109.526 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.48 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -134.41 162.99 30.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 109.075 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.537 ' CG1' HD23 ' A' ' 23' ' ' LEU . 23.9 t -152.28 157.32 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.061 -1.025 . . . . 0.0 109.742 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.496 ' CG2' ' C ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -158.57 119.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 108.879 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.61 ' CE1' ' CD2' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -95.19 157.17 16.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 109.682 -179.381 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.51 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 9.4 t -123.26 169.6 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.447 -0.783 . . . . 0.0 109.096 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.553 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 84.5 p -123.12 162.69 22.0 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.477 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -65.31 -6.53 10.09 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.828 -1.17 . . . . 0.0 109.203 179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -110.07 -5.6 15.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.062 -1.024 . . . . 0.0 110.319 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.65 -33.39 5.25 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.689 -1.244 . . . . 0.0 110.282 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.6 m -49.61 114.09 0.98 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.974 -1.31 . . . . 0.0 109.48 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.483 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -133.83 122.77 23.72 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.648 -0.657 . . . . 0.0 109.695 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.515 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 1.3 mtt180 -97.95 173.78 6.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.121 -0.987 . . . . 0.0 108.544 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.463 ' HB3' HG11 ' A' ' 4' ' ' VAL . 10.9 pt20 -131.96 134.66 45.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.051 -1.031 . . . . 0.0 110.212 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.61 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -134.28 -176.84 4.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.269 -0.895 . . . . 0.0 109.471 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.68 80.97 1.97 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.732 -0.605 . . . . 0.0 109.505 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.53 ' CG2' HD22 ' A' ' 23' ' ' LEU . 85.8 t -68.88 114.32 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.62 175.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.882 . . . . 0.0 109.817 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HB3' ' A' ' 92' ' ' PRO . 67.8 m-20 -83.05 126.29 32.39 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.477 -0.764 . . . . 0.0 109.076 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.12 10.67 44.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.529 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 0.7 OUTLIER -115.52 155.48 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -1.144 . . . . 0.0 109.199 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 7.2 t -93.6 133.01 37.36 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.403 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.537 HD23 ' CG1' ' A' ' 3' ' ' VAL . 10.8 mt -42.64 -29.41 0.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.484 ' HE1' ' N ' ' A' ' 41' ' ' GLY . 1.9 tmt? -70.81 -50.52 34.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 108.811 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -49.22 -50.86 36.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.262 -0.899 . . . . 0.0 108.751 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.521 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -63.23 -32.06 73.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -0.844 . . . . 0.0 108.757 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.519 ' HB3' ' N ' ' A' ' 33' ' ' TYR . . . -62.25 -25.45 67.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.351 -0.843 . . . . 0.0 109.213 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.576 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 47.0 t -57.43 -42.97 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.135 -0.978 . . . . 0.0 109.172 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 t -82.51 -53.11 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 0.0 109.284 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.455 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 37.2 m-80 -54.81 -16.72 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.461 -0.775 . . . . 0.0 109.406 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' HG13 ' A' ' 35' ' ' ILE . . . 79.14 21.82 66.88 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.523 ' HA ' ' CD1' ' A' ' 35' ' ' ILE . 1.1 mt -99.2 -28.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.175 -1.191 . . . . 0.0 108.535 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.605 ' CG ' ' N ' ' A' ' 34' ' ' ASP . 1.6 p90 -47.45 -46.35 26.66 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.605 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 19.3 t70 -74.44 -30.49 61.91 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 32' ' ' ILE . 60.0 mt -58.98 -17.28 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.09 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.473 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 8.0 p -170.13 81.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.843 . . . . 0.0 109.47 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.424 ' C ' ' OG1' ' A' ' 47' ' ' THR . . . -163.62 179.55 38.6 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.523 ' HB2' ' CG2' ' A' ' 47' ' ' THR . 3.2 t0 -163.96 -69.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 109.667 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 42' ' ' SER . 16.3 p -83.3 10.05 9.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.698 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.04 -162.6 46.02 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.484 ' N ' ' HE1' ' A' ' 24' ' ' MET . . . -47.34 -23.98 2.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.447 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -59.89 177.49 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -1.165 . . . . 0.0 109.368 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.69 91.15 2.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.471 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.8 t -160.05 22.03 0.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 9.1 p -130.17 -151.55 0.48 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.958 . . . . 0.0 109.461 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.506 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -157.82 19.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.141 -0.975 . . . . 0.0 109.999 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 38' ' ' ASP . 1.6 p -89.94 -19.39 24.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.113 -0.992 . . . . 0.0 109.455 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 23.4 p -86.62 43.36 1.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 110.073 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.717 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 67.5 t60 -76.93 65.41 2.6 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 82' ' ' SER . 12.6 m -87.14 147.89 4.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.345 -1.472 . . . . 0.0 110.384 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.717 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 6.2 m-30 -107.16 111.4 23.81 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.526 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 5.3 t -94.85 170.14 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.937 0.875 . . . . 0.0 112.306 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.445 ' ND2' ' HB ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER -74.24 144.51 44.63 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -4.84 13.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.17 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -94.96 -30.07 14.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.214 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.635 ' CD2' ' CB ' ' A' ' 97' ' ' ILE . 61.6 m-85 -97.98 -17.79 18.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.007 -1.058 . . . . 0.0 109.878 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.526 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -64.59 -37.21 86.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.97 . . . . 0.0 109.429 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -62.14 1.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.542 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 13.8 mptt -49.93 -38.57 36.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.527 ' CG2' ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -51.24 161.17 0.79 Allowed Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.901 . . . . 0.0 109.049 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.527 ' HD2' ' CG2' ' A' ' 60' ' ' VAL . 4.3 Cg_exo -59.96 159.22 26.28 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.18 1.92 . . . . 0.0 110.22 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.15 58.89 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.883 . . . . 0.0 109.439 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.89 132.85 3.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.415 -0.803 . . . . 0.0 109.557 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -51.79 -174.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 109.63 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.515 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 31.0 tt0 -89.47 -16.43 30.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.415 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.438 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . 5.2 tpp180 -44.57 -61.79 1.43 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.477 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.438 ' OE1' ' HB3' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -66.23 -23.84 66.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.431 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.515 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 18.9 mt -63.12 -32.48 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.99 -51.6 39.54 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.7 mtt -66.69 -23.36 66.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -1.152 . . . . 0.0 109.372 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.525 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -89.72 -7.06 55.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.497 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -82.17 -36.79 27.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 109.367 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.87 57.62 4.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.398 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 71' ' ' LEU . 8.9 m -93.94 172.02 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.527 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 25.5 m -64.94 -10.23 27.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.518 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.516 ' CB ' ' HD2' ' A' ' 104' ' ' ARG . . . -128.22 -155.85 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.149 -0.97 . . . . 0.0 109.969 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.571 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -111.82 150.39 30.43 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.629 ' HG ' ' HB2' ' A' ' 82' ' ' SER . 0.4 OUTLIER -106.54 169.1 8.72 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.397 -1.321 . . . . 0.0 111.203 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.509 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -153.22 170.78 7.68 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 3.4 Cg_exo -57.83 -13.45 14.75 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.037 1.824 . . . . 0.0 109.905 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -95.35 -25.0 16.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 110.836 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.629 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -85.79 155.9 20.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.818 -1.176 . . . . 0.0 110.477 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HB3' HD13 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -161.53 -157.68 0.51 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 179.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.586 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -104.29 95.19 5.78 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.226 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.528 ' HA ' ' CG1' ' A' ' 88' ' ' ILE . 1.9 t -42.57 -25.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.46 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 13.0 p -75.72 -43.53 46.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.098 -1.001 . . . . 0.0 110.544 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.527 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -89.62 8.87 29.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.002 -1.061 . . . . 0.0 111.334 -178.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 2.9 mm -79.98 154.66 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.552 -1.342 . . . . 0.0 108.913 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.481 HD12 ' O ' ' A' ' 88' ' ' ILE . 30.1 mm -128.98 165.47 28.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.532 ' SD ' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -127.3 96.32 4.54 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.3 p -82.52 157.19 67.83 Favored Pre-proline 0 C--N 1.297 -1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 109.262 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.465 ' HB3' ' OD2' ' A' ' 19' ' ' ASP . 5.8 Cg_exo -59.77 -13.35 21.79 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.02 1.813 . . . . 0.0 110.264 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -80.3 -31.79 38.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.412 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.517 ' CD2' ' HB2' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -83.35 127.41 33.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.634 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -135.82 125.51 25.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.204 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.576 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 70.86 50.57 23.4 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.635 ' CB ' ' CD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -74.82 159.1 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.331 -1.099 . . . . 0.0 108.868 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.513 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 5.2 t -125.82 103.53 11.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.021 -1.049 . . . . 0.0 110.186 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -95.44 156.65 3.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 51' ' ' TYR . 12.0 m-20 -131.91 178.35 6.84 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.059 -1.025 . . . . 0.0 109.401 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.595 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 27.6 t -110.45 146.84 35.14 Favored Pre-proline 0 C--N 1.297 -1.715 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.95 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.635 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 8.4 Cg_exo -53.95 -173.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.391 2.061 . . . . 0.0 110.369 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 19.3 t0 -102.68 -22.71 13.91 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -131.09 -168.68 2.04 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.578 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -128.99 -82.63 0.57 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.024 -1.048 . . . . 0.0 109.186 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.578 ' CD1' ' O ' ' A' ' 105' ' ' GLN . 2.1 m95 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.38 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.471 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -136.61 161.46 35.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.277 -0.889 . . . . 0.0 109.175 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.556 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.1 t -160.7 133.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 109.531 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.592 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 2.9 p -136.98 161.39 35.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.123 -0.985 . . . . 0.0 108.648 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.626 ' CE1' ' CD2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -129.04 157.99 40.17 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.185 -0.947 . . . . 0.0 109.786 -178.543 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 12' ' ' ARG . 3.4 t -126.9 143.39 40.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.558 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 5.1 p -75.98 -158.7 0.1 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.59 ' CD2' ' O ' ' A' ' 102' ' ' PRO . 55.8 m80 -59.2 -103.43 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.26 77.71 1.06 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.4 -1.437 . . . . 0.0 109.239 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.99 -101.31 0.2 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 118.958 -1.591 . . . . 0.0 111.053 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -121.46 -170.55 2.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -1.1 . . . . 0.0 109.954 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -149.31 139.59 22.29 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.656 -0.652 . . . . 0.0 110.32 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.439 ' C ' HG21 ' A' ' 4' ' ' VAL . 18.0 mtt180 -104.25 119.31 38.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.351 -0.843 . . . . 0.0 108.958 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.592 ' HA ' ' CB ' ' A' ' 4' ' ' VAL . 4.9 pt20 -79.78 171.43 15.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.973 . . . . 0.0 110.554 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.626 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -173.48 -177.98 1.58 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.611 0.72 . . . . 0.0 109.059 178.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -135.24 93.17 2.95 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.66 -0.65 . . . . 0.0 109.685 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.52 ' HB ' ' CB ' ' A' ' 90' ' ' MET . 21.1 t -69.13 149.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 109.305 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.431 ' C ' HG22 ' A' ' 21' ' ' VAL . . . -83.22 173.38 11.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.397 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -79.97 124.67 28.91 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.274 -0.891 . . . . 0.0 109.067 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.8 18.06 39.05 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.512 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 2.2 t -115.1 170.3 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -1.123 . . . . 0.0 109.27 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.496 ' OG ' ' CD1' ' A' ' 89' ' ' ILE . 70.6 m -111.76 138.79 47.87 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 108.677 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.504 HD21 ' CG2' ' A' ' 17' ' ' VAL . 1.5 mt -48.31 -23.6 0.96 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.945 -1.097 . . . . 0.0 108.709 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.465 ' HB2' ' HA ' ' A' ' 86' ' ' CYS . 13.2 ttp -73.07 -46.84 49.3 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.416 ' O ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -54.14 -59.61 4.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.363 -0.835 . . . . 0.0 109.004 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.432 ' C ' ' OD1' ' A' ' 30' ' ' ASN . . . -53.22 -46.48 69.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 108.945 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.467 ' HB2' ' N ' ' A' ' 33' ' ' TYR . . . -45.37 -37.39 4.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.865 . . . . 0.0 109.885 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.528 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 58.7 t -43.57 -50.12 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.098 -1.001 . . . . 0.0 109.858 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 31' ' ' GLY . 6.1 t -87.02 -51.33 6.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.303 -0.873 . . . . 0.0 109.591 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.559 ' HB2' HG13 ' A' ' 32' ' ' ILE . 4.8 m120 -40.31 -25.86 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.462 0.649 . . . . 0.0 109.731 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 95.24 -5.17 67.9 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.559 HG13 ' HB2' ' A' ' 30' ' ' ASN . 0.8 OUTLIER -79.61 -28.35 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.056 -1.261 . . . . 0.0 107.962 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -48.7 -31.45 6.85 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.046 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.619 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 13.1 t0 -93.08 -25.38 17.94 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.663 -0.648 . . . . 0.0 109.295 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.525 ' CG2' HG23 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -60.11 -31.83 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.0 109.194 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 35' ' ' ILE . 3.4 m -163.75 -171.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.404 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.08 166.05 12.06 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.464 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 12.3 t70 -154.16 -92.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -1.146 . . . . 0.0 109.716 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 40' ' ' GLY . 14.6 p -81.87 -9.87 59.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 109.625 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.76 77.15 0.1 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 87' ' ' GLN . . . 171.28 -157.17 27.65 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.2 p -60.83 171.83 1.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -1.137 . . . . 0.0 109.486 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.553 ' CB ' ' CG ' ' A' ' 67' ' ' GLU . . . -61.93 99.59 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.89 . . . . 0.0 109.41 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.81 5.84 2.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 0.0 109.636 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 13.2 p -144.33 -152.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 0.0 109.615 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.522 ' HB3' ' CG1' ' A' ' 74' ' ' VAL . . . -156.09 19.2 0.37 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.634 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -90.4 -28.78 18.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.583 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.464 ' O ' ' N ' ' A' ' 50' ' ' VAL . 22.0 p -86.5 42.3 1.0 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.953 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.733 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 68.1 t60 -58.71 79.95 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.591 ' CG1' ' CB ' ' A' ' 85' ' ' CYS . 7.6 m -90.59 146.71 5.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.055 -1.653 . . . . 0.0 111.987 -177.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.733 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 4.1 m-30 -112.63 113.09 25.05 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 6.4 t -101.45 171.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.877 0.846 . . . . 0.0 112.209 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.23 155.36 39.63 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -81.43 11.63 4.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.148 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.48 -28.89 8.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.95 -1.094 . . . . 0.0 110.121 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.637 ' CD2' ' CB ' ' A' ' 97' ' ' ILE . 43.0 m-85 -100.14 -19.34 16.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.08 -1.012 . . . . 0.0 109.695 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.534 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -61.55 -22.71 65.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.205 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -85.71 -25.69 26.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.891 . . . . 0.0 109.475 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.533 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 13.6 mmtm -76.83 -10.54 59.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 0.0 109.443 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.547 ' CG1' ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -95.68 170.39 7.79 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.276 -0.89 . . . . 0.0 108.785 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.547 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 5.7 Cg_exo -59.43 167.84 5.83 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.03 1.82 . . . . 0.0 110.394 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.18 59.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.865 . . . . 0.0 109.375 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -41.6 121.64 1.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.593 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.497 ' O ' ' CD1' ' A' ' 68' ' ' ILE . 7.0 m-80 -57.54 -158.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.545 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 14.8 tp10 -84.11 -10.06 58.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.537 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -58.24 -54.31 48.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.456 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.553 ' CG ' ' CB ' ' A' ' 43' ' ' ALA . 2.4 mp0 -67.64 -8.21 32.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.529 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.578 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.5 mp -88.66 -34.09 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.373 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.43 -59.01 3.75 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.451 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -67.89 -26.61 66.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -1.151 . . . . 0.0 109.299 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.458 HD23 HD12 ' A' ' 84' ' ' LEU . 19.8 tp -90.83 7.24 40.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.893 . . . . 0.0 109.408 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -99.23 -24.22 14.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 109.393 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.86 31.75 0.94 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.439 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.522 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 3.6 m -75.9 170.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.384 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.589 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 16.3 m -75.9 -17.79 59.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.97 . . . . 0.0 109.328 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.62 -161.28 0.77 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.273 -0.892 . . . . 0.0 110.027 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.564 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.7 OUTLIER -111.65 151.63 28.61 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.599 ' HG ' ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -104.2 173.09 6.45 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.98 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.572 ' HE3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -158.27 170.13 9.45 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.513 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 2.6 Cg_endo -58.95 -12.51 15.43 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.284 1.989 . . . . 0.0 110.155 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.23 -22.09 16.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.22 -0.925 . . . . 0.0 110.84 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.599 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -75.42 153.32 37.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.004 -1.06 . . . . 0.0 110.649 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.512 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -161.31 -159.43 0.64 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.444 -0.785 . . . . 0.0 109.356 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 3.1 mm? -109.61 79.34 1.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.337 -0.852 . . . . 0.0 108.73 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.591 ' CB ' ' CG1' ' A' ' 50' ' ' VAL . 43.2 t -45.38 -22.5 0.14 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.39 -0.819 . . . . 0.0 110.846 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 24' ' ' MET . 28.6 p -75.73 -40.88 54.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.897 -1.127 . . . . 0.0 110.914 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.545 ' CG ' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -96.14 11.64 33.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.852 -1.155 . . . . 0.0 111.193 -178.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.539 ' CG1' ' HA ' ' A' ' 85' ' ' CYS . 4.4 mm -79.5 160.25 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.683 -1.26 . . . . 0.0 108.811 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.511 HG21 ' N ' ' A' ' 90' ' ' MET . 16.9 mm -123.72 155.69 30.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.838 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.543 ' CG ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -116.27 88.08 2.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.471 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.69 165.07 34.56 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 121.415 -0.803 . . . . 0.0 109.315 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.36 -12.9 22.1 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.18 1.92 . . . . 0.0 110.227 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -72.42 -51.05 22.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.533 ' CD2' ' HB2' ' A' ' 59' ' ' LYS . 1.6 mp -73.16 141.81 47.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.533 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -143.48 119.0 10.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 109.744 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.587 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 71.61 47.02 36.21 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.637 ' CB ' ' CD2' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -74.61 156.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.209 -1.171 . . . . 0.0 108.74 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.511 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 3.6 t -124.37 106.17 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.047 -1.033 . . . . 0.0 109.939 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -101.73 159.78 4.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.473 ' OD1' HG22 ' A' ' 6' ' ' VAL . 1.6 m-20 -139.33 170.03 16.69 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.236 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.558 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 0.7 OUTLIER -105.09 157.97 33.11 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.512 178.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.638 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 6.3 Cg_exo -55.86 -167.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.546 2.164 . . . . 0.0 111.585 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 13.4 t0 -106.87 -22.84 12.56 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.529 ' HG3' ' CG2' ' A' ' 75' ' ' THR . 0.0 OUTLIER -131.31 127.95 38.74 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.57 20.03 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.968 -1.083 . . . . 0.0 110.036 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.589 ' CE2' ' OG1' ' A' ' 75' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.013 . . . . 0.0 109.467 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.471 0.653 . . . . 0.0 109.579 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.419 ' O ' HG21 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -145.63 153.43 41.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.001 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.546 ' CG1' HD23 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -149.13 122.95 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.125 -0.984 . . . . 0.0 109.802 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.452 ' O ' HG21 ' A' ' 99' ' ' VAL . 16.6 t -124.06 132.11 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.589 ' CE1' HD23 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -100.04 154.99 17.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.953 -1.092 . . . . 0.0 109.605 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.524 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 11.6 t -121.79 167.78 14.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.483 -0.761 . . . . 0.0 109.011 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.541 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 42.0 t -124.3 161.75 25.2 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.503 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.51 -7.36 9.89 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.85 -1.156 . . . . 0.0 109.149 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -110.3 -4.09 15.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.014 -1.054 . . . . 0.0 110.606 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 12' ' ' ARG . . . 110.3 -19.03 27.46 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.303 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.2 m -59.87 111.88 1.64 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.908 -1.348 . . . . 0.0 109.252 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.513 ' CG ' HG11 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -125.58 121.93 35.04 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.515 -0.741 . . . . 0.0 110.268 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.575 ' NH1' ' CD1' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -102.53 126.36 49.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -88.78 157.17 18.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.099 -1.001 . . . . 0.0 110.654 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.589 HD23 ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -166.81 -176.85 3.62 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.707 0.765 . . . . 0.0 109.322 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.25 116.07 17.86 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.415 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.517 ' CG1' ' HB3' ' A' ' 90' ' ' MET . 49.2 t -93.29 106.36 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -47.07 174.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.586 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 92' ' ' PRO . 65.8 m-20 -83.51 126.26 32.61 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.317 -0.865 . . . . 0.0 109.18 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.84 21.77 20.11 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.468 ' O ' HD11 ' A' ' 89' ' ' ILE . 1.5 t -125.01 164.65 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -1.177 . . . . 0.0 109.294 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 33.0 t -109.33 143.89 38.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 108.986 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.546 HD23 ' CG1' ' A' ' 3' ' ' VAL . 16.0 mt -44.61 -34.63 2.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.152 -0.968 . . . . 0.0 108.878 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -48.59 76.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.047 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.46 ' O ' HG11 ' A' ' 28' ' ' VAL . 3.3 mt-30 -52.73 -55.73 20.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.01 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.16 -21.69 66.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.199 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.52 ' HB2' ' CB ' ' A' ' 33' ' ' TYR . . . -76.42 -24.37 54.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.561 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 25' ' ' GLN . 5.4 p -59.93 -33.75 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.167 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 t -91.79 -52.7 4.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 109.075 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 21.0 m-80 -55.04 -17.6 4.13 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.506 -0.746 . . . . 0.0 109.22 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.36 24.64 56.43 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.533 ' HA ' ' CG1' ' A' ' 35' ' ' ILE . 1.1 mt -102.9 -27.26 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.128 -1.219 . . . . 0.0 108.738 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.52 ' CB ' ' HB2' ' A' ' 27' ' ' ALA . 0.7 OUTLIER -50.5 -40.44 51.23 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.478 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 45.1 t0 -73.3 -32.91 64.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.575 ' CD1' ' NH1' ' A' ' 13' ' ' ARG . 1.0 OUTLIER -98.42 14.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.942 -1.098 . . . . 0.0 109.448 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 35' ' ' ILE . 94.6 t -160.29 69.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.435 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 48' ' ' CYS . . . 154.41 -171.93 32.92 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.482 ' CG ' ' CG2' ' A' ' 47' ' ' THR . 0.3 OUTLIER -165.42 -79.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.172 . . . . 0.0 109.639 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.499 ' SG ' ' N ' ' A' ' 40' ' ' GLY . 16.4 p -61.97 -40.32 95.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.562 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.499 ' N ' ' SG ' ' A' ' 39' ' ' CYS . . . 64.11 138.83 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.73 -102.68 0.86 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.452 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.4 OUTLIER -60.43 99.71 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -1.179 . . . . 0.0 109.437 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.54 109.71 1.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.505 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.3 m -152.45 17.13 0.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.654 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 12.9 p -121.26 -149.55 0.43 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.534 ' CB ' ' N ' ' A' ' 74' ' ' VAL . . . -156.13 18.71 0.36 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.033 -1.042 . . . . 0.0 109.997 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.482 ' CG2' ' CG ' ' A' ' 38' ' ' ASP . 1.7 p -90.11 -20.73 22.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.144 -0.973 . . . . 0.0 109.728 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.524 ' HB2' ' CB ' ' A' ' 85' ' ' CYS . 22.2 p -87.69 41.9 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.068 -1.02 . . . . 0.0 110.05 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.637 ' CD2' ' CD1' ' A' ' 78' ' ' LEU . 37.2 t-80 -81.9 61.94 5.46 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 82' ' ' SER . 12.5 m -77.35 148.09 6.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 120.588 -1.32 . . . . 0.0 110.612 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.514 ' CE2' ' CE1' ' A' ' 49' ' ' HIS . 7.0 m-85 -107.59 110.87 22.87 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.546 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 8.4 t -93.91 170.39 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 121.928 0.871 . . . . 0.0 112.251 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.426 ' ND2' HG22 ' A' ' 98' ' ' VAL . 1.3 m-20 -69.16 165.3 20.7 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.17 9.3 26.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 109.869 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.32 -28.55 8.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.157 -0.964 . . . . 0.0 109.964 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.629 ' CD1' ' HA ' ' A' ' 97' ' ' ILE . 93.7 m-85 -97.91 -19.39 18.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 109.64 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.546 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -63.82 -23.06 67.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.4 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.03 -35.73 25.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.681 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 2.7 mmtm -63.74 -12.94 39.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.38 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.535 ' CG1' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -97.94 161.75 24.56 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.268 -0.895 . . . . 0.0 108.969 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.535 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 5.0 Cg_exo -59.43 164.49 10.89 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.124 1.882 . . . . 0.0 110.371 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.19 59.35 0.61 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 109.428 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -41.98 130.19 3.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.548 -0.72 . . . . 0.0 109.593 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' ALA . 8.5 m-20 -57.08 -160.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.542 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.525 ' HA ' ' CD1' ' A' ' 68' ' ' ILE . 57.0 tt0 -99.25 -10.39 22.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.466 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' NE ' ' OE2' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -47.13 -72.28 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.599 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -61.04 -20.06 62.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 65' ' ' GLU . 13.6 mt -66.13 -31.93 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.69 -59.51 3.7 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.45 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -68.44 -28.1 66.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -1.116 . . . . 0.0 109.056 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.525 ' CD2' ' HG ' ' A' ' 84' ' ' LEU . 1.3 tp -85.5 4.49 35.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.324 -0.86 . . . . 0.0 109.167 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 68' ' ' ILE . 3.2 tm-20 -95.84 -12.53 25.1 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.081 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.465 ' O ' ' C ' ' A' ' 74' ' ' VAL . 1.3 m -59.92 -14.69 16.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.673 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.631 ' CG2' ' CD2' ' A' ' 49' ' ' HIS . 3.9 m -34.41 134.11 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.364 0.602 . . . . 0.0 109.941 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.542 ' HB ' ' CG ' ' A' ' 104' ' ' ARG . 88.4 m -44.69 -25.5 0.29 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 108.761 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' O ' ' CG2' ' A' ' 74' ' ' VAL . . . -110.1 -152.6 0.5 Allowed 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.373 -0.83 . . . . 0.0 109.834 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.634 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -114.74 148.59 38.11 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.637 ' CD1' ' CD2' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -104.15 130.05 51.89 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 117.406 -1.718 . . . . 0.0 111.288 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.518 ' HE2' ' CD ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -108.63 166.52 10.69 Favored Pre-proline 0 C--N 1.295 -1.801 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.518 ' CD ' ' HE2' ' A' ' 79' ' ' LYS . 3.4 Cg_exo -52.37 -27.85 32.86 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.733 1.622 . . . . 0.0 109.582 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -42.04 85.07 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.677 -0.639 . . . . 0.0 109.449 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -83.18 168.27 16.96 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.435 -0.791 . . . . 0.0 109.671 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.529 ' HB3' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -161.57 -177.27 5.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.086 -1.009 . . . . 0.0 109.687 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.525 ' HG ' ' CD2' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -83.93 114.22 21.53 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.332 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.524 ' CB ' ' HB2' ' A' ' 48' ' ' CYS . 9.4 t -59.66 -14.87 15.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 0.0 109.12 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.3 p -108.54 30.21 6.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 109.76 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.516 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -152.92 13.72 0.52 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.986 -1.071 . . . . 0.0 110.377 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -112.39 150.2 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.923 -1.111 . . . . 0.0 108.938 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.468 HD11 ' O ' ' A' ' 21' ' ' VAL . 38.2 mm -129.45 142.27 44.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.315 -0.866 . . . . 0.0 109.881 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.56 ' CE ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -97.95 82.15 2.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 108.936 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.57 165.85 41.58 Favored Pre-proline 0 C--N 1.294 -1.805 0 O-C-N 121.606 -0.684 . . . . 0.0 109.174 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 5.8 Cg_exo -59.25 -13.8 21.54 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.067 1.845 . . . . 0.0 110.103 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -76.96 -42.39 39.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -80.07 160.01 25.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.52 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -173.98 125.24 0.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.613 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 75.34 40.34 33.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.629 ' HA ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -79.83 149.11 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -1.082 . . . . 0.0 109.165 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.426 HG22 ' ND2' ' A' ' 53' ' ' ASN . 2.3 t -113.73 108.54 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.227 -0.92 . . . . 0.0 109.759 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.526 HG23 ' CD1' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -99.71 153.18 4.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -129.93 179.34 5.92 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.049 -1.032 . . . . 0.0 109.939 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.573 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 25.4 t -109.01 146.59 34.16 Favored Pre-proline 0 C--N 1.296 -1.757 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.544 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.573 ' HD2' ' CG1' ' A' ' 101' ' ' VAL . 12.1 Cg_exo -53.72 137.8 67.38 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.223 1.949 . . . . 0.0 109.762 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.555 ' CB ' ' HD2' ' A' ' 104' ' ' ARG . 1.3 m-20 -47.14 -26.28 1.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.884 -1.135 . . . . 0.0 108.417 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -117.4 -167.34 1.3 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.18 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 106' ' ' TRP . 11.8 pt20 -160.07 27.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.056 . . . . 0.0 109.75 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.504 ' NE1' ' N ' ' A' ' 75' ' ' THR . 41.4 m95 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.67 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.46 ' O ' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -147.88 161.99 40.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 109.355 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.535 ' CG1' HD23 ' A' ' 23' ' ' LEU . 1.5 t -147.04 132.04 11.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.304 -0.873 . . . . 0.0 109.301 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 13' ' ' ARG . 72.2 t -129.32 127.7 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.649 ' CE2' ' CD2' ' A' ' 15' ' ' LEU . 44.5 m-85 -97.57 153.72 17.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.818 -1.176 . . . . 0.0 110.263 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.522 HG23 ' CD ' ' A' ' 12' ' ' ARG . 2.6 t -132.46 141.77 44.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -76.77 -156.78 0.08 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.258 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -58.18 -105.93 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -112.07 77.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.477 -1.389 . . . . 0.0 108.887 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.05 -100.39 0.19 Allowed Glycine 0 N--CA 1.493 2.439 0 C-N-CA 118.931 -1.605 . . . . 0.0 111.027 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.469 ' O ' HG11 ' A' ' 6' ' ' VAL . 1.3 m -119.56 -177.27 3.34 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.333 -1.098 . . . . 0.0 110.061 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 12.8 ptt180 -153.0 147.79 26.33 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.523 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 8.0 mtt180 -106.25 173.47 6.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 108.522 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.451 ' C ' HD21 ' A' ' 15' ' ' LEU . 4.0 pt20 -123.76 163.76 20.53 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.004 -1.06 . . . . 0.0 110.567 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.649 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -169.71 -175.32 2.08 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -131.9 91.33 2.96 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.063 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.528 ' CG1' ' HB3' ' A' ' 90' ' ' MET . 46.9 t -62.2 153.38 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 108.872 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.528 ' CB ' HG23 ' A' ' 21' ' ' VAL . . . -91.03 172.37 8.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.0 . . . . 0.0 109.496 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -78.19 125.25 29.07 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.323 -0.861 . . . . 0.0 109.029 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.79 26.89 28.15 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.528 HG23 ' CB ' ' A' ' 18' ' ' ALA . 2.1 t -120.89 163.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -1.15 . . . . 0.0 109.172 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.5 t -106.07 140.72 38.62 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 108.534 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.535 HD23 ' CG1' ' A' ' 3' ' ' VAL . 12.1 mt -46.38 -26.08 0.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.099 -1.001 . . . . 0.0 108.623 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.0 ttt -71.71 -47.96 50.44 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.523 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 3.2 tp-100 -51.34 -55.5 18.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 108.836 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.403 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -54.1 -31.38 51.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.904 . . . . 0.0 108.903 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.504 ' HA ' HG12 ' A' ' 32' ' ' ILE . . . -61.19 -39.51 90.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.344 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.537 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 49.0 t -46.16 -22.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.857 . . . . 0.0 110.446 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 t -110.64 -50.29 2.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.019 -1.051 . . . . 0.0 110.325 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.515 ' ND2' HD12 ' A' ' 15' ' ' LEU . 56.1 m-80 -59.56 -11.64 5.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 110.123 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.412 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 98.88 -31.49 8.13 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.585 HG13 ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -51.53 -21.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.215 -1.168 . . . . 0.0 109.178 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.626 ' CG ' ' N ' ' A' ' 34' ' ' ASP . 1.2 p90 -43.16 -47.89 6.32 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.626 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 1.2 t0 -87.12 -21.2 26.14 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.496 ' CG1' ' HA ' ' A' ' 32' ' ' ILE . 4.5 mm -85.71 5.72 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.936 -1.102 . . . . 0.0 109.437 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.458 ' CG2' ' SG ' ' A' ' 85' ' ' CYS . 10.0 p -170.52 171.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.24 173.83 39.82 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.552 ' CB ' ' CG2' ' A' ' 47' ' ' THR . 6.9 t0 -169.96 -89.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -1.107 . . . . 0.0 109.542 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 44' ' ' SER . 17.7 p -65.05 -22.78 67.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.155 -0.966 . . . . 0.0 109.525 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.6 -177.18 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.55 -109.84 3.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.0 -177.16 3.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -1.152 . . . . 0.0 109.449 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . . . -61.81 110.11 1.44 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.431 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -134.98 8.36 3.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.45 ' SG ' HG21 ' A' ' 47' ' ' THR . 9.0 p -165.46 -160.51 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.659 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB2' HG13 ' A' ' 74' ' ' VAL . . . -145.52 13.36 1.37 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.502 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.552 ' CG2' ' CB ' ' A' ' 38' ' ' ASP . 8.8 t -78.51 -18.75 54.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.585 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.493 ' HB2' ' CB ' ' A' ' 85' ' ' CYS . 21.8 p -87.54 41.9 1.01 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 0.0 109.948 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.644 ' CE1' ' O ' ' A' ' 77' ' ' GLU . 14.6 t60 -70.54 76.13 0.57 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.526 HG12 ' CB ' ' A' ' 85' ' ' CYS . 8.4 m -80.02 144.74 10.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 120.214 -1.554 . . . . 0.0 110.673 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.506 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 2.0 m-85 -110.98 102.72 11.18 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.521 ' CG2' HG11 ' A' ' 99' ' ' VAL . 7.0 t -101.13 156.32 4.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.85 0.834 . . . . 0.0 112.859 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.557 ' OD1' ' HB ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -46.22 177.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.468 0.651 . . . . 0.0 109.267 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.479 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -101.68 -0.28 34.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 110.115 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.57 -22.81 11.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.97 -1.081 . . . . 0.0 110.649 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.609 ' CD1' ' HB ' ' A' ' 97' ' ' ILE . 65.8 m-85 -91.71 -27.08 18.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.988 -1.07 . . . . 0.0 109.747 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.51 HG22 ' ND2' ' A' ' 81' ' ' ASN . 5.8 p -58.07 -38.13 75.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.18 -0.95 . . . . 0.0 109.475 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 1.2 m-20 -57.46 -64.61 0.83 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.777 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.527 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 46.2 mmtt -49.81 -37.96 32.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.912 . . . . 0.0 109.396 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.524 ' CG2' HG23 ' A' ' 88' ' ' ILE . 1.1 t -54.91 157.37 5.71 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.951 . . . . 0.0 108.754 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.523 ' N ' HG11 ' A' ' 60' ' ' VAL . 5.6 Cg_exo -56.13 156.83 19.08 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.087 1.858 . . . . 0.0 110.309 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.52 61.13 0.6 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.325 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.511 ' HB1' ' NH2' ' A' ' 83' ' ' ARG . . . -40.83 146.46 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.626 -0.671 . . . . 0.0 109.689 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -51.59 -174.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.679 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.462 ' HA ' HD11 ' A' ' 68' ' ' ILE . 58.0 tt0 -96.71 -9.81 28.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.86 . . . . 0.0 109.543 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -50.3 -49.12 54.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.927 . . . . 0.0 109.516 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 28.0 mt-10 -74.59 -21.35 59.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.435 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.568 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -68.21 -35.32 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.878 . . . . 0.0 109.314 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.59 -52.6 44.24 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -66.84 -24.31 66.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -1.15 . . . . 0.0 109.273 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.518 ' HA ' ' CG1' ' A' ' 74' ' ' VAL . 5.7 tp -88.24 -7.29 57.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.378 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -80.09 -37.64 33.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.334 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.413 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 42.6 t -104.2 38.61 1.82 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.393 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.518 ' CG1' ' HA ' ' A' ' 71' ' ' LEU . 16.4 m -63.17 174.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.85 . . . . 0.0 109.597 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 98.3 m -65.28 -9.37 23.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.747 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HA ' ' CZ ' ' A' ' 104' ' ' ARG . . . -116.5 -149.92 0.45 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 109.511 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.644 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.2 pt-20 -111.52 155.24 23.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.635 ' CD1' ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -129.8 135.66 48.68 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 117.991 -1.483 . . . . 0.0 111.454 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -117.83 171.02 5.45 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 4.4 Cg_exo -57.52 -10.6 7.13 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 C-N-CA 122.394 2.063 . . . . 0.0 111.09 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.51 ' ND2' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -104.78 16.57 25.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 0.0 111.499 -178.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.602 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.4 m -100.26 161.09 13.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.675 -1.266 . . . . 0.0 110.029 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.514 ' NH1' ' O ' ' A' ' 61' ' ' PRO . 1.5 mtp180 -161.62 -165.11 1.22 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 109.287 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.53 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 1.7 mp -104.95 131.09 52.89 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.314 -0.866 . . . . 0.0 108.887 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.526 ' CB ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -67.13 -10.41 49.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.399 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.1 p -110.35 15.26 22.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.797 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -131.95 -0.55 3.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.007 . . . . 0.0 109.925 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.53 ' CG1' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -97.9 147.14 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.03 -1.044 . . . . 0.0 108.97 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 90' ' ' MET . 10.7 mm -121.3 165.68 16.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.293 -0.88 . . . . 0.0 109.775 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.534 ' HG3' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -122.97 90.33 3.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.352 -0.842 . . . . 0.0 109.341 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.01 162.48 40.78 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.417 -0.802 . . . . 0.0 109.303 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.0 -13.99 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.151 1.901 . . . . 0.0 110.233 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' A' ' 94' ' ' LEU . 21.6 pt-20 -70.92 -45.92 63.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.43 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -78.46 144.4 35.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -146.41 122.03 10.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 75.22 39.53 36.5 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.609 ' HB ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -78.11 134.66 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.441 -1.035 . . . . 0.0 109.197 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.557 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 2.0 t -107.23 110.12 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.976 -1.078 . . . . 0.0 110.012 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.525 HG12 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -100.82 146.57 9.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.487 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 1.6 m-20 -122.15 174.25 7.07 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.968 -1.083 . . . . 0.0 110.256 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.616 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 39.7 t -108.01 145.21 30.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.633 ' HG3' ' HB3' ' A' ' 49' ' ' HIS . 7.2 Cg_exo -50.95 159.82 2.26 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.492 2.128 . . . . 0.0 111.548 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -14.7 60.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.596 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.522 ' CZ ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -119.87 -159.51 0.78 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 106' ' ' TRP . 3.8 pt20 -159.87 27.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.025 -1.047 . . . . 0.0 109.78 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.576 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 5.9 m95 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.658 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -147.48 168.39 22.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -0.863 . . . . 0.0 109.253 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.525 HG13 ' CD2' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -153.54 129.95 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.295 -0.878 . . . . 0.0 109.677 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 13' ' ' ARG . 77.7 t -130.17 135.42 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 108.651 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.635 ' CE1' ' CD2' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -104.0 155.14 18.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.922 -1.111 . . . . 0.0 109.393 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 101' ' ' VAL . 2.4 t -135.25 133.02 52.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.536 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -80.0 -174.27 4.36 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -50.02 161.48 0.26 Allowed 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.528 ' C ' ' O ' ' A' ' 8' ' ' HIS . 33.9 t0 -29.86 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.147 0.499 . . . . 0.0 110.72 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 8' ' ' HIS . . . -167.45 -95.51 0.1 Allowed Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.484 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.459 ' O ' HG11 ' A' ' 6' ' ' VAL . 1.6 m -124.97 -178.53 4.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -1.186 . . . . 0.0 109.77 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -157.15 142.64 17.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.625 -0.672 . . . . 0.0 110.032 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.525 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -100.33 176.2 5.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.255 -0.903 . . . . 0.0 108.899 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -132.43 160.83 35.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.126 -0.984 . . . . 0.0 110.52 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.635 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -177.14 -176.04 0.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.579 0.704 . . . . 0.0 109.115 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -128.94 113.88 15.76 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.581 -0.699 . . . . 0.0 109.965 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.525 HG21 ' CB ' ' A' ' 26' ' ' ALA . 28.6 t -78.12 133.37 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.046 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.527 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -69.76 171.81 8.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.498 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -78.44 125.25 29.09 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.269 -0.895 . . . . 0.0 109.084 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.16 39.59 7.86 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.527 HG22 ' CB ' ' A' ' 18' ' ' ALA . 1.5 t -131.11 160.69 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -1.117 . . . . 0.0 109.327 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -99.35 135.07 41.29 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 108.65 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.525 ' CD2' HG13 ' A' ' 3' ' ' VAL . 6.6 mt -46.28 -26.24 0.77 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.965 -1.085 . . . . 0.0 108.6 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.401 ' HE1' ' HB2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -72.74 -47.45 46.86 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.6 tp60 -51.97 -55.08 22.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.36 -0.837 . . . . 0.0 108.845 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.525 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -57.67 -28.5 63.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 108.737 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.525 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -68.09 -33.89 75.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.47 -0.769 . . . . 0.0 109.451 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.575 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 53.7 t -54.58 -39.89 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.475 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 t -79.87 -51.78 8.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.858 . . . . 0.0 109.398 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.46 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 29.4 m-80 -58.57 -13.41 5.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.424 -0.798 . . . . 0.0 109.567 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.47 14.54 78.18 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.537 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 1.2 mt -90.41 -34.65 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -1.146 . . . . 0.0 108.851 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -51.48 -37.06 47.12 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.624 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 5.3 t0 -82.83 -26.94 31.21 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.537 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 4.8 tp -44.48 -26.13 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 109.325 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.504 ' N ' HG21 ' A' ' 35' ' ' ILE . 2.5 p -131.17 -52.15 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.563 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 38' ' ' ASP . . . 69.2 120.12 0.03 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 94.9 m-20 -136.4 -120.36 0.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -1.171 . . . . 0.0 109.53 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.522 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 16.7 p -109.79 -6.48 15.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.75 -1.219 . . . . 0.0 109.594 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 44.62 -168.51 0.02 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 43.89 -125.95 5.69 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.12 63.86 1.46 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -1.121 . . . . 0.0 109.543 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 39' ' ' CYS . . . -88.8 -147.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 109.431 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.516 ' CB ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -139.78 60.86 1.55 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.152 -0.968 . . . . 0.0 109.773 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 38' ' ' ASP . 6.7 p -99.22 -164.57 1.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.033 -1.042 . . . . 0.0 109.379 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.519 ' O ' ' CG1' ' A' ' 74' ' ' VAL . . . -148.92 17.74 0.98 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.525 ' CG2' ' OD1' ' A' ' 38' ' ' ASP . 58.5 m -90.02 -17.19 28.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 84' ' ' LEU . 24.5 p -87.6 42.51 1.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 110.269 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.664 ' NE2' ' CE2' ' A' ' 51' ' ' TYR . 15.3 t60 -75.56 71.19 2.46 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 85' ' ' CYS . 12.7 m -77.88 146.1 8.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.257 -1.527 . . . . 0.0 110.168 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.664 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -112.53 100.71 8.95 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.309 1.052 . . . . 0.0 108.182 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.541 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 4.5 t -89.76 172.88 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.803 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.86 -178.36 1.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.88 -1.21 35.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 109.967 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.14 -14.38 14.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.085 -1.01 . . . . 0.0 110.187 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.608 ' CD2' ' HA ' ' A' ' 97' ' ' ILE . 80.3 m-85 -103.67 -21.42 13.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.975 . . . . 0.0 109.7 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.541 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -68.7 -6.47 26.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.563 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -88.08 -56.17 3.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.123 -0.986 . . . . 0.0 109.6 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.527 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 2.5 mptp? -52.29 -38.69 59.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -50.14 164.57 0.37 Allowed Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.17 -0.956 . . . . 0.0 109.414 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 5.8 Cg_exo -58.16 176.66 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.109 1.873 . . . . 0.0 110.353 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.25 59.37 0.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.29 120.73 1.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.483 -0.761 . . . . 0.0 109.553 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 63' ' ' ALA . 9.7 m-20 -57.0 -160.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 0.6 OUTLIER -100.05 -12.1 19.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.467 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.474 ' HD2' ' N ' ' A' ' 67' ' ' GLU . 5.1 ppt_? -54.51 -44.66 72.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.474 ' N ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -81.17 -14.51 57.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.404 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.454 ' HB ' ' HG2' ' A' ' 65' ' ' GLU . 26.0 mm -77.12 -32.17 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.476 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.13 -54.69 11.66 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.516 ' SD ' ' CB ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -67.89 -24.92 65.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -1.155 . . . . 0.0 109.257 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.537 ' CD2' ' CD2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -90.04 0.15 57.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.872 . . . . 0.0 109.43 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -89.99 -25.47 20.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.942 . . . . 0.0 109.299 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.64 34.55 2.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.426 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.525 HG23 ' CD1' ' A' ' 71' ' ' LEU . 2.1 t -63.38 165.01 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.581 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 28.4 m -71.68 -4.25 26.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.477 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.527 ' CB ' ' OD1' ' A' ' 103' ' ' ASP . . . -115.96 -149.8 0.45 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.114 -0.991 . . . . 0.0 109.34 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.63 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.7 pt-20 -112.19 155.06 24.59 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.632 ' CD1' ' CE1' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -133.49 166.34 22.78 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.465 -1.694 . . . . 0.0 112.547 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.518 ' HE2' ' CB ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -155.7 170.62 8.46 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 5.3 Cg_exo -56.45 -14.68 13.27 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 121.997 1.798 . . . . 0.0 109.992 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.518 ' CB ' ' HE2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -87.03 -30.33 21.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 0.0 110.71 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.598 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -74.62 152.87 39.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.021 -1.049 . . . . 0.0 110.354 -179.374 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.567 ' NH2' ' CG2' ' A' ' 88' ' ' ILE . 8.8 mtp180 -161.8 -175.38 4.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.545 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 4.9 mp -98.99 103.43 15.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.324 -0.86 . . . . 0.0 108.698 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.536 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 6.1 p -48.85 -21.99 0.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.142 -0.974 . . . . 0.0 109.924 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 20.7 p -76.57 -40.11 50.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.084 -1.01 . . . . 0.0 110.093 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.484 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -89.74 38.44 0.91 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.112 -0.992 . . . . 0.0 110.405 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.567 ' CG2' ' NH2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -140.06 149.01 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.975 -1.078 . . . . 0.0 109.312 179.294 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 90' ' ' MET . 12.7 mm -116.23 167.09 9.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.421 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.541 ' CE ' HG23 ' A' ' 97' ' ' ILE . 12.9 tpt -130.18 96.87 4.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.525 ' CG2' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -95.53 171.45 6.44 Favored Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 121.549 -0.72 . . . . 0.0 109.385 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.525 ' HD2' ' CG2' ' A' ' 91' ' ' THR . 5.6 Cg_exo -59.03 -14.49 23.42 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.05 1.833 . . . . 0.0 110.054 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.45 ' OE1' ' HB3' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -62.8 -37.23 85.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 109.312 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -95.07 139.75 30.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.234 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 11.2 p-10 -138.72 124.68 19.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.803 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.469 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 71.51 39.22 61.37 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.608 ' HA ' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -72.91 147.66 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -1.107 . . . . 0.0 109.302 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.432 ' C ' HD12 ' A' ' 97' ' ' ILE . 3.5 t -116.75 106.73 20.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 O-C-N 121.126 -0.983 . . . . 0.0 109.853 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.525 HG11 ' CD1' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -101.25 142.71 15.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.499 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 3.1 m-20 -122.97 177.44 5.5 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.967 -1.083 . . . . 0.0 110.269 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.626 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 44.8 t -108.49 145.07 30.8 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.638 ' HG3' ' HB3' ' A' ' 49' ' ' HIS . 7.7 Cg_exo -51.14 -174.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.263 1.975 . . . . 0.0 111.293 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -100.7 -27.03 13.59 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -130.07 149.7 51.67 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -122.93 41.94 3.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.044 -1.035 . . . . 0.0 109.849 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.581 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 43.6 m95 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.476 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.47 ' O ' ' HE1' ' A' ' 90' ' ' MET . 0.1 OUTLIER -138.29 169.51 17.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.215 -0.928 . . . . 0.0 109.428 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.534 ' CG1' HD23 ' A' ' 23' ' ' LEU . 11.3 t -152.34 158.64 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.272 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.532 ' CG1' ' HD2' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -157.8 120.67 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.104 -0.998 . . . . 0.0 108.905 -179.409 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.654 ' CE2' ' CD2' ' A' ' 15' ' ' LEU . 54.9 m-85 -98.5 155.62 17.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.66 -1.275 . . . . 0.0 110.634 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.474 ' CG2' ' HG3' ' A' ' 12' ' ' ARG . 3.0 t -130.84 142.48 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -76.5 -158.53 0.1 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 103' ' ' ASP . 0.3 OUTLIER -58.31 -103.97 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.18 75.15 0.9 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.482 -1.386 . . . . 0.0 108.496 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.29 -100.42 0.24 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 118.863 -1.636 . . . . 0.0 111.453 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.46 ' O ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -114.9 -176.59 2.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.289 -1.124 . . . . 0.0 110.584 -178.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.535 ' CG ' ' O ' ' A' ' 5' ' ' TYR . 13.7 ttp180 -149.27 134.59 18.35 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.522 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 6.6 mtt180 -105.11 171.51 7.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.941 -1.1 . . . . 0.0 108.774 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.469 ' HA ' HG11 ' A' ' 4' ' ' VAL . 1.7 mt-30 -127.08 163.47 23.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.949 -1.094 . . . . 0.0 111.141 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.654 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -161.65 -172.96 3.53 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.671 0.748 . . . . 0.0 109.019 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 17' ' ' VAL . 46.4 t0 -131.22 69.96 1.47 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.627 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.525 HG12 ' CB ' ' A' ' 90' ' ' MET . 26.6 t -43.81 163.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.185 -0.947 . . . . 0.0 109.068 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.511 ' CB ' HG23 ' A' ' 21' ' ' VAL . . . -105.07 173.1 6.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.959 . . . . 0.0 109.744 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -81.99 125.81 31.22 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.371 -0.831 . . . . 0.0 108.898 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.11 23.3 38.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.523 ' CG1' ' HB3' ' A' ' 25' ' ' GLN . 3.0 t -118.04 167.34 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.43 -1.041 . . . . 0.0 109.113 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 23' ' ' LEU . 10.4 t -105.89 137.45 43.75 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.574 HD21 ' CE1' ' A' ' 5' ' ' TYR . 8.3 mt -44.9 -26.69 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.051 . . . . 0.0 108.794 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 3.3 ttm -75.03 -47.53 28.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.523 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -49.8 -54.77 17.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 108.803 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.524 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -52.24 -35.81 50.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.263 -0.898 . . . . 0.0 108.971 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.518 ' HA ' HG12 ' A' ' 32' ' ' ILE . . . -42.15 -42.38 2.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.849 . . . . 0.0 110.076 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.558 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 63.6 t -39.65 -50.41 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.19 -0.944 . . . . 0.0 110.588 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -90.8 -45.36 8.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.876 . . . . 0.0 110.017 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.537 ' OD1' ' CD1' ' A' ' 15' ' ' LEU . 2.4 m120 -50.13 -17.19 0.38 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.725 -0.609 . . . . 0.0 109.774 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.31 -21.64 36.78 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.623 HG13 ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -66.62 -22.17 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.254 -1.144 . . . . 0.0 108.554 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.558 ' CB ' ' HA ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -48.02 -28.74 2.96 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 179.076 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -100.17 -23.39 14.85 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.536 ' CG1' ' HA ' ' A' ' 32' ' ' ILE . 18.6 mm -60.36 -51.14 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.089 -1.007 . . . . 0.0 109.405 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.442 HG21 ' N ' ' A' ' 37' ' ' GLY . 11.8 m -134.06 -153.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.935 . . . . 0.0 109.538 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.442 ' N ' HG21 ' A' ' 36' ' ' VAL . . . 112.83 150.89 10.99 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.516 ' OD1' ' CB ' ' A' ' 45' ' ' CYS . 6.8 t70 -152.17 -92.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.178 -1.19 . . . . 0.0 109.714 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.513 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 15.6 p -85.27 -33.28 22.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.987 . . . . 0.0 109.603 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 56.57 162.23 0.03 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.01 -103.67 2.26 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.26 169.4 8.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -1.159 . . . . 0.0 109.488 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.58 ' CB ' ' CD2' ' A' ' 71' ' ' LEU . . . -65.5 111.95 3.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.488 ' HB2' ' CB ' ' A' ' 39' ' ' CYS . 44.3 m -140.73 11.3 2.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.652 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.516 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . 8.9 p -157.32 -157.41 0.67 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 109.626 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 73' ' ' CYS . . . -150.0 15.22 0.83 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.687 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.487 HG21 ' CB ' ' A' ' 105' ' ' GLN . 22.0 m -82.05 -18.41 43.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.355 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.464 ' HB2' ' SG ' ' A' ' 85' ' ' CYS . 23.4 p -86.34 43.13 1.04 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 110.112 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.654 ' NE2' ' CE2' ' A' ' 51' ' ' TYR . 48.0 t60 -77.36 65.56 2.94 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 85' ' ' CYS . 8.8 m -74.94 143.33 13.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.284 -1.51 . . . . 0.0 110.449 -177.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.654 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 1.0 OUTLIER -109.46 109.55 20.41 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 7.1 t -97.28 171.42 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-O 122.005 0.907 . . . . 0.0 112.531 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.509 ' O ' ' ND2' ' A' ' 81' ' ' ASN . 0.4 OUTLIER -65.33 176.8 1.26 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.298 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.75 7.72 45.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.151 -0.968 . . . . 0.0 109.626 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.33 -27.96 8.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.883 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.583 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 88.1 m-85 -98.27 -18.54 18.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.739 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.534 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -62.5 -39.01 92.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.611 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.38 -41.18 94.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 109.776 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.564 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -54.41 -42.65 70.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.907 . . . . 0.0 109.579 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.537 ' CG1' ' HD2' ' A' ' 61' ' ' PRO . 62.3 t -62.54 142.38 96.57 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.084 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.537 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 5.7 Cg_exo -56.36 168.8 1.89 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.075 1.85 . . . . 0.0 110.468 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.48 63.51 0.61 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.366 -0.834 . . . . 0.0 109.125 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -36.52 139.66 0.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.275 0.56 . . . . 0.0 110.068 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -50.52 -177.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.347 -0.846 . . . . 0.0 109.804 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.524 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 23.9 tt0 -97.07 -12.77 22.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 109.507 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -50.07 -67.18 0.28 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.456 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -66.09 -10.22 38.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.524 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 26.5 mm -76.38 -31.93 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.521 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.77 -54.91 8.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.3 mtt -68.25 -26.28 65.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -1.15 . . . . 0.0 108.987 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.58 ' CD2' ' CB ' ' A' ' 43' ' ' ALA . 38.3 mt -84.21 -2.96 57.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.35 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.415 ' C ' ' OE1' ' A' ' 72' ' ' GLU . 0.6 OUTLIER -91.13 -10.11 43.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.289 -0.882 . . . . 0.0 109.353 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -86.24 51.37 2.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.418 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.489 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 6.2 m -92.76 169.1 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 109.295 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.602 ' OG1' ' HG3' ' A' ' 104' ' ' ARG . 5.4 t -66.36 -34.56 78.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.797 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.405 ' N ' ' CG2' ' A' ' 75' ' ' THR . . . -106.62 -151.23 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.387 -0.821 . . . . 0.0 110.633 -178.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.558 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -112.51 149.9 32.03 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.559 ' HG ' ' HB2' ' A' ' 82' ' ' SER . 0.3 OUTLIER -108.29 165.44 11.5 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.609 -1.236 . . . . 0.0 110.465 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.53 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -158.97 172.87 5.57 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 6.0 Cg_exo -54.38 -18.77 15.43 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 121.309 1.339 . . . . 0.0 108.803 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -83.18 -35.93 25.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.712 -0.617 . . . . 0.0 109.739 179.532 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.559 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -95.48 159.22 15.1 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.19 -0.944 . . . . 0.0 110.398 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.524 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -161.69 -164.22 1.08 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.343 -0.848 . . . . 0.0 109.03 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.581 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 1.3 mm? -104.19 123.53 47.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.53 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 13.9 p -64.13 -10.75 24.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.014 -1.054 . . . . 0.0 109.553 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 22.6 p -100.21 14.7 29.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.276 -0.89 . . . . 0.0 109.914 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -143.3 0.34 1.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.013 -1.054 . . . . 0.0 110.694 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -96.9 151.69 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.764 -1.21 . . . . 0.0 108.911 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.506 HG21 ' N ' ' A' ' 90' ' ' MET . 18.0 mm -124.23 158.66 30.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.165 -0.959 . . . . 0.0 109.927 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.531 ' HG3' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -120.93 90.33 3.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 109.176 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.4 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -82.0 167.07 33.38 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.399 -0.813 . . . . 0.0 109.456 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 3.3 Cg_exo -60.49 -13.33 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.115 1.877 . . . . 0.0 110.097 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.05 -39.99 65.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.564 ' CD2' ' CB ' ' A' ' 59' ' ' LYS . 4.6 mp -81.99 135.25 35.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.43 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.4 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 11.4 p-10 -135.67 124.24 23.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 68.25 49.28 47.14 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.583 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -75.9 151.11 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.187 -1.184 . . . . 0.0 108.455 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.458 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 5.6 t -121.81 102.62 12.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.947 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -96.08 154.23 3.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -130.5 172.79 11.52 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.036 -1.04 . . . . 0.0 109.225 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.603 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 55.5 t -107.38 144.31 28.94 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.282 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.651 ' HG3' ' HB3' ' A' ' 49' ' ' HIS . 5.8 Cg_exo -57.26 -178.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.326 2.017 . . . . 0.0 110.364 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.595 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 6.9 t0 -90.2 -32.89 16.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 108.503 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.602 ' HG3' ' OG1' ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.17 -161.19 1.12 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.487 ' CB ' HG21 ' A' ' 47' ' ' THR . 7.8 pt20 -159.45 27.76 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.956 . . . . 0.0 109.535 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 73' ' ' CYS . 10.9 m95 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.459 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.34 0.59 . . . . 0.0 109.513 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.476 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 3.0 ttmt -139.54 174.42 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.06 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.551 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 5.0 t -152.58 157.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.742 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 67.2 t -156.93 117.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.805 . . . . 0.0 109.154 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.637 ' CZ ' ' CD1' ' A' ' 23' ' ' LEU . 1.2 m-85 -95.47 154.05 17.4 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.344 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.521 ' CG2' ' HB3' ' A' ' 12' ' ' ARG . 2.4 t -133.87 142.44 41.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 8' ' ' HIS . 6.9 t -77.65 -158.05 0.11 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.596 ' CG ' ' O ' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -58.08 -103.24 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -112.22 77.28 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.513 -1.367 . . . . 0.0 108.973 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.72 -101.06 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 118.977 -1.582 . . . . 0.0 111.093 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.458 ' O ' HG11 ' A' ' 6' ' ' VAL . 1.3 m -120.12 -176.56 3.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.298 -1.119 . . . . 0.0 109.932 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.546 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -152.71 138.53 17.98 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.738 -0.601 . . . . 0.0 109.981 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.46 ' NH2' HD12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -90.98 177.63 6.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.192 -0.943 . . . . 0.0 108.965 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 2.4 pt20 -140.5 128.18 21.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.211 -0.931 . . . . 0.0 110.37 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.617 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -139.7 -175.45 4.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.217 179.218 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.12 82.64 1.95 Allowed 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.943 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.532 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 42.8 t -59.72 111.92 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 109.009 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -43.56 168.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 109.925 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.448 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 57.5 m-20 -84.32 126.45 33.21 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.339 -0.851 . . . . 0.0 108.989 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.3 15.25 35.98 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' A' ' 25' ' ' GLN . 4.4 t -115.5 169.71 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.363 -1.081 . . . . 0.0 109.138 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -106.73 135.82 47.61 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.17 -0.957 . . . . 0.0 108.69 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.637 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -44.35 -26.3 0.32 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.049 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.415 ' N ' ' O ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -73.24 -48.68 32.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.289 -0.882 . . . . 0.0 108.74 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.482 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 1.3 tp60 -53.16 -56.11 18.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.057 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.532 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -58.54 -26.9 64.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 108.911 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.515 ' HB3' ' N ' ' A' ' 33' ' ' TYR . . . -69.98 -32.39 70.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.429 -0.794 . . . . 0.0 109.215 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.565 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 59.8 t -52.95 -35.57 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.478 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -88.54 -52.26 5.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.479 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.513 ' ND2' HD12 ' A' ' 15' ' ' LEU . 24.9 m-80 -54.15 -16.21 1.92 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.656 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.45 ' O ' HG13 ' A' ' 35' ' ' ILE . . . 84.87 19.3 59.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.575 ' CD1' ' CG ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -99.61 -27.64 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -1.156 . . . . 0.0 108.494 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.565 ' CD1' ' HA ' ' A' ' 28' ' ' VAL . 1.1 p90 -47.96 -44.89 30.68 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.554 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 0.9 OUTLIER -74.56 -31.4 62.09 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 35' ' ' ILE . 56.4 mt -60.94 -20.22 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 109.098 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 101' ' ' VAL . 2.5 p -170.1 112.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 109.515 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 38' ' ' ASP . . . 177.91 176.99 46.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.515 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -163.1 -86.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -1.182 . . . . 0.0 109.803 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 41' ' ' GLY . 12.6 p -83.49 10.07 9.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.679 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 86' ' ' CYS . . . 51.93 -90.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 39' ' ' CYS . . . -54.46 -169.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.18 99.98 12.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -1.15 . . . . 0.0 109.481 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.461 ' HB1' ' SG ' ' A' ' 39' ' ' CYS . . . -118.07 -99.28 0.45 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.463 ' HA ' ' CG ' ' A' ' 70' ' ' MET . 13.6 t -160.57 40.64 0.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.918 -1.114 . . . . 0.0 109.965 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.515 ' SG ' ' CB ' ' A' ' 38' ' ' ASP . 1.7 p -99.99 149.86 23.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.068 . . . . 0.0 109.331 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 73' ' ' CYS . . . -105.89 23.78 13.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.474 ' CB ' ' CG ' ' A' ' 38' ' ' ASP . 22.0 m -90.25 -19.9 23.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.902 . . . . 0.0 109.756 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 21.9 p -91.03 42.73 1.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.099 -1.001 . . . . 0.0 110.287 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.635 ' CE1' ' O ' ' A' ' 77' ' ' GLU . 11.7 t60 -76.29 70.27 2.89 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.526 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 10.3 m -77.85 144.27 11.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 120.123 -1.611 . . . . 0.0 109.755 -178.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.626 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 0.9 OUTLIER -109.57 99.11 8.36 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.515 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 3.8 t -89.98 173.98 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.844 0.831 . . . . 0.0 112.124 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -68.88 -177.94 1.11 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.19 -1.64 33.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.139 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.3 -21.61 12.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.996 -1.065 . . . . 0.0 110.446 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.603 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 85.5 m-85 -95.18 -23.79 17.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.024 -1.047 . . . . 0.0 109.895 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.515 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -63.46 -34.1 77.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.149 -0.969 . . . . 0.0 109.39 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.61 -63.77 1.0 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.549 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.524 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 20.3 mmtp -49.88 -23.41 1.91 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.929 . . . . 0.0 109.385 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.53 ' CG2' HG23 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -57.94 162.71 5.01 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 108.994 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.528 ' HD2' ' CG2' ' A' ' 60' ' ' VAL . 5.5 Cg_exo -58.71 171.38 2.03 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.128 1.885 . . . . 0.0 110.243 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.22 59.65 0.61 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -0.922 . . . . 0.0 109.507 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.574 ' CB ' ' NH2' ' A' ' 83' ' ' ARG . . . -42.43 151.95 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.45 -0.781 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -61.72 -162.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 109.56 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.525 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 2.0 tm-20 -100.16 -22.18 15.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 109.543 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.442 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.7 mtt180 -43.9 -56.99 3.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HB2' HD23 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -64.63 -30.84 71.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.525 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 36.9 mm -56.0 -43.82 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 109.528 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.76 -30.13 62.22 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.508 ' N ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -68.5 -16.08 63.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -1.131 . . . . 0.0 109.342 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.528 ' HG ' ' CD1' ' A' ' 78' ' ' LEU . 10.0 tp -90.89 -8.95 48.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.81 -23.0 42.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.388 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -85.32 45.14 1.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.89 . . . . 0.0 109.462 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.517 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 4.1 m -106.59 163.8 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.388 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.575 ' OG1' ' CZ2' ' A' ' 106' ' ' TRP . 96.0 m -85.44 6.69 25.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.942 . . . . 0.0 109.544 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.47 -156.12 0.59 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.132 -0.98 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.635 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.7 pt-20 -112.55 151.42 30.03 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.628 ' CD1' ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -128.03 159.83 33.83 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 117.912 -1.515 . . . . 0.0 111.631 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.539 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -149.37 171.38 6.38 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 5.0 Cg_exo -56.59 -15.02 14.55 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 121.956 1.77 . . . . 0.0 109.84 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.515 ' ND2' HG22 ' A' ' 57' ' ' THR . 2.7 t-20 -86.53 -30.93 21.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.392 -0.818 . . . . 0.0 110.542 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.611 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -68.59 159.25 32.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.953 -1.092 . . . . 0.0 110.481 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.574 ' NH2' ' CB ' ' A' ' 63' ' ' ALA . 2.6 mtp180 -161.53 166.38 27.14 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.365 -0.834 . . . . 0.0 109.124 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.521 ' HG ' ' CD1' ' A' ' 71' ' ' LEU . 6.2 mp -79.76 118.94 22.01 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.157 -0.965 . . . . 0.0 108.598 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.526 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 2.2 t -47.12 -24.35 0.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 109.475 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 30.6 p -88.19 30.88 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 0.0 109.769 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.424 ' NE2' ' HB3' ' A' ' 63' ' ' ALA . 7.8 mm100 -149.66 12.65 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.049 -1.032 . . . . 0.0 109.994 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.53 HG23 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -108.87 140.52 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.082 -1.012 . . . . 0.0 108.704 179.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.47 HD11 ' O ' ' A' ' 21' ' ' VAL . 23.9 mm -125.91 146.03 32.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.762 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.524 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -98.32 83.31 3.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -0.852 . . . . 0.0 109.112 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 p -81.83 155.99 70.29 Favored Pre-proline 0 C--N 1.297 -1.686 0 O-C-N 121.486 -0.759 . . . . 0.0 109.203 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 19' ' ' ASP . 6.3 Cg_exo -58.42 -14.94 22.42 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.021 1.814 . . . . 0.0 109.905 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -73.12 -41.19 64.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.836 . . . . 0.0 109.323 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.524 ' CD2' ' HB2' ' A' ' 59' ' ' LYS . 5.6 mp -86.11 142.68 28.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -138.16 126.35 22.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.703 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.591 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 68.14 49.72 44.79 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.603 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -77.79 151.71 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.224 -1.162 . . . . 0.0 108.878 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.43 ' O ' HG11 ' A' ' 52' ' ' VAL . 4.8 t -122.06 104.7 15.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.034 -1.041 . . . . 0.0 110.363 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.494 ' CG1' HD13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -98.93 144.86 11.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.04 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -122.79 176.3 6.05 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.914 -1.116 . . . . 0.0 109.733 -179.288 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.607 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 51.0 t -108.6 144.02 28.7 Favored Pre-proline 0 C--N 1.298 -1.641 0 C-N-CA 119.671 -0.812 . . . . 0.0 108.943 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.626 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 4.1 Cg_exo -54.36 172.37 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.461 2.107 . . . . 0.0 111.492 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.421 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -82.03 -17.53 46.45 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.533 ' HG2' ' CG2' ' A' ' 75' ' ' THR . 0.0 OUTLIER -128.87 107.4 9.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.381 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 106' ' ' TRP . 8.3 pt20 -79.76 5.03 14.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.145 -0.972 . . . . 0.0 109.59 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.575 ' CZ2' ' OG1' ' A' ' 75' ' ' THR . 62.2 m95 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.495 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.318 0.58 . . . . 0.0 109.504 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.436 ' O ' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -151.48 159.38 44.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.187 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.536 HG13 ' CD2' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -147.95 125.2 3.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.211 -0.93 . . . . 0.0 109.38 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.459 ' O ' HG22 ' A' ' 99' ' ' VAL . 97.4 t -126.01 129.64 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 108.887 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CD2' ' CG2' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -97.69 154.59 17.48 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.944 -1.097 . . . . 0.0 109.374 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.528 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 5.1 t -123.96 170.19 14.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.446 -0.784 . . . . 0.0 108.977 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.542 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 14.6 p -121.43 162.89 19.65 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.477 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.43 -8.38 13.26 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 120.872 -1.142 . . . . 0.0 109.051 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 4.5 t70 -110.25 -6.06 15.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.114 -0.991 . . . . 0.0 110.316 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.41 -31.75 5.67 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.266 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.56 ' CG2' ' NH1' ' A' ' 13' ' ' ARG . 54.1 m -49.71 114.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.043 -1.269 . . . . 0.0 109.486 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 18.3 ptt180 -130.78 126.05 35.33 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.596 -0.69 . . . . 0.0 109.694 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.56 ' NH1' ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -104.24 125.96 50.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.949 . . . . 0.0 108.714 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -85.83 157.37 20.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.122 -0.986 . . . . 0.0 110.567 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.595 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -167.4 -177.32 3.57 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.698 0.761 . . . . 0.0 109.334 179.153 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.41 106.23 8.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.714 -0.616 . . . . 0.0 109.574 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.523 HG22 ' CD2' ' A' ' 23' ' ' LEU . 78.5 t -81.05 108.71 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.404 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -46.31 172.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.548 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.459 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 75.1 m-20 -83.27 125.19 31.33 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.327 -0.858 . . . . 0.0 109.137 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.81 29.31 8.74 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.521 ' O ' ' CG2' ' A' ' 89' ' ' ILE . 2.1 t -130.58 170.96 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.342 -1.093 . . . . 0.0 109.378 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.506 ' HB2' ' CD1' ' A' ' 89' ' ' ILE . 13.2 t -115.92 146.43 42.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 108.926 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.536 ' CD2' HG13 ' A' ' 3' ' ' VAL . 16.2 mt -47.53 -25.48 1.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.961 -1.087 . . . . 0.0 108.478 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.526 ' CG ' ' N ' ' A' ' 25' ' ' GLN . 24.2 ptt? -71.6 -46.3 59.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.847 . . . . 0.0 108.832 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.526 ' N ' ' CG ' ' A' ' 24' ' ' MET . 0.0 OUTLIER -55.14 -56.54 18.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.144 -0.972 . . . . 0.0 108.805 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 30' ' ' ASN . . . -60.17 -19.25 53.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.3 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.53 ' CB ' ' HB ' ' A' ' 32' ' ' ILE . . . -70.76 -40.07 72.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.847 . . . . 0.0 110.127 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 25' ' ' GLN . 32.6 m -45.65 -33.05 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.181 -0.95 . . . . 0.0 110.366 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 31' ' ' GLY . 3.7 t -107.39 -59.64 1.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 109.815 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.569 ' ND2' ' CD1' ' A' ' 15' ' ' LEU . 47.2 m-20 -38.8 -27.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.342 0.592 . . . . 0.0 109.989 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 107.63 -9.69 38.04 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.634 ' CG2' ' CD2' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -68.29 -13.15 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -1.223 . . . . 0.0 107.913 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.496 ' N ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -49.51 -28.72 5.77 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 178.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -92.15 -30.16 16.1 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.544 ' CG2' ' NH2' ' A' ' 13' ' ' ARG . 3.0 mt -105.83 40.66 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.128 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.58 ' CG1' ' N ' ' A' ' 37' ' ' GLY . 1.3 p -143.16 -151.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.58 ' N ' ' CG1' ' A' ' 36' ' ' VAL . . . -72.0 -159.91 4.39 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -141.5 -53.95 0.46 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.974 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 42' ' ' SER . 15.1 p -63.7 -11.1 23.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.079 -1.013 . . . . 0.0 109.695 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 86' ' ' CYS . . . 85.19 -164.99 39.0 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.499 ' N ' ' SD ' ' A' ' 24' ' ' MET . . . -42.56 -27.43 0.5 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 67.8 p -59.91 168.86 1.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -1.15 . . . . 0.0 109.37 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.456 ' HA ' ' S1 ' ' A' ' 107' ' ' FES . . . -128.68 71.04 1.39 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -124.71 -10.81 7.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.791 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.522 ' O ' ' CE ' ' A' ' 70' ' ' MET . 1.8 p -111.83 -178.92 3.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.662 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.508 ' HB1' ' NE1' ' A' ' 106' ' ' TRP . . . -133.03 12.89 4.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.181 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.6 p -75.57 -16.15 60.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.448 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.49 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 25.6 p -86.72 41.61 0.96 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.289 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.653 ' CE1' ' O ' ' A' ' 77' ' ' GLU . 26.7 t60 -82.25 64.16 6.78 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 83' ' ' ARG . 12.5 m -80.68 147.22 6.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.55 -1.344 . . . . 0.0 110.076 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.639 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 8.0 m-85 -107.86 106.41 16.68 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.56 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 4.5 t -89.78 166.79 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.791 0.805 . . . . 0.0 112.151 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -64.61 -176.79 0.27 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -100.64 -6.6 24.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 110.28 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.5 1.53 18.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.965 -1.084 . . . . 0.0 110.463 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.619 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 49.5 m-85 -115.14 -20.96 10.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.93 -1.106 . . . . 0.0 110.087 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.56 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -78.36 1.44 21.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.991 -1.068 . . . . 0.0 109.523 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -85.08 -58.62 2.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.673 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.582 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . 3.4 mptt -49.98 -39.93 42.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.569 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -56.68 164.36 2.19 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.136 -0.977 . . . . 0.0 109.412 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 4.8 Cg_exo -59.16 172.14 1.93 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.149 1.899 . . . . 0.0 110.261 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.14 59.39 0.61 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.379 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.05 111.27 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.523 -0.736 . . . . 0.0 109.56 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 63' ' ' ALA . 5.8 m-20 -57.11 -160.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.526 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 21.1 tt0 -85.07 -10.36 56.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -48.28 -67.62 0.26 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -65.63 -12.94 57.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.503 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.526 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 14.5 mt -73.89 -31.92 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.75 -58.58 4.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.526 ' HE3' ' CD2' ' A' ' 84' ' ' LEU . 6.1 ptm -67.95 -27.04 66.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -1.141 . . . . 0.0 109.298 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.521 ' HG ' ' CD1' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -89.99 6.41 42.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.332 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 68' ' ' ILE . 9.7 tp10 -94.62 -30.34 14.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.249 -0.907 . . . . 0.0 109.16 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 74' ' ' VAL . 77.4 m -98.64 15.79 24.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.886 . . . . 0.0 109.233 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.518 ' CG1' HD12 ' A' ' 71' ' ' LEU . 17.1 m -46.27 171.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.474 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.575 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 62.2 m -73.77 -2.14 22.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.739 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.488 ' CA ' ' HD2' ' A' ' 104' ' ' ARG . . . -126.43 -152.52 0.52 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.004 -1.06 . . . . 0.0 109.812 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.653 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.6 pt-20 -112.57 155.72 23.89 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.64 ' CD1' ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -129.54 152.45 49.05 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 117.779 -1.568 . . . . 0.0 111.989 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.53 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 2.5 mmtm -132.67 166.32 29.92 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.53 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 6.2 Cg_exo -54.94 -17.25 13.62 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.254 1.969 . . . . 0.0 110.717 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.42 -31.44 22.88 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 110.644 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.568 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.3 m -60.45 159.55 10.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.889 -1.132 . . . . 0.0 109.578 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.519 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -162.04 139.67 8.65 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.819 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.526 ' CD2' ' HE3' ' A' ' 70' ' ' MET . 1.3 mp -63.0 107.75 1.07 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -43.02 -26.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.878 -179.438 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 28.6 p -86.83 31.76 0.69 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 110.24 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 86' ' ' CYS . 12.3 mt-30 -153.36 24.24 0.54 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.872 -1.143 . . . . 0.0 110.492 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.475 ' CG2' HG13 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -140.63 131.31 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 0.0 109.649 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.524 HG21 ' N ' ' A' ' 90' ' ' MET . 31.1 mm -110.0 148.44 13.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.362 -0.837 . . . . 0.0 109.436 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.537 ' CE ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -103.69 84.95 2.35 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.169 -0.957 . . . . 0.0 109.132 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.533 ' CG2' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -78.03 171.69 11.81 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 91' ' ' THR . 5.5 Cg_exo -59.14 -14.06 22.13 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.104 1.869 . . . . 0.0 110.117 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -69.54 -50.9 40.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 0.0 109.336 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.582 ' CD1' ' CB ' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -83.46 138.96 33.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 109.378 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -145.31 132.14 20.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 0.0 109.632 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.433 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 70.69 37.39 67.22 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.619 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -71.92 147.89 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.408 -1.054 . . . . 0.0 109.522 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.439 ' C ' HD12 ' A' ' 97' ' ' ILE . 5.5 t -114.09 106.68 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.239 -0.913 . . . . 0.0 109.8 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.513 HG23 ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -98.0 152.22 4.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -128.07 176.05 7.93 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.922 -1.111 . . . . 0.0 109.807 -179.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.582 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 21.5 t -106.42 146.48 33.09 Favored Pre-proline 0 C--N 1.296 -1.735 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.527 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.627 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 11.6 Cg_exo -52.99 177.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.428 2.086 . . . . 0.0 110.303 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 21.8 t0 -74.77 -22.62 58.67 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -130.87 -167.51 1.85 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 106' ' ' TRP . 50.3 tp60 -139.01 28.19 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.939 -1.101 . . . . 0.0 109.657 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.575 ' CE2' ' OG1' ' A' ' 75' ' ' THR . 8.9 m95 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.515 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.507 ' S1 ' ' CD2' ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.311 0.577 . . . . 0.0 109.581 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.448 ' O ' HG21 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -139.81 161.62 37.11 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.871 . . . . 0.0 109.116 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.535 HG13 ' CD2' ' A' ' 23' ' ' LEU . 1.4 t -150.75 128.43 2.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.27 -0.894 . . . . 0.0 109.683 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.533 ' O ' ' CG2' ' A' ' 99' ' ' VAL . 42.6 t -132.04 164.5 34.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.638 ' CD1' ' N ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -137.72 159.56 41.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.073 . . . . 0.0 109.903 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.468 ' O ' HG21 ' A' ' 101' ' ' VAL . 4.0 t -131.2 137.24 56.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.587 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 35.2 t -93.19 171.15 9.12 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.494 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -66.98 -6.05 15.3 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.028 -1.045 . . . . 0.0 109.156 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.35 -2.99 16.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.977 . . . . 0.0 110.219 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.66 17.34 15.12 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.215 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.529 ' OG1' ' CB ' ' A' ' 7' ' ' SER . 69.5 m -49.82 112.97 0.74 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.037 -1.272 . . . . 0.0 109.1 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.07 105.71 16.48 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.564 -0.71 . . . . 0.0 110.325 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.454 ' O ' HG11 ' A' ' 4' ' ' VAL . 22.8 ttm180 -148.33 133.86 18.71 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.465 ' HB3' ' CG2' ' A' ' 4' ' ' VAL . 3.5 mp0 -120.03 179.4 4.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.004 -1.06 . . . . 0.0 110.986 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.503 ' CD2' HD12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER -176.12 -176.03 0.76 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.27 100.0 5.89 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.545 -0.722 . . . . 0.0 109.53 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 90' ' ' MET . 39.5 t -65.51 108.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.352 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -46.55 172.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.42 ' OD2' ' HG3' ' A' ' 92' ' ' PRO . 52.8 m-20 -82.2 125.03 30.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.259 -0.901 . . . . 0.0 109.151 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.04 41.13 6.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' CG1' ' HB3' ' A' ' 25' ' ' GLN . 1.9 t -133.79 162.37 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -1.165 . . . . 0.0 109.414 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.462 ' OG ' ' CD1' ' A' ' 89' ' ' ILE . 46.6 m -98.09 137.08 37.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 108.854 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.535 ' CD2' HG13 ' A' ' 3' ' ' VAL . 6.5 mt -46.29 -26.36 0.79 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.012 -1.055 . . . . 0.0 108.613 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.26 -47.09 45.91 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.503 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -51.96 -51.22 58.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.038 179.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.484 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -60.84 -29.59 69.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 108.821 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.525 ' CB ' ' N ' ' A' ' 33' ' ' TYR . . . -73.02 -25.2 60.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.552 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.57 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 88.4 t -57.07 -42.13 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.069 -1.019 . . . . 0.0 109.385 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.2 t -84.56 -55.08 4.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.401 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 24.5 m-80 -52.92 -18.53 2.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.376 -0.828 . . . . 0.0 109.606 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.89 23.61 57.22 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.503 HD12 ' CD2' ' A' ' 15' ' ' LEU . 1.1 mt -101.33 -25.55 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.272 . . . . 0.0 108.286 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.632 ' CG ' ' N ' ' A' ' 34' ' ' ASP . 2.3 p90 -48.74 -47.17 41.66 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.632 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 34.0 t70 -69.46 -33.08 72.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.517 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 53.5 mt -57.72 -19.28 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.182 -0.949 . . . . 0.0 108.936 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.525 ' CG1' HG12 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -170.03 133.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.442 -0.786 . . . . 0.0 109.377 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' OD1' ' A' ' 38' ' ' ASP . . . 133.86 169.06 11.97 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.483 ' CG ' ' CG2' ' A' ' 47' ' ' THR . 0.2 OUTLIER -161.73 -89.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -1.201 . . . . 0.0 109.824 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 40' ' ' GLY . 13.1 p -50.97 -41.97 59.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.568 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.513 ' N ' ' SG ' ' A' ' 39' ' ' CYS . . . 71.05 -83.9 0.4 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 43' ' ' ALA . . . -70.92 -79.1 0.39 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.461 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 59.8 p -59.71 88.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -1.139 . . . . 0.0 109.813 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.518 ' CB ' ' OE1' ' A' ' 87' ' ' GLN . . . -60.29 99.68 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.481 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.457 ' HA ' ' HG2' ' A' ' 70' ' ' MET . 2.3 m -160.03 22.06 0.17 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.713 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 7.8 p -116.05 -157.89 0.66 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 109.432 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.503 ' HB1' ' NE1' ' A' ' 106' ' ' TRP . . . -147.81 12.8 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.098 -1.001 . . . . 0.0 109.877 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.519 HG21 ' CB ' ' A' ' 106' ' ' TRP . 5.0 p -77.93 -23.74 48.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.997 . . . . 0.0 109.496 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 27.1 p -86.66 42.66 1.02 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 110.312 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.734 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 69.8 t60 -77.85 67.03 3.64 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.427 ' O ' HG21 ' A' ' 50' ' ' VAL . 11.4 m -87.16 147.71 5.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.471 -1.393 . . . . 0.0 110.862 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.734 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 6.8 m-30 -107.26 106.31 16.71 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 122.159 0.981 . . . . 0.0 108.393 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.545 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 9.6 t -90.0 164.46 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.852 0.834 . . . . 0.0 112.431 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -69.0 152.49 45.19 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -77.27 7.49 5.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -0.877 . . . . 0.0 110.619 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.33 -12.52 14.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.778 -1.202 . . . . 0.0 110.046 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.614 ' CD1' ' HA ' ' A' ' 97' ' ' ILE . 80.2 m-85 -111.36 -19.71 12.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 0.0 109.587 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.574 ' CG2' ' ND2' ' A' ' 81' ' ' ASN . 1.9 p -68.78 -12.17 61.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.241 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -88.97 -37.95 14.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.568 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 1.2 mptm? -71.44 -33.14 69.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.165 -0.96 . . . . 0.0 109.487 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -51.91 164.21 0.58 Allowed Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.223 -0.923 . . . . 0.0 109.218 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 5.7 Cg_exo -56.33 -166.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.044 1.829 . . . . 0.0 110.234 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.39 58.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -43.41 107.46 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.455 -0.778 . . . . 0.0 109.355 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' ALA . 4.3 m-20 -56.86 -160.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.613 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.523 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 62.1 tt0 -100.09 -16.95 17.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.489 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 65' ' ' GLU . 2.1 mtp180 -44.74 -61.12 1.7 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.457 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.515 ' OE1' ' CB ' ' A' ' 43' ' ' ALA . 1.2 mt-10 -66.86 -23.63 66.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.523 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 32.2 mm -63.65 -31.87 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.503 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.59 -50.76 47.36 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.457 ' HG2' ' HA ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -65.9 -23.8 66.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -1.145 . . . . 0.0 109.3 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.522 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 5.2 tp -87.76 -10.49 50.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.428 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -76.22 -35.62 58.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.355 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.99 45.07 0.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 0.0 109.363 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 71' ' ' LEU . 10.9 m -82.16 171.05 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 0.0 109.514 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.465 HG22 ' CB ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -57.41 -16.14 8.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.604 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -124.86 -151.23 0.47 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.114 -0.991 . . . . 0.0 110.52 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.576 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 2.2 pm0 -112.59 153.01 28.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.562 ' HG ' ' CB ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -111.22 127.36 55.58 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.803 -1.559 . . . . 0.0 111.672 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 1.9 mptp? -98.61 167.85 10.76 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 2.2 Cg_endo -60.05 -9.73 10.83 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.456 2.104 . . . . 0.0 111.37 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.574 ' ND2' ' CG2' ' A' ' 57' ' ' THR . 0.2 OUTLIER -107.26 4.92 27.1 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.086 -1.009 . . . . 0.0 111.836 -178.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.562 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -88.6 155.95 19.33 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.54 -1.35 . . . . 0.0 109.964 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.49 ' HG2' ' CD1' ' A' ' 88' ' ' ILE . 6.5 ttt180 -162.14 158.05 24.11 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.731 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.523 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 4.1 mp -78.84 106.28 10.74 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 108.648 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 48' ' ' CYS . 20.2 p -48.72 -22.11 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.596 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 26.6 p -81.3 -38.65 26.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.19 -0.944 . . . . 0.0 110.245 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.518 ' OE1' ' CB ' ' A' ' 43' ' ' ALA . 4.0 tp60 -89.47 42.85 1.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.084 -1.01 . . . . 0.0 110.865 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -149.31 146.64 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.889 -1.132 . . . . 0.0 109.534 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 90' ' ' MET . 11.4 mm -115.26 166.98 8.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.391 -0.818 . . . . 0.0 109.229 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.577 ' CE ' HG23 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -130.13 97.59 4.49 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.213 -0.929 . . . . 0.0 109.462 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.524 ' CG2' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -90.13 172.17 7.46 Favored Pre-proline 0 C--N 1.298 -1.666 0 O-C-N 121.56 -0.713 . . . . 0.0 109.146 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.524 ' HD2' ' CG2' ' A' ' 91' ' ' THR . 3.8 Cg_exo -60.79 -11.03 16.02 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.161 1.907 . . . . 0.0 110.481 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -68.23 -51.1 49.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -0.999 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -78.49 127.45 32.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 109.37 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.31 126.46 33.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.918 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.577 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 78.23 35.28 34.36 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.614 ' HA ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -71.54 133.21 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -1.087 . . . . 0.0 109.541 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.584 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 3.7 t -107.02 108.49 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -99.08 153.55 4.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -126.58 174.07 8.96 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.072 -1.018 . . . . 0.0 109.284 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.614 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 28.8 t -107.59 147.09 34.67 Favored Pre-proline 0 N--CA 1.494 1.725 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.95 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.645 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 8.2 Cg_exo -53.76 -171.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.32 2.013 . . . . 0.0 110.458 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -89.45 -26.66 20.84 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.465 ' CB ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -120.86 -157.96 0.74 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 105' ' ' GLN . 9.7 tt0 -154.97 24.4 0.43 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.001 -1.062 . . . . 0.0 109.586 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.519 ' CB ' HG21 ' A' ' 47' ' ' THR . 24.4 m95 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.715 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.514 ' S1 ' ' CD2' ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.433 ' HB2' ' HE2' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.469 ' O ' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -137.59 165.57 26.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.284 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.535 ' CG1' HD23 ' A' ' 23' ' ' LEU . 6.7 t -154.32 161.64 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.159 -0.963 . . . . 0.0 109.052 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.53 HG11 ' N ' ' A' ' 5' ' ' TYR . 51.9 t -159.46 148.68 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.075 -1.016 . . . . 0.0 109.202 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.636 ' CE1' ' CD2' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -124.68 154.08 41.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.097 -1.002 . . . . 0.0 109.498 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.502 HG23 ' HB3' ' A' ' 12' ' ' ARG . 3.0 t -136.71 141.4 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.438 -0.789 . . . . 0.0 110.177 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.557 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 1.5 p -81.52 169.52 17.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -41.87 -89.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.872 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.23 74.95 0.89 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.789 -1.194 . . . . 0.0 109.267 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.23 -105.08 0.37 Allowed Glycine 0 N--CA 1.489 2.208 0 C-N-CA 118.465 -1.826 . . . . 0.0 110.918 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -130.5 -176.09 3.86 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.544 -0.974 . . . . 0.0 109.57 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 5.0 ptp180 -150.98 124.35 8.91 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.291 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.475 ' O ' HG11 ' A' ' 4' ' ' VAL . 50.4 mtt180 -89.27 175.52 7.31 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.497 ' CB ' HG21 ' A' ' 4' ' ' VAL . 9.7 pt20 -134.97 141.11 46.17 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.974 -1.079 . . . . 0.0 110.324 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.636 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -136.69 -176.52 4.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.365 -0.834 . . . . 0.0 109.353 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -126.72 71.43 1.3 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.677 -0.639 . . . . 0.0 109.484 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.521 HG23 ' CD2' ' A' ' 23' ' ' LEU . 61.7 t -54.41 112.9 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.541 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -47.15 174.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 0.0 109.549 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.463 ' OD1' ' HA ' ' A' ' 92' ' ' PRO . 80.9 m-20 -83.66 125.3 31.7 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.359 -0.838 . . . . 0.0 109.192 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.46 19.01 31.2 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.517 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 0.6 OUTLIER -118.13 155.75 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -1.135 . . . . 0.0 109.293 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 23' ' ' LEU . 2.0 m -92.4 135.04 34.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.231 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.535 HD23 ' CG1' ' A' ' 3' ' ' VAL . 16.7 mt -45.27 -35.28 3.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.001 . . . . 0.0 108.968 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.446 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 1.8 tmt? -65.61 -46.24 80.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.263 -0.898 . . . . 0.0 108.976 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.471 ' O ' HG21 ' A' ' 28' ' ' VAL . 4.5 tp-100 -53.75 -52.08 61.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 109.206 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.453 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -63.2 -23.39 67.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.915 . . . . 0.0 109.171 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.527 ' HB3' ' N ' ' A' ' 33' ' ' TYR . . . -68.11 -26.33 65.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.358 -0.839 . . . . 0.0 109.712 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.509 ' CG2' ' N ' ' A' ' 29' ' ' SER . 2.7 m -57.52 -43.62 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.996 -1.065 . . . . 0.0 109.368 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 2.7 t -81.63 -56.26 4.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.329 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.469 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 33.1 m-80 -50.06 -20.8 1.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.446 -0.784 . . . . 0.0 109.372 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' HG22 ' A' ' 35' ' ' ILE . . . 83.55 22.21 56.67 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.53 HG22 ' CD1' ' A' ' 35' ' ' ILE . 1.4 mt -98.63 -31.3 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.208 -1.172 . . . . 0.0 108.848 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -51.64 -36.69 47.12 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.586 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 20.9 t70 -72.22 -35.62 68.93 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.53 ' CD1' HG22 ' A' ' 32' ' ' ILE . 3.7 pt -83.09 5.08 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.958 -1.089 . . . . 0.0 109.423 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 35' ' ' ILE . 0.3 OUTLIER -169.53 120.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.407 ' C ' HG22 ' A' ' 47' ' ' THR . . . 130.36 170.01 12.61 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.521 ' HB2' ' CG2' ' A' ' 47' ' ' THR . 5.0 m-20 -162.31 -59.93 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -1.158 . . . . 0.0 109.795 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.469 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 8.1 p -82.86 9.43 9.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' GLY . . . 57.64 -89.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 40' ' ' GLY . . . -60.63 -124.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.4 ' O ' ' HE2' ' A' ' 70' ' ' MET . 52.7 p -138.48 48.67 1.93 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.16 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' A' ' 39' ' ' CYS . . . -59.78 -93.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.515 ' HA ' ' CB ' ' A' ' 70' ' ' MET . 37.2 t -160.4 60.08 0.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.059 -1.026 . . . . 0.0 109.936 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 70' ' ' MET . 1.7 p -107.5 -171.71 1.93 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.085 -1.01 . . . . 0.0 109.21 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.502 ' HB3' ' N ' ' A' ' 74' ' ' VAL . . . -146.92 20.49 1.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 0.0 109.516 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 38' ' ' ASP . 7.9 t -90.3 -21.94 21.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.765 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 84' ' ' LEU . 21.8 p -87.18 42.55 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.145 -0.972 . . . . 0.0 110.398 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.649 ' CD2' ' CG2' ' A' ' 74' ' ' VAL . 44.8 t-80 -81.56 60.92 4.76 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 14.1 m -76.28 149.09 6.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 120.752 -1.218 . . . . 0.0 110.912 -177.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.512 ' CE2' ' CE1' ' A' ' 49' ' ' HIS . 7.7 m-85 -108.21 103.09 12.2 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.552 ' O ' ' ND2' ' A' ' 81' ' ' ASN . 4.3 t -89.15 174.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 121.662 0.744 . . . . 0.0 111.941 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.526 ' O ' ' CG2' ' A' ' 57' ' ' THR . 0.3 OUTLIER -70.41 -175.78 1.09 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -101.3 4.59 41.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.915 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.37 -25.54 10.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.081 -1.012 . . . . 0.0 110.258 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.637 ' CD2' ' CG2' ' A' ' 97' ' ' ILE . 73.8 m-85 -99.69 -17.05 17.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.068 -1.02 . . . . 0.0 109.816 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.542 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 25.1 p -63.87 -43.63 95.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 109.612 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -55.72 -51.77 66.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.904 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.541 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -49.86 -41.8 46.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 109.623 -179.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.542 ' CG1' ' HD2' ' A' ' 61' ' ' PRO . 54.6 t -54.22 142.83 47.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.998 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.542 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 5.2 Cg_exo -55.79 173.43 0.39 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.076 1.851 . . . . 0.0 110.519 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.72 62.52 0.61 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -0.818 . . . . 0.0 109.373 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -38.92 126.52 1.57 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.72 -0.612 . . . . 0.0 109.849 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.528 ' ND2' ' N ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -51.39 -174.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.896 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.491 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 3.9 tp10 -76.86 -10.19 59.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.357 -0.839 . . . . 0.0 109.548 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -58.82 -51.25 70.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.336 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' HG2' ' HE1' ' A' ' 70' ' ' MET . 86.3 mt-10 -72.73 -7.06 48.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.403 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.493 HG23 HD11 ' A' ' 68' ' ' ILE . 15.2 mt -76.65 -36.93 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 0.0 109.556 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.23 -54.1 24.89 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.515 ' CB ' ' HA ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -68.45 -27.06 65.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.287 -1.125 . . . . 0.0 108.779 179.591 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.525 ' CD1' HD12 ' A' ' 78' ' ' LEU . 3.7 tt -83.34 8.13 14.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.144 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 72' ' ' GLU . 4.0 tp10 -100.51 -10.58 20.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.478 ' CB ' ' CB ' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -82.24 -13.49 56.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.186 -0.946 . . . . 0.0 109.85 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.649 ' CG2' ' CD2' ' A' ' 49' ' ' HIS . 4.1 m -40.02 137.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.472 -0.768 . . . . 0.0 109.736 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.525 HG22 ' CB ' ' A' ' 104' ' ' ARG . 5.5 m -44.58 -25.3 0.26 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.243 -0.911 . . . . 0.0 109.289 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.531 ' O ' ' CG2' ' A' ' 74' ' ' VAL . . . -116.94 -148.94 0.43 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.629 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.6 OUTLIER -114.51 150.18 35.26 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.646 ' CD1' ' CD2' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -104.13 130.59 51.86 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 117.232 -1.787 . . . . 0.0 111.269 179.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.544 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 0.5 OUTLIER -104.76 166.1 12.09 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.544 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 5.0 Cg_exo -53.79 -26.37 38.59 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.937 1.758 . . . . 0.0 109.931 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.552 ' ND2' ' O ' ' A' ' 52' ' ' VAL . 1.9 t30 -75.41 -35.06 61.08 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 110.128 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.566 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -87.07 165.52 15.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.006 -1.059 . . . . 0.0 109.471 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.525 ' HB3' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -162.33 -162.34 0.81 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.449 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.549 ' O ' ' CD1' ' A' ' 88' ' ' ILE . 1.5 mt -98.04 108.28 20.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.523 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 23.3 t -42.81 -25.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.108 -0.995 . . . . 0.0 110.034 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' LEU . 29.1 p -82.9 -39.35 21.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.987 . . . . 0.0 110.607 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.416 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 0.7 OUTLIER -88.91 27.0 1.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 111.192 -178.524 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.549 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -106.68 149.39 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.654 -1.279 . . . . 0.0 108.902 178.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 88' ' ' ILE . 28.7 mm -128.24 161.61 36.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.93 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.529 ' HE3' ' CG2' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -130.33 95.91 4.02 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.451 -0.781 . . . . 0.0 109.12 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.464 ' OG1' HD11 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -82.38 164.93 45.38 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.545 -0.722 . . . . 0.0 109.586 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.463 ' HA ' ' OD1' ' A' ' 19' ' ' ASP . 4.0 Cg_exo -60.87 -28.49 86.45 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.138 1.892 . . . . 0.0 110.057 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.68 -37.74 85.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.541 ' CD2' ' CB ' ' A' ' 59' ' ' LYS . 4.2 mp -77.41 143.93 38.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.395 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.12 124.35 8.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 109.538 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.573 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 76.53 48.98 8.47 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.637 ' CG2' ' CD2' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -77.07 145.75 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -1.188 . . . . 0.0 108.549 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.482 ' N ' HD11 ' A' ' 97' ' ' ILE . 1.8 t -119.17 113.24 40.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 120.849 -1.157 . . . . 0.0 109.869 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -106.77 144.81 15.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 51' ' ' TYR . 9.2 m-20 -122.28 174.09 7.21 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.113 -0.992 . . . . 0.0 109.527 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.582 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 12.0 t -103.63 147.39 34.16 Favored Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.462 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.584 ' HG3' ' HB3' ' A' ' 49' ' ' HIS . 12.8 Cg_exo -52.59 163.48 1.82 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.413 2.075 . . . . 0.0 110.05 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.521 ' HB3' ' NH2' ' A' ' 104' ' ' ARG . 3.2 m-20 -57.99 -27.37 63.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.013 -1.054 . . . . 0.0 108.751 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.525 ' CB ' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -130.67 -163.45 1.32 Allowed 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -152.2 23.38 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.487 ' NE1' ' N ' ' A' ' 75' ' ' THR . 38.0 m95 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.642 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.453 ' S1 ' HD21 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.59 135.64 21.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.274 -0.891 . . . . 0.0 109.177 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.566 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 1.1 t -133.24 123.79 47.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.587 ' CG1' ' CG ' ' A' ' 12' ' ' ARG . 65.9 t -121.82 128.81 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.128 -0.982 . . . . 0.0 108.636 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.641 ' CZ ' ' CD1' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -98.21 153.8 18.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.953 -1.092 . . . . 0.0 109.478 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.527 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 12.0 t -121.52 168.87 13.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.535 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 41.0 t -122.99 161.52 24.09 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.496 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.55 -8.13 12.81 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.089 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -110.66 -3.33 15.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.079 -1.013 . . . . 0.0 110.643 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.68 -23.63 13.12 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.173 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' A' ' 7' ' ' SER . 74.6 m -49.52 112.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.031 -1.276 . . . . 0.0 109.065 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.587 ' CG ' ' CG1' ' A' ' 4' ' ' VAL . 3.6 ttm180 -125.49 117.34 23.43 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.575 -0.703 . . . . 0.0 110.187 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' CD ' HG12 ' A' ' 32' ' ' ILE . 1.2 ptp180 -108.7 124.95 51.35 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.402 ' HB3' HG23 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -91.37 155.55 18.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.018 -1.051 . . . . 0.0 110.569 -178.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.585 HD23 ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -163.02 -176.13 4.72 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.639 0.733 . . . . 0.0 109.169 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -129.37 114.63 16.43 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.5 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.519 ' CG1' ' HB3' ' A' ' 90' ' ' MET . 46.2 t -77.48 110.31 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.49 ' CB ' HG23 ' A' ' 21' ' ' VAL . . . -46.95 172.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 0.0 109.337 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -81.52 124.73 29.73 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.225 -0.922 . . . . 0.0 109.153 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.77 44.25 6.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.49 HG23 ' CB ' ' A' ' 18' ' ' ALA . 1.5 t -133.07 165.57 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.46 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 p -105.87 141.91 36.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.169 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.641 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -48.68 -23.79 1.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.137 -0.977 . . . . 0.0 108.985 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 0.1 OUTLIER -76.83 -43.88 34.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 108.657 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.496 ' O ' HG21 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -56.77 -51.15 70.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.374 -0.829 . . . . 0.0 109.259 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.51 -24.51 65.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.0 109.308 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.524 ' CB ' ' N ' ' A' ' 33' ' ' TYR . . . -74.64 -26.45 59.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.323 -0.861 . . . . 0.0 109.927 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.571 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 1.7 m -56.57 -44.15 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.788 -1.195 . . . . 0.0 109.448 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.499 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 3.3 t -80.59 -52.7 7.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.433 -0.792 . . . . 0.0 109.527 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 25.9 m-80 -57.24 -14.58 4.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.832 . . . . 0.0 109.622 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' O ' ' CD1' ' A' ' 35' ' ' ILE . . . 77.33 22.78 69.74 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 27' ' ' ALA . 1.1 mt -100.14 -25.85 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.208 -1.172 . . . . 0.0 108.271 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.617 ' CG ' ' N ' ' A' ' 34' ' ' ASP . 2.1 p90 -48.63 -46.95 40.55 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.617 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 12.5 t70 -66.44 -35.5 80.45 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.534 ' CG2' ' O ' ' A' ' 35' ' ' ILE . 2.6 mp -92.3 40.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.197 -0.939 . . . . 0.0 108.889 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 35' ' ' ILE . 49.1 t -160.88 -93.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.594 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.527 ' CA ' ' HB3' ' A' ' 48' ' ' CYS . . . -84.18 167.82 43.94 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.28 -50.0 1.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -1.129 . . . . 0.0 109.689 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.513 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 16.8 p -65.15 -18.86 65.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 109.537 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 42.98 93.21 0.01 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.61 -140.76 11.06 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.7 p -60.0 161.64 6.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -1.149 . . . . 0.0 109.353 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . . . -59.91 101.3 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.412 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.513 ' HB3' ' CB ' ' A' ' 39' ' ' CYS . 4.6 t -132.93 18.72 4.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.687 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.9 p -168.08 -167.61 0.85 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.943 . . . . 0.0 109.683 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB3' ' CG1' ' A' ' 74' ' ' VAL . . . -135.48 5.54 3.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.331 -0.856 . . . . 0.0 109.331 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -63.07 -28.78 70.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.396 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.527 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 25.1 p -84.25 42.32 0.88 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.449 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.638 ' CE1' ' CD1' ' A' ' 78' ' ' LEU . 28.3 t60 -81.35 64.09 5.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.27 147.33 6.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.569 -1.332 . . . . 0.0 110.061 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 9.6 m-85 -107.03 104.12 13.71 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.558 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 4.6 t -89.41 172.6 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-O 121.948 0.88 . . . . 0.0 112.201 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.6 157.98 30.01 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -81.88 12.57 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.233 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.29 -25.95 9.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.98 -1.075 . . . . 0.0 109.75 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.613 ' CD1' ' HA ' ' A' ' 97' ' ' ILE . 90.8 m-85 -104.49 -17.35 14.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.558 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -66.16 -34.97 79.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.814 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.15 -46.88 72.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.21 -0.931 . . . . 0.0 110.346 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.588 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -49.51 -43.99 45.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.736 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.525 ' CG1' ' HD2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -100.45 143.24 26.16 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.892 . . . . 0.0 109.259 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.525 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 6.2 Cg_exo -58.15 -179.59 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.811 1.674 . . . . 0.0 109.219 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.472 ' HA ' ' HD3' ' A' ' 83' ' ' ARG . . . -110.29 -105.2 0.37 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.839 -1.163 . . . . 0.0 109.573 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.522 ' HB2' ' CG1' ' A' ' 68' ' ' ILE . . . -111.7 -160.14 0.7 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.071 . . . . 0.0 109.894 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.542 ' O ' ' CG1' ' A' ' 68' ' ' ILE . 12.3 m-20 -137.62 -145.43 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.87 -34.75 9.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.912 -1.117 . . . . 0.0 109.463 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -84.06 -48.37 9.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.903 . . . . 0.0 109.595 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.527 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 15.2 pt-20 -68.79 -27.0 65.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.564 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.542 ' CG1' ' O ' ' A' ' 64' ' ' ASN . 1.3 mt -66.34 -43.25 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.105 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.83 -55.8 21.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -25.61 65.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -1.16 . . . . 0.0 109.398 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.521 HD12 ' CG1' ' A' ' 74' ' ' VAL . 0.2 OUTLIER -87.86 -3.63 58.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.247 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 68' ' ' ILE . 15.0 tp10 -82.47 -26.05 32.99 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.22 -0.925 . . . . 0.0 109.211 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.74 75.77 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.391 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.521 ' CG1' HD12 ' A' ' 71' ' ' LEU . 4.9 m -97.75 174.66 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.925 . . . . 0.0 109.633 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.574 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 18.2 m -74.13 -11.95 60.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.852 . . . . 0.0 109.934 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.433 ' HB1' ' HG2' ' A' ' 104' ' ' ARG . . . -122.42 -151.41 0.48 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.029 -1.045 . . . . 0.0 109.874 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.628 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -112.26 156.13 22.89 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.638 ' CD1' ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -128.62 152.79 47.95 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 117.596 -1.641 . . . . 0.0 112.096 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.557 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 13.7 mmtt -137.52 167.26 21.3 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.557 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 5.8 Cg_exo -54.41 -17.99 13.68 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.17 1.913 . . . . 0.0 110.589 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 52' ' ' VAL . 0.2 OUTLIER -82.62 -33.75 27.81 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.375 -0.828 . . . . 0.0 110.45 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.59 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.1 m -61.7 159.68 13.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.951 -1.093 . . . . 0.0 109.595 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.538 ' CZ ' ' HB3' ' A' ' 83' ' ' ARG . 6.9 mmm-85 -160.4 167.96 26.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.737 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.518 HD11 ' NE2' ' A' ' 87' ' ' GLN . 0.3 OUTLIER -88.44 112.37 22.86 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 24' ' ' MET . 0.3 OUTLIER -65.35 -6.99 11.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.286 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.449 ' SG ' HD21 ' A' ' 84' ' ' LEU . 30.3 p -105.89 13.23 29.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.961 -1.087 . . . . 0.0 110.305 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.518 ' NE2' HD11 ' A' ' 84' ' ' LEU . 2.9 pt20 -139.06 3.28 2.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.796 -1.19 . . . . 0.0 110.399 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.521 HD11 HG22 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -105.08 146.88 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.946 -1.097 . . . . 0.0 109.201 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.505 HG21 ' N ' ' A' ' 90' ' ' MET . 12.1 mm -116.32 158.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.27 -0.894 . . . . 0.0 109.505 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.532 ' CE ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -127.89 95.24 4.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.292 -0.88 . . . . 0.0 109.271 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.514 ' CG2' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -87.62 171.23 10.05 Favored Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.589 -0.694 . . . . 0.0 109.533 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.514 ' HD2' ' CG2' ' A' ' 91' ' ' THR . 3.9 Cg_exo -60.34 -15.17 33.65 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.189 1.926 . . . . 0.0 110.33 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 94' ' ' LEU . 22.3 pt-20 -66.29 -47.88 72.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.234 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.588 ' CD2' ' CB ' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -86.38 152.18 22.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.886 . . . . 0.0 109.23 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -161.42 133.99 6.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.98 . . . . 0.0 110.022 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.585 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 78.41 37.32 27.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.613 ' HA ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -78.22 149.64 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.178 -1.189 . . . . 0.0 109.047 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.44 ' C ' HD12 ' A' ' 97' ' ' ILE . 3.7 t -114.18 110.35 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.061 -1.024 . . . . 0.0 109.884 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.513 HG21 ' CD1' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -102.75 148.72 7.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -126.15 176.63 6.92 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.74 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.571 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 21.6 t -106.02 146.32 32.68 Favored Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.685 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.636 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 10.5 Cg_exo -54.06 -173.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.458 2.105 . . . . 0.0 110.656 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -92.21 -18.01 24.05 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -130.29 -162.36 1.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 106' ' ' TRP . 4.8 tm0? -151.36 22.56 0.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.838 -1.163 . . . . 0.0 109.895 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.574 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 6.5 m95 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.533 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.516 ' S1 ' ' CD2' ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.487 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -138.17 159.52 41.82 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.261 -0.899 . . . . 0.0 109.167 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.526 HG13 ' CG2' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -157.28 130.54 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.23 -0.919 . . . . 0.0 109.659 -179.215 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 13' ' ' ARG . 75.5 t -129.02 140.93 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 109.023 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CE1' ' CD2' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -109.24 156.87 19.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 109.252 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 101' ' ' VAL . 2.7 t -133.28 132.97 58.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.551 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -78.91 -177.37 5.5 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -48.59 162.95 0.08 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.513 ' C ' ' O ' ' A' ' 8' ' ' HIS . 5.1 t0 -29.75 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.032 0.444 . . . . 0.0 110.78 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 8' ' ' HIS . . . -168.47 -95.39 0.1 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.476 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.458 ' O ' HG11 ' A' ' 6' ' ' VAL . 1.4 m -125.37 -175.87 3.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -1.156 . . . . 0.0 109.666 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 11.5 ptt180 -156.69 141.09 16.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.631 -0.668 . . . . 0.0 109.904 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -100.41 174.63 6.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.21 -0.931 . . . . 0.0 108.718 179.266 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -130.38 162.91 28.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.029 -1.044 . . . . 0.0 110.788 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.639 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -175.84 -176.53 0.85 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.627 0.727 . . . . 0.0 109.193 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 1' ' ' SER . 7.3 t0 -132.24 88.59 2.56 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.059 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 90' ' ' MET . 49.4 t -54.24 145.61 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 108.918 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.531 ' CB ' HG23 ' A' ' 21' ' ' VAL . . . -86.42 172.98 9.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 109.662 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.428 ' CG ' ' HG3' ' A' ' 92' ' ' PRO . 78.8 m-20 -80.92 125.75 30.51 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.354 -0.841 . . . . 0.0 108.927 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.38 22.44 34.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.531 HG23 ' CB ' ' A' ' 18' ' ' ALA . 1.9 t -117.16 162.86 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -1.086 . . . . 0.0 108.918 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -100.62 134.92 42.86 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.981 -1.074 . . . . 0.0 108.568 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.637 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -46.64 -25.27 0.68 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.016 -1.052 . . . . 0.0 108.699 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.5 ' CE ' ' HB2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -74.44 -46.69 38.32 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.404 ' HG3' ' OG ' ' A' ' 22' ' ' SER . 2.7 mm-40 -52.23 -54.29 32.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 108.95 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.22 -29.08 63.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 0.0 108.677 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.525 ' HB2' ' CA ' ' A' ' 33' ' ' TYR . . . -67.93 -34.15 76.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -0.809 . . . . 0.0 109.145 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.563 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 88.4 t -52.8 -40.49 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 109.399 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 t -79.95 -48.85 12.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.848 . . . . 0.0 109.402 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.459 ' CB ' HG13 ' A' ' 32' ' ' ILE . 29.1 m-80 -65.62 -6.19 10.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.795 . . . . 0.0 109.68 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 72.09 17.6 77.32 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -95.56 -27.18 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -1.157 . . . . 0.0 108.538 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.563 ' CD1' ' HA ' ' A' ' 28' ' ' VAL . 1.2 p90 -46.96 -45.11 20.59 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.557 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 10.9 t70 -77.31 -29.06 53.46 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 31' ' ' GLY . 20.0 mm -64.86 -10.03 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 37' ' ' GLY . 2.5 p -160.12 -51.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.134 -0.979 . . . . 0.0 109.826 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' TYR . . . -42.9 166.29 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.465 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 13.7 t0 -154.15 -93.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -1.203 . . . . 0.0 109.863 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 42' ' ' SER . 20.8 p -65.49 -9.5 26.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.131 -0.98 . . . . 0.0 109.765 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 86' ' ' CYS . . . 89.59 -167.47 33.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -42.01 -27.09 0.37 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.457 ' O ' ' SG ' ' A' ' 86' ' ' CYS . 19.3 m -59.68 159.57 8.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.136 -1.214 . . . . 0.0 109.286 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.477 ' CB ' ' OE1' ' A' ' 67' ' ' GLU . . . -124.57 74.45 1.33 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.356 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 m -129.6 -2.33 4.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 109.735 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 38' ' ' ASP . 1.4 p -120.96 -169.24 1.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.085 -1.009 . . . . 0.0 109.613 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.495 ' HB1' ' NE1' ' A' ' 106' ' ' TRP . . . -141.83 11.44 2.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.297 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.523 ' OG1' ' CB ' ' A' ' 106' ' ' TRP . 9.5 m -71.54 -21.0 61.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.51 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.523 ' HB2' ' CB ' ' A' ' 85' ' ' CYS . 23.5 p -86.75 42.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.645 ' CE1' ' O ' ' A' ' 77' ' ' GLU . 21.6 t60 -74.47 72.65 1.88 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 10.1 m -81.64 145.41 8.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.285 -1.509 . . . . 0.0 110.728 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.638 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 6.1 m-85 -107.26 99.97 9.46 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.539 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 3.8 t -89.93 172.08 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-O 122.053 0.93 . . . . 0.0 112.461 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -77.39 159.34 29.54 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.18 11.71 5.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.38 -0.825 . . . . 0.0 110.103 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.29 -29.91 7.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.015 -1.053 . . . . 0.0 109.755 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.64 ' CD2' ' CB ' ' A' ' 97' ' ' ILE . 47.2 m-85 -99.53 -18.47 17.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.174 -0.954 . . . . 0.0 109.4 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.539 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -64.16 -14.33 54.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.073 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.85 -36.06 17.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.526 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . 1.9 mptp? -72.88 -32.92 65.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.462 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 57' ' ' THR . 1.3 m -56.18 163.05 2.55 Favored Pre-proline 0 C--N 1.305 -1.344 0 O-C-N 121.222 -0.924 . . . . 0.0 109.455 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 5.8 Cg_exo -58.16 166.47 5.7 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.166 1.911 . . . . 0.0 110.179 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -110.25 60.21 0.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -41.86 164.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.53 -0.731 . . . . 0.0 109.611 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.41 ' O ' HG12 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -94.15 -175.23 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 0.0 109.695 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.518 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 38.2 tt0 -88.13 -17.98 29.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 0.0 109.521 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -46.54 -64.53 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.477 ' OE1' ' CB ' ' A' ' 43' ' ' ALA . 4.7 mt-10 -65.56 -21.29 66.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.433 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.518 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 23.5 mm -65.37 -31.7 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -45.12 -56.42 6.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 57.2 mtt -68.21 -26.79 65.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -1.176 . . . . 0.0 109.106 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -88.11 2.78 51.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.346 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 68' ' ' ILE . 55.7 tt0 -88.15 -30.53 19.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.85 . . . . 0.0 109.008 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -101.95 29.86 4.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.168 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 73' ' ' CYS . 5.3 m -46.07 171.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.593 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.574 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 83.4 m -75.2 -4.22 37.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.786 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -123.76 -150.71 0.45 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.063 -1.023 . . . . 0.0 109.651 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.645 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -111.85 156.64 21.7 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 179.333 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.636 ' CD1' ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -130.71 153.91 48.49 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.964 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.528 ' HD2' ' CD ' ' A' ' 80' ' ' PRO . 4.5 mmmt -136.88 166.85 24.22 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.528 ' CD ' ' HD2' ' A' ' 79' ' ' LYS . 6.0 Cg_exo -54.68 -17.41 13.19 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.246 1.964 . . . . 0.0 110.697 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.78 -31.66 23.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.615 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.598 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.4 m -61.6 162.83 7.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.965 -1.084 . . . . 0.0 110.307 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.511 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -161.03 -159.08 0.63 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.369 -0.832 . . . . 0.0 109.278 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -110.93 118.54 36.37 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.285 -0.885 . . . . 0.0 108.97 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.528 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 1.8 t -60.79 -19.62 59.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.125 -0.984 . . . . 0.0 108.991 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 17.2 p -110.66 30.16 7.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.426 -0.796 . . . . 0.0 109.973 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.453 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -143.26 9.55 1.66 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.019 -1.051 . . . . 0.0 110.048 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.504 HG21 ' NH2' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -123.35 131.27 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.072 -1.017 . . . . 0.0 109.287 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.528 ' CG2' ' N ' ' A' ' 90' ' ' MET . 13.8 mm -96.29 166.39 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.342 -0.849 . . . . 0.0 109.622 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.531 ' HB3' ' CG1' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.87 90.33 3.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.375 -0.828 . . . . 0.0 109.417 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.409 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -88.2 167.51 19.34 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.382 -0.824 . . . . 0.0 109.336 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.428 ' HG3' ' CG ' ' A' ' 19' ' ' ASP . 3.5 Cg_exo -60.09 -12.84 20.79 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.138 1.892 . . . . 0.0 110.353 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 94' ' ' LEU . 24.9 pt-20 -69.83 -45.87 66.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.589 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 59' ' ' LYS . 1.3 mp -75.98 136.02 40.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.924 . . . . 0.0 109.556 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -139.8 119.89 13.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.59 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 72.78 46.82 28.63 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.64 ' CB ' ' CD2' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -74.96 148.77 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.375 -1.074 . . . . 0.0 109.101 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.454 ' N ' HD13 ' A' ' 97' ' ' ILE . 2.9 t -116.23 106.34 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.11 -0.994 . . . . 0.0 109.443 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.524 HG21 ' CD1' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -104.84 147.14 11.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -126.38 174.27 8.73 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.722 -179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.624 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 40.1 t -108.3 145.79 32.24 Favored Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.093 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.624 ' HD2' ' CG1' ' A' ' 101' ' ' VAL . 8.6 Cg_exo -50.24 177.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.304 2.003 . . . . 0.0 111.031 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.07 -22.87 33.36 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.61 -157.03 0.69 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.436 ' O ' ' C ' ' A' ' 106' ' ' TRP . 20.0 mt-30 -153.36 23.99 0.54 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.953 -1.092 . . . . 0.0 109.728 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.574 ' CE2' ' OG1' ' A' ' 75' ' ' THR . 5.0 m95 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.589 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.456 ' S1 ' HD22 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.361 0.6 . . . . 0.0 109.526 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.48 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -134.41 162.99 30.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 109.075 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.537 ' CG1' HD23 ' A' ' 23' ' ' LEU . 23.9 t -152.28 157.32 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.061 -1.025 . . . . 0.0 109.742 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.496 ' CG2' ' C ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -158.57 119.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 108.879 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.61 ' CE1' ' CD2' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -95.19 157.17 16.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 109.682 -179.381 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.51 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 9.4 t -123.26 169.6 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.447 -0.783 . . . . 0.0 109.096 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.553 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 84.5 p -123.12 162.69 22.0 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.477 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -65.31 -6.53 10.09 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.828 -1.17 . . . . 0.0 109.203 179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -110.07 -5.6 15.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.062 -1.024 . . . . 0.0 110.319 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.65 -33.39 5.25 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.689 -1.244 . . . . 0.0 110.282 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.6 m -49.61 114.09 0.98 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.974 -1.31 . . . . 0.0 109.48 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.483 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -133.83 122.77 23.72 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.648 -0.657 . . . . 0.0 109.695 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.515 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 1.3 mtt180 -97.95 173.78 6.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.121 -0.987 . . . . 0.0 108.544 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.463 ' HB3' HG11 ' A' ' 4' ' ' VAL . 10.9 pt20 -131.96 134.66 45.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.051 -1.031 . . . . 0.0 110.212 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.61 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -134.28 -176.84 4.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.269 -0.895 . . . . 0.0 109.471 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.68 80.97 1.97 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.732 -0.605 . . . . 0.0 109.505 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.53 ' CG2' HD22 ' A' ' 23' ' ' LEU . 85.8 t -68.88 114.32 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.62 175.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.882 . . . . 0.0 109.817 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' OD2' ' HB3' ' A' ' 92' ' ' PRO . 67.8 m-20 -83.05 126.29 32.39 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.477 -0.764 . . . . 0.0 109.076 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.12 10.67 44.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.529 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 0.7 OUTLIER -115.52 155.48 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -1.144 . . . . 0.0 109.199 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 7.2 t -93.6 133.01 37.36 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.403 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.537 HD23 ' CG1' ' A' ' 3' ' ' VAL . 10.8 mt -42.64 -29.41 0.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.484 ' HE1' ' N ' ' A' ' 41' ' ' GLY . 1.9 tmt? -70.81 -50.52 34.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 108.811 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -49.22 -50.86 36.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.262 -0.899 . . . . 0.0 108.751 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.521 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -63.23 -32.06 73.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -0.844 . . . . 0.0 108.757 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.519 ' HB3' ' N ' ' A' ' 33' ' ' TYR . . . -62.25 -25.45 67.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.351 -0.843 . . . . 0.0 109.213 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.576 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 47.0 t -57.43 -42.97 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.135 -0.978 . . . . 0.0 109.172 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 t -82.51 -53.11 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 0.0 109.284 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.455 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 37.2 m-80 -54.81 -16.72 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.461 -0.775 . . . . 0.0 109.406 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' HG13 ' A' ' 35' ' ' ILE . . . 79.14 21.82 66.88 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.523 ' HA ' ' CD1' ' A' ' 35' ' ' ILE . 1.1 mt -99.2 -28.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.175 -1.191 . . . . 0.0 108.535 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.605 ' CG ' ' N ' ' A' ' 34' ' ' ASP . 1.6 p90 -47.45 -46.35 26.66 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.605 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 19.3 t70 -74.44 -30.49 61.91 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 32' ' ' ILE . 60.0 mt -58.98 -17.28 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.09 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.473 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 8.0 p -170.13 81.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.843 . . . . 0.0 109.47 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.424 ' C ' ' OG1' ' A' ' 47' ' ' THR . . . -163.62 179.55 38.6 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.523 ' HB2' ' CG2' ' A' ' 47' ' ' THR . 3.2 t0 -163.96 -69.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 109.667 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 42' ' ' SER . 16.3 p -83.3 10.05 9.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.698 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.04 -162.6 46.02 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.484 ' N ' ' HE1' ' A' ' 24' ' ' MET . . . -47.34 -23.98 2.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.447 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -59.89 177.49 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -1.165 . . . . 0.0 109.368 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.458 ' HA ' ' S1 ' ' A' ' 107' ' ' FES . . . -137.69 91.15 2.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.471 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.8 t -160.05 22.03 0.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 9.1 p -130.17 -151.55 0.48 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.958 . . . . 0.0 109.461 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.506 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -157.82 19.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.141 -0.975 . . . . 0.0 109.999 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 38' ' ' ASP . 1.6 p -89.94 -19.39 24.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.113 -0.992 . . . . 0.0 109.455 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 23.4 p -86.62 43.36 1.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 110.073 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.717 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 67.5 t60 -76.93 65.41 2.6 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 82' ' ' SER . 12.6 m -87.14 147.89 4.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.345 -1.472 . . . . 0.0 110.384 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.717 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 6.2 m-30 -107.16 111.4 23.81 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.526 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 5.3 t -94.85 170.14 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.937 0.875 . . . . 0.0 112.306 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.445 ' ND2' ' HB ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER -74.24 144.51 44.63 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -4.84 13.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.17 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -94.96 -30.07 14.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.214 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.635 ' CD2' ' CB ' ' A' ' 97' ' ' ILE . 61.6 m-85 -97.98 -17.79 18.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.007 -1.058 . . . . 0.0 109.878 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.526 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -64.59 -37.21 86.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.97 . . . . 0.0 109.429 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -62.14 1.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.542 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 13.8 mptt -49.93 -38.57 36.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.527 ' CG2' ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -51.24 161.17 0.79 Allowed Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.901 . . . . 0.0 109.049 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.527 ' HD2' ' CG2' ' A' ' 60' ' ' VAL . 4.3 Cg_exo -59.96 159.22 26.28 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.18 1.92 . . . . 0.0 110.22 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.15 58.89 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.883 . . . . 0.0 109.439 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.89 132.85 3.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.415 -0.803 . . . . 0.0 109.557 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -51.79 -174.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 109.63 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.515 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 31.0 tt0 -89.47 -16.43 30.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.415 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.438 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . 5.2 tpp180 -44.57 -61.79 1.43 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.477 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.438 ' OE1' ' HB3' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -66.23 -23.84 66.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.431 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.515 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 18.9 mt -63.12 -32.48 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.99 -51.6 39.54 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.7 mtt -66.69 -23.36 66.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -1.152 . . . . 0.0 109.372 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.525 ' O ' ' CG1' ' A' ' 74' ' ' VAL . 0.1 OUTLIER -89.72 -7.06 55.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.497 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -82.17 -36.79 27.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 109.367 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.87 57.62 4.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.398 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 71' ' ' LEU . 8.9 m -93.94 172.02 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.527 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 25.5 m -64.94 -10.23 27.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.518 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.516 ' CB ' ' HD2' ' A' ' 104' ' ' ARG . . . -128.22 -155.85 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.149 -0.97 . . . . 0.0 109.969 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.571 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -111.82 150.39 30.43 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.629 ' HG ' ' HB2' ' A' ' 82' ' ' SER . 0.4 OUTLIER -106.54 169.1 8.72 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.397 -1.321 . . . . 0.0 111.203 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.509 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -153.22 170.78 7.68 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 3.4 Cg_exo -57.83 -13.45 14.75 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.037 1.824 . . . . 0.0 109.905 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -95.35 -25.0 16.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 110.836 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.629 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -85.79 155.9 20.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.818 -1.176 . . . . 0.0 110.477 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HB3' HD13 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -161.53 -157.68 0.51 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 179.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.586 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -104.29 95.19 5.78 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.226 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.528 ' HA ' ' CG1' ' A' ' 88' ' ' ILE . 1.9 t -42.57 -25.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.46 ' HB2' ' HA2' ' A' ' 41' ' ' GLY . 13.0 p -75.72 -43.53 46.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.098 -1.001 . . . . 0.0 110.544 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.527 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -89.62 8.87 29.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.002 -1.061 . . . . 0.0 111.334 -178.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' A' ' 84' ' ' LEU . 2.9 mm -79.98 154.66 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.552 -1.342 . . . . 0.0 108.913 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.481 HD12 ' O ' ' A' ' 88' ' ' ILE . 30.1 mm -128.98 165.47 28.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.532 ' SD ' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -127.3 96.32 4.54 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.3 p -82.52 157.19 67.83 Favored Pre-proline 0 C--N 1.297 -1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 109.262 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.465 ' HB3' ' OD2' ' A' ' 19' ' ' ASP . 5.8 Cg_exo -59.77 -13.35 21.79 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.02 1.813 . . . . 0.0 110.264 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -80.3 -31.79 38.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.412 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.517 ' CD2' ' HB2' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -83.35 127.41 33.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.634 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -135.82 125.51 25.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.204 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.576 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 70.86 50.57 23.4 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.635 ' CB ' ' CD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -74.82 159.1 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.331 -1.099 . . . . 0.0 108.868 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.513 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 5.2 t -125.82 103.53 11.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.021 -1.049 . . . . 0.0 110.186 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -95.44 156.65 3.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 51' ' ' TYR . 12.0 m-20 -131.91 178.35 6.84 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.059 -1.025 . . . . 0.0 109.401 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.595 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 27.6 t -110.45 146.84 35.14 Favored Pre-proline 0 C--N 1.297 -1.715 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.95 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.635 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 8.4 Cg_exo -53.95 -173.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.391 2.061 . . . . 0.0 110.369 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 19.3 t0 -102.68 -22.71 13.91 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -131.09 -168.68 2.04 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.578 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -128.99 -82.63 0.57 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.024 -1.048 . . . . 0.0 109.186 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.578 ' CD1' ' O ' ' A' ' 105' ' ' GLN . 2.1 m95 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.38 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.458 ' S1 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -136.61 161.46 35.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.277 -0.889 . . . . 0.0 109.175 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.556 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 1.1 t -160.7 133.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 109.531 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.592 ' CB ' ' HA ' ' A' ' 14' ' ' GLN . 2.9 p -136.98 161.39 35.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.123 -0.985 . . . . 0.0 108.648 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.626 ' CE1' ' CD2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -129.04 157.99 40.17 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.185 -0.947 . . . . 0.0 109.786 -178.543 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 12' ' ' ARG . 3.4 t -126.9 143.39 40.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.558 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 5.1 p -75.98 -158.7 0.1 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.59 ' CD2' ' O ' ' A' ' 102' ' ' PRO . 55.8 m80 -59.2 -103.43 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.26 77.71 1.06 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.4 -1.437 . . . . 0.0 109.239 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.99 -101.31 0.2 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 118.958 -1.591 . . . . 0.0 111.053 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -121.46 -170.55 2.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -1.1 . . . . 0.0 109.954 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -149.31 139.59 22.29 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.656 -0.652 . . . . 0.0 110.32 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.439 ' C ' HG21 ' A' ' 4' ' ' VAL . 18.0 mtt180 -104.25 119.31 38.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.351 -0.843 . . . . 0.0 108.958 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.592 ' HA ' ' CB ' ' A' ' 4' ' ' VAL . 4.9 pt20 -79.78 171.43 15.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.973 . . . . 0.0 110.554 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.626 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -173.48 -177.98 1.58 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.611 0.72 . . . . 0.0 109.059 178.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -135.24 93.17 2.95 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.66 -0.65 . . . . 0.0 109.685 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.52 ' HB ' ' CB ' ' A' ' 90' ' ' MET . 21.1 t -69.13 149.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 109.305 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.431 ' C ' HG22 ' A' ' 21' ' ' VAL . . . -83.22 173.38 11.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.397 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -79.97 124.67 28.91 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.274 -0.891 . . . . 0.0 109.067 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.8 18.06 39.05 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.512 ' HB ' ' CG1' ' A' ' 17' ' ' VAL . 2.2 t -115.1 170.3 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -1.123 . . . . 0.0 109.27 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.496 ' OG ' ' CD1' ' A' ' 89' ' ' ILE . 70.6 m -111.76 138.79 47.87 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 108.677 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.504 HD21 ' CG2' ' A' ' 17' ' ' VAL . 1.5 mt -48.31 -23.6 0.96 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.945 -1.097 . . . . 0.0 108.709 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.465 ' HB2' ' HA ' ' A' ' 86' ' ' CYS . 13.2 ttp -73.07 -46.84 49.3 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.416 ' O ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -54.14 -59.61 4.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.363 -0.835 . . . . 0.0 109.004 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.432 ' C ' ' OD1' ' A' ' 30' ' ' ASN . . . -53.22 -46.48 69.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 108.945 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.467 ' HB2' ' N ' ' A' ' 33' ' ' TYR . . . -45.37 -37.39 4.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.865 . . . . 0.0 109.885 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.528 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 58.7 t -43.57 -50.12 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.098 -1.001 . . . . 0.0 109.858 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 31' ' ' GLY . 6.1 t -87.02 -51.33 6.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.303 -0.873 . . . . 0.0 109.591 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.559 ' HB2' HG13 ' A' ' 32' ' ' ILE . 4.8 m120 -40.31 -25.86 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.462 0.649 . . . . 0.0 109.731 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 95.24 -5.17 67.9 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.559 HG13 ' HB2' ' A' ' 30' ' ' ASN . 0.8 OUTLIER -79.61 -28.35 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.056 -1.261 . . . . 0.0 107.962 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -48.7 -31.45 6.85 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.046 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.619 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 13.1 t0 -93.08 -25.38 17.94 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.663 -0.648 . . . . 0.0 109.295 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.525 ' CG2' HG23 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -60.11 -31.83 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.0 109.194 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 35' ' ' ILE . 3.4 m -163.75 -171.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.404 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.08 166.05 12.06 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.464 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 12.3 t70 -154.16 -92.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -1.146 . . . . 0.0 109.716 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 40' ' ' GLY . 14.6 p -81.87 -9.87 59.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 109.625 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.76 77.15 0.1 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 87' ' ' GLN . . . 171.28 -157.17 27.65 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.2 p -60.83 171.83 1.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -1.137 . . . . 0.0 109.486 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.553 ' CB ' ' CG ' ' A' ' 67' ' ' GLU . . . -61.93 99.59 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.89 . . . . 0.0 109.41 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.81 5.84 2.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 0.0 109.636 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 13.2 p -144.33 -152.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 0.0 109.615 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.522 ' HB3' ' CG1' ' A' ' 74' ' ' VAL . . . -156.09 19.2 0.37 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.634 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -90.4 -28.78 18.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.583 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.464 ' O ' ' N ' ' A' ' 50' ' ' VAL . 22.0 p -86.5 42.3 1.0 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.953 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.733 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 68.1 t60 -58.71 79.95 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.591 ' CG1' ' CB ' ' A' ' 85' ' ' CYS . 7.6 m -90.59 146.71 5.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.055 -1.653 . . . . 0.0 111.987 -177.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.733 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 4.1 m-30 -112.63 113.09 25.05 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 6.4 t -101.45 171.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.877 0.846 . . . . 0.0 112.209 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.23 155.36 39.63 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -81.43 11.63 4.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.148 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.48 -28.89 8.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.95 -1.094 . . . . 0.0 110.121 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.637 ' CD2' ' CB ' ' A' ' 97' ' ' ILE . 43.0 m-85 -100.14 -19.34 16.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.08 -1.012 . . . . 0.0 109.695 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.534 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -61.55 -22.71 65.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.205 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -85.71 -25.69 26.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.891 . . . . 0.0 109.475 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.533 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 13.6 mmtm -76.83 -10.54 59.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 0.0 109.443 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.547 ' CG1' ' HD2' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -95.68 170.39 7.79 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.276 -0.89 . . . . 0.0 108.785 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.547 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 5.7 Cg_exo -59.43 167.84 5.83 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.03 1.82 . . . . 0.0 110.394 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.18 59.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.865 . . . . 0.0 109.375 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -41.6 121.64 1.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.593 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.497 ' O ' ' CD1' ' A' ' 68' ' ' ILE . 7.0 m-80 -57.54 -158.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.545 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 14.8 tp10 -84.11 -10.06 58.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.537 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -58.24 -54.31 48.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.456 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.553 ' CG ' ' CB ' ' A' ' 43' ' ' ALA . 2.4 mp0 -67.64 -8.21 32.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.529 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.578 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.5 mp -88.66 -34.09 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.373 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.43 -59.01 3.75 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.451 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -67.89 -26.61 66.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -1.151 . . . . 0.0 109.299 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.458 HD23 HD12 ' A' ' 84' ' ' LEU . 19.8 tp -90.83 7.24 40.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.893 . . . . 0.0 109.408 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -99.23 -24.22 14.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 109.393 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.86 31.75 0.94 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.439 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.522 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 3.6 m -75.9 170.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.384 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.589 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 16.3 m -75.9 -17.79 59.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.97 . . . . 0.0 109.328 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.62 -161.28 0.77 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.273 -0.892 . . . . 0.0 110.027 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.564 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.7 OUTLIER -111.65 151.63 28.61 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.599 ' HG ' ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -104.2 173.09 6.45 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.98 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.572 ' HE3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -158.27 170.13 9.45 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.513 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 2.6 Cg_endo -58.95 -12.51 15.43 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.284 1.989 . . . . 0.0 110.155 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.23 -22.09 16.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.22 -0.925 . . . . 0.0 110.84 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.599 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -75.42 153.32 37.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.004 -1.06 . . . . 0.0 110.649 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.512 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -161.31 -159.43 0.64 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.444 -0.785 . . . . 0.0 109.356 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 3.1 mm? -109.61 79.34 1.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.337 -0.852 . . . . 0.0 108.73 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.591 ' CB ' ' CG1' ' A' ' 50' ' ' VAL . 43.2 t -45.38 -22.5 0.14 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.39 -0.819 . . . . 0.0 110.846 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 24' ' ' MET . 28.6 p -75.73 -40.88 54.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.897 -1.127 . . . . 0.0 110.914 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.545 ' CG ' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -96.14 11.64 33.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.852 -1.155 . . . . 0.0 111.193 -178.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.539 ' CG1' ' HA ' ' A' ' 85' ' ' CYS . 4.4 mm -79.5 160.25 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.683 -1.26 . . . . 0.0 108.811 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.511 HG21 ' N ' ' A' ' 90' ' ' MET . 16.9 mm -123.72 155.69 30.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.838 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.543 ' CG ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -116.27 88.08 2.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.471 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.69 165.07 34.56 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 121.415 -0.803 . . . . 0.0 109.315 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.36 -12.9 22.1 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.18 1.92 . . . . 0.0 110.227 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -72.42 -51.05 22.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.533 ' CD2' ' HB2' ' A' ' 59' ' ' LYS . 1.6 mp -73.16 141.81 47.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.533 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -143.48 119.0 10.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 109.744 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.587 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 71.61 47.02 36.21 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.637 ' CB ' ' CD2' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -74.61 156.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.209 -1.171 . . . . 0.0 108.74 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.511 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 3.6 t -124.37 106.17 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.047 -1.033 . . . . 0.0 109.939 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -101.73 159.78 4.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.473 ' OD1' HG22 ' A' ' 6' ' ' VAL . 1.6 m-20 -139.33 170.03 16.69 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.236 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.558 ' HB ' ' HA ' ' A' ' 7' ' ' SER . 0.7 OUTLIER -105.09 157.97 33.11 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.512 178.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.638 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 6.3 Cg_exo -55.86 -167.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.546 2.164 . . . . 0.0 111.585 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 13.4 t0 -106.87 -22.84 12.56 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.529 ' HG3' ' CG2' ' A' ' 75' ' ' THR . 0.0 OUTLIER -131.31 127.95 38.74 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.57 20.03 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.968 -1.083 . . . . 0.0 110.036 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.589 ' CE2' ' OG1' ' A' ' 75' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.013 . . . . 0.0 109.467 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.458 ' S1 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.471 0.653 . . . . 0.0 109.579 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.419 ' O ' HG21 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -145.63 153.43 41.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.001 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.546 ' CG1' HD23 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -149.13 122.95 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.125 -0.984 . . . . 0.0 109.802 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.452 ' O ' HG21 ' A' ' 99' ' ' VAL . 16.6 t -124.06 132.11 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.589 ' CE1' HD23 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -100.04 154.99 17.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.953 -1.092 . . . . 0.0 109.605 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.524 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 11.6 t -121.79 167.78 14.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.483 -0.761 . . . . 0.0 109.011 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.541 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 42.0 t -124.3 161.75 25.2 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.503 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.51 -7.36 9.89 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.85 -1.156 . . . . 0.0 109.149 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -110.3 -4.09 15.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.014 -1.054 . . . . 0.0 110.606 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 12' ' ' ARG . . . 110.3 -19.03 27.46 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.303 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.2 m -59.87 111.88 1.64 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.908 -1.348 . . . . 0.0 109.252 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.513 ' CG ' HG11 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -125.58 121.93 35.04 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.515 -0.741 . . . . 0.0 110.268 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.575 ' NH1' ' CD1' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -102.53 126.36 49.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -88.78 157.17 18.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.099 -1.001 . . . . 0.0 110.654 -178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.589 HD23 ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -166.81 -176.85 3.62 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.707 0.765 . . . . 0.0 109.322 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.25 116.07 17.86 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.415 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.517 ' CG1' ' HB3' ' A' ' 90' ' ' MET . 49.2 t -93.29 106.36 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -47.07 174.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.586 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 92' ' ' PRO . 65.8 m-20 -83.51 126.26 32.61 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.317 -0.865 . . . . 0.0 109.18 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.84 21.77 20.11 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.468 ' O ' HD11 ' A' ' 89' ' ' ILE . 1.5 t -125.01 164.65 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -1.177 . . . . 0.0 109.294 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 33.0 t -109.33 143.89 38.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 108.986 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.546 HD23 ' CG1' ' A' ' 3' ' ' VAL . 16.0 mt -44.61 -34.63 2.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.152 -0.968 . . . . 0.0 108.878 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -48.59 76.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.047 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.46 ' O ' HG11 ' A' ' 28' ' ' VAL . 3.3 mt-30 -52.73 -55.73 20.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.01 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.16 -21.69 66.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.199 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.52 ' HB2' ' CB ' ' A' ' 33' ' ' TYR . . . -76.42 -24.37 54.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.561 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 25' ' ' GLN . 5.4 p -59.93 -33.75 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.167 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 t -91.79 -52.7 4.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 109.075 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 21.0 m-80 -55.04 -17.6 4.13 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.506 -0.746 . . . . 0.0 109.22 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.36 24.64 56.43 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.533 ' HA ' ' CG1' ' A' ' 35' ' ' ILE . 1.1 mt -102.9 -27.26 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.128 -1.219 . . . . 0.0 108.738 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.52 ' CB ' ' HB2' ' A' ' 27' ' ' ALA . 0.7 OUTLIER -50.5 -40.44 51.23 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.478 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 45.1 t0 -73.3 -32.91 64.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.575 ' CD1' ' NH1' ' A' ' 13' ' ' ARG . 1.0 OUTLIER -98.42 14.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.942 -1.098 . . . . 0.0 109.448 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 35' ' ' ILE . 94.6 t -160.29 69.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.435 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 48' ' ' CYS . . . 154.41 -171.93 32.92 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.482 ' CG ' ' CG2' ' A' ' 47' ' ' THR . 0.3 OUTLIER -165.42 -79.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.172 . . . . 0.0 109.639 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.499 ' SG ' ' N ' ' A' ' 40' ' ' GLY . 16.4 p -61.97 -40.32 95.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.562 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.499 ' N ' ' SG ' ' A' ' 39' ' ' CYS . . . 64.11 138.83 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.73 -102.68 0.86 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.452 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.4 OUTLIER -60.43 99.71 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -1.179 . . . . 0.0 109.437 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.451 ' HA ' ' S1 ' ' A' ' 107' ' ' FES . . . -63.54 109.71 1.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.505 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.3 m -152.45 17.13 0.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.654 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 12.9 p -121.26 -149.55 0.43 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.534 ' CB ' ' N ' ' A' ' 74' ' ' VAL . . . -156.13 18.71 0.36 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.033 -1.042 . . . . 0.0 109.997 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.482 ' CG2' ' CG ' ' A' ' 38' ' ' ASP . 1.7 p -90.11 -20.73 22.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.144 -0.973 . . . . 0.0 109.728 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.524 ' HB2' ' CB ' ' A' ' 85' ' ' CYS . 22.2 p -87.69 41.9 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.068 -1.02 . . . . 0.0 110.05 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.637 ' CD2' ' CD1' ' A' ' 78' ' ' LEU . 37.2 t-80 -81.9 61.94 5.46 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 82' ' ' SER . 12.5 m -77.35 148.09 6.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 120.588 -1.32 . . . . 0.0 110.612 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.514 ' CE2' ' CE1' ' A' ' 49' ' ' HIS . 7.0 m-85 -107.59 110.87 22.87 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.546 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 8.4 t -93.91 170.39 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 121.928 0.871 . . . . 0.0 112.251 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.426 ' ND2' HG22 ' A' ' 98' ' ' VAL . 1.3 m-20 -69.16 165.3 20.7 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.17 9.3 26.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 109.869 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.32 -28.55 8.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.157 -0.964 . . . . 0.0 109.964 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.629 ' CD1' ' HA ' ' A' ' 97' ' ' ILE . 93.7 m-85 -97.91 -19.39 18.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 109.64 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.546 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -63.82 -23.06 67.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.4 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.03 -35.73 25.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.681 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 2.7 mmtm -63.74 -12.94 39.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.38 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.535 ' CG1' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -97.94 161.75 24.56 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.268 -0.895 . . . . 0.0 108.969 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.535 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 5.0 Cg_exo -59.43 164.49 10.89 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.124 1.882 . . . . 0.0 110.371 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.19 59.35 0.61 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 109.428 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -41.98 130.19 3.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.548 -0.72 . . . . 0.0 109.593 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' ALA . 8.5 m-20 -57.08 -160.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.542 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.525 ' HA ' ' CD1' ' A' ' 68' ' ' ILE . 57.0 tt0 -99.25 -10.39 22.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.466 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' NE ' ' OE2' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -47.13 -72.28 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.599 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -61.04 -20.06 62.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 65' ' ' GLU . 13.6 mt -66.13 -31.93 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.69 -59.51 3.7 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.45 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -68.44 -28.1 66.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -1.116 . . . . 0.0 109.056 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.525 ' CD2' ' HG ' ' A' ' 84' ' ' LEU . 1.3 tp -85.5 4.49 35.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.324 -0.86 . . . . 0.0 109.167 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 68' ' ' ILE . 3.2 tm-20 -95.84 -12.53 25.1 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.081 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.465 ' O ' ' C ' ' A' ' 74' ' ' VAL . 1.3 m -59.92 -14.69 16.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.673 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.631 ' CG2' ' CD2' ' A' ' 49' ' ' HIS . 3.9 m -34.41 134.11 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.364 0.602 . . . . 0.0 109.941 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.542 ' HB ' ' CG ' ' A' ' 104' ' ' ARG . 88.4 m -44.69 -25.5 0.29 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 108.761 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' O ' ' CG2' ' A' ' 74' ' ' VAL . . . -110.1 -152.6 0.5 Allowed 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.373 -0.83 . . . . 0.0 109.834 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.634 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -114.74 148.59 38.11 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.637 ' CD1' ' CD2' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -104.15 130.05 51.89 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 117.406 -1.718 . . . . 0.0 111.288 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.518 ' HE2' ' CD ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -108.63 166.52 10.69 Favored Pre-proline 0 C--N 1.295 -1.801 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.518 ' CD ' ' HE2' ' A' ' 79' ' ' LYS . 3.4 Cg_exo -52.37 -27.85 32.86 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.733 1.622 . . . . 0.0 109.582 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.14 -42.04 85.07 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.677 -0.639 . . . . 0.0 109.449 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -83.18 168.27 16.96 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.435 -0.791 . . . . 0.0 109.671 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.529 ' HB3' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -161.57 -177.27 5.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.086 -1.009 . . . . 0.0 109.687 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.525 ' HG ' ' CD2' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -83.93 114.22 21.53 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.332 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.524 ' CB ' ' HB2' ' A' ' 48' ' ' CYS . 9.4 t -59.66 -14.87 15.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 0.0 109.12 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.3 p -108.54 30.21 6.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 109.76 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.516 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -152.92 13.72 0.52 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.986 -1.071 . . . . 0.0 110.377 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -112.39 150.2 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.923 -1.111 . . . . 0.0 108.938 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.468 HD11 ' O ' ' A' ' 21' ' ' VAL . 38.2 mm -129.45 142.27 44.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.315 -0.866 . . . . 0.0 109.881 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.56 ' CE ' HG23 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -97.95 82.15 2.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 108.936 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.57 165.85 41.58 Favored Pre-proline 0 C--N 1.294 -1.805 0 O-C-N 121.606 -0.684 . . . . 0.0 109.174 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 5.8 Cg_exo -59.25 -13.8 21.54 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.067 1.845 . . . . 0.0 110.103 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -76.96 -42.39 39.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -80.07 160.01 25.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.52 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -173.98 125.24 0.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.613 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 75.34 40.34 33.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.629 ' HA ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -79.83 149.11 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -1.082 . . . . 0.0 109.165 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.426 HG22 ' ND2' ' A' ' 53' ' ' ASN . 2.3 t -113.73 108.54 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.227 -0.92 . . . . 0.0 109.759 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.526 HG23 ' CD1' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -99.71 153.18 4.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -129.93 179.34 5.92 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.049 -1.032 . . . . 0.0 109.939 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.573 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 25.4 t -109.01 146.59 34.16 Favored Pre-proline 0 C--N 1.296 -1.757 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.544 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.573 ' HD2' ' CG1' ' A' ' 101' ' ' VAL . 12.1 Cg_exo -53.72 137.8 67.38 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.223 1.949 . . . . 0.0 109.762 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.555 ' CB ' ' HD2' ' A' ' 104' ' ' ARG . 1.3 m-20 -47.14 -26.28 1.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.884 -1.135 . . . . 0.0 108.417 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -117.4 -167.34 1.3 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.18 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 106' ' ' TRP . 11.8 pt20 -160.07 27.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.056 . . . . 0.0 109.75 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.504 ' NE1' ' N ' ' A' ' 75' ' ' THR . 41.4 m95 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.67 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.451 ' S1 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.46 ' O ' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -147.88 161.99 40.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 109.355 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.535 ' CG1' HD23 ' A' ' 23' ' ' LEU . 1.5 t -147.04 132.04 11.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.304 -0.873 . . . . 0.0 109.301 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 13' ' ' ARG . 72.2 t -129.32 127.7 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.649 ' CE2' ' CD2' ' A' ' 15' ' ' LEU . 44.5 m-85 -97.57 153.72 17.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.818 -1.176 . . . . 0.0 110.263 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.522 HG23 ' CD ' ' A' ' 12' ' ' ARG . 2.6 t -132.46 141.77 44.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -76.77 -156.78 0.08 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.258 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -58.18 -105.93 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -112.07 77.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.477 -1.389 . . . . 0.0 108.887 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.05 -100.39 0.19 Allowed Glycine 0 N--CA 1.493 2.439 0 C-N-CA 118.931 -1.605 . . . . 0.0 111.027 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.469 ' O ' HG11 ' A' ' 6' ' ' VAL . 1.3 m -119.56 -177.27 3.34 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.333 -1.098 . . . . 0.0 110.061 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.533 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 12.8 ptt180 -153.0 147.79 26.33 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.523 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 8.0 mtt180 -106.25 173.47 6.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 108.522 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.451 ' C ' HD21 ' A' ' 15' ' ' LEU . 4.0 pt20 -123.76 163.76 20.53 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.004 -1.06 . . . . 0.0 110.567 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.649 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -169.71 -175.32 2.08 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -131.9 91.33 2.96 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.063 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.528 ' CG1' ' HB3' ' A' ' 90' ' ' MET . 46.9 t -62.2 153.38 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 108.872 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.528 ' CB ' HG23 ' A' ' 21' ' ' VAL . . . -91.03 172.37 8.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.0 . . . . 0.0 109.496 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -78.19 125.25 29.07 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.323 -0.861 . . . . 0.0 109.029 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.79 26.89 28.15 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.528 HG23 ' CB ' ' A' ' 18' ' ' ALA . 2.1 t -120.89 163.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -1.15 . . . . 0.0 109.172 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.5 t -106.07 140.72 38.62 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 108.534 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.535 HD23 ' CG1' ' A' ' 3' ' ' VAL . 12.1 mt -46.38 -26.08 0.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.099 -1.001 . . . . 0.0 108.623 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 22.0 ttt -71.71 -47.96 50.44 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.523 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 3.2 tp-100 -51.34 -55.5 18.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 108.836 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.403 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -54.1 -31.38 51.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.904 . . . . 0.0 108.903 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.504 ' HA ' HG12 ' A' ' 32' ' ' ILE . . . -61.19 -39.51 90.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.344 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.537 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 49.0 t -46.16 -22.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.857 . . . . 0.0 110.446 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 t -110.64 -50.29 2.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.019 -1.051 . . . . 0.0 110.325 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.515 ' ND2' HD12 ' A' ' 15' ' ' LEU . 56.1 m-80 -59.56 -11.64 5.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 110.123 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.412 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 98.88 -31.49 8.13 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.585 HG13 ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -51.53 -21.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.215 -1.168 . . . . 0.0 109.178 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.626 ' CG ' ' N ' ' A' ' 34' ' ' ASP . 1.2 p90 -43.16 -47.89 6.32 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.626 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 1.2 t0 -87.12 -21.2 26.14 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.496 ' CG1' ' HA ' ' A' ' 32' ' ' ILE . 4.5 mm -85.71 5.72 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.936 -1.102 . . . . 0.0 109.437 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.458 ' CG2' ' SG ' ' A' ' 85' ' ' CYS . 10.0 p -170.52 171.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.24 173.83 39.82 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.552 ' CB ' ' CG2' ' A' ' 47' ' ' THR . 6.9 t0 -169.96 -89.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -1.107 . . . . 0.0 109.542 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 44' ' ' SER . 17.7 p -65.05 -22.78 67.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.155 -0.966 . . . . 0.0 109.525 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.6 -177.18 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.55 -109.84 3.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.0 -177.16 3.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -1.152 . . . . 0.0 109.449 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . . . -61.81 110.11 1.44 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.431 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -134.98 8.36 3.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.45 ' SG ' HG21 ' A' ' 47' ' ' THR . 9.0 p -165.46 -160.51 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.659 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB2' HG13 ' A' ' 74' ' ' VAL . . . -145.52 13.36 1.37 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.502 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.552 ' CG2' ' CB ' ' A' ' 38' ' ' ASP . 8.8 t -78.51 -18.75 54.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.585 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.493 ' HB2' ' CB ' ' A' ' 85' ' ' CYS . 21.8 p -87.54 41.9 1.01 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 0.0 109.948 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.644 ' CE1' ' O ' ' A' ' 77' ' ' GLU . 14.6 t60 -70.54 76.13 0.57 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.526 HG12 ' CB ' ' A' ' 85' ' ' CYS . 8.4 m -80.02 144.74 10.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 120.214 -1.554 . . . . 0.0 110.673 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.506 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 2.0 m-85 -110.98 102.72 11.18 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.521 ' CG2' HG11 ' A' ' 99' ' ' VAL . 7.0 t -101.13 156.32 4.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.85 0.834 . . . . 0.0 112.859 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.557 ' OD1' ' HB ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -46.22 177.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.468 0.651 . . . . 0.0 109.267 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.479 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -101.68 -0.28 34.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 110.115 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.57 -22.81 11.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.97 -1.081 . . . . 0.0 110.649 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.609 ' CD1' ' HB ' ' A' ' 97' ' ' ILE . 65.8 m-85 -91.71 -27.08 18.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.988 -1.07 . . . . 0.0 109.747 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.51 HG22 ' ND2' ' A' ' 81' ' ' ASN . 5.8 p -58.07 -38.13 75.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.18 -0.95 . . . . 0.0 109.475 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 1.2 m-20 -57.46 -64.61 0.83 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.777 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.527 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 46.2 mmtt -49.81 -37.96 32.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.912 . . . . 0.0 109.396 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.524 ' CG2' HG23 ' A' ' 88' ' ' ILE . 1.1 t -54.91 157.37 5.71 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.951 . . . . 0.0 108.754 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.523 ' N ' HG11 ' A' ' 60' ' ' VAL . 5.6 Cg_exo -56.13 156.83 19.08 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.087 1.858 . . . . 0.0 110.309 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.52 61.13 0.6 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.325 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.511 ' HB1' ' NH2' ' A' ' 83' ' ' ARG . . . -40.83 146.46 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.626 -0.671 . . . . 0.0 109.689 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -51.59 -174.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.679 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.462 ' HA ' HD11 ' A' ' 68' ' ' ILE . 58.0 tt0 -96.71 -9.81 28.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.86 . . . . 0.0 109.543 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -50.3 -49.12 54.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.927 . . . . 0.0 109.516 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 28.0 mt-10 -74.59 -21.35 59.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.435 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.568 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -68.21 -35.32 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.878 . . . . 0.0 109.314 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.59 -52.6 44.24 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -66.84 -24.31 66.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -1.15 . . . . 0.0 109.273 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.518 ' HA ' ' CG1' ' A' ' 74' ' ' VAL . 5.7 tp -88.24 -7.29 57.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.378 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -80.09 -37.64 33.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.334 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.413 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 42.6 t -104.2 38.61 1.82 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.393 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.518 ' CG1' ' HA ' ' A' ' 71' ' ' LEU . 16.4 m -63.17 174.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.85 . . . . 0.0 109.597 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 98.3 m -65.28 -9.37 23.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.747 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.522 ' HA ' ' CZ ' ' A' ' 104' ' ' ARG . . . -116.5 -149.92 0.45 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 109.511 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.644 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.2 pt-20 -111.52 155.24 23.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.635 ' CD1' ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -129.8 135.66 48.68 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 117.991 -1.483 . . . . 0.0 111.454 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -117.83 171.02 5.45 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 4.4 Cg_exo -57.52 -10.6 7.13 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 C-N-CA 122.394 2.063 . . . . 0.0 111.09 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.51 ' ND2' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER -104.78 16.57 25.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 0.0 111.499 -178.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.602 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.4 m -100.26 161.09 13.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.675 -1.266 . . . . 0.0 110.029 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.514 ' NH1' ' O ' ' A' ' 61' ' ' PRO . 1.5 mtp180 -161.62 -165.11 1.22 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 109.287 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.53 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 1.7 mp -104.95 131.09 52.89 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.314 -0.866 . . . . 0.0 108.887 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.526 ' CB ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -67.13 -10.41 49.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.399 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.1 p -110.35 15.26 22.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.797 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -131.95 -0.55 3.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.007 . . . . 0.0 109.925 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.53 ' CG1' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -97.9 147.14 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.03 -1.044 . . . . 0.0 108.97 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 90' ' ' MET . 10.7 mm -121.3 165.68 16.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.293 -0.88 . . . . 0.0 109.775 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.534 ' HG3' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -122.97 90.33 3.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.352 -0.842 . . . . 0.0 109.341 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.01 162.48 40.78 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.417 -0.802 . . . . 0.0 109.303 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.0 -13.99 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.151 1.901 . . . . 0.0 110.233 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' A' ' 94' ' ' LEU . 21.6 pt-20 -70.92 -45.92 63.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.43 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -78.46 144.4 35.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -146.41 122.03 10.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 75.22 39.53 36.5 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.609 ' HB ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -78.11 134.66 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.441 -1.035 . . . . 0.0 109.197 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.557 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 2.0 t -107.23 110.12 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.976 -1.078 . . . . 0.0 110.012 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.525 HG12 ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -100.82 146.57 9.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.487 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 1.6 m-20 -122.15 174.25 7.07 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.968 -1.083 . . . . 0.0 110.256 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.616 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 39.7 t -108.01 145.21 30.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.633 ' HG3' ' HB3' ' A' ' 49' ' ' HIS . 7.2 Cg_exo -50.95 159.82 2.26 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.492 2.128 . . . . 0.0 111.548 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -14.7 60.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.596 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.522 ' CZ ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -119.87 -159.51 0.78 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 106' ' ' TRP . 3.8 pt20 -159.87 27.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.025 -1.047 . . . . 0.0 109.78 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.576 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 5.9 m95 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.658 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -147.48 168.39 22.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -0.863 . . . . 0.0 109.253 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.525 HG13 ' CD2' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -153.54 129.95 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.295 -0.878 . . . . 0.0 109.677 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 13' ' ' ARG . 77.7 t -130.17 135.42 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 108.651 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.635 ' CE1' ' CD2' ' A' ' 15' ' ' LEU . 0.5 OUTLIER -104.0 155.14 18.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.922 -1.111 . . . . 0.0 109.393 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 101' ' ' VAL . 2.4 t -135.25 133.02 52.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.536 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -80.0 -174.27 4.36 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -50.02 161.48 0.26 Allowed 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.528 ' C ' ' O ' ' A' ' 8' ' ' HIS . 33.9 t0 -29.86 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.147 0.499 . . . . 0.0 110.72 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 8' ' ' HIS . . . -167.45 -95.51 0.1 Allowed Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.484 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.459 ' O ' HG11 ' A' ' 6' ' ' VAL . 1.6 m -124.97 -178.53 4.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -1.186 . . . . 0.0 109.77 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -157.15 142.64 17.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.625 -0.672 . . . . 0.0 110.032 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.525 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -100.33 176.2 5.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.255 -0.903 . . . . 0.0 108.899 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -132.43 160.83 35.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.126 -0.984 . . . . 0.0 110.52 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.635 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -177.14 -176.04 0.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.579 0.704 . . . . 0.0 109.115 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -128.94 113.88 15.76 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.581 -0.699 . . . . 0.0 109.965 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.525 HG21 ' CB ' ' A' ' 26' ' ' ALA . 28.6 t -78.12 133.37 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.046 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.527 ' CB ' HG22 ' A' ' 21' ' ' VAL . . . -69.76 171.81 8.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.498 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -78.44 125.25 29.09 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.269 -0.895 . . . . 0.0 109.084 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.16 39.59 7.86 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.527 HG22 ' CB ' ' A' ' 18' ' ' ALA . 1.5 t -131.11 160.69 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -1.117 . . . . 0.0 109.327 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -99.35 135.07 41.29 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 108.65 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.525 ' CD2' HG13 ' A' ' 3' ' ' VAL . 6.6 mt -46.28 -26.24 0.77 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.965 -1.085 . . . . 0.0 108.6 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.401 ' HE1' ' HB2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -72.74 -47.45 46.86 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.6 tp60 -51.97 -55.08 22.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.36 -0.837 . . . . 0.0 108.845 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.525 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -57.67 -28.5 63.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 108.737 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.525 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -68.09 -33.89 75.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.47 -0.769 . . . . 0.0 109.451 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.575 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 53.7 t -54.58 -39.89 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.475 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 t -79.87 -51.78 8.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.858 . . . . 0.0 109.398 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.46 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 29.4 m-80 -58.57 -13.41 5.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.424 -0.798 . . . . 0.0 109.567 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.47 14.54 78.18 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.537 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 1.2 mt -90.41 -34.65 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -1.146 . . . . 0.0 108.851 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -51.48 -37.06 47.12 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.624 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 5.3 t0 -82.83 -26.94 31.21 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.537 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 4.8 tp -44.48 -26.13 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 109.325 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.504 ' N ' HG21 ' A' ' 35' ' ' ILE . 2.5 p -131.17 -52.15 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.563 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 38' ' ' ASP . . . 69.2 120.12 0.03 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 94.9 m-20 -136.4 -120.36 0.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -1.171 . . . . 0.0 109.53 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.522 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . 16.7 p -109.79 -6.48 15.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.75 -1.219 . . . . 0.0 109.594 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 44.62 -168.51 0.02 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 43.89 -125.95 5.69 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.12 63.86 1.46 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -1.121 . . . . 0.0 109.543 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 39' ' ' CYS . . . -88.8 -147.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 109.431 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.516 ' CB ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -139.78 60.86 1.55 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.152 -0.968 . . . . 0.0 109.773 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 38' ' ' ASP . 6.7 p -99.22 -164.57 1.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.033 -1.042 . . . . 0.0 109.379 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.519 ' O ' ' CG1' ' A' ' 74' ' ' VAL . . . -148.92 17.74 0.98 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.525 ' CG2' ' OD1' ' A' ' 38' ' ' ASP . 58.5 m -90.02 -17.19 28.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 84' ' ' LEU . 24.5 p -87.6 42.51 1.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 110.269 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.664 ' NE2' ' CE2' ' A' ' 51' ' ' TYR . 15.3 t60 -75.56 71.19 2.46 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 85' ' ' CYS . 12.7 m -77.88 146.1 8.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.257 -1.527 . . . . 0.0 110.168 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.664 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -112.53 100.71 8.95 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.309 1.052 . . . . 0.0 108.182 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.541 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 4.5 t -89.76 172.88 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.803 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.86 -178.36 1.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.88 -1.21 35.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 109.967 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.14 -14.38 14.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.085 -1.01 . . . . 0.0 110.187 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.608 ' CD2' ' HA ' ' A' ' 97' ' ' ILE . 80.3 m-85 -103.67 -21.42 13.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.975 . . . . 0.0 109.7 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.541 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -68.7 -6.47 26.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.563 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -88.08 -56.17 3.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.123 -0.986 . . . . 0.0 109.6 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.527 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 2.5 mptp? -52.29 -38.69 59.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -50.14 164.57 0.37 Allowed Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.17 -0.956 . . . . 0.0 109.414 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 5.8 Cg_exo -58.16 176.66 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.109 1.873 . . . . 0.0 110.353 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.25 59.37 0.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.29 120.73 1.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.483 -0.761 . . . . 0.0 109.553 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 63' ' ' ALA . 9.7 m-20 -57.0 -160.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 0.6 OUTLIER -100.05 -12.1 19.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.467 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.474 ' HD2' ' N ' ' A' ' 67' ' ' GLU . 5.1 ppt_? -54.51 -44.66 72.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.474 ' N ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -81.17 -14.51 57.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.404 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.454 ' HB ' ' HG2' ' A' ' 65' ' ' GLU . 26.0 mm -77.12 -32.17 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.476 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.13 -54.69 11.66 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.516 ' SD ' ' CB ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -67.89 -24.92 65.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -1.155 . . . . 0.0 109.257 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.537 ' CD2' ' CD2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -90.04 0.15 57.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.872 . . . . 0.0 109.43 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -89.99 -25.47 20.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.942 . . . . 0.0 109.299 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.64 34.55 2.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.426 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.525 HG23 ' CD1' ' A' ' 71' ' ' LEU . 2.1 t -63.38 165.01 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.581 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 28.4 m -71.68 -4.25 26.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.477 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.527 ' CB ' ' OD1' ' A' ' 103' ' ' ASP . . . -115.96 -149.8 0.45 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.114 -0.991 . . . . 0.0 109.34 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.63 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.7 pt-20 -112.19 155.06 24.59 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.632 ' CD1' ' CE1' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -133.49 166.34 22.78 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.465 -1.694 . . . . 0.0 112.547 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.518 ' HE2' ' CB ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -155.7 170.62 8.46 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 5.3 Cg_exo -56.45 -14.68 13.27 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 121.997 1.798 . . . . 0.0 109.992 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.518 ' CB ' ' HE2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -87.03 -30.33 21.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 0.0 110.71 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.598 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -74.62 152.87 39.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.021 -1.049 . . . . 0.0 110.354 -179.374 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.567 ' NH2' ' CG2' ' A' ' 88' ' ' ILE . 8.8 mtp180 -161.8 -175.38 4.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.545 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 4.9 mp -98.99 103.43 15.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.324 -0.86 . . . . 0.0 108.698 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.536 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 6.1 p -48.85 -21.99 0.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.142 -0.974 . . . . 0.0 109.924 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 20.7 p -76.57 -40.11 50.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.084 -1.01 . . . . 0.0 110.093 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.484 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -89.74 38.44 0.91 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.112 -0.992 . . . . 0.0 110.405 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.567 ' CG2' ' NH2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -140.06 149.01 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.975 -1.078 . . . . 0.0 109.312 179.294 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 90' ' ' MET . 12.7 mm -116.23 167.09 9.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.421 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.541 ' CE ' HG23 ' A' ' 97' ' ' ILE . 12.9 tpt -130.18 96.87 4.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.525 ' CG2' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -95.53 171.45 6.44 Favored Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 121.549 -0.72 . . . . 0.0 109.385 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.525 ' HD2' ' CG2' ' A' ' 91' ' ' THR . 5.6 Cg_exo -59.03 -14.49 23.42 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.05 1.833 . . . . 0.0 110.054 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.45 ' OE1' ' HB3' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -62.8 -37.23 85.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 109.312 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -95.07 139.75 30.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.234 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 11.2 p-10 -138.72 124.68 19.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.803 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.469 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 71.51 39.22 61.37 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.608 ' HA ' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -72.91 147.66 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -1.107 . . . . 0.0 109.302 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.432 ' C ' HD12 ' A' ' 97' ' ' ILE . 3.5 t -116.75 106.73 20.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 O-C-N 121.126 -0.983 . . . . 0.0 109.853 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.525 HG11 ' CD1' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -101.25 142.71 15.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.499 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 3.1 m-20 -122.97 177.44 5.5 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.967 -1.083 . . . . 0.0 110.269 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.626 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 44.8 t -108.49 145.07 30.8 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.638 ' HG3' ' HB3' ' A' ' 49' ' ' HIS . 7.7 Cg_exo -51.14 -174.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.263 1.975 . . . . 0.0 111.293 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -100.7 -27.03 13.59 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -130.07 149.7 51.67 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -122.93 41.94 3.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.044 -1.035 . . . . 0.0 109.849 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.581 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 43.6 m95 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.476 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.512 ' S1 ' ' CD2' ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.47 ' O ' ' HE1' ' A' ' 90' ' ' MET . 0.1 OUTLIER -138.29 169.51 17.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.215 -0.928 . . . . 0.0 109.428 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.534 ' CG1' HD23 ' A' ' 23' ' ' LEU . 11.3 t -152.34 158.64 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.272 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.532 ' CG1' ' HD2' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -157.8 120.67 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.104 -0.998 . . . . 0.0 108.905 -179.409 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.654 ' CE2' ' CD2' ' A' ' 15' ' ' LEU . 54.9 m-85 -98.5 155.62 17.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.66 -1.275 . . . . 0.0 110.634 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.474 ' CG2' ' HG3' ' A' ' 12' ' ' ARG . 3.0 t -130.84 142.48 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -76.5 -158.53 0.1 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 103' ' ' ASP . 0.3 OUTLIER -58.31 -103.97 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.18 75.15 0.9 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.482 -1.386 . . . . 0.0 108.496 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.29 -100.42 0.24 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 118.863 -1.636 . . . . 0.0 111.453 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.46 ' O ' HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -114.9 -176.59 2.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.289 -1.124 . . . . 0.0 110.584 -178.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.535 ' CG ' ' O ' ' A' ' 5' ' ' TYR . 13.7 ttp180 -149.27 134.59 18.35 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.522 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 6.6 mtt180 -105.11 171.51 7.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.941 -1.1 . . . . 0.0 108.774 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.469 ' HA ' HG11 ' A' ' 4' ' ' VAL . 1.7 mt-30 -127.08 163.47 23.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.949 -1.094 . . . . 0.0 111.141 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.654 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -161.65 -172.96 3.53 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.671 0.748 . . . . 0.0 109.019 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 17' ' ' VAL . 46.4 t0 -131.22 69.96 1.47 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.627 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.525 HG12 ' CB ' ' A' ' 90' ' ' MET . 26.6 t -43.81 163.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.185 -0.947 . . . . 0.0 109.068 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.511 ' CB ' HG23 ' A' ' 21' ' ' VAL . . . -105.07 173.1 6.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.959 . . . . 0.0 109.744 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -81.99 125.81 31.22 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.371 -0.831 . . . . 0.0 108.898 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.11 23.3 38.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.523 ' CG1' ' HB3' ' A' ' 25' ' ' GLN . 3.0 t -118.04 167.34 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.43 -1.041 . . . . 0.0 109.113 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 23' ' ' LEU . 10.4 t -105.89 137.45 43.75 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.574 HD21 ' CE1' ' A' ' 5' ' ' TYR . 8.3 mt -44.9 -26.69 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.051 . . . . 0.0 108.794 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 3.3 ttm -75.03 -47.53 28.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.523 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -49.8 -54.77 17.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 108.803 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.524 ' CB ' HG21 ' A' ' 17' ' ' VAL . . . -52.24 -35.81 50.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.263 -0.898 . . . . 0.0 108.971 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.518 ' HA ' HG12 ' A' ' 32' ' ' ILE . . . -42.15 -42.38 2.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.849 . . . . 0.0 110.076 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.558 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 63.6 t -39.65 -50.41 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.19 -0.944 . . . . 0.0 110.588 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -90.8 -45.36 8.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.876 . . . . 0.0 110.017 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.537 ' OD1' ' CD1' ' A' ' 15' ' ' LEU . 2.4 m120 -50.13 -17.19 0.38 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.725 -0.609 . . . . 0.0 109.774 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.31 -21.64 36.78 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.623 HG13 ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -66.62 -22.17 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.254 -1.144 . . . . 0.0 108.554 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.558 ' CB ' ' HA ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -48.02 -28.74 2.96 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 179.076 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -100.17 -23.39 14.85 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.536 ' CG1' ' HA ' ' A' ' 32' ' ' ILE . 18.6 mm -60.36 -51.14 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.089 -1.007 . . . . 0.0 109.405 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.442 HG21 ' N ' ' A' ' 37' ' ' GLY . 11.8 m -134.06 -153.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.935 . . . . 0.0 109.538 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.442 ' N ' HG21 ' A' ' 36' ' ' VAL . . . 112.83 150.89 10.99 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.516 ' OD1' ' CB ' ' A' ' 45' ' ' CYS . 6.8 t70 -152.17 -92.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.178 -1.19 . . . . 0.0 109.714 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.513 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 15.6 p -85.27 -33.28 22.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.987 . . . . 0.0 109.603 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 56.57 162.23 0.03 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.01 -103.67 2.26 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.26 169.4 8.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -1.159 . . . . 0.0 109.488 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.58 ' CB ' ' CD2' ' A' ' 71' ' ' LEU . . . -65.5 111.95 3.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.488 ' HB2' ' CB ' ' A' ' 39' ' ' CYS . 44.3 m -140.73 11.3 2.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.652 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.516 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . 8.9 p -157.32 -157.41 0.67 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 109.626 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 73' ' ' CYS . . . -150.0 15.22 0.83 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.687 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.487 HG21 ' CB ' ' A' ' 105' ' ' GLN . 22.0 m -82.05 -18.41 43.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.355 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.464 ' HB2' ' SG ' ' A' ' 85' ' ' CYS . 23.4 p -86.34 43.13 1.04 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 110.112 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.654 ' NE2' ' CE2' ' A' ' 51' ' ' TYR . 48.0 t60 -77.36 65.56 2.94 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 85' ' ' CYS . 8.8 m -74.94 143.33 13.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.284 -1.51 . . . . 0.0 110.449 -177.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.654 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 1.0 OUTLIER -109.46 109.55 20.41 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 7.1 t -97.28 171.42 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-O 122.005 0.907 . . . . 0.0 112.531 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.509 ' O ' ' ND2' ' A' ' 81' ' ' ASN . 0.4 OUTLIER -65.33 176.8 1.26 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.298 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.75 7.72 45.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.151 -0.968 . . . . 0.0 109.626 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.33 -27.96 8.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.883 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.583 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 88.1 m-85 -98.27 -18.54 18.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.739 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.534 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -62.5 -39.01 92.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.611 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.38 -41.18 94.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 109.776 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.564 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -54.41 -42.65 70.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.907 . . . . 0.0 109.579 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.537 ' CG1' ' HD2' ' A' ' 61' ' ' PRO . 62.3 t -62.54 142.38 96.57 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.084 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.537 ' HD2' ' CG1' ' A' ' 60' ' ' VAL . 5.7 Cg_exo -56.36 168.8 1.89 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.075 1.85 . . . . 0.0 110.468 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.48 63.51 0.61 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.366 -0.834 . . . . 0.0 109.125 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -36.52 139.66 0.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.275 0.56 . . . . 0.0 110.068 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -50.52 -177.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.347 -0.846 . . . . 0.0 109.804 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.524 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 23.9 tt0 -97.07 -12.77 22.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 109.507 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -50.07 -67.18 0.28 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.456 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -66.09 -10.22 38.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.524 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 26.5 mm -76.38 -31.93 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.521 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.77 -54.91 8.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.3 mtt -68.25 -26.28 65.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -1.15 . . . . 0.0 108.987 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.58 ' CD2' ' CB ' ' A' ' 43' ' ' ALA . 38.3 mt -84.21 -2.96 57.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.35 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.415 ' C ' ' OE1' ' A' ' 72' ' ' GLU . 0.6 OUTLIER -91.13 -10.11 43.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.289 -0.882 . . . . 0.0 109.353 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -86.24 51.37 2.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.418 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.489 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 6.2 m -92.76 169.1 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 109.295 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.602 ' OG1' ' HG3' ' A' ' 104' ' ' ARG . 5.4 t -66.36 -34.56 78.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.797 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.405 ' N ' ' CG2' ' A' ' 75' ' ' THR . . . -106.62 -151.23 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.387 -0.821 . . . . 0.0 110.633 -178.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.558 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -112.51 149.9 32.03 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.559 ' HG ' ' HB2' ' A' ' 82' ' ' SER . 0.3 OUTLIER -108.29 165.44 11.5 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.609 -1.236 . . . . 0.0 110.465 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.53 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -158.97 172.87 5.57 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 6.0 Cg_exo -54.38 -18.77 15.43 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 121.309 1.339 . . . . 0.0 108.803 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 0.2 OUTLIER -83.18 -35.93 25.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.712 -0.617 . . . . 0.0 109.739 179.532 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.559 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -95.48 159.22 15.1 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.19 -0.944 . . . . 0.0 110.398 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.524 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -161.69 -164.22 1.08 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.343 -0.848 . . . . 0.0 109.03 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.581 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 1.3 mm? -104.19 123.53 47.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.53 ' HB3' ' CG1' ' A' ' 50' ' ' VAL . 13.9 p -64.13 -10.75 24.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.014 -1.054 . . . . 0.0 109.553 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 22.6 p -100.21 14.7 29.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.276 -0.89 . . . . 0.0 109.914 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -143.3 0.34 1.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.013 -1.054 . . . . 0.0 110.694 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.525 ' CG1' ' O ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -96.9 151.69 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.764 -1.21 . . . . 0.0 108.911 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.506 HG21 ' N ' ' A' ' 90' ' ' MET . 18.0 mm -124.23 158.66 30.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.165 -0.959 . . . . 0.0 109.927 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.531 ' HG3' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -120.93 90.33 3.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 109.176 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.4 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -82.0 167.07 33.38 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.399 -0.813 . . . . 0.0 109.456 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 3.3 Cg_exo -60.49 -13.33 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.115 1.877 . . . . 0.0 110.097 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.05 -39.99 65.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.564 ' CD2' ' CB ' ' A' ' 59' ' ' LYS . 4.6 mp -81.99 135.25 35.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.43 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.4 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 11.4 p-10 -135.67 124.24 23.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 68.25 49.28 47.14 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.583 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -75.9 151.11 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.187 -1.184 . . . . 0.0 108.455 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.458 ' N ' ' CD1' ' A' ' 97' ' ' ILE . 5.6 t -121.81 102.62 12.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.947 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -96.08 154.23 3.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -130.5 172.79 11.52 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.036 -1.04 . . . . 0.0 109.225 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.603 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 55.5 t -107.38 144.31 28.94 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.282 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.651 ' HG3' ' HB3' ' A' ' 49' ' ' HIS . 5.8 Cg_exo -57.26 -178.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.326 2.017 . . . . 0.0 110.364 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.595 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 6.9 t0 -90.2 -32.89 16.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 108.503 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.602 ' HG3' ' OG1' ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.17 -161.19 1.12 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.487 ' CB ' HG21 ' A' ' 47' ' ' THR . 7.8 pt20 -159.45 27.76 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.956 . . . . 0.0 109.535 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 73' ' ' CYS . 10.9 m95 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.459 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.514 ' S1 ' ' CD2' ' A' ' 71' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.34 0.59 . . . . 0.0 109.513 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.476 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 3.0 ttmt -139.54 174.42 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.06 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.551 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 5.0 t -152.58 157.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.742 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 67.2 t -156.93 117.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.805 . . . . 0.0 109.154 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.637 ' CZ ' ' CD1' ' A' ' 23' ' ' LEU . 1.2 m-85 -95.47 154.05 17.4 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.344 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.521 ' CG2' ' HB3' ' A' ' 12' ' ' ARG . 2.4 t -133.87 142.44 41.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 8' ' ' HIS . 6.9 t -77.65 -158.05 0.11 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.596 ' CG ' ' O ' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -58.08 -103.24 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -112.22 77.28 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.513 -1.367 . . . . 0.0 108.973 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.72 -101.06 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 118.977 -1.582 . . . . 0.0 111.093 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.458 ' O ' HG11 ' A' ' 6' ' ' VAL . 1.3 m -120.12 -176.56 3.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.298 -1.119 . . . . 0.0 109.932 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.546 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -152.71 138.53 17.98 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.738 -0.601 . . . . 0.0 109.981 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.46 ' NH2' HD12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -90.98 177.63 6.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.192 -0.943 . . . . 0.0 108.965 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 2.4 pt20 -140.5 128.18 21.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.211 -0.931 . . . . 0.0 110.37 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.617 ' CD2' ' CE1' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -139.7 -175.45 4.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.217 179.218 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.12 82.64 1.95 Allowed 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.943 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.532 ' CG2' ' CB ' ' A' ' 26' ' ' ALA . 42.8 t -59.72 111.92 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 109.009 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -43.56 168.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 109.925 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.448 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 57.5 m-20 -84.32 126.45 33.21 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.339 -0.851 . . . . 0.0 108.989 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.3 15.25 35.98 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.482 ' CG1' ' HB3' ' A' ' 25' ' ' GLN . 4.4 t -115.5 169.71 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.363 -1.081 . . . . 0.0 109.138 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -106.73 135.82 47.61 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.17 -0.957 . . . . 0.0 108.69 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.637 ' CD1' ' CZ ' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -44.35 -26.3 0.32 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.049 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.415 ' N ' ' O ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -73.24 -48.68 32.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.289 -0.882 . . . . 0.0 108.74 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.482 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 1.3 tp60 -53.16 -56.11 18.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.057 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.532 ' CB ' ' CG2' ' A' ' 17' ' ' VAL . . . -58.54 -26.9 64.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 108.911 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.515 ' HB3' ' N ' ' A' ' 33' ' ' TYR . . . -69.98 -32.39 70.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.429 -0.794 . . . . 0.0 109.215 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.565 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 59.8 t -52.95 -35.57 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.478 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -88.54 -52.26 5.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.479 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.513 ' ND2' HD12 ' A' ' 15' ' ' LEU . 24.9 m-80 -54.15 -16.21 1.92 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.656 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.45 ' O ' HG13 ' A' ' 35' ' ' ILE . . . 84.87 19.3 59.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.575 ' CD1' ' CG ' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -99.61 -27.64 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -1.156 . . . . 0.0 108.494 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.565 ' CD1' ' HA ' ' A' ' 28' ' ' VAL . 1.1 p90 -47.96 -44.89 30.68 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.554 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 0.9 OUTLIER -74.56 -31.4 62.09 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 35' ' ' ILE . 56.4 mt -60.94 -20.22 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 109.098 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 101' ' ' VAL . 2.5 p -170.1 112.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 109.515 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 38' ' ' ASP . . . 177.91 176.99 46.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.515 ' CB ' ' SG ' ' A' ' 45' ' ' CYS . 0.3 OUTLIER -163.1 -86.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -1.182 . . . . 0.0 109.803 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 41' ' ' GLY . 12.6 p -83.49 10.07 9.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.679 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 86' ' ' CYS . . . 51.93 -90.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 39' ' ' CYS . . . -54.46 -169.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.18 99.98 12.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -1.15 . . . . 0.0 109.481 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.461 ' HB1' ' SG ' ' A' ' 39' ' ' CYS . . . -118.07 -99.28 0.45 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.463 ' HA ' ' CG ' ' A' ' 70' ' ' MET . 13.6 t -160.57 40.64 0.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.918 -1.114 . . . . 0.0 109.965 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.515 ' SG ' ' CB ' ' A' ' 38' ' ' ASP . 1.7 p -99.99 149.86 23.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.068 . . . . 0.0 109.331 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 73' ' ' CYS . . . -105.89 23.78 13.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.474 ' CB ' ' CG ' ' A' ' 38' ' ' ASP . 22.0 m -90.25 -19.9 23.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.902 . . . . 0.0 109.756 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 21.9 p -91.03 42.73 1.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.099 -1.001 . . . . 0.0 110.287 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.635 ' CE1' ' O ' ' A' ' 77' ' ' GLU . 11.7 t60 -76.29 70.27 2.89 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.526 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 10.3 m -77.85 144.27 11.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 120.123 -1.611 . . . . 0.0 109.755 -178.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.626 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 0.9 OUTLIER -109.57 99.11 8.36 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.515 ' HB ' ' CG2' ' A' ' 57' ' ' THR . 3.8 t -89.98 173.98 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.844 0.831 . . . . 0.0 112.124 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -68.88 -177.94 1.11 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.19 -1.64 33.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.139 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.3 -21.61 12.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.996 -1.065 . . . . 0.0 110.446 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.603 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 85.5 m-85 -95.18 -23.79 17.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.024 -1.047 . . . . 0.0 109.895 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.515 ' CG2' ' HB ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -63.46 -34.1 77.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.149 -0.969 . . . . 0.0 109.39 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.61 -63.77 1.0 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.549 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.524 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 20.3 mmtp -49.88 -23.41 1.91 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.929 . . . . 0.0 109.385 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.53 ' CG2' HG23 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -57.94 162.71 5.01 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 108.994 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.528 ' HD2' ' CG2' ' A' ' 60' ' ' VAL . 5.5 Cg_exo -58.71 171.38 2.03 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.128 1.885 . . . . 0.0 110.243 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.22 59.65 0.61 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -0.922 . . . . 0.0 109.507 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.574 ' CB ' ' NH2' ' A' ' 83' ' ' ARG . . . -42.43 151.95 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.45 -0.781 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -61.72 -162.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 109.56 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.525 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 2.0 tm-20 -100.16 -22.18 15.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 109.543 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.442 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.7 mtt180 -43.9 -56.99 3.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HB2' HD23 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -64.63 -30.84 71.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.525 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 36.9 mm -56.0 -43.82 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 109.528 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.76 -30.13 62.22 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.508 ' N ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -68.5 -16.08 63.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -1.131 . . . . 0.0 109.342 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.528 ' HG ' ' CD1' ' A' ' 78' ' ' LEU . 10.0 tp -90.89 -8.95 48.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.81 -23.0 42.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.388 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -85.32 45.14 1.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.89 . . . . 0.0 109.462 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.517 ' CG1' ' HB3' ' A' ' 46' ' ' ALA . 4.1 m -106.59 163.8 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.388 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.575 ' OG1' ' CZ2' ' A' ' 106' ' ' TRP . 96.0 m -85.44 6.69 25.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.942 . . . . 0.0 109.544 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.47 -156.12 0.59 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.132 -0.98 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.635 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.7 pt-20 -112.55 151.42 30.03 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.628 ' CD1' ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -128.03 159.83 33.83 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 117.912 -1.515 . . . . 0.0 111.631 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.539 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -149.37 171.38 6.38 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 5.0 Cg_exo -56.59 -15.02 14.55 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 121.956 1.77 . . . . 0.0 109.84 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.515 ' ND2' HG22 ' A' ' 57' ' ' THR . 2.7 t-20 -86.53 -30.93 21.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.392 -0.818 . . . . 0.0 110.542 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.611 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -68.59 159.25 32.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.953 -1.092 . . . . 0.0 110.481 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.574 ' NH2' ' CB ' ' A' ' 63' ' ' ALA . 2.6 mtp180 -161.53 166.38 27.14 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.365 -0.834 . . . . 0.0 109.124 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.521 ' HG ' ' CD1' ' A' ' 71' ' ' LEU . 6.2 mp -79.76 118.94 22.01 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.157 -0.965 . . . . 0.0 108.598 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.526 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . 2.2 t -47.12 -24.35 0.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 109.475 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 30.6 p -88.19 30.88 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 0.0 109.769 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.424 ' NE2' ' HB3' ' A' ' 63' ' ' ALA . 7.8 mm100 -149.66 12.65 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.049 -1.032 . . . . 0.0 109.994 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.53 HG23 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -108.87 140.52 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.082 -1.012 . . . . 0.0 108.704 179.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.47 HD11 ' O ' ' A' ' 21' ' ' VAL . 23.9 mm -125.91 146.03 32.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.762 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.524 ' HB2' ' CG1' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -98.32 83.31 3.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -0.852 . . . . 0.0 109.112 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 p -81.83 155.99 70.29 Favored Pre-proline 0 C--N 1.297 -1.686 0 O-C-N 121.486 -0.759 . . . . 0.0 109.203 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 19' ' ' ASP . 6.3 Cg_exo -58.42 -14.94 22.42 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.021 1.814 . . . . 0.0 109.905 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -73.12 -41.19 64.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.836 . . . . 0.0 109.323 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.524 ' CD2' ' HB2' ' A' ' 59' ' ' LYS . 5.6 mp -86.11 142.68 28.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -138.16 126.35 22.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.703 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.591 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 68.14 49.72 44.79 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.603 ' HA ' ' CG ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -77.79 151.71 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.224 -1.162 . . . . 0.0 108.878 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.43 ' O ' HG11 ' A' ' 52' ' ' VAL . 4.8 t -122.06 104.7 15.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.034 -1.041 . . . . 0.0 110.363 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.494 ' CG1' HD13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -98.93 144.86 11.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.04 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -122.79 176.3 6.05 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.914 -1.116 . . . . 0.0 109.733 -179.288 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.607 ' CG1' ' HD2' ' A' ' 102' ' ' PRO . 51.0 t -108.6 144.02 28.7 Favored Pre-proline 0 C--N 1.298 -1.641 0 C-N-CA 119.671 -0.812 . . . . 0.0 108.943 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.626 ' HB3' ' HB3' ' A' ' 49' ' ' HIS . 4.1 Cg_exo -54.36 172.37 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.461 2.107 . . . . 0.0 111.492 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.421 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -82.03 -17.53 46.45 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.533 ' HG2' ' CG2' ' A' ' 75' ' ' THR . 0.0 OUTLIER -128.87 107.4 9.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.381 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 106' ' ' TRP . 8.3 pt20 -79.76 5.03 14.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.145 -0.972 . . . . 0.0 109.59 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.575 ' CZ2' ' OG1' ' A' ' 75' ' ' THR . 62.2 m95 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.495 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.517 ' S1 ' ' CD2' ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.318 0.58 . . . . 0.0 109.504 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.408 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -151.48 159.38 44.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.187 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.839 HG11 HD22 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -147.95 125.2 3.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.211 -0.93 . . . . 0.0 109.38 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 99' ' ' VAL . 97.4 t -126.01 129.64 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 108.887 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.161 ' CD2' HG21 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -97.69 154.59 17.48 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.944 -1.097 . . . . 0.0 109.374 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.942 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.1 t -123.96 170.19 14.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.446 -0.784 . . . . 0.0 108.977 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.602 ' H ' HG12 ' A' ' 6' ' ' VAL . 14.6 p -121.43 162.89 19.65 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.477 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.43 -8.38 13.26 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 120.872 -1.142 . . . . 0.0 109.051 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 4.5 t70 -110.25 -6.06 15.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.114 -0.991 . . . . 0.0 110.316 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.41 -31.75 5.67 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.266 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.768 HG22 ' NH1' ' A' ' 13' ' ' ARG . 54.1 m -49.71 114.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.043 -1.269 . . . . 0.0 109.486 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 18.3 ptt180 -130.78 126.05 35.33 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.596 -0.69 . . . . 0.0 109.694 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 1.041 ' NH2' HG21 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -104.24 125.96 50.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.949 . . . . 0.0 108.714 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -85.83 157.37 20.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.122 -0.986 . . . . 0.0 110.567 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.1 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -167.4 -177.32 3.57 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.698 0.761 . . . . 0.0 109.334 179.153 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.41 106.23 8.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.714 -0.616 . . . . 0.0 109.574 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.961 HG21 HD23 ' A' ' 23' ' ' LEU . 78.5 t -81.05 108.71 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.404 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.614 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -46.31 172.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.548 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 75.1 m-20 -83.27 125.19 31.33 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.327 -0.858 . . . . 0.0 109.137 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.81 29.31 8.74 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.908 ' O ' HG23 ' A' ' 89' ' ' ILE . 2.1 t -130.58 170.96 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.342 -1.093 . . . . 0.0 109.378 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.509 ' HB2' ' CD1' ' A' ' 89' ' ' ILE . 13.2 t -115.92 146.43 42.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 108.926 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.961 HD23 HG21 ' A' ' 17' ' ' VAL . 16.2 mt -47.53 -25.48 1.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.961 -1.087 . . . . 0.0 108.478 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.579 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 24.2 ptt? -71.6 -46.3 59.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.847 . . . . 0.0 108.832 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 1.049 ' O ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -55.14 -56.54 18.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.144 -0.972 . . . . 0.0 108.805 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 30' ' ' ASN . . . -60.17 -19.25 53.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.3 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 24' ' ' MET . . . -70.76 -40.07 72.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.847 . . . . 0.0 110.127 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.049 HG22 ' O ' ' A' ' 25' ' ' GLN . 32.6 m -45.65 -33.05 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.181 -0.95 . . . . 0.0 110.366 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 31' ' ' GLY . 3.7 t -107.39 -59.64 1.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 109.815 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.842 ' OD1' HD13 ' A' ' 15' ' ' LEU . 7.5 m120 -38.8 -27.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.342 0.592 . . . . 0.0 109.989 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 107.63 -9.69 38.04 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.161 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -68.29 -13.15 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -1.223 . . . . 0.0 107.913 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.554 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -49.51 -28.72 5.77 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 178.284 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -92.15 -30.16 16.1 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.065 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.041 HG21 ' NH2' ' A' ' 13' ' ' ARG . 3.0 mt -105.83 40.66 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.128 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.832 HG13 ' N ' ' A' ' 37' ' ' GLY . 1.3 p -143.16 -151.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.832 ' N ' HG13 ' A' ' 36' ' ' VAL . . . -72.0 -159.91 4.39 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -141.5 -53.95 0.46 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.974 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 42' ' ' SER . 15.1 p -63.7 -11.1 23.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.079 -1.013 . . . . 0.0 109.695 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 86' ' ' CYS . . . 85.19 -164.99 39.0 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.513 ' CA ' ' HB2' ' A' ' 86' ' ' CYS . . . -42.56 -27.43 0.5 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 67.8 p -59.91 168.86 1.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -1.15 . . . . 0.0 109.37 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.451 ' O ' ' SD ' ' A' ' 70' ' ' MET . . . -128.68 71.04 1.39 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -124.71 -10.81 7.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.791 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.522 ' O ' ' CE ' ' A' ' 70' ' ' MET . 1.8 p -111.83 -178.92 3.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.662 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.736 ' HB3' ' NE1' ' A' ' 106' ' ' TRP . . . -133.03 12.89 4.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.181 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.856 HG22 ' CB ' ' A' ' 106' ' ' TRP . 5.6 p -75.57 -16.15 60.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.448 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.502 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 25.6 p -86.72 41.61 0.96 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.289 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.04 ' CE1' HD12 ' A' ' 78' ' ' LEU . 26.7 t60 -82.25 64.16 6.78 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 83' ' ' ARG . 12.5 m -80.68 147.22 6.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.55 -1.344 . . . . 0.0 110.076 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.639 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 8.0 m-85 -107.86 106.41 16.68 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.695 ' HB ' HG23 ' A' ' 57' ' ' THR . 4.5 t -89.78 166.79 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.791 0.805 . . . . 0.0 112.151 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.483 ' N ' HG12 ' A' ' 52' ' ' VAL . 1.2 m-20 -64.61 -176.79 0.27 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -100.64 -6.6 24.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 110.28 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.5 1.53 18.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.965 -1.084 . . . . 0.0 110.463 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.634 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 49.5 m-85 -115.14 -20.96 10.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.93 -1.106 . . . . 0.0 110.087 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.695 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -78.36 1.44 21.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.991 -1.068 . . . . 0.0 109.523 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -85.08 -58.62 2.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.673 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.831 ' CB ' HD11 ' A' ' 94' ' ' LEU . 3.4 mptt -49.98 -39.93 42.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.569 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -56.68 164.36 2.19 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.136 -0.977 . . . . 0.0 109.412 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 4.8 Cg_exo -59.16 172.14 1.93 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.149 1.899 . . . . 0.0 110.261 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.14 59.39 0.61 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.379 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.05 111.27 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.523 -0.736 . . . . 0.0 109.56 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 63' ' ' ALA . 5.8 m-20 -57.11 -160.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.665 ' HA ' HD12 ' A' ' 68' ' ' ILE . 21.1 tt0 -85.07 -10.36 56.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -48.28 -67.62 0.26 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -65.63 -12.94 57.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.503 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 65' ' ' GLU . 14.5 mt -73.89 -31.92 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.75 -58.58 4.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.522 ' CE ' ' O ' ' A' ' 45' ' ' CYS . 6.1 ptm -67.95 -27.04 66.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -1.141 . . . . 0.0 109.298 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.062 HD13 HG11 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -89.99 6.41 42.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.332 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 68' ' ' ILE . 9.7 tp10 -94.62 -30.34 14.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.249 -0.907 . . . . 0.0 109.16 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 74' ' ' VAL . 77.4 m -98.64 15.79 24.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.886 . . . . 0.0 109.233 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.062 HG11 HD13 ' A' ' 71' ' ' LEU . 17.1 m -46.27 171.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.474 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.568 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 62.2 m -73.77 -2.14 22.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.739 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.782 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -126.43 -152.52 0.52 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.004 -1.06 . . . . 0.0 109.812 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.653 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.6 pt-20 -112.57 155.72 23.89 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.04 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -129.54 152.45 49.05 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 117.779 -1.568 . . . . 0.0 111.989 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.56 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 2.5 mmtm -132.67 166.32 29.92 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.56 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 6.2 Cg_exo -54.94 -17.25 13.62 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.254 1.969 . . . . 0.0 110.717 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.42 -31.44 22.88 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 110.644 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.576 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.3 m -60.45 159.55 10.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.889 -1.132 . . . . 0.0 109.578 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.528 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -162.04 139.67 8.65 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.819 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.91 HD21 HD23 ' A' ' 71' ' ' LEU . 1.3 mp -63.0 107.75 1.07 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -43.02 -26.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.878 -179.438 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 28.6 p -86.83 31.76 0.69 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 110.24 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 86' ' ' CYS . 12.3 mt-30 -153.36 24.24 0.54 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.872 -1.143 . . . . 0.0 110.492 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.447 HD13 ' HB3' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -140.63 131.31 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 0.0 109.649 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.908 HG23 ' O ' ' A' ' 21' ' ' VAL . 31.1 mm -110.0 148.44 13.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.362 -0.837 . . . . 0.0 109.436 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.548 ' HE2' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -103.69 84.95 2.35 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.169 -0.957 . . . . 0.0 109.132 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.685 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -78.03 171.69 11.81 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.685 ' HD2' HG22 ' A' ' 91' ' ' THR . 5.5 Cg_exo -59.14 -14.06 22.13 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.104 1.869 . . . . 0.0 110.117 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -69.54 -50.9 40.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 0.0 109.336 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.831 HD11 ' CB ' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -83.46 138.96 33.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 109.378 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -145.31 132.14 20.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 0.0 109.632 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.433 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 70.69 37.39 67.22 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.714 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -71.92 147.89 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.408 -1.054 . . . . 0.0 109.522 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.531 ' N ' HD13 ' A' ' 97' ' ' ILE . 5.5 t -114.09 106.68 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.239 -0.913 . . . . 0.0 109.8 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.797 HG21 HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -98.0 152.22 4.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.746 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.533 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -128.07 176.05 7.93 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.922 -1.111 . . . . 0.0 109.807 -179.476 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 6' ' ' VAL . 21.5 t -106.42 146.48 33.09 Favored Pre-proline 0 C--N 1.296 -1.735 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.527 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.879 ' HD2' HG13 ' A' ' 101' ' ' VAL . 11.6 Cg_exo -52.99 177.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.428 2.086 . . . . 0.0 110.303 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 21.8 t0 -74.77 -22.62 58.67 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.551 ' HD3' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -130.87 -167.51 1.85 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.655 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 106' ' ' TRP . 50.3 tp60 -139.01 28.19 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.939 -1.101 . . . . 0.0 109.657 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.856 ' CB ' HG22 ' A' ' 47' ' ' THR . 8.9 m95 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.515 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.311 0.577 . . . . 0.0 109.581 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.81 161.62 37.11 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.871 . . . . 0.0 109.116 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.604 HG11 ' CD2' ' A' ' 23' ' ' LEU . 1.4 t -150.75 128.43 2.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.27 -0.894 . . . . 0.0 109.683 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.935 HG22 ' HB3' ' A' ' 14' ' ' GLN . 42.6 t -132.04 164.5 34.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.901 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -137.72 159.56 41.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.073 . . . . 0.0 109.903 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 101' ' ' VAL . 4.0 t -131.2 137.24 56.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.554 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 35.2 t -93.19 171.15 9.12 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.494 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -66.98 -6.05 15.3 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.028 -1.045 . . . . 0.0 109.156 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.35 -2.99 16.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.977 . . . . 0.0 110.219 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.66 17.34 15.12 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.215 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.529 ' OG1' ' CB ' ' A' ' 7' ' ' SER . 69.5 m -49.82 112.97 0.74 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.037 -1.272 . . . . 0.0 109.1 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.07 105.71 16.48 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.564 -0.71 . . . . 0.0 110.325 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.422 ' O ' HG13 ' A' ' 4' ' ' VAL . 22.8 ttm180 -148.33 133.86 18.71 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.935 ' HB3' HG22 ' A' ' 4' ' ' VAL . 3.5 mp0 -120.03 179.4 4.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.004 -1.06 . . . . 0.0 110.986 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.901 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -176.12 -176.03 0.76 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.27 100.0 5.89 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.545 -0.722 . . . . 0.0 109.53 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.998 HG11 ' HB3' ' A' ' 90' ' ' MET . 39.5 t -65.51 108.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.352 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.886 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -46.55 172.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.424 ' OD2' ' HG3' ' A' ' 92' ' ' PRO . 52.8 m-20 -82.2 125.03 30.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.259 -0.901 . . . . 0.0 109.151 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.04 41.13 6.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.886 HG21 ' HB3' ' A' ' 18' ' ' ALA . 1.9 t -133.79 162.37 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -1.165 . . . . 0.0 109.414 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.462 ' OG ' ' CD1' ' A' ' 89' ' ' ILE . 46.6 m -98.09 137.08 37.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 108.854 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.739 HD23 HG21 ' A' ' 17' ' ' VAL . 6.5 mt -46.29 -26.36 0.79 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.012 -1.055 . . . . 0.0 108.613 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.26 -47.09 45.91 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.788 ' HB3' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -51.96 -51.22 58.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.038 179.413 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.494 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -60.84 -29.59 69.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 108.821 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.997 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -73.02 -25.2 60.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.552 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.579 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 88.4 t -57.07 -42.13 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.069 -1.019 . . . . 0.0 109.385 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.2 t -84.56 -55.08 4.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.401 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.811 ' CG ' HD22 ' A' ' 15' ' ' LEU . 24.5 m-80 -52.92 -18.53 2.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.376 -0.828 . . . . 0.0 109.606 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.89 23.61 57.22 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.986 HG23 HD12 ' A' ' 35' ' ' ILE . 1.1 mt -101.33 -25.55 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.272 . . . . 0.0 108.286 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.997 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 2.3 p90 -48.74 -47.17 41.66 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.632 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 34.0 t70 -69.46 -33.08 72.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.986 HD12 HG23 ' A' ' 32' ' ' ILE . 53.5 mt -57.72 -19.28 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.182 -0.949 . . . . 0.0 108.936 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -170.03 133.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.442 -0.786 . . . . 0.0 109.377 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' OD1' ' A' ' 38' ' ' ASP . . . 133.86 169.06 11.97 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.932 ' CG ' HG21 ' A' ' 47' ' ' THR . 0.2 OUTLIER -161.73 -89.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -1.201 . . . . 0.0 109.824 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 40' ' ' GLY . 13.1 p -50.97 -41.97 59.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.568 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.513 ' N ' ' SG ' ' A' ' 39' ' ' CYS . . . 71.05 -83.9 0.4 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 43' ' ' ALA . . . -70.92 -79.1 0.39 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.461 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 59.8 p -59.71 88.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -1.139 . . . . 0.0 109.813 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.6 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -60.29 99.68 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.481 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.458 ' HA ' ' HG2' ' A' ' 70' ' ' MET . 2.3 m -160.03 22.06 0.17 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.713 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 7.8 p -116.05 -157.89 0.66 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 109.432 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.793 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -147.81 12.8 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.098 -1.001 . . . . 0.0 109.877 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.953 HG22 ' CB ' ' A' ' 106' ' ' TRP . 5.0 p -77.93 -23.74 48.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.997 . . . . 0.0 109.496 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 27.1 p -86.66 42.66 1.02 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 110.312 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.734 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 69.8 t60 -77.85 67.03 3.64 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 83' ' ' ARG . 11.4 m -87.16 147.71 5.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.471 -1.393 . . . . 0.0 110.862 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.734 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 6.8 m-30 -107.26 106.31 16.71 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 122.159 0.981 . . . . 0.0 108.393 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.801 HG22 HG12 ' A' ' 99' ' ' VAL . 9.6 t -90.0 164.46 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.852 0.834 . . . . 0.0 112.431 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.488 ' N ' HG12 ' A' ' 52' ' ' VAL . 1.4 t-20 -69.0 152.49 45.19 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.58 ' HA ' HD22 ' A' ' 81' ' ' ASN . 3.3 pm0 -77.27 7.49 5.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -0.877 . . . . 0.0 110.619 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.33 -12.52 14.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.778 -1.202 . . . . 0.0 110.046 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 1.098 ' CB ' HD13 ' A' ' 97' ' ' ILE . 80.2 m-85 -111.36 -19.71 12.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 0.0 109.587 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.598 HG21 ' OD1' ' A' ' 81' ' ' ASN . 1.9 p -68.78 -12.17 61.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.241 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -88.97 -37.95 14.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.568 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.681 ' HB2' HD21 ' A' ' 94' ' ' LEU . 1.2 mptm? -71.44 -33.14 69.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.165 -0.96 . . . . 0.0 109.487 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -51.91 164.21 0.58 Allowed Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.223 -0.923 . . . . 0.0 109.218 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 5.7 Cg_exo -56.33 -166.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.044 1.829 . . . . 0.0 110.234 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.39 58.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -43.41 107.46 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.455 -0.778 . . . . 0.0 109.355 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' ALA . 4.3 m-20 -56.86 -160.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.613 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.532 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 62.1 tt0 -100.09 -16.95 17.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.489 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 65' ' ' GLU . 2.1 mtp180 -44.74 -61.12 1.7 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.457 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.6 ' OE1' ' HB3' ' A' ' 43' ' ' ALA . 1.2 mt-10 -66.86 -23.63 66.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.532 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 32.2 mm -63.65 -31.87 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.503 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.59 -50.76 47.36 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.458 ' HG2' ' HA ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -65.9 -23.8 66.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -1.145 . . . . 0.0 109.3 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.853 ' O ' HG13 ' A' ' 74' ' ' VAL . 5.2 tp -87.76 -10.49 50.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.428 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -76.22 -35.62 58.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.355 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.99 45.07 0.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 0.0 109.363 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.882 HG23 ' H ' ' A' ' 76' ' ' ALA . 10.9 m -82.16 171.05 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 0.0 109.514 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -57.41 -16.14 8.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.604 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.882 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -124.86 -151.23 0.47 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.114 -0.991 . . . . 0.0 110.52 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.576 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 2.2 pm0 -112.59 153.01 28.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.602 HD11 HD23 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -111.22 127.36 55.58 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.803 -1.559 . . . . 0.0 111.672 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 1.9 mptp? -98.61 167.85 10.76 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 2.2 Cg_endo -60.05 -9.73 10.83 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.456 2.104 . . . . 0.0 111.37 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.598 ' OD1' HG21 ' A' ' 57' ' ' THR . 0.5 OUTLIER -107.26 4.92 27.1 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.086 -1.009 . . . . 0.0 111.836 -178.613 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.57 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -88.6 155.95 19.33 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.54 -1.35 . . . . 0.0 109.964 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.556 ' O ' HG22 ' A' ' 50' ' ' VAL . 6.5 ttt180 -162.14 158.05 24.11 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.731 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.774 HD12 ' H ' ' A' ' 84' ' ' LEU . 4.1 mp -78.84 106.28 10.74 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 108.648 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 48' ' ' CYS . 20.2 p -48.72 -22.11 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.596 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 26.6 p -81.3 -38.65 26.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.19 -0.944 . . . . 0.0 110.245 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.518 ' OE1' ' CB ' ' A' ' 43' ' ' ALA . 4.0 tp60 -89.47 42.85 1.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.084 -1.01 . . . . 0.0 110.865 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -149.31 146.64 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.889 -1.132 . . . . 0.0 109.534 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.619 HG22 ' N ' ' A' ' 90' ' ' MET . 11.4 mm -115.26 166.98 8.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.391 -0.818 . . . . 0.0 109.229 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.998 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -130.13 97.59 4.49 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.213 -0.929 . . . . 0.0 109.462 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.673 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -90.13 172.17 7.46 Favored Pre-proline 0 C--N 1.298 -1.666 0 O-C-N 121.56 -0.713 . . . . 0.0 109.146 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.673 ' HD2' HG22 ' A' ' 91' ' ' THR . 3.8 Cg_exo -60.79 -11.03 16.02 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.161 1.907 . . . . 0.0 110.481 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -68.23 -51.1 49.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -0.999 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.79 HD23 ' HD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -78.49 127.45 32.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 109.37 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.31 126.46 33.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.918 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.577 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 78.23 35.28 34.36 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.098 HD13 ' CB ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -71.54 133.21 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -1.087 . . . . 0.0 109.541 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.097 ' N ' HD12 ' A' ' 97' ' ' ILE . 3.7 t -107.02 108.49 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.801 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -99.08 153.55 4.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.544 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -126.58 174.07 8.96 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.072 -1.018 . . . . 0.0 109.284 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.916 HG13 ' HD2' ' A' ' 102' ' ' PRO . 28.8 t -107.59 147.09 34.67 Favored Pre-proline 0 N--CA 1.494 1.725 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.95 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.916 ' HD2' HG13 ' A' ' 101' ' ' VAL . 8.2 Cg_exo -53.76 -171.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.32 2.013 . . . . 0.0 110.458 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.402 ' CB ' HH21 ' A' ' 104' ' ' ARG . 13.7 m-20 -89.45 -26.66 20.84 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.521 ' HB3' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -120.86 -157.96 0.74 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 105' ' ' GLN . 44.4 tt0 -154.97 24.4 0.43 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.001 -1.062 . . . . 0.0 109.586 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.953 ' CB ' HG22 ' A' ' 47' ' ' THR . 24.4 m95 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.715 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.513 ' HB2' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.5 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -137.59 165.57 26.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.284 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.88 HG11 HD22 ' A' ' 23' ' ' LEU . 6.7 t -154.32 161.64 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.159 -0.963 . . . . 0.0 109.052 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.739 HG13 ' O ' ' A' ' 13' ' ' ARG . 51.9 t -159.46 148.68 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.075 -1.016 . . . . 0.0 109.202 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.108 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -124.68 154.08 41.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.097 -1.002 . . . . 0.0 109.498 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.723 HG22 ' HB3' ' A' ' 12' ' ' ARG . 3.0 t -136.71 141.4 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.438 -0.789 . . . . 0.0 110.177 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.515 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 1.5 p -81.52 169.52 17.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -41.87 -89.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.872 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.23 74.95 0.89 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.789 -1.194 . . . . 0.0 109.267 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.23 -105.08 0.37 Allowed Glycine 0 N--CA 1.489 2.208 0 C-N-CA 118.465 -1.826 . . . . 0.0 110.918 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.2 m -130.5 -176.09 3.86 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.544 -0.974 . . . . 0.0 109.57 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.723 ' HB3' HG22 ' A' ' 6' ' ' VAL . 5.0 ptp180 -150.98 124.35 8.91 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.291 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.739 ' O ' HG13 ' A' ' 4' ' ' VAL . 50.4 mtt180 -89.27 175.52 7.31 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.63 ' CB ' HG22 ' A' ' 4' ' ' VAL . 9.7 pt20 -134.97 141.11 46.17 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.974 -1.079 . . . . 0.0 110.324 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.108 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -136.69 -176.52 4.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.365 -0.834 . . . . 0.0 109.353 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -126.72 71.43 1.3 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.677 -0.639 . . . . 0.0 109.484 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.098 HG21 HD23 ' A' ' 23' ' ' LEU . 61.7 t -54.41 112.9 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.541 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.814 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -47.15 174.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 0.0 109.549 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.449 ' OD2' ' HB3' ' A' ' 92' ' ' PRO . 80.9 m-20 -83.66 125.3 31.7 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.359 -0.838 . . . . 0.0 109.192 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.46 19.01 31.2 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.814 HG21 ' HB3' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -118.13 155.75 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -1.135 . . . . 0.0 109.293 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 23' ' ' LEU . 2.0 m -92.4 135.04 34.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.231 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.098 HD23 HG21 ' A' ' 17' ' ' VAL . 16.7 mt -45.27 -35.28 3.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.001 . . . . 0.0 108.968 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.495 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 1.8 tmt? -65.61 -46.24 80.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.263 -0.898 . . . . 0.0 108.976 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.613 ' O ' HG13 ' A' ' 28' ' ' VAL . 4.5 tp-100 -53.75 -52.08 61.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 109.206 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.69 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -63.2 -23.39 67.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.915 . . . . 0.0 109.171 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.893 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -68.11 -26.33 65.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.358 -0.839 . . . . 0.0 109.712 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 25' ' ' GLN . 2.7 m -57.52 -43.62 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.996 -1.065 . . . . 0.0 109.368 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 2.7 t -81.63 -56.26 4.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.329 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.642 ' ND2' ' HB3' ' A' ' 15' ' ' LEU . 9.5 m120 -50.06 -20.8 1.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.446 -0.784 . . . . 0.0 109.372 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 83.55 22.21 56.67 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.789 HG23 HD11 ' A' ' 35' ' ' ILE . 1.4 mt -98.63 -31.3 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.208 -1.172 . . . . 0.0 108.848 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.893 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -51.64 -36.69 47.12 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.586 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 20.9 t70 -72.22 -35.62 68.93 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.857 ' O ' HG13 ' A' ' 36' ' ' VAL . 3.7 pt -83.09 5.08 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.958 -1.089 . . . . 0.0 109.423 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 35' ' ' ILE . 0.3 OUTLIER -169.53 120.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.36 170.01 12.61 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB2' ' CG2' ' A' ' 47' ' ' THR . 5.0 m-20 -162.31 -59.93 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -1.158 . . . . 0.0 109.795 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 41' ' ' GLY . 8.1 p -82.86 9.43 9.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' GLY . . . 57.64 -89.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 40' ' ' GLY . . . -60.63 -124.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.565 ' O ' ' HE1' ' A' ' 70' ' ' MET . 52.7 p -138.48 48.67 1.93 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.16 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.78 -93.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.522 ' HA ' ' CB ' ' A' ' 70' ' ' MET . 37.2 t -160.4 60.08 0.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.059 -1.026 . . . . 0.0 109.936 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 70' ' ' MET . 1.7 p -107.5 -171.71 1.93 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.085 -1.01 . . . . 0.0 109.21 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.838 ' HB1' ' N ' ' A' ' 74' ' ' VAL . . . -146.92 20.49 1.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 0.0 109.516 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.517 ' CG2' ' HB2' ' A' ' 38' ' ' ASP . 7.9 t -90.3 -21.94 21.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.765 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.484 ' SG ' HD23 ' A' ' 84' ' ' LEU . 21.8 p -87.18 42.55 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.145 -0.972 . . . . 0.0 110.398 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.144 ' CD2' HD12 ' A' ' 78' ' ' LEU . 44.8 t-80 -81.56 60.92 4.76 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 85' ' ' CYS . 14.1 m -76.28 149.09 6.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 120.752 -1.218 . . . . 0.0 110.912 -177.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.512 ' CE2' ' CE1' ' A' ' 49' ' ' HIS . 7.7 m-85 -108.21 103.09 12.2 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.907 HG22 HG12 ' A' ' 99' ' ' VAL . 4.3 t -89.15 174.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 121.662 0.744 . . . . 0.0 111.941 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.723 ' O ' HG23 ' A' ' 57' ' ' THR . 0.3 OUTLIER -70.41 -175.78 1.09 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -101.3 4.59 41.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.915 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.37 -25.54 10.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.081 -1.012 . . . . 0.0 110.258 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.871 ' CD2' HG22 ' A' ' 97' ' ' ILE . 73.8 m-85 -99.69 -17.05 17.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.068 -1.02 . . . . 0.0 109.816 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 53' ' ' ASN . 25.1 p -63.87 -43.63 95.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 109.612 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -55.72 -51.77 66.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.904 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.037 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -49.86 -41.8 46.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 109.623 -179.686 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.761 HG13 ' HD2' ' A' ' 61' ' ' PRO . 54.6 t -54.22 142.83 47.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.998 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.761 ' HD2' HG13 ' A' ' 60' ' ' VAL . 5.2 Cg_exo -55.79 173.43 0.39 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.076 1.851 . . . . 0.0 110.519 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.72 62.52 0.61 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -0.818 . . . . 0.0 109.373 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -38.92 126.52 1.57 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.72 -0.612 . . . . 0.0 109.849 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.458 ' O ' ' O ' ' A' ' 63' ' ' ALA . 1.2 p30 -51.39 -174.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.896 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.555 ' CD ' HD12 ' A' ' 68' ' ' ILE . 3.9 tp10 -76.86 -10.19 59.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.357 -0.839 . . . . 0.0 109.548 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -58.82 -51.25 70.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.336 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.496 ' HG2' ' HE3' ' A' ' 70' ' ' MET . 86.3 mt-10 -72.73 -7.06 48.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.403 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.555 HD12 ' CD ' ' A' ' 65' ' ' GLU . 15.2 mt -76.65 -36.93 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 0.0 109.556 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.23 -54.1 24.89 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.565 ' HE1' ' O ' ' A' ' 42' ' ' SER . 0.0 OUTLIER -68.45 -27.06 65.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.287 -1.125 . . . . 0.0 108.779 179.591 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.037 HD11 HD13 ' A' ' 78' ' ' LEU . 3.7 tt -83.34 8.13 14.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.144 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 4.0 tp10 -100.51 -10.58 20.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.61 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -82.24 -13.49 56.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.186 -0.946 . . . . 0.0 109.85 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.993 HG21 ' CD2' ' A' ' 49' ' ' HIS . 4.1 m -40.02 137.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.472 -0.768 . . . . 0.0 109.736 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.615 HG21 ' CB ' ' A' ' 104' ' ' ARG . 5.5 m -44.58 -25.3 0.26 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.243 -0.911 . . . . 0.0 109.289 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.709 ' O ' HG23 ' A' ' 74' ' ' VAL . . . -116.94 -148.94 0.43 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.629 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.6 OUTLIER -114.51 150.18 35.26 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.144 HD12 ' CD2' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -104.13 130.59 51.86 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 117.232 -1.787 . . . . 0.0 111.269 179.359 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.574 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 0.5 OUTLIER -104.76 166.1 12.09 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.574 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 5.0 Cg_exo -53.79 -26.37 38.59 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.937 1.758 . . . . 0.0 109.931 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.574 ' HA ' HG21 ' A' ' 57' ' ' THR . 1.9 t30 -75.41 -35.06 61.08 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 110.128 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.724 ' O ' HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -87.07 165.52 15.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.006 -1.059 . . . . 0.0 109.471 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.548 ' HB3' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -162.33 -162.34 0.81 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.449 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.822 HD21 ' HB2' ' A' ' 71' ' ' LEU . 1.5 mt -98.04 108.28 20.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.666 ' HB2' HG11 ' A' ' 50' ' ' VAL . 23.3 t -42.81 -25.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.108 -0.995 . . . . 0.0 110.034 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' LEU . 29.1 p -82.9 -39.35 21.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.987 . . . . 0.0 110.607 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.416 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 0.7 OUTLIER -88.91 27.0 1.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 111.192 -178.524 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.71 ' O ' HD13 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -106.68 149.39 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.654 -1.279 . . . . 0.0 108.902 178.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 88' ' ' ILE . 28.7 mm -128.24 161.61 36.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.93 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.658 ' HE2' HG23 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -130.33 95.91 4.02 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.451 -0.781 . . . . 0.0 109.12 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.446 ' OG1' ' CD1' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -82.38 164.93 45.38 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.545 -0.722 . . . . 0.0 109.586 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.449 ' HB3' ' OD2' ' A' ' 19' ' ' ASP . 4.0 Cg_exo -60.87 -28.49 86.45 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.138 1.892 . . . . 0.0 110.057 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.68 -37.74 85.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.037 HD21 ' CB ' ' A' ' 59' ' ' LYS . 4.2 mp -77.41 143.93 38.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.395 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.12 124.35 8.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 109.538 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.573 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 76.53 48.98 8.47 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.871 HG22 ' CD2' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -77.07 145.75 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -1.188 . . . . 0.0 108.549 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.491 ' N ' HD12 ' A' ' 97' ' ' ILE . 1.8 t -119.17 113.24 40.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 120.849 -1.157 . . . . 0.0 109.869 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -106.77 144.81 15.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 51' ' ' TYR . 9.2 m-20 -122.28 174.09 7.21 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.113 -0.992 . . . . 0.0 109.527 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.94 HG13 ' HD2' ' A' ' 102' ' ' PRO . 12.0 t -103.63 147.39 34.16 Favored Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.462 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.94 ' HD2' HG13 ' A' ' 101' ' ' VAL . 12.8 Cg_exo -52.59 163.48 1.82 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.413 2.075 . . . . 0.0 110.05 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 3.2 m-20 -57.99 -27.37 63.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.013 -1.054 . . . . 0.0 108.751 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.615 ' CB ' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -130.67 -163.45 1.32 Allowed 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -152.2 23.38 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.487 ' NE1' ' N ' ' A' ' 75' ' ' THR . 38.0 m95 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.642 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.59 135.64 21.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.274 -0.891 . . . . 0.0 109.177 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.977 HG21 HD21 ' A' ' 23' ' ' LEU . 1.1 t -133.24 123.79 47.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.923 HG11 ' HD3' ' A' ' 12' ' ' ARG . 65.9 t -121.82 128.81 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.128 -0.982 . . . . 0.0 108.636 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.073 ' CE1' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -98.21 153.8 18.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.953 -1.092 . . . . 0.0 109.478 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.938 ' O ' HG23 ' A' ' 101' ' ' VAL . 12.0 t -121.52 168.87 13.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.59 ' N ' HG12 ' A' ' 6' ' ' VAL . 41.0 t -122.99 161.52 24.09 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.496 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.55 -8.13 12.81 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.089 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -110.66 -3.33 15.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.079 -1.013 . . . . 0.0 110.643 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.68 -23.63 13.12 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.173 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.538 ' HB ' ' CB ' ' A' ' 7' ' ' SER . 74.6 m -49.52 112.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.031 -1.276 . . . . 0.0 109.065 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.923 ' HD3' HG11 ' A' ' 4' ' ' VAL . 3.6 ttm180 -125.49 117.34 23.43 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.575 -0.703 . . . . 0.0 110.187 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.538 HH12 HD13 ' A' ' 35' ' ' ILE . 1.2 ptp180 -108.7 124.95 51.35 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.421 ' CB ' HG22 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -91.37 155.55 18.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.018 -1.051 . . . . 0.0 110.569 -178.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.073 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -163.02 -176.13 4.72 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.639 0.733 . . . . 0.0 109.169 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -129.37 114.63 16.43 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.5 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.856 HG11 ' HB3' ' A' ' 90' ' ' MET . 46.2 t -77.48 110.31 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.944 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -46.95 172.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 0.0 109.337 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -81.52 124.73 29.73 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.225 -0.922 . . . . 0.0 109.153 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.77 44.25 6.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.944 HG21 ' HB3' ' A' ' 18' ' ' ALA . 1.5 t -133.07 165.57 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.46 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 p -105.87 141.91 36.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.169 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.003 HD13 ' OH ' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -48.68 -23.79 1.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.137 -0.977 . . . . 0.0 108.985 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 0.1 OUTLIER -76.83 -43.88 34.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 108.657 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.611 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -56.77 -51.15 70.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.374 -0.829 . . . . 0.0 109.259 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.51 -24.51 65.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.0 109.308 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.971 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -74.64 -26.45 59.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.323 -0.861 . . . . 0.0 109.927 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 25' ' ' GLN . 1.7 m -56.57 -44.15 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.788 -1.195 . . . . 0.0 109.448 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.499 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 3.3 t -80.59 -52.7 7.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.433 -0.792 . . . . 0.0 109.527 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.5 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 25.9 m-80 -57.24 -14.58 4.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.832 . . . . 0.0 109.622 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.854 ' O ' HD12 ' A' ' 35' ' ' ILE . . . 77.33 22.78 69.74 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.479 HG12 ' HD2' ' A' ' 13' ' ' ARG . 1.1 mt -100.14 -25.85 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.208 -1.172 . . . . 0.0 108.271 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.971 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 2.1 p90 -48.63 -46.95 40.55 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.617 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 12.5 t70 -66.44 -35.5 80.45 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.854 HD12 ' O ' ' A' ' 31' ' ' GLY . 2.6 mp -92.3 40.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.197 -0.939 . . . . 0.0 108.889 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.674 HG12 ' N ' ' A' ' 37' ' ' GLY . 49.1 t -160.88 -93.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.594 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.674 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -84.18 167.82 43.94 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.688 ' OD1' HG21 ' A' ' 47' ' ' THR . 0.1 OUTLIER -129.28 -50.0 1.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -1.129 . . . . 0.0 109.689 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.521 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 16.8 p -65.15 -18.86 65.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 109.537 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 42.98 93.21 0.01 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.61 -140.76 11.06 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.7 p -60.0 161.64 6.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -1.149 . . . . 0.0 109.353 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . . . -59.91 101.3 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.412 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.521 ' HB3' ' CB ' ' A' ' 39' ' ' CYS . 4.6 t -132.93 18.72 4.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.687 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.9 p -168.08 -167.61 0.85 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.943 . . . . 0.0 109.683 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.895 ' HB3' ' NE1' ' A' ' 106' ' ' TRP . . . -135.48 5.54 3.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.331 -0.856 . . . . 0.0 109.331 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.688 HG21 ' OD1' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -63.07 -28.78 70.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.396 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.536 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 25.1 p -84.25 42.32 0.88 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.449 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.017 ' CE1' HD12 ' A' ' 78' ' ' LEU . 28.3 t60 -81.35 64.09 5.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.27 147.33 6.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.569 -1.332 . . . . 0.0 110.061 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.668 ' HH ' ' HE2' ' A' ' 49' ' ' HIS . 9.6 m-85 -107.03 104.12 13.71 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.734 HG22 HG12 ' A' ' 99' ' ' VAL . 4.6 t -89.41 172.6 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-O 121.948 0.88 . . . . 0.0 112.201 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.581 ' H ' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -77.6 157.98 30.01 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.067 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -81.88 12.57 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.233 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.29 -25.95 9.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.98 -1.075 . . . . 0.0 109.75 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.628 ' CD1' ' HA ' ' A' ' 97' ' ' ILE . 90.8 m-85 -104.49 -17.35 14.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.68 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -66.16 -34.97 79.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.814 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.15 -46.88 72.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.21 -0.931 . . . . 0.0 110.346 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.06 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -49.51 -43.99 45.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.736 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.139 HG11 HG22 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -100.45 143.24 26.16 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.892 . . . . 0.0 109.259 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.817 ' HD2' HG12 ' A' ' 60' ' ' VAL . 6.2 Cg_exo -58.15 -179.59 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.811 1.674 . . . . 0.0 109.219 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.516 ' HA ' ' HD3' ' A' ' 83' ' ' ARG . . . -110.29 -105.2 0.37 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.839 -1.163 . . . . 0.0 109.573 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.517 ' CB ' HG13 ' A' ' 68' ' ' ILE . . . -111.7 -160.14 0.7 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.071 . . . . 0.0 109.894 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.687 ' O ' HD12 ' A' ' 68' ' ' ILE . 12.3 m-20 -137.62 -145.43 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.87 -34.75 9.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.912 -1.117 . . . . 0.0 109.463 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -84.06 -48.37 9.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.903 . . . . 0.0 109.595 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 15.2 pt-20 -68.79 -27.0 65.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.564 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.687 HD12 ' O ' ' A' ' 64' ' ' ASN . 1.3 mt -66.34 -43.25 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.105 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.83 -55.8 21.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -25.61 65.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -1.16 . . . . 0.0 109.398 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.62 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -87.86 -3.63 58.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.247 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 68' ' ' ILE . 15.0 tp10 -82.47 -26.05 32.99 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.22 -0.925 . . . . 0.0 109.211 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.74 75.77 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.391 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.815 HG23 ' H ' ' A' ' 76' ' ' ALA . 4.9 m -97.75 174.66 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.925 . . . . 0.0 109.633 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.571 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 18.2 m -74.13 -11.95 60.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.852 . . . . 0.0 109.934 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.85 ' HB2' ' HG2' ' A' ' 104' ' ' ARG . . . -122.42 -151.41 0.48 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.029 -1.045 . . . . 0.0 109.874 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.628 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -112.26 156.13 22.89 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.017 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -128.62 152.79 47.95 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 117.596 -1.641 . . . . 0.0 112.096 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.589 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 13.7 mmtt -137.52 167.26 21.3 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.589 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 5.8 Cg_exo -54.41 -17.99 13.68 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.17 1.913 . . . . 0.0 110.589 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.458 ' OD1' HG21 ' A' ' 57' ' ' THR . 6.1 t-20 -82.62 -33.75 27.81 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.375 -0.828 . . . . 0.0 110.45 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.6 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.1 m -61.7 159.68 13.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.951 -1.093 . . . . 0.0 109.595 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.581 HH12 HG23 ' A' ' 88' ' ' ILE . 6.9 mmm-85 -160.4 167.96 26.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.737 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.58 HD11 ' HG ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -88.44 112.37 22.86 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' MET . 0.3 OUTLIER -65.35 -6.99 11.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.286 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.3 p -105.89 13.23 29.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.961 -1.087 . . . . 0.0 110.305 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.515 ' NE2' HD13 ' A' ' 84' ' ' LEU . 2.9 pt20 -139.06 3.28 2.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.796 -1.19 . . . . 0.0 110.399 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.139 HG22 HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -105.08 146.88 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.946 -1.097 . . . . 0.0 109.201 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 90' ' ' MET . 12.1 mm -116.32 158.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.27 -0.894 . . . . 0.0 109.505 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.856 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -127.89 95.24 4.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.292 -0.88 . . . . 0.0 109.271 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.664 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -87.62 171.23 10.05 Favored Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.589 -0.694 . . . . 0.0 109.533 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.664 ' HD2' HG22 ' A' ' 91' ' ' THR . 3.9 Cg_exo -60.34 -15.17 33.65 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.189 1.926 . . . . 0.0 110.33 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.781 ' HG3' HD12 ' A' ' 94' ' ' LEU . 22.3 pt-20 -66.29 -47.88 72.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.234 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.06 HD21 ' CB ' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -86.38 152.18 22.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.886 . . . . 0.0 109.23 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.417 ' HB3' ' HA ' ' A' ' 1' ' ' SER . 1.3 p30 -161.42 133.99 6.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.98 . . . . 0.0 110.022 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.585 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 78.41 37.32 27.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.721 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -78.22 149.64 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.178 -1.189 . . . . 0.0 109.047 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.455 ' N ' HD13 ' A' ' 97' ' ' ILE . 3.7 t -114.18 110.35 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.061 -1.024 . . . . 0.0 109.884 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.734 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -102.75 148.72 7.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.516 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -126.15 176.63 6.92 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.74 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 6' ' ' VAL . 21.6 t -106.02 146.32 32.68 Favored Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.685 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.888 ' HD2' HG13 ' A' ' 101' ' ' VAL . 10.5 Cg_exo -54.06 -173.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.458 2.105 . . . . 0.0 110.656 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -92.21 -18.01 24.05 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.222 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.85 ' HG2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -130.29 -162.36 1.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.478 ' O ' HG23 ' A' ' 47' ' ' THR . 4.8 tm0? -151.36 22.56 0.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.838 -1.163 . . . . 0.0 109.895 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.895 ' NE1' ' HB3' ' A' ' 46' ' ' ALA . 6.5 m95 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.533 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.511 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -138.17 159.52 41.82 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.261 -0.899 . . . . 0.0 109.167 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.6 HG21 ' HG3' ' A' ' 90' ' ' MET . 0.9 OUTLIER -157.28 130.54 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.23 -0.919 . . . . 0.0 109.659 -179.215 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.988 HG13 ' O ' ' A' ' 13' ' ' ARG . 75.5 t -129.02 140.93 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 109.023 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.109 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -109.24 156.87 19.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 109.252 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.7 t -133.28 132.97 58.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.547 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -78.91 -177.37 5.5 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.771 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -48.59 162.95 0.08 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.513 ' C ' ' O ' ' A' ' 8' ' ' HIS . 5.1 t0 -29.75 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.032 0.444 . . . . 0.0 110.78 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 8' ' ' HIS . . . -168.47 -95.39 0.1 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.476 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.4 m -125.37 -175.87 3.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -1.156 . . . . 0.0 109.666 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.716 ' H ' HG22 ' A' ' 11' ' ' THR . 11.5 ptt180 -156.69 141.09 16.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.631 -0.668 . . . . 0.0 109.904 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.988 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -100.41 174.63 6.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.21 -0.931 . . . . 0.0 108.718 179.266 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.417 ' CB ' HG22 ' A' ' 4' ' ' VAL . 9.1 pm0 -130.38 162.91 28.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.029 -1.044 . . . . 0.0 110.788 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.109 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -175.84 -176.53 0.85 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.627 0.727 . . . . 0.0 109.193 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 1' ' ' SER . 7.3 t0 -132.24 88.59 2.56 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.059 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.732 HG21 HD22 ' A' ' 23' ' ' LEU . 49.4 t -54.24 145.61 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 108.918 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 1.016 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -86.42 172.98 9.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 109.662 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.412 ' OD2' ' HG3' ' A' ' 92' ' ' PRO . 78.8 m-20 -80.92 125.75 30.51 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.354 -0.841 . . . . 0.0 108.927 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.38 22.44 34.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.016 HG21 ' HB3' ' A' ' 18' ' ' ALA . 1.9 t -117.16 162.86 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -1.086 . . . . 0.0 108.918 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -100.62 134.92 42.86 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.981 -1.074 . . . . 0.0 108.568 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.958 HD13 ' OH ' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -46.64 -25.27 0.68 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.016 -1.052 . . . . 0.0 108.699 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.602 ' HE2' ' HB2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -74.44 -46.69 38.32 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.66 ' HB2' HG12 ' A' ' 21' ' ' VAL . 2.7 mm-40 -52.23 -54.29 32.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 108.95 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.473 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -57.22 -29.08 63.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 0.0 108.677 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.952 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -67.93 -34.15 76.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -0.809 . . . . 0.0 109.145 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.572 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 88.4 t -52.8 -40.49 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 109.399 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 t -79.95 -48.85 12.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.848 . . . . 0.0 109.402 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.732 ' CG ' HD22 ' A' ' 15' ' ' LEU . 29.1 m-80 -65.62 -6.19 10.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.795 . . . . 0.0 109.68 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.483 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 72.09 17.6 77.32 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.476 HG13 ' CB ' ' A' ' 30' ' ' ASN . 1.0 OUTLIER -95.56 -27.18 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -1.157 . . . . 0.0 108.538 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.952 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 1.2 p90 -46.96 -45.11 20.59 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.557 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 10.9 t70 -77.31 -29.06 53.46 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 35' ' ' ILE . 20.0 mm -64.86 -10.03 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.681 HG21 HG12 ' A' ' 50' ' ' VAL . 2.5 p -160.12 -51.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.134 -0.979 . . . . 0.0 109.826 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' H ' HG13 ' A' ' 36' ' ' VAL . . . -42.9 166.29 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.494 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 13.7 t0 -154.15 -93.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -1.203 . . . . 0.0 109.863 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 42' ' ' SER . 20.8 p -65.49 -9.5 26.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.131 -0.98 . . . . 0.0 109.765 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 86' ' ' CYS . . . 89.59 -167.47 33.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -42.01 -27.09 0.37 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.453 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 19.3 m -59.68 159.57 8.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.136 -1.214 . . . . 0.0 109.286 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.596 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -124.57 74.45 1.33 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.356 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 m -129.6 -2.33 4.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 109.735 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 38' ' ' ASP . 1.4 p -120.96 -169.24 1.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.085 -1.009 . . . . 0.0 109.613 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.788 ' HB3' ' NE1' ' A' ' 106' ' ' TRP . . . -141.83 11.44 2.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.297 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 105' ' ' GLN . 9.5 m -71.54 -21.0 61.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.51 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.536 ' HB2' ' CB ' ' A' ' 85' ' ' CYS . 23.5 p -86.75 42.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.02 ' CE1' HD12 ' A' ' 78' ' ' LEU . 21.6 t60 -74.47 72.65 1.88 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.681 HG12 HG21 ' A' ' 36' ' ' VAL . 10.1 m -81.64 145.41 8.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.285 -1.509 . . . . 0.0 110.728 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 6.1 m-85 -107.26 99.97 9.46 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.709 HG22 HG12 ' A' ' 99' ' ' VAL . 3.8 t -89.93 172.08 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-O 122.053 0.93 . . . . 0.0 112.461 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.581 ' H ' HG12 ' A' ' 52' ' ' VAL . 1.3 m-20 -77.39 159.34 29.54 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.18 11.71 5.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.38 -0.825 . . . . 0.0 110.103 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.29 -29.91 7.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.015 -1.053 . . . . 0.0 109.755 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.757 ' HD2' HD23 ' A' ' 94' ' ' LEU . 47.2 m-85 -99.53 -18.47 17.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.174 -0.954 . . . . 0.0 109.4 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.685 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -64.16 -14.33 54.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.073 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.85 -36.06 17.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.767 ' HB2' HD21 ' A' ' 94' ' ' LEU . 1.9 mptp? -72.88 -32.92 65.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.462 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.582 ' HB ' HG22 ' A' ' 88' ' ' ILE . 1.3 m -56.18 163.05 2.55 Favored Pre-proline 0 C--N 1.305 -1.344 0 O-C-N 121.222 -0.924 . . . . 0.0 109.455 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.663 ' HD2' HG22 ' A' ' 88' ' ' ILE . 5.8 Cg_exo -58.16 166.47 5.7 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.166 1.911 . . . . 0.0 110.179 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -110.25 60.21 0.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -41.86 164.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.53 -0.731 . . . . 0.0 109.611 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.434 ' O ' HG12 ' A' ' 68' ' ' ILE . 1.5 p30 -94.15 -175.23 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 0.0 109.695 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.527 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 38.2 tt0 -88.13 -17.98 29.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 0.0 109.521 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -46.54 -64.53 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.713 ' O ' HD12 ' A' ' 71' ' ' LEU . 4.7 mt-10 -65.56 -21.29 66.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.433 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.527 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 23.5 mm -65.37 -31.7 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -45.12 -56.42 6.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 57.2 mtt -68.21 -26.79 65.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -1.176 . . . . 0.0 109.106 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.109 ' CD1' HD11 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -88.11 2.78 51.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.346 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 68' ' ' ILE . 55.7 tt0 -88.15 -30.53 19.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.85 . . . . 0.0 109.008 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -101.95 29.86 4.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.168 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.91 HG23 ' H ' ' A' ' 76' ' ' ALA . 5.3 m -46.07 171.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.593 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.567 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 83.4 m -75.2 -4.22 37.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.786 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.91 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -123.76 -150.71 0.45 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.063 -1.023 . . . . 0.0 109.651 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.645 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -111.85 156.64 21.7 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 179.333 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.02 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -130.71 153.91 48.49 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.964 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.539 ' CE ' ' HD2' ' A' ' 80' ' ' PRO . 4.5 mmmt -136.88 166.85 24.22 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.539 ' HD2' ' CE ' ' A' ' 79' ' ' LYS . 6.0 Cg_exo -54.68 -17.41 13.19 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.246 1.964 . . . . 0.0 110.697 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -84.78 -31.66 23.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.615 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.606 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.4 m -61.6 162.83 7.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.965 -1.084 . . . . 0.0 110.307 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.514 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -161.03 -159.08 0.63 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.369 -0.832 . . . . 0.0 109.278 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.109 HD11 ' CD1' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -110.93 118.54 36.37 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.285 -0.885 . . . . 0.0 108.97 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.609 ' SG ' HG11 ' A' ' 50' ' ' VAL . 1.8 t -60.79 -19.62 59.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.125 -0.984 . . . . 0.0 108.991 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 17.2 p -110.66 30.16 7.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.426 -0.796 . . . . 0.0 109.973 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -143.26 9.55 1.66 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.019 -1.051 . . . . 0.0 110.048 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.663 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -123.35 131.27 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.072 -1.017 . . . . 0.0 109.287 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.597 HG22 ' N ' ' A' ' 90' ' ' MET . 13.8 mm -96.29 166.39 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.342 -0.849 . . . . 0.0 109.622 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.666 ' CB ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.87 90.33 3.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.375 -0.828 . . . . 0.0 109.417 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.423 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -88.2 167.51 19.34 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.382 -0.824 . . . . 0.0 109.336 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 3.5 Cg_exo -60.09 -12.84 20.79 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.138 1.892 . . . . 0.0 110.353 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.59 ' CG ' HD12 ' A' ' 94' ' ' LEU . 24.9 pt-20 -69.83 -45.87 66.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.589 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' A' ' 59' ' ' LYS . 1.3 mp -75.98 136.02 40.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.924 . . . . 0.0 109.556 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -139.8 119.89 13.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.59 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 72.78 46.82 28.63 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.01 HD11 HG22 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -74.96 148.77 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.375 -1.074 . . . . 0.0 109.101 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.88 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.9 t -116.23 106.34 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.11 -0.994 . . . . 0.0 109.443 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.01 HG22 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -104.84 147.14 11.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -126.38 174.27 8.73 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.722 -179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.892 HG13 ' HD2' ' A' ' 102' ' ' PRO . 40.1 t -108.3 145.79 32.24 Favored Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.093 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.892 ' HD2' HG13 ' A' ' 101' ' ' VAL . 8.6 Cg_exo -50.24 177.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.304 2.003 . . . . 0.0 111.031 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.07 -22.87 33.36 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 0.0 OUTLIER -119.61 -157.03 0.69 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.829 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.644 ' O ' HG23 ' A' ' 47' ' ' THR . 20.0 mt-30 -153.36 23.99 0.54 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.953 -1.092 . . . . 0.0 109.728 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.788 ' NE1' ' HB3' ' A' ' 46' ' ' ALA . 5.0 m95 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.589 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.361 0.6 . . . . 0.0 109.526 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -134.41 162.99 30.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 109.075 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.782 HG21 HD21 ' A' ' 23' ' ' LEU . 23.9 t -152.28 157.32 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.061 -1.025 . . . . 0.0 109.742 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -158.57 119.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 108.879 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.085 ' CE1' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -95.19 157.17 16.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 109.682 -179.381 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.935 ' O ' HG23 ' A' ' 101' ' ' VAL . 9.4 t -123.26 169.6 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.447 -0.783 . . . . 0.0 109.096 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.58 ' N ' HG12 ' A' ' 6' ' ' VAL . 84.5 p -123.12 162.69 22.0 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.477 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -65.31 -6.53 10.09 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.828 -1.17 . . . . 0.0 109.203 179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -110.07 -5.6 15.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.062 -1.024 . . . . 0.0 110.319 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' HD2' ' A' ' 12' ' ' ARG . . . 115.65 -33.39 5.25 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.689 -1.244 . . . . 0.0 110.282 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.6 m -49.61 114.09 0.98 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.974 -1.31 . . . . 0.0 109.48 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.488 ' HB3' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -133.83 122.77 23.72 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.648 -0.657 . . . . 0.0 109.695 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.726 ' NH1' HD11 ' A' ' 35' ' ' ILE . 1.3 mtt180 -97.95 173.78 6.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.121 -0.987 . . . . 0.0 108.544 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.556 ' HB3' HG13 ' A' ' 4' ' ' VAL . 10.9 pt20 -131.96 134.66 45.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.051 -1.031 . . . . 0.0 110.212 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.085 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -134.28 -176.84 4.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.269 -0.895 . . . . 0.0 109.471 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.68 80.97 1.97 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.732 -0.605 . . . . 0.0 109.505 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.008 HG21 HD23 ' A' ' 23' ' ' LEU . 85.8 t -68.88 114.32 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.52 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -52.62 175.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.882 . . . . 0.0 109.817 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 92' ' ' PRO . 67.8 m-20 -83.05 126.29 32.39 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.477 -0.764 . . . . 0.0 109.076 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.12 10.67 44.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.652 HG12 ' HB3' ' A' ' 25' ' ' GLN . 0.7 OUTLIER -115.52 155.48 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -1.144 . . . . 0.0 109.199 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 7.2 t -93.6 133.01 37.36 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.403 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.008 HD23 HG21 ' A' ' 17' ' ' VAL . 10.8 mt -42.64 -29.41 0.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.556 ' HE1' ' H ' ' A' ' 41' ' ' GLY . 1.9 tmt? -70.81 -50.52 34.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 108.811 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.652 ' HB3' HG12 ' A' ' 21' ' ' VAL . 5.5 tp-100 -49.22 -50.86 36.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.262 -0.899 . . . . 0.0 108.751 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.957 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -63.23 -32.06 73.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -0.844 . . . . 0.0 108.757 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.93 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -62.25 -25.45 67.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.351 -0.843 . . . . 0.0 109.213 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.584 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 47.0 t -57.43 -42.97 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.135 -0.978 . . . . 0.0 109.172 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 t -82.51 -53.11 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 0.0 109.284 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.625 ' ND2' ' HB3' ' A' ' 15' ' ' LEU . 11.0 m120 -54.81 -16.72 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.461 -0.775 . . . . 0.0 109.406 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 35' ' ' ILE . . . 79.14 21.82 66.88 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.809 ' HA ' HD12 ' A' ' 35' ' ' ILE . 1.1 mt -99.2 -28.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.175 -1.191 . . . . 0.0 108.535 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.93 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 1.6 p90 -47.45 -46.35 26.66 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.605 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 19.3 t70 -74.44 -30.49 61.91 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.809 HD12 ' HA ' ' A' ' 32' ' ' ILE . 60.0 mt -58.98 -17.28 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.09 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.715 ' O ' HG13 ' A' ' 36' ' ' VAL . 8.0 p -170.13 81.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.843 . . . . 0.0 109.47 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.496 ' C ' ' HG1' ' A' ' 47' ' ' THR . . . -163.62 179.55 38.6 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.566 ' CG ' HG21 ' A' ' 47' ' ' THR . 3.2 t0 -163.96 -69.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 109.667 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 42' ' ' SER . 16.3 p -83.3 10.05 9.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.698 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.04 -162.6 46.02 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.556 ' H ' ' HE1' ' A' ' 24' ' ' MET . . . -47.34 -23.98 2.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.447 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -59.89 177.49 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -1.165 . . . . 0.0 109.368 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.69 91.15 2.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.471 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.8 t -160.05 22.03 0.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 9.1 p -130.17 -151.55 0.48 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.958 . . . . 0.0 109.461 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.514 ' HB3' ' NE1' ' A' ' 106' ' ' TRP . . . -157.82 19.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.141 -0.975 . . . . 0.0 109.999 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.566 HG21 ' CG ' ' A' ' 38' ' ' ASP . 1.6 p -89.94 -19.39 24.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.113 -0.992 . . . . 0.0 109.455 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.499 ' HA ' HG22 ' A' ' 36' ' ' VAL . 23.4 p -86.62 43.36 1.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 110.073 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.717 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 67.5 t60 -76.93 65.41 2.6 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 82' ' ' SER . 12.6 m -87.14 147.89 4.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.345 -1.472 . . . . 0.0 110.384 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.717 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 6.2 m-30 -107.16 111.4 23.81 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.694 HG22 HG12 ' A' ' 99' ' ' VAL . 5.3 t -94.85 170.14 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.937 0.875 . . . . 0.0 112.306 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.568 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -74.24 144.51 44.63 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.261 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -4.84 13.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.17 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -94.96 -30.07 14.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.214 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.816 ' CD2' HG22 ' A' ' 97' ' ' ILE . 61.6 m-85 -97.98 -17.79 18.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.007 -1.058 . . . . 0.0 109.878 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.627 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -64.59 -37.21 86.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.97 . . . . 0.0 109.429 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -62.14 1.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.542 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.842 ' HB2' HD21 ' A' ' 94' ' ' LEU . 13.8 mptt -49.93 -38.57 36.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.909 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -51.24 161.17 0.79 Allowed Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.901 . . . . 0.0 109.049 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.909 ' HD2' HG22 ' A' ' 60' ' ' VAL . 4.3 Cg_exo -59.96 159.22 26.28 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.18 1.92 . . . . 0.0 110.22 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.15 58.89 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.883 . . . . 0.0 109.439 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.89 132.85 3.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.415 -0.803 . . . . 0.0 109.557 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -51.79 -174.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 109.63 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.591 ' HA ' HD12 ' A' ' 68' ' ' ILE . 31.0 tt0 -89.47 -16.43 30.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.415 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.438 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . 5.2 tpp180 -44.57 -61.79 1.43 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.477 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.438 ' OE1' ' HB3' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -66.23 -23.84 66.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.431 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 65' ' ' GLU . 18.9 mt -63.12 -32.48 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.99 -51.6 39.54 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.7 mtt -66.69 -23.36 66.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -1.152 . . . . 0.0 109.372 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.696 ' O ' HG13 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -89.72 -7.06 55.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.497 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -82.17 -36.79 27.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 109.367 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.87 57.62 4.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.398 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.903 HG23 ' H ' ' A' ' 76' ' ' ALA . 8.9 m -93.94 172.02 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.527 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 25.5 m -64.94 -10.23 27.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.518 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.903 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -128.22 -155.85 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.149 -0.97 . . . . 0.0 109.969 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.571 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -111.82 150.39 30.43 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.641 ' HG ' ' HB2' ' A' ' 82' ' ' SER . 0.4 OUTLIER -106.54 169.1 8.72 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.397 -1.321 . . . . 0.0 111.203 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.549 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -153.22 170.78 7.68 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.159 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 3.4 Cg_exo -57.83 -13.45 14.75 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.037 1.824 . . . . 0.0 109.905 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.505 ' HA ' HG21 ' A' ' 57' ' ' THR . 1.3 m-20 -95.35 -25.0 16.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 110.836 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.641 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -85.79 155.9 20.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.818 -1.176 . . . . 0.0 110.477 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.403 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -161.53 -157.68 0.51 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 179.729 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.904 HD12 ' CB ' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -104.29 95.19 5.78 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.226 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.541 ' HA ' ' CG1' ' A' ' 88' ' ' ILE . 1.9 t -42.57 -25.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 84' ' ' LEU . 13.0 p -75.72 -43.53 46.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.098 -1.001 . . . . 0.0 110.544 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.904 ' CB ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -89.62 8.87 29.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.002 -1.061 . . . . 0.0 111.334 -178.557 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.689 ' O ' HD13 ' A' ' 89' ' ' ILE . 2.9 mm -79.98 154.66 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.552 -1.342 . . . . 0.0 108.913 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 88' ' ' ILE . 30.1 mm -128.98 165.47 28.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.716 ' HE3' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -127.3 96.32 4.54 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.725 ' OG1' HD12 ' A' ' 94' ' ' LEU . 16.3 p -82.52 157.19 67.83 Favored Pre-proline 0 C--N 1.297 -1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 109.262 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.456 ' HB3' ' OD2' ' A' ' 19' ' ' ASP . 5.8 Cg_exo -59.77 -13.35 21.79 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.02 1.813 . . . . 0.0 110.264 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -80.3 -31.79 38.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.412 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.842 HD21 ' HB2' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -83.35 127.41 33.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.634 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -135.82 125.51 25.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.204 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.576 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 70.86 50.57 23.4 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.035 HD11 HG22 ' A' ' 99' ' ' VAL . 0.5 OUTLIER -74.82 159.1 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.331 -1.099 . . . . 0.0 108.868 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.006 ' N ' HD12 ' A' ' 97' ' ' ILE . 5.2 t -125.82 103.53 11.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.021 -1.049 . . . . 0.0 110.186 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.035 HG22 HD11 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -95.44 156.65 3.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 51' ' ' TYR . 12.0 m-20 -131.91 178.35 6.84 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.059 -1.025 . . . . 0.0 109.401 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 6' ' ' VAL . 27.6 t -110.45 146.84 35.14 Favored Pre-proline 0 C--N 1.297 -1.715 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.95 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.897 ' HD2' HG13 ' A' ' 101' ' ' VAL . 8.4 Cg_exo -53.95 -173.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.391 2.061 . . . . 0.0 110.369 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 19.3 t0 -102.68 -22.71 13.91 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.614 ' HD2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -131.09 -168.68 2.04 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.578 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -128.99 -82.63 0.57 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.024 -1.048 . . . . 0.0 109.186 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.578 ' CD1' ' O ' ' A' ' 105' ' ' GLN . 2.1 m95 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.38 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -136.61 161.46 35.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.277 -0.889 . . . . 0.0 109.175 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.717 HG21 ' CG ' ' A' ' 90' ' ' MET . 1.1 t -160.7 133.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 109.531 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.9 p -136.98 161.39 35.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.123 -0.985 . . . . 0.0 108.648 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.084 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -129.04 157.99 40.17 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.185 -0.947 . . . . 0.0 109.786 -178.543 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 12' ' ' ARG . 3.4 t -126.9 143.39 40.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.552 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 5.1 p -75.98 -158.7 0.1 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.684 ' N ' HG12 ' A' ' 101' ' ' VAL . 55.8 m80 -59.2 -103.43 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.26 77.71 1.06 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.4 -1.437 . . . . 0.0 109.239 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.99 -101.31 0.2 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 118.958 -1.591 . . . . 0.0 111.053 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -121.46 -170.55 2.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -1.1 . . . . 0.0 109.954 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.767 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -149.31 139.59 22.29 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.656 -0.652 . . . . 0.0 110.32 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.517 ' C ' HG23 ' A' ' 4' ' ' VAL . 18.0 mtt180 -104.25 119.31 38.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.351 -0.843 . . . . 0.0 108.958 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.619 ' HA ' HG23 ' A' ' 4' ' ' VAL . 4.9 pt20 -79.78 171.43 15.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.973 . . . . 0.0 110.554 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.084 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -173.48 -177.98 1.58 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.611 0.72 . . . . 0.0 109.059 178.542 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -135.24 93.17 2.95 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.66 -0.65 . . . . 0.0 109.685 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.976 HG21 ' CD2' ' A' ' 23' ' ' LEU . 21.1 t -69.13 149.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 109.305 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.873 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -83.22 173.38 11.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.397 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -79.97 124.67 28.91 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.274 -0.891 . . . . 0.0 109.067 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.8 18.06 39.05 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.873 HG21 ' HB3' ' A' ' 18' ' ' ALA . 2.2 t -115.1 170.3 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -1.123 . . . . 0.0 109.27 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.496 ' OG ' ' CD1' ' A' ' 89' ' ' ILE . 70.6 m -111.76 138.79 47.87 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 108.677 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.976 ' CD2' HG21 ' A' ' 17' ' ' VAL . 1.5 mt -48.31 -23.6 0.96 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.945 -1.097 . . . . 0.0 108.709 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.478 ' HB2' ' HA ' ' A' ' 86' ' ' CYS . 13.2 ttp -73.07 -46.84 49.3 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.692 ' HB2' HG12 ' A' ' 21' ' ' VAL . 2.0 mt-30 -54.14 -59.61 4.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.363 -0.835 . . . . 0.0 109.004 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.432 ' C ' ' OD1' ' A' ' 30' ' ' ASN . . . -53.22 -46.48 69.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 108.945 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.526 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -45.37 -37.39 4.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.865 . . . . 0.0 109.885 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.538 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 58.7 t -43.57 -50.12 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.098 -1.001 . . . . 0.0 109.858 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 31' ' ' GLY . 6.1 t -87.02 -51.33 6.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.303 -0.873 . . . . 0.0 109.591 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.037 ' OD1' HD13 ' A' ' 15' ' ' LEU . 4.8 m120 -40.31 -25.86 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.462 0.649 . . . . 0.0 109.731 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 95.24 -5.17 67.9 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.735 HG22 ' CG2' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -79.61 -28.35 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.056 -1.261 . . . . 0.0 107.962 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -48.7 -31.45 6.85 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.046 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.619 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 13.1 t0 -93.08 -25.38 17.94 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.663 -0.648 . . . . 0.0 109.295 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.93 ' CG2' HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -60.11 -31.83 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.0 109.194 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.93 HG22 ' CG2' ' A' ' 35' ' ' ILE . 3.4 m -163.75 -171.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.404 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.08 166.05 12.06 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 12.3 t70 -154.16 -92.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -1.146 . . . . 0.0 109.716 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 40' ' ' GLY . 14.6 p -81.87 -9.87 59.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 109.625 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.76 77.15 0.1 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 87' ' ' GLN . . . 171.28 -157.17 27.65 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.2 p -60.83 171.83 1.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -1.137 . . . . 0.0 109.486 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.888 ' HB3' ' CG ' ' A' ' 67' ' ' GLU . . . -61.93 99.59 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.89 . . . . 0.0 109.41 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.81 5.84 2.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 0.0 109.636 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 13.2 p -144.33 -152.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 0.0 109.615 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 1.004 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -156.09 19.2 0.37 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.634 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -90.4 -28.78 18.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.583 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.686 ' O ' HG13 ' A' ' 50' ' ' VAL . 22.0 p -86.5 42.3 1.0 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.953 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.733 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 68.1 t60 -58.71 79.95 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.113 HG11 ' CB ' ' A' ' 85' ' ' CYS . 7.6 m -90.59 146.71 5.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.055 -1.653 . . . . 0.0 111.987 -177.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.733 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 4.1 m-30 -112.63 113.09 25.05 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.823 HG22 HG12 ' A' ' 99' ' ' VAL . 6.4 t -101.45 171.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.877 0.846 . . . . 0.0 112.209 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.582 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -73.23 155.36 39.63 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.012 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.418 ' HB3' HD22 ' A' ' 81' ' ' ASN . 1.7 pp20? -81.43 11.63 4.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.148 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.48 -28.89 8.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.95 -1.094 . . . . 0.0 110.121 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.856 ' CD2' HG22 ' A' ' 97' ' ' ILE . 43.0 m-85 -100.14 -19.34 16.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.08 -1.012 . . . . 0.0 109.695 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.612 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -61.55 -22.71 65.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.205 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -85.71 -25.69 26.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.891 . . . . 0.0 109.475 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.767 ' HB2' HD21 ' A' ' 94' ' ' LEU . 13.6 mmtm -76.83 -10.54 59.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 0.0 109.443 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.785 HG11 ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -95.68 170.39 7.79 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.276 -0.89 . . . . 0.0 108.785 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.706 ' HD2' HG12 ' A' ' 60' ' ' VAL . 5.7 Cg_exo -59.43 167.84 5.83 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.03 1.82 . . . . 0.0 110.394 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.18 59.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.865 . . . . 0.0 109.375 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -41.6 121.64 1.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.593 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.822 ' O ' HD13 ' A' ' 68' ' ' ILE . 7.0 m-80 -57.54 -158.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.545 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 14.8 tp10 -84.11 -10.06 58.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.537 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -58.24 -54.31 48.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.456 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.888 ' CG ' ' HB3' ' A' ' 43' ' ' ALA . 2.4 mp0 -67.64 -8.21 32.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.529 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.5 mp -88.66 -34.09 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.373 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.43 -59.01 3.75 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.787 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -67.89 -26.61 66.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -1.151 . . . . 0.0 109.299 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.669 HD13 HD11 ' A' ' 84' ' ' LEU . 19.8 tp -90.83 7.24 40.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.893 . . . . 0.0 109.408 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -99.23 -24.22 14.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 109.393 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.86 31.75 0.94 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.439 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.004 HG12 ' HB1' ' A' ' 46' ' ' ALA . 3.6 m -75.9 170.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.384 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 16.3 m -75.9 -17.79 59.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.97 . . . . 0.0 109.328 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.603 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -107.62 -161.28 0.77 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.273 -0.892 . . . . 0.0 110.027 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.564 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.7 OUTLIER -111.65 151.63 28.61 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.614 ' HG ' ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -104.2 173.09 6.45 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.98 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.59 ' HE3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -158.27 170.13 9.45 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 2.6 Cg_endo -58.95 -12.51 15.43 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.284 1.989 . . . . 0.0 110.155 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.418 HD22 ' HB3' ' A' ' 54' ' ' GLU . 1.0 OUTLIER -97.23 -22.09 16.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.22 -0.925 . . . . 0.0 110.84 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.614 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -75.42 153.32 37.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.004 -1.06 . . . . 0.0 110.649 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.652 ' C ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -161.31 -159.43 0.64 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.444 -0.785 . . . . 0.0 109.356 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.79 ' N ' HD22 ' A' ' 84' ' ' LEU . 3.1 mm? -109.61 79.34 1.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.337 -0.852 . . . . 0.0 108.73 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 1.113 ' CB ' HG11 ' A' ' 50' ' ' VAL . 43.2 t -45.38 -22.5 0.14 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.39 -0.819 . . . . 0.0 110.846 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 24' ' ' MET . 28.6 p -75.73 -40.88 54.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.897 -1.127 . . . . 0.0 110.914 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.573 ' CG ' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -96.14 11.64 33.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.852 -1.155 . . . . 0.0 111.193 -178.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.785 ' CG2' HG11 ' A' ' 60' ' ' VAL . 4.4 mm -79.5 160.25 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.683 -1.26 . . . . 0.0 108.811 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 ' O ' ' A' ' 88' ' ' ILE . 16.9 mm -123.72 155.69 30.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.838 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.717 ' CG ' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -116.27 88.08 2.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.471 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.69 165.07 34.56 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 121.415 -0.803 . . . . 0.0 109.315 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.36 -12.9 22.1 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.18 1.92 . . . . 0.0 110.227 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -72.42 -51.05 22.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' A' ' 59' ' ' LYS . 1.6 mp -73.16 141.81 47.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.533 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -143.48 119.0 10.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 109.744 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.587 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 71.61 47.02 36.21 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.987 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER -74.61 156.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.209 -1.171 . . . . 0.0 108.74 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.987 ' N ' HD12 ' A' ' 97' ' ' ILE . 3.6 t -124.37 106.17 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.047 -1.033 . . . . 0.0 109.939 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.937 HG22 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -101.73 159.78 4.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 1.6 m-20 -139.33 170.03 16.69 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.236 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.895 HG22 ' HD2' ' A' ' 102' ' ' PRO . 0.7 OUTLIER -105.09 157.97 33.11 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.512 178.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.895 ' HD2' HG22 ' A' ' 101' ' ' VAL . 6.3 Cg_exo -55.86 -167.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.546 2.164 . . . . 0.0 111.585 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 13.4 t0 -106.87 -22.84 12.56 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -131.31 127.95 38.74 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.57 20.03 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.968 -1.083 . . . . 0.0 110.036 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.572 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.013 . . . . 0.0 109.467 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.478 ' HB2' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.471 0.653 . . . . 0.0 109.579 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.415 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -145.63 153.43 41.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.001 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.89 HG21 HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -149.13 122.95 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.125 -0.984 . . . . 0.0 109.802 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.646 HG13 ' HG3' ' A' ' 14' ' ' GLN . 16.6 t -124.06 132.11 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.082 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -100.04 154.99 17.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.953 -1.092 . . . . 0.0 109.605 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.936 ' O ' HG23 ' A' ' 101' ' ' VAL . 11.6 t -121.79 167.78 14.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.483 -0.761 . . . . 0.0 109.011 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.586 ' N ' HG12 ' A' ' 6' ' ' VAL . 42.0 t -124.3 161.75 25.2 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.503 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.51 -7.36 9.89 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.85 -1.156 . . . . 0.0 109.149 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -110.3 -4.09 15.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.014 -1.054 . . . . 0.0 110.606 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.3 -19.03 27.46 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.303 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.2 m -59.87 111.88 1.64 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.908 -1.348 . . . . 0.0 109.252 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.75 ' HG2' HG13 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -125.58 121.93 35.04 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.515 -0.741 . . . . 0.0 110.268 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.632 ' NH1' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -102.53 126.36 49.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.646 ' HG3' HG13 ' A' ' 4' ' ' VAL . 2.4 mt-30 -88.78 157.17 18.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.099 -1.001 . . . . 0.0 110.654 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.082 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -166.81 -176.85 3.62 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.707 0.765 . . . . 0.0 109.322 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.25 116.07 17.86 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.415 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.014 HG21 HD23 ' A' ' 23' ' ' LEU . 49.2 t -93.29 106.36 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.577 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -47.07 174.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.586 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 92' ' ' PRO . 65.8 m-20 -83.51 126.26 32.61 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.317 -0.865 . . . . 0.0 109.18 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.84 21.77 20.11 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.736 HG12 ' HB2' ' A' ' 25' ' ' GLN . 1.5 t -125.01 164.65 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -1.177 . . . . 0.0 109.294 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 33.0 t -109.33 143.89 38.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 108.986 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.014 HD23 HG21 ' A' ' 17' ' ' VAL . 16.0 mt -44.61 -34.63 2.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.152 -0.968 . . . . 0.0 108.878 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -48.59 76.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.047 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.811 ' O ' HG12 ' A' ' 28' ' ' VAL . 3.3 mt-30 -52.73 -55.73 20.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.01 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.16 -21.69 66.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.199 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.94 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -76.42 -24.37 54.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.561 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 25' ' ' GLN . 5.4 p -59.93 -33.75 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.167 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 t -91.79 -52.7 4.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 109.075 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.493 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 21.0 m-80 -55.04 -17.6 4.13 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.506 -0.746 . . . . 0.0 109.22 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.36 24.64 56.43 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.655 HD11 HD22 ' A' ' 15' ' ' LEU . 1.1 mt -102.9 -27.26 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.128 -1.219 . . . . 0.0 108.738 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.94 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.7 OUTLIER -50.5 -40.44 51.23 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.695 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.478 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 45.1 t0 -73.3 -32.91 64.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.632 HD13 ' NH1' ' A' ' 13' ' ' ARG . 1.0 OUTLIER -98.42 14.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.942 -1.098 . . . . 0.0 109.448 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.608 HG12 ' SG ' ' A' ' 85' ' ' CYS . 94.6 t -160.29 69.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.435 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 48' ' ' CYS . . . 154.41 -171.93 32.92 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.889 ' CG ' HG21 ' A' ' 47' ' ' THR . 0.3 OUTLIER -165.42 -79.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.172 . . . . 0.0 109.639 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.499 ' SG ' ' N ' ' A' ' 40' ' ' GLY . 16.4 p -61.97 -40.32 95.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.562 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.499 ' N ' ' SG ' ' A' ' 39' ' ' CYS . . . 64.11 138.83 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.73 -102.68 0.86 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.43 99.71 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -1.179 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.54 109.71 1.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.505 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.3 m -152.45 17.13 0.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.654 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 12.9 p -121.26 -149.55 0.43 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.988 ' HB1' ' N ' ' A' ' 74' ' ' VAL . . . -156.13 18.71 0.36 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.033 -1.042 . . . . 0.0 109.997 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.889 HG21 ' CG ' ' A' ' 38' ' ' ASP . 1.7 p -90.11 -20.73 22.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.144 -0.973 . . . . 0.0 109.728 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.584 ' SG ' HD11 ' A' ' 71' ' ' LEU . 22.2 p -87.69 41.9 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.068 -1.02 . . . . 0.0 110.05 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.137 ' CD2' HD12 ' A' ' 78' ' ' LEU . 37.2 t-80 -81.9 61.94 5.46 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 82' ' ' SER . 12.5 m -77.35 148.09 6.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 120.588 -1.32 . . . . 0.0 110.612 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.514 ' CE2' ' CE1' ' A' ' 49' ' ' HIS . 7.0 m-85 -107.59 110.87 22.87 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.765 HG22 HG12 ' A' ' 99' ' ' VAL . 8.4 t -93.91 170.39 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 121.928 0.871 . . . . 0.0 112.251 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.566 ' N ' HG12 ' A' ' 52' ' ' VAL . 1.3 m-20 -69.16 165.3 20.7 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.17 9.3 26.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 109.869 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.32 -28.55 8.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.157 -0.964 . . . . 0.0 109.964 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.815 ' HD2' HD23 ' A' ' 94' ' ' LEU . 93.7 m-85 -97.91 -19.39 18.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 109.64 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.678 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -63.82 -23.06 67.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.4 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.03 -35.73 25.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.681 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.917 ' HB2' HD21 ' A' ' 94' ' ' LEU . 2.7 mmtm -63.74 -12.94 39.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.38 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.955 HG11 ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -97.94 161.75 24.56 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.268 -0.895 . . . . 0.0 108.969 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.832 ' HD2' HG12 ' A' ' 60' ' ' VAL . 5.0 Cg_exo -59.43 164.49 10.89 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.124 1.882 . . . . 0.0 110.371 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.19 59.35 0.61 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 109.428 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -41.98 130.19 3.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.548 -0.72 . . . . 0.0 109.593 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' ALA . 8.5 m-20 -57.08 -160.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.542 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.66 ' HA ' HD12 ' A' ' 68' ' ' ILE . 57.0 tt0 -99.25 -10.39 22.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.466 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' NE ' ' OE2' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -47.13 -72.28 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.599 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -61.04 -20.06 62.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 65' ' ' GLU . 13.6 mt -66.13 -31.93 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.69 -59.51 3.7 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.45 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -68.44 -28.1 66.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -1.116 . . . . 0.0 109.056 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.068 HD13 HD23 ' A' ' 84' ' ' LEU . 1.3 tp -85.5 4.49 35.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.324 -0.86 . . . . 0.0 109.167 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 68' ' ' ILE . 3.2 tm-20 -95.84 -12.53 25.1 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.081 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.745 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 1.3 m -59.92 -14.69 16.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.673 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.989 HG21 ' CD2' ' A' ' 49' ' ' HIS . 3.9 m -34.41 134.11 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.364 0.602 . . . . 0.0 109.941 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.549 ' HB ' ' CG ' ' A' ' 104' ' ' ARG . 88.4 m -44.69 -25.5 0.29 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 108.761 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.762 ' O ' HG23 ' A' ' 74' ' ' VAL . . . -110.1 -152.6 0.5 Allowed 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.373 -0.83 . . . . 0.0 109.834 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.634 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -114.74 148.59 38.11 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.137 HD12 ' CD2' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -104.15 130.05 51.89 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 117.406 -1.718 . . . . 0.0 111.288 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.538 ' HE2' ' CD ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -108.63 166.52 10.69 Favored Pre-proline 0 C--N 1.295 -1.801 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.538 ' CD ' ' HE2' ' A' ' 79' ' ' LYS . 3.4 Cg_exo -52.37 -27.85 32.86 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.733 1.622 . . . . 0.0 109.582 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.673 ' HA ' HG21 ' A' ' 57' ' ' THR . 1.0 OUTLIER -67.14 -42.04 85.07 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.677 -0.639 . . . . 0.0 109.449 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -83.18 168.27 16.96 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.435 -0.791 . . . . 0.0 109.671 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.541 ' HB3' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -161.57 -177.27 5.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.086 -1.009 . . . . 0.0 109.687 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.068 HD23 HD13 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -83.93 114.22 21.53 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.332 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.608 ' SG ' HG12 ' A' ' 36' ' ' VAL . 9.4 t -59.66 -14.87 15.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 0.0 109.12 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.3 p -108.54 30.21 6.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 109.76 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.819 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -152.92 13.72 0.52 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.986 -1.071 . . . . 0.0 110.377 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.955 ' CG2' HG11 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -112.39 150.2 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.923 -1.111 . . . . 0.0 108.938 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.749 HD13 ' O ' ' A' ' 88' ' ' ILE . 38.2 mm -129.45 142.27 44.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.315 -0.866 . . . . 0.0 109.881 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.81 ' SD ' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -97.95 82.15 2.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 108.936 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.57 165.85 41.58 Favored Pre-proline 0 C--N 1.294 -1.805 0 O-C-N 121.606 -0.684 . . . . 0.0 109.174 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 5.8 Cg_exo -59.25 -13.8 21.54 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.067 1.845 . . . . 0.0 110.103 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -76.96 -42.39 39.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.917 HD21 ' HB2' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -80.07 160.01 25.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.52 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -173.98 125.24 0.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.613 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 75.34 40.34 33.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.736 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -79.83 149.11 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -1.082 . . . . 0.0 109.165 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.417 ' N ' HD13 ' A' ' 97' ' ' ILE . 2.3 t -113.73 108.54 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.227 -0.92 . . . . 0.0 109.759 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.765 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -99.71 153.18 4.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -129.93 179.34 5.92 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.049 -1.032 . . . . 0.0 109.939 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 6' ' ' VAL . 25.4 t -109.01 146.59 34.16 Favored Pre-proline 0 C--N 1.296 -1.757 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.544 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.887 ' HD2' HG13 ' A' ' 101' ' ' VAL . 12.1 Cg_exo -53.72 137.8 67.38 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.223 1.949 . . . . 0.0 109.762 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.58 ' CB ' ' HD2' ' A' ' 104' ' ' ARG . 1.3 m-20 -47.14 -26.28 1.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.884 -1.135 . . . . 0.0 108.417 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -117.4 -167.34 1.3 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.18 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 106' ' ' TRP . 11.8 pt20 -160.07 27.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.056 . . . . 0.0 109.75 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.504 ' NE1' ' N ' ' A' ' 75' ' ' THR . 41.4 m95 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.67 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.88 161.99 40.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 109.355 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.752 ' CG2' HD21 ' A' ' 23' ' ' LEU . 1.5 t -147.04 132.04 11.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.304 -0.873 . . . . 0.0 109.301 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.935 HG13 ' O ' ' A' ' 13' ' ' ARG . 72.2 t -129.32 127.7 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.782 ' CD2' HD21 ' A' ' 15' ' ' LEU . 44.5 m-85 -97.57 153.72 17.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.818 -1.176 . . . . 0.0 110.263 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.69 HG22 ' HB3' ' A' ' 12' ' ' ARG . 2.6 t -132.46 141.77 44.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -76.77 -156.78 0.08 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.258 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.685 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -58.18 -105.93 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -112.07 77.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.477 -1.389 . . . . 0.0 108.887 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.05 -100.39 0.19 Allowed Glycine 0 N--CA 1.493 2.439 0 C-N-CA 118.931 -1.605 . . . . 0.0 111.027 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.702 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.3 m -119.56 -177.27 3.34 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.333 -1.098 . . . . 0.0 110.061 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.702 ' H ' HG22 ' A' ' 11' ' ' THR . 12.8 ptt180 -153.0 147.79 26.33 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.935 ' O ' HG13 ' A' ' 4' ' ' VAL . 8.0 mtt180 -106.25 173.47 6.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 108.522 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.453 ' C ' HD23 ' A' ' 15' ' ' LEU . 11.2 pt20 -123.76 163.76 20.53 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.004 -1.06 . . . . 0.0 110.567 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.782 HD21 ' CD2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -169.71 -175.32 2.08 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -131.9 91.33 2.96 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.063 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.925 HG21 HD23 ' A' ' 23' ' ' LEU . 46.9 t -62.2 153.38 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 108.872 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 1.055 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -91.03 172.37 8.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.0 . . . . 0.0 109.496 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -78.19 125.25 29.07 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.323 -0.861 . . . . 0.0 109.029 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.79 26.89 28.15 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.055 HG21 ' HB3' ' A' ' 18' ' ' ALA . 2.1 t -120.89 163.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -1.15 . . . . 0.0 109.172 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.5 t -106.07 140.72 38.62 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 108.534 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.013 HD13 HG21 ' A' ' 99' ' ' VAL . 12.1 mt -46.38 -26.08 0.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.099 -1.001 . . . . 0.0 108.623 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.589 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 22.0 ttt -71.71 -47.96 50.44 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.873 ' HB3' HG12 ' A' ' 21' ' ' VAL . 3.2 tp-100 -51.34 -55.5 18.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 108.836 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.597 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -54.1 -31.38 51.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.904 . . . . 0.0 108.903 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.83 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -61.19 -39.51 90.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.344 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.555 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 49.0 t -46.16 -22.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.857 . . . . 0.0 110.446 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 t -110.64 -50.29 2.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.019 -1.051 . . . . 0.0 110.325 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.674 ' HB3' HD11 ' A' ' 32' ' ' ILE . 17.7 m120 -59.56 -11.64 5.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 110.123 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.425 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 98.88 -31.49 8.13 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.674 HD11 ' HB3' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -51.53 -21.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.215 -1.168 . . . . 0.0 109.178 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.83 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 1.2 p90 -43.16 -47.89 6.32 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.626 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 1.2 t0 -87.12 -21.2 26.14 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.505 ' CG1' ' HA ' ' A' ' 32' ' ' ILE . 4.5 mm -85.71 5.72 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.936 -1.102 . . . . 0.0 109.437 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 32' ' ' ILE . 10.0 p -170.52 171.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.572 ' H ' HG22 ' A' ' 36' ' ' VAL . . . 77.24 173.83 39.82 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.739 ' HB2' HG21 ' A' ' 47' ' ' THR . 6.9 t0 -169.96 -89.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -1.107 . . . . 0.0 109.542 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 44' ' ' SER . 17.7 p -65.05 -22.78 67.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.155 -0.966 . . . . 0.0 109.525 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.6 -177.18 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.55 -109.84 3.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.0 -177.16 3.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -1.152 . . . . 0.0 109.449 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -61.81 110.11 1.44 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.431 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.502 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -134.98 8.36 3.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.748 ' SG ' HG22 ' A' ' 47' ' ' THR . 9.0 p -165.46 -160.51 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.659 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.857 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -145.52 13.36 1.37 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.502 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.748 HG22 ' SG ' ' A' ' 45' ' ' CYS . 8.8 t -78.51 -18.75 54.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.585 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.503 ' HB2' ' CB ' ' A' ' 85' ' ' CYS . 21.8 p -87.54 41.9 1.01 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 0.0 109.948 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.013 ' CE1' HD12 ' A' ' 78' ' ' LEU . 14.6 t60 -70.54 76.13 0.57 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.781 HG11 ' SG ' ' A' ' 85' ' ' CYS . 8.4 m -80.02 144.74 10.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 120.214 -1.554 . . . . 0.0 110.673 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.506 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 2.0 m-85 -110.98 102.72 11.18 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.052 HG22 HG12 ' A' ' 99' ' ' VAL . 7.0 t -101.13 156.32 4.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.85 0.834 . . . . 0.0 112.859 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.749 HD22 HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -46.22 177.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.468 0.651 . . . . 0.0 109.267 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -101.68 -0.28 34.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 110.115 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.57 -22.81 11.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.97 -1.081 . . . . 0.0 110.649 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.812 ' HD1' HD23 ' A' ' 94' ' ' LEU . 65.8 m-85 -91.71 -27.08 18.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.988 -1.07 . . . . 0.0 109.747 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.854 HG21 HD22 ' A' ' 81' ' ' ASN . 5.8 p -58.07 -38.13 75.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.18 -0.95 . . . . 0.0 109.475 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 1.2 m-20 -57.46 -64.61 0.83 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.777 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.638 ' HB2' HD21 ' A' ' 94' ' ' LEU . 46.2 mmtt -49.81 -37.96 32.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.912 . . . . 0.0 109.396 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.825 ' CG2' HG22 ' A' ' 88' ' ' ILE . 1.1 t -54.91 157.37 5.71 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.951 . . . . 0.0 108.754 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.604 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.6 Cg_exo -56.13 156.83 19.08 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.087 1.858 . . . . 0.0 110.309 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.52 61.13 0.6 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.325 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.621 ' HB2' ' NH2' ' A' ' 83' ' ' ARG . . . -40.83 146.46 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.626 -0.671 . . . . 0.0 109.689 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.591 ' O ' HD13 ' A' ' 68' ' ' ILE . 1.5 p30 -51.59 -174.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.679 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.527 ' HA ' HD13 ' A' ' 68' ' ' ILE . 58.0 tt0 -96.71 -9.81 28.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.86 . . . . 0.0 109.543 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -50.3 -49.12 54.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.927 . . . . 0.0 109.516 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.469 ' CG ' ' HB2' ' A' ' 43' ' ' ALA . 28.0 mt-10 -74.59 -21.35 59.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.435 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.632 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -68.21 -35.32 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.878 . . . . 0.0 109.314 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.59 -52.6 44.24 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -66.84 -24.31 66.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -1.15 . . . . 0.0 109.273 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.891 ' O ' HD13 ' A' ' 78' ' ' LEU . 5.7 tp -88.24 -7.29 57.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.378 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -80.09 -37.64 33.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.334 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.413 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 42.6 t -104.2 38.61 1.82 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.393 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.857 HG12 ' HB1' ' A' ' 46' ' ' ALA . 16.4 m -63.17 174.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.85 . . . . 0.0 109.597 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.569 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 98.3 m -65.28 -9.37 23.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.747 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.842 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -116.5 -149.92 0.45 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 109.511 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.644 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.2 pt-20 -111.52 155.24 23.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.013 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -129.8 135.66 48.68 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 117.991 -1.483 . . . . 0.0 111.454 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.594 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -117.83 171.02 5.45 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 4.4 Cg_exo -57.52 -10.6 7.13 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 C-N-CA 122.394 2.063 . . . . 0.0 111.09 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.854 HD22 HG21 ' A' ' 57' ' ' THR . 0.0 OUTLIER -104.78 16.57 25.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 0.0 111.499 -178.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.615 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.4 m -100.26 161.09 13.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.675 -1.266 . . . . 0.0 110.029 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.621 ' NH2' ' HB2' ' A' ' 63' ' ' ALA . 1.5 mtp180 -161.62 -165.11 1.22 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 109.287 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.53 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 1.7 mp -104.95 131.09 52.89 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.314 -0.866 . . . . 0.0 108.887 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.781 ' SG ' HG11 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -67.13 -10.41 49.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.399 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.1 p -110.35 15.26 22.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.797 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -131.95 -0.55 3.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.007 . . . . 0.0 109.925 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.825 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -97.9 147.14 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.03 -1.044 . . . . 0.0 108.97 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.619 HG22 ' N ' ' A' ' 90' ' ' MET . 10.7 mm -121.3 165.68 16.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.293 -0.88 . . . . 0.0 109.775 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.638 ' CB ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -122.97 90.33 3.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.352 -0.842 . . . . 0.0 109.341 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.01 162.48 40.78 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.417 -0.802 . . . . 0.0 109.303 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.0 -13.99 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.151 1.901 . . . . 0.0 110.233 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' A' ' 94' ' ' LEU . 21.6 pt-20 -70.92 -45.92 63.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.43 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.812 HD23 ' HD1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -78.46 144.4 35.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -146.41 122.03 10.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 75.22 39.53 36.5 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.948 HD11 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -78.11 134.66 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.441 -1.035 . . . . 0.0 109.197 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.68 HG11 HH11 ' A' ' 12' ' ' ARG . 2.0 t -107.23 110.12 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.976 -1.078 . . . . 0.0 110.012 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.052 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -100.82 146.57 9.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.177 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.501 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 1.6 m-20 -122.15 174.25 7.07 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.968 -1.083 . . . . 0.0 110.256 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.897 HG13 ' HD2' ' A' ' 102' ' ' PRO . 39.7 t -108.01 145.21 30.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.897 ' HD2' HG13 ' A' ' 101' ' ' VAL . 7.2 Cg_exo -50.95 159.82 2.26 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.492 2.128 . . . . 0.0 111.548 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -14.7 60.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.596 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -119.87 -159.51 0.78 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 106' ' ' TRP . 11.4 pt20 -159.87 27.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.025 -1.047 . . . . 0.0 109.78 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.681 ' NE1' ' HB3' ' A' ' 46' ' ' ALA . 5.9 m95 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.658 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -147.48 168.39 22.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -0.863 . . . . 0.0 109.253 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.673 ' CG2' HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -153.54 129.95 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.295 -0.878 . . . . 0.0 109.677 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.974 HG13 ' O ' ' A' ' 13' ' ' ARG . 77.7 t -130.17 135.42 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 108.651 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.113 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -104.0 155.14 18.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.922 -1.111 . . . . 0.0 109.393 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.749 HG13 ' HB3' ' A' ' 12' ' ' ARG . 2.4 t -135.25 133.02 52.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.531 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -80.0 -174.27 4.36 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -50.02 161.48 0.26 Allowed 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.528 ' C ' ' O ' ' A' ' 8' ' ' HIS . 33.9 t0 -29.86 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.147 0.499 . . . . 0.0 110.72 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 8' ' ' HIS . . . -167.45 -95.51 0.1 Allowed Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.484 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.6 m -124.97 -178.53 4.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -1.186 . . . . 0.0 109.77 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.749 ' HB3' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -157.15 142.64 17.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.625 -0.672 . . . . 0.0 110.032 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.974 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -100.33 176.2 5.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.255 -0.903 . . . . 0.0 108.899 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -132.43 160.83 35.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.126 -0.984 . . . . 0.0 110.52 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.113 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -177.14 -176.04 0.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.579 0.704 . . . . 0.0 109.115 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -128.94 113.88 15.76 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.581 -0.699 . . . . 0.0 109.965 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.917 HG11 ' HB3' ' A' ' 90' ' ' MET . 28.6 t -78.12 133.37 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.046 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.936 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -69.76 171.81 8.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.498 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -78.44 125.25 29.09 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.269 -0.895 . . . . 0.0 109.084 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.16 39.59 7.86 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.936 HG21 ' HB3' ' A' ' 18' ' ' ALA . 1.5 t -131.11 160.69 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -1.117 . . . . 0.0 109.327 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -99.35 135.07 41.29 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 108.65 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.736 HD23 HG21 ' A' ' 17' ' ' VAL . 6.6 mt -46.28 -26.24 0.77 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.965 -1.085 . . . . 0.0 108.6 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.541 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -72.74 -47.45 46.86 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.639 ' HB3' HG12 ' A' ' 21' ' ' VAL . 39.6 tp60 -51.97 -55.08 22.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.36 -0.837 . . . . 0.0 108.845 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.527 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -57.67 -28.5 63.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 108.737 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.703 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -68.09 -33.89 75.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.47 -0.769 . . . . 0.0 109.451 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.585 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 53.7 t -54.58 -39.89 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.475 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 t -79.87 -51.78 8.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.858 . . . . 0.0 109.398 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.878 ' ND2' HD13 ' A' ' 15' ' ' LEU . 29.4 m-80 -58.57 -13.41 5.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.424 -0.798 . . . . 0.0 109.567 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.47 14.54 78.18 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.954 ' O ' HG22 ' A' ' 35' ' ' ILE . 1.2 mt -90.41 -34.65 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -1.146 . . . . 0.0 108.851 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.703 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -51.48 -37.06 47.12 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.624 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 5.3 t0 -82.83 -26.94 31.21 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.954 HG22 ' O ' ' A' ' 32' ' ' ILE . 4.8 tp -44.48 -26.13 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 109.325 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.582 HG13 ' H ' ' A' ' 37' ' ' GLY . 2.5 p -131.17 -52.15 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.563 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' H ' HG13 ' A' ' 36' ' ' VAL . . . 69.2 120.12 0.03 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 94.9 m-20 -136.4 -120.36 0.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -1.171 . . . . 0.0 109.53 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 1.016 ' SG ' ' HB3' ' A' ' 43' ' ' ALA . 16.7 p -109.79 -6.48 15.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.75 -1.219 . . . . 0.0 109.594 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 44.62 -168.51 0.02 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 43.89 -125.95 5.69 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.12 63.86 1.46 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -1.121 . . . . 0.0 109.543 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 1.016 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . . . -88.8 -147.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 109.431 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.516 ' CB ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -139.78 60.86 1.55 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.152 -0.968 . . . . 0.0 109.773 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.414 ' SG ' ' HB3' ' A' ' 38' ' ' ASP . 6.7 p -99.22 -164.57 1.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.033 -1.042 . . . . 0.0 109.379 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.88 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -148.92 17.74 0.98 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.525 ' CG2' ' OD1' ' A' ' 38' ' ' ASP . 58.5 m -90.02 -17.19 28.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.465 ' HB2' ' SG ' ' A' ' 85' ' ' CYS . 24.5 p -87.6 42.51 1.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 110.269 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.948 ' CE1' HD12 ' A' ' 78' ' ' LEU . 15.3 t60 -75.56 71.19 2.46 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.013 HG11 ' HB3' ' A' ' 85' ' ' CYS . 12.7 m -77.88 146.1 8.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.257 -1.527 . . . . 0.0 110.168 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.661 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -112.53 100.71 8.95 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.309 1.052 . . . . 0.0 108.182 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.797 HG22 HG12 ' A' ' 99' ' ' VAL . 4.5 t -89.76 172.88 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.803 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.579 ' H ' HG12 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -68.86 -178.36 1.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.88 -1.21 35.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 109.967 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.14 -14.38 14.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.085 -1.01 . . . . 0.0 110.187 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.723 ' HD1' HD23 ' A' ' 94' ' ' LEU . 80.3 m-85 -103.67 -21.42 13.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.975 . . . . 0.0 109.7 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.718 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -68.7 -6.47 26.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.563 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -88.08 -56.17 3.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.123 -0.986 . . . . 0.0 109.6 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.64 ' HB2' HD21 ' A' ' 94' ' ' LEU . 2.5 mptp? -52.29 -38.69 59.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -50.14 164.57 0.37 Allowed Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.17 -0.956 . . . . 0.0 109.414 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 5.8 Cg_exo -58.16 176.66 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.109 1.873 . . . . 0.0 110.353 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.25 59.37 0.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.29 120.73 1.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.483 -0.761 . . . . 0.0 109.553 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 63' ' ' ALA . 9.7 m-20 -57.0 -160.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.473 ' HG2' ' HB ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -100.05 -12.1 19.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.467 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 67' ' ' GLU . 5.1 ppt_? -54.51 -44.66 72.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.476 ' N ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -81.17 -14.51 57.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.404 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.473 ' HB ' ' HG2' ' A' ' 65' ' ' GLU . 26.0 mm -77.12 -32.17 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.476 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.13 -54.69 11.66 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.516 ' SD ' ' CB ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -67.89 -24.92 65.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -1.155 . . . . 0.0 109.257 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.036 HD23 HD21 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -90.04 0.15 57.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.872 . . . . 0.0 109.43 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -89.99 -25.47 20.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.942 . . . . 0.0 109.299 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.64 34.55 2.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.426 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.922 HG11 ' HB2' ' A' ' 49' ' ' HIS . 2.1 t -63.38 165.01 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.581 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 28.4 m -71.68 -4.25 26.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.477 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.527 ' CB ' ' OD1' ' A' ' 103' ' ' ASP . . . -115.96 -149.8 0.45 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.114 -0.991 . . . . 0.0 109.34 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.63 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.7 pt-20 -112.19 155.06 24.59 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.948 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -133.49 166.34 22.78 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.465 -1.694 . . . . 0.0 112.547 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.698 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -155.7 170.62 8.46 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 5.3 Cg_exo -56.45 -14.68 13.27 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 121.997 1.798 . . . . 0.0 109.992 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.543 ' CB ' ' HE2' ' A' ' 79' ' ' LYS . 1.3 t-20 -87.03 -30.33 21.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 0.0 110.71 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.61 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -74.62 152.87 39.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.021 -1.049 . . . . 0.0 110.354 -179.374 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 1.096 ' NH2' HG23 ' A' ' 88' ' ' ILE . 8.8 mtp180 -161.8 -175.38 4.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.036 HD21 HD23 ' A' ' 71' ' ' LEU . 4.9 mp -98.99 103.43 15.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.324 -0.86 . . . . 0.0 108.698 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 1.013 ' HB3' HG11 ' A' ' 50' ' ' VAL . 6.1 p -48.85 -21.99 0.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.142 -0.974 . . . . 0.0 109.924 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 20.7 p -76.57 -40.11 50.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.084 -1.01 . . . . 0.0 110.093 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.484 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -89.74 38.44 0.91 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.112 -0.992 . . . . 0.0 110.405 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.096 HG23 ' NH2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -140.06 149.01 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.975 -1.078 . . . . 0.0 109.312 179.294 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.629 HG22 ' N ' ' A' ' 90' ' ' MET . 12.7 mm -116.23 167.09 9.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.421 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.917 ' HB3' HG11 ' A' ' 17' ' ' VAL . 12.9 tpt -130.18 96.87 4.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.665 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -95.53 171.45 6.44 Favored Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 121.549 -0.72 . . . . 0.0 109.385 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.665 ' HD2' HG22 ' A' ' 91' ' ' THR . 5.6 Cg_exo -59.03 -14.49 23.42 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.05 1.833 . . . . 0.0 110.054 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.44 ' OE1' ' HB3' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -62.8 -37.23 85.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 109.312 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.723 HD23 ' HD1' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -95.07 139.75 30.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.234 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 11.2 p-10 -138.72 124.68 19.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.803 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.469 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 71.51 39.22 61.37 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.966 HD11 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -72.91 147.66 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -1.107 . . . . 0.0 109.302 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.509 ' N ' HD13 ' A' ' 97' ' ' ILE . 3.5 t -116.75 106.73 20.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 O-C-N 121.126 -0.983 . . . . 0.0 109.853 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.966 HG13 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -101.25 142.71 15.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.514 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 3.1 m-20 -122.97 177.44 5.5 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.967 -1.083 . . . . 0.0 110.269 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.903 HG13 ' HD2' ' A' ' 102' ' ' PRO . 44.8 t -108.49 145.07 30.8 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.903 ' HD2' HG13 ' A' ' 101' ' ' VAL . 7.7 Cg_exo -51.14 -174.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.263 1.975 . . . . 0.0 111.293 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -100.7 -27.03 13.59 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -130.07 149.7 51.67 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -122.93 41.94 3.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.044 -1.035 . . . . 0.0 109.849 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.581 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 43.6 m95 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.476 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.491 ' HB2' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -138.29 169.51 17.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.215 -0.928 . . . . 0.0 109.428 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.572 HG21 ' CG2' ' A' ' 17' ' ' VAL . 11.3 t -152.34 158.64 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.272 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.672 HG12 ' O ' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -157.8 120.67 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.104 -0.998 . . . . 0.0 108.905 -179.409 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.654 ' CE2' ' CD2' ' A' ' 15' ' ' LEU . 54.9 m-85 -98.5 155.62 17.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.66 -1.275 . . . . 0.0 110.634 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.806 HG22 ' HG3' ' A' ' 12' ' ' ARG . 3.0 t -130.84 142.48 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -76.5 -158.53 0.1 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.76 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -58.31 -103.97 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.18 75.15 0.9 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.482 -1.386 . . . . 0.0 108.496 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.29 -100.42 0.24 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 118.863 -1.636 . . . . 0.0 111.453 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.71 HG22 ' H ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -114.9 -176.59 2.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.289 -1.124 . . . . 0.0 110.584 -178.287 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.806 ' HG3' HG22 ' A' ' 6' ' ' VAL . 13.7 ttp180 -149.27 134.59 18.35 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.871 ' NH2' HD11 ' A' ' 35' ' ' ILE . 6.6 mtt180 -105.11 171.51 7.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.941 -1.1 . . . . 0.0 108.774 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.481 ' CG ' HG13 ' A' ' 4' ' ' VAL . 1.7 mt-30 -127.08 163.47 23.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.949 -1.094 . . . . 0.0 111.141 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.046 HD13 ' OD1' ' A' ' 30' ' ' ASN . 0.4 OUTLIER -161.65 -172.96 3.53 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.671 0.748 . . . . 0.0 109.019 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 17' ' ' VAL . 46.4 t0 -131.22 69.96 1.47 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.627 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.918 HG21 HD23 ' A' ' 23' ' ' LEU . 26.6 t -43.81 163.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.185 -0.947 . . . . 0.0 109.068 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 1.027 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -105.07 173.1 6.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.959 . . . . 0.0 109.744 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -81.99 125.81 31.22 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.371 -0.831 . . . . 0.0 108.898 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.11 23.3 38.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.027 HG21 ' HB3' ' A' ' 18' ' ' ALA . 3.0 t -118.04 167.34 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.43 -1.041 . . . . 0.0 109.113 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 23' ' ' LEU . 10.4 t -105.89 137.45 43.75 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.918 HD23 HG21 ' A' ' 17' ' ' VAL . 8.3 mt -44.9 -26.69 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.051 . . . . 0.0 108.794 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.622 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 3.3 ttm -75.03 -47.53 28.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.546 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -49.8 -54.77 17.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 108.803 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.767 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -52.24 -35.81 50.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.263 -0.898 . . . . 0.0 108.971 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.69 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -42.15 -42.38 2.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.849 . . . . 0.0 110.076 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.581 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 63.6 t -39.65 -50.41 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.19 -0.944 . . . . 0.0 110.588 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -90.8 -45.36 8.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.876 . . . . 0.0 110.017 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 1.046 ' OD1' HD13 ' A' ' 15' ' ' LEU . 2.4 m120 -50.13 -17.19 0.38 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.725 -0.609 . . . . 0.0 109.774 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.31 -21.64 36.78 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.65 HG13 ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -66.62 -22.17 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.254 -1.144 . . . . 0.0 108.554 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.69 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -48.02 -28.74 2.96 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 179.076 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -100.17 -23.39 14.85 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.925 HG22 HG13 ' A' ' 36' ' ' VAL . 18.6 mm -60.36 -51.14 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.089 -1.007 . . . . 0.0 109.405 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.925 HG13 HG22 ' A' ' 35' ' ' ILE . 11.8 m -134.06 -153.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.935 . . . . 0.0 109.538 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.492 ' HA2' ' HE1' ' A' ' 24' ' ' MET . . . 112.83 150.89 10.99 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.516 ' OD1' ' CB ' ' A' ' 45' ' ' CYS . 6.8 t70 -152.17 -92.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.178 -1.19 . . . . 0.0 109.714 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.513 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 15.6 p -85.27 -33.28 22.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.987 . . . . 0.0 109.603 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 56.57 162.23 0.03 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.01 -103.67 2.26 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.26 169.4 8.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -1.159 . . . . 0.0 109.488 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.981 ' HB1' HD21 ' A' ' 71' ' ' LEU . . . -65.5 111.95 3.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.508 ' HB2' ' CB ' ' A' ' 39' ' ' CYS . 44.3 m -140.73 11.3 2.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.652 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.516 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . 8.9 p -157.32 -157.41 0.67 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 109.626 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.728 ' HB1' ' HA ' ' A' ' 74' ' ' VAL . . . -150.0 15.22 0.83 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.687 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.779 HG23 ' CB ' ' A' ' 105' ' ' GLN . 22.0 m -82.05 -18.41 43.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.355 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.54 ' SG ' HD12 ' A' ' 84' ' ' LEU . 23.4 p -86.34 43.13 1.04 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 110.112 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.89 ' CE1' HD12 ' A' ' 78' ' ' LEU . 48.0 t60 -77.36 65.56 2.94 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.59 HG11 ' HB3' ' A' ' 85' ' ' CYS . 8.8 m -74.94 143.33 13.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.284 -1.51 . . . . 0.0 110.449 -177.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.645 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 1.0 OUTLIER -109.46 109.55 20.41 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.094 HG22 HG12 ' A' ' 99' ' ' VAL . 7.1 t -97.28 171.42 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-O 122.005 0.907 . . . . 0.0 112.531 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.565 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -65.33 176.8 1.26 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.298 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.75 7.72 45.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.151 -0.968 . . . . 0.0 109.626 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.33 -27.96 8.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.883 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.611 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 88.1 m-85 -98.27 -18.54 18.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.739 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.941 HG21 ' HA ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER -62.5 -39.01 92.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.611 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.38 -41.18 94.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 109.776 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.856 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -54.41 -42.65 70.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.907 . . . . 0.0 109.579 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.889 HG11 HG23 ' A' ' 88' ' ' ILE . 62.3 t -62.54 142.38 96.57 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.084 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.747 ' HD2' HG13 ' A' ' 60' ' ' VAL . 5.7 Cg_exo -56.36 168.8 1.89 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.075 1.85 . . . . 0.0 110.468 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.48 63.51 0.61 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.366 -0.834 . . . . 0.0 109.125 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -36.52 139.66 0.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.275 0.56 . . . . 0.0 110.068 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -50.52 -177.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.347 -0.846 . . . . 0.0 109.804 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.534 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 23.9 tt0 -97.07 -12.77 22.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 109.507 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -50.07 -67.18 0.28 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.463 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -66.09 -10.22 38.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.534 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 26.5 mm -76.38 -31.93 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.521 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.77 -54.91 8.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.3 mtt -68.25 -26.28 65.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -1.15 . . . . 0.0 108.987 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.981 HD21 ' HB1' ' A' ' 43' ' ' ALA . 38.3 mt -84.21 -2.96 57.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.35 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.415 ' C ' ' OE1' ' A' ' 72' ' ' GLU . 0.6 OUTLIER -91.13 -10.11 43.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.289 -0.882 . . . . 0.0 109.353 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -86.24 51.37 2.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.418 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.728 ' HA ' ' HB1' ' A' ' 46' ' ' ALA . 6.2 m -92.76 169.1 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 109.295 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.825 HG21 ' CB ' ' A' ' 104' ' ' ARG . 5.4 t -66.36 -34.56 78.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.797 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.405 ' N ' ' CG2' ' A' ' 75' ' ' THR . . . -106.62 -151.23 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.387 -0.821 . . . . 0.0 110.633 -178.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.558 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -112.51 149.9 32.03 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.89 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -108.29 165.44 11.5 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.609 -1.236 . . . . 0.0 110.465 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.543 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -158.97 172.87 5.57 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.579 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 6.0 Cg_exo -54.38 -18.77 15.43 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 121.309 1.339 . . . . 0.0 108.803 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.941 ' HA ' HG21 ' A' ' 57' ' ' THR . 1.6 m-20 -83.18 -35.93 25.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.712 -0.617 . . . . 0.0 109.739 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.565 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -95.48 159.22 15.1 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.19 -0.944 . . . . 0.0 110.398 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.605 ' HD2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -161.69 -164.22 1.08 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.343 -0.848 . . . . 0.0 109.03 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.865 ' N ' HD22 ' A' ' 84' ' ' LEU . 1.3 mm? -104.19 123.53 47.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.59 ' HB3' HG11 ' A' ' 50' ' ' VAL . 13.9 p -64.13 -10.75 24.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.014 -1.054 . . . . 0.0 109.553 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 22.6 p -100.21 14.7 29.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.276 -0.89 . . . . 0.0 109.914 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -143.3 0.34 1.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.013 -1.054 . . . . 0.0 110.694 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.889 HG23 HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -96.9 151.69 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.764 -1.21 . . . . 0.0 108.911 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 88' ' ' ILE . 18.0 mm -124.23 158.66 30.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.165 -0.959 . . . . 0.0 109.927 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.652 ' CB ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.93 90.33 3.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 109.176 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.413 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -82.0 167.07 33.38 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.399 -0.813 . . . . 0.0 109.456 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 3.3 Cg_exo -60.49 -13.33 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.115 1.877 . . . . 0.0 110.097 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.05 -39.99 65.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.856 HD21 ' CB ' ' A' ' 59' ' ' LYS . 4.6 mp -81.99 135.25 35.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.43 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.4 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 11.4 p-10 -135.67 124.24 23.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 68.25 49.28 47.14 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.975 HD11 HG22 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -75.9 151.11 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.187 -1.184 . . . . 0.0 108.455 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.944 ' N ' HD12 ' A' ' 97' ' ' ILE . 5.6 t -121.81 102.62 12.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.947 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.094 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -96.08 154.23 3.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.74 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -130.5 172.79 11.52 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.036 -1.04 . . . . 0.0 109.225 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.86 HG13 ' HD2' ' A' ' 102' ' ' PRO . 55.5 t -107.38 144.31 28.94 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.282 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.86 ' HD2' HG13 ' A' ' 101' ' ' VAL . 5.8 Cg_exo -57.26 -178.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.326 2.017 . . . . 0.0 110.364 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.595 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 6.9 t0 -90.2 -32.89 16.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 108.503 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.825 ' CB ' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.17 -161.19 1.12 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.779 ' CB ' HG23 ' A' ' 47' ' ' THR . 7.8 pt20 -159.45 27.76 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.956 . . . . 0.0 109.535 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 73' ' ' CYS . 10.9 m95 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.459 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.34 0.59 . . . . 0.0 109.513 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.499 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 3.0 ttmt -139.54 174.42 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.06 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.754 HG13 HD11 ' A' ' 23' ' ' LEU . 5.0 t -152.58 157.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.742 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 13' ' ' ARG . 67.2 t -156.93 117.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.805 . . . . 0.0 109.154 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 1.085 ' CE1' HD21 ' A' ' 15' ' ' LEU . 1.2 m-85 -95.47 154.05 17.4 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.344 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.78 HG22 ' HB3' ' A' ' 12' ' ' ARG . 2.4 t -133.87 142.44 41.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 8' ' ' HIS . 6.9 t -77.65 -158.05 0.11 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.727 ' CD2' HG12 ' A' ' 101' ' ' VAL . 17.3 m170 -58.08 -103.24 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -112.22 77.28 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.513 -1.367 . . . . 0.0 108.973 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.72 -101.06 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 118.977 -1.582 . . . . 0.0 111.093 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.697 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.3 m -120.12 -176.56 3.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.298 -1.119 . . . . 0.0 109.932 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.78 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -152.71 138.53 17.98 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.738 -0.601 . . . . 0.0 109.981 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.797 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -90.98 177.63 6.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.192 -0.943 . . . . 0.0 108.965 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 2.4 pt20 -140.5 128.18 21.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.211 -0.931 . . . . 0.0 110.37 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.085 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -139.7 -175.45 4.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.217 179.218 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.12 82.64 1.95 Allowed 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.943 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.081 HG22 ' CB ' ' A' ' 26' ' ' ALA . 42.8 t -59.72 111.92 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 109.009 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.735 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -43.56 168.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 109.925 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.433 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 57.5 m-20 -84.32 126.45 33.21 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.339 -0.851 . . . . 0.0 108.989 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.3 15.25 35.98 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.735 HG21 ' HB3' ' A' ' 18' ' ' ALA . 4.4 t -115.5 169.71 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.363 -1.081 . . . . 0.0 109.138 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.487 ' HA ' HD13 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -106.73 135.82 47.61 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.17 -0.957 . . . . 0.0 108.69 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.909 HD13 ' CZ ' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -44.35 -26.3 0.32 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.049 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.474 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -73.24 -48.68 32.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.289 -0.882 . . . . 0.0 108.74 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.504 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 1.3 tp60 -53.16 -56.11 18.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.057 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 1.081 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.54 -26.9 64.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 108.911 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -69.98 -32.39 70.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.429 -0.794 . . . . 0.0 109.215 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.575 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 59.8 t -52.95 -35.57 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.478 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -88.54 -52.26 5.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.479 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.872 ' ND2' HD13 ' A' ' 15' ' ' LEU . 24.9 m-80 -54.15 -16.21 1.92 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.656 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 35' ' ' ILE . . . 84.87 19.3 59.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.634 HG23 HD12 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -99.61 -27.64 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -1.156 . . . . 0.0 108.494 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.651 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 1.1 p90 -47.96 -44.89 30.68 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.554 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 0.9 OUTLIER -74.56 -31.4 62.09 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.634 HD12 HG23 ' A' ' 32' ' ' ILE . 56.4 mt -60.94 -20.22 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 109.098 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.514 HG11 HG22 ' A' ' 101' ' ' VAL . 2.5 p -170.1 112.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 109.515 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 38' ' ' ASP . . . 177.91 176.99 46.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.563 ' OD1' HG21 ' A' ' 47' ' ' THR . 0.3 OUTLIER -163.1 -86.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -1.182 . . . . 0.0 109.803 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 41' ' ' GLY . 12.6 p -83.49 10.07 9.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.679 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 86' ' ' CYS . . . 51.93 -90.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 39' ' ' CYS . . . -54.46 -169.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.18 99.98 12.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -1.15 . . . . 0.0 109.481 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.427 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . . . -118.07 -99.28 0.45 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 70' ' ' MET . 13.6 t -160.57 40.64 0.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.918 -1.114 . . . . 0.0 109.965 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.515 ' SG ' ' CB ' ' A' ' 38' ' ' ASP . 1.7 p -99.99 149.86 23.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.068 . . . . 0.0 109.331 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 1.044 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -105.89 23.78 13.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.563 HG21 ' OD1' ' A' ' 38' ' ' ASP . 22.0 m -90.25 -19.9 23.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.902 . . . . 0.0 109.756 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 21.9 p -91.03 42.73 1.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.099 -1.001 . . . . 0.0 110.287 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 1.008 ' CE1' HD12 ' A' ' 78' ' ' LEU . 11.7 t60 -76.29 70.27 2.89 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.582 HG11 ' SG ' ' A' ' 85' ' ' CYS . 10.3 m -77.85 144.27 11.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 120.123 -1.611 . . . . 0.0 109.755 -178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.626 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 0.9 OUTLIER -109.57 99.11 8.36 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.849 HG22 HG12 ' A' ' 99' ' ' VAL . 3.8 t -89.98 173.98 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.844 0.831 . . . . 0.0 112.124 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.617 ' H ' HG12 ' A' ' 52' ' ' VAL . 1.3 m-20 -68.88 -177.94 1.11 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.19 -1.64 33.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.139 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.3 -21.61 12.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.996 -1.065 . . . . 0.0 110.446 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.625 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 85.5 m-85 -95.18 -23.79 17.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.024 -1.047 . . . . 0.0 109.895 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.641 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -63.46 -34.1 77.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.149 -0.969 . . . . 0.0 109.39 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.61 -63.77 1.0 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.549 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.62 ' HB3' HD11 ' A' ' 94' ' ' LEU . 20.3 mmtp -49.88 -23.41 1.91 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.929 . . . . 0.0 109.385 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.877 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -57.94 162.71 5.01 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 108.994 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.877 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.5 Cg_exo -58.71 171.38 2.03 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.128 1.885 . . . . 0.0 110.243 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.22 59.65 0.61 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -0.922 . . . . 0.0 109.507 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.032 ' HB3' ' NH2' ' A' ' 83' ' ' ARG . . . -42.43 151.95 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.45 -0.781 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.72 -162.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 109.56 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.534 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 2.0 tm-20 -100.16 -22.18 15.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 109.543 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.442 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.7 mtt180 -43.9 -56.99 3.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.646 ' OE2' ' HB1' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -64.63 -30.84 71.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.534 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 36.9 mm -56.0 -43.82 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 109.528 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.76 -30.13 62.22 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.508 ' N ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -68.5 -16.08 63.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -1.131 . . . . 0.0 109.342 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.026 HD13 ' HG ' ' A' ' 84' ' ' LEU . 10.0 tp -90.89 -8.95 48.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.81 -23.0 42.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.388 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -85.32 45.14 1.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.89 . . . . 0.0 109.462 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.044 HG12 ' HB1' ' A' ' 46' ' ' ALA . 4.1 m -106.59 163.8 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.388 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 75' ' ' THR . 96.0 m -85.44 6.69 25.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.942 . . . . 0.0 109.544 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.735 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -114.47 -156.12 0.59 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.132 -0.98 . . . . 0.0 109.463 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.635 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.7 pt-20 -112.55 151.42 30.03 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.008 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -128.03 159.83 33.83 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 117.912 -1.515 . . . . 0.0 111.631 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.546 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -149.37 171.38 6.38 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 5.0 Cg_exo -56.59 -15.02 14.55 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 121.956 1.77 . . . . 0.0 109.84 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.574 ' OD1' HG21 ' A' ' 57' ' ' THR . 12.8 t30 -86.53 -30.93 21.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.392 -0.818 . . . . 0.0 110.542 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.623 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -68.59 159.25 32.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.953 -1.092 . . . . 0.0 110.481 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 1.032 ' NH2' ' HB3' ' A' ' 63' ' ' ALA . 2.6 mtp180 -161.53 166.38 27.14 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.365 -0.834 . . . . 0.0 109.124 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.026 ' HG ' HD13 ' A' ' 71' ' ' LEU . 6.2 mp -79.76 118.94 22.01 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.157 -0.965 . . . . 0.0 108.598 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.582 ' SG ' HG11 ' A' ' 50' ' ' VAL . 2.2 t -47.12 -24.35 0.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 109.475 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 30.6 p -88.19 30.88 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 0.0 109.769 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.563 ' C ' HD13 ' A' ' 88' ' ' ILE . 33.8 mm-40 -149.66 12.65 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.049 -1.032 . . . . 0.0 109.994 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.832 HG22 HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -108.87 140.52 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.082 -1.012 . . . . 0.0 108.704 179.484 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.691 HD13 ' O ' ' A' ' 88' ' ' ILE . 23.9 mm -125.91 146.03 32.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.762 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.686 ' HE3' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -98.32 83.31 3.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -0.852 . . . . 0.0 109.112 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 p -81.83 155.99 70.29 Favored Pre-proline 0 C--N 1.297 -1.686 0 O-C-N 121.486 -0.759 . . . . 0.0 109.203 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 19' ' ' ASP . 6.3 Cg_exo -58.42 -14.94 22.42 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.021 1.814 . . . . 0.0 109.905 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -73.12 -41.19 64.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.836 . . . . 0.0 109.323 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 59' ' ' LYS . 5.6 mp -86.11 142.68 28.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -138.16 126.35 22.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.703 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.591 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 68.14 49.72 44.79 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.979 HD11 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -77.79 151.71 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.224 -1.162 . . . . 0.0 108.878 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.402 ' N ' HG12 ' A' ' 97' ' ' ILE . 4.8 t -122.06 104.7 15.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.034 -1.041 . . . . 0.0 110.363 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.979 HG13 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -98.93 144.86 11.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.04 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -122.79 176.3 6.05 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.914 -1.116 . . . . 0.0 109.733 -179.288 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.88 HG13 ' HD2' ' A' ' 102' ' ' PRO . 51.0 t -108.6 144.02 28.7 Favored Pre-proline 0 C--N 1.298 -1.641 0 C-N-CA 119.671 -0.812 . . . . 0.0 108.943 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.88 ' HD2' HG13 ' A' ' 101' ' ' VAL . 4.1 Cg_exo -54.36 172.37 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.461 2.107 . . . . 0.0 111.492 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.03 -17.53 46.45 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.544 ' HG3' ' NH1' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -128.87 107.4 9.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.381 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 106' ' ' TRP . 8.3 pt20 -79.76 5.03 14.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.145 -0.972 . . . . 0.0 109.59 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.572 ' CZ2' ' OG1' ' A' ' 75' ' ' THR . 62.2 m95 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.495 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.318 0.58 . . . . 0.0 109.504 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.408 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -151.48 159.38 44.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.187 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.839 HG11 HD22 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -147.95 125.2 3.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.211 -0.93 . . . . 0.0 109.38 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 99' ' ' VAL . 97.4 t -126.01 129.64 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 108.887 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.161 ' CD2' HG21 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -97.69 154.59 17.48 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.944 -1.097 . . . . 0.0 109.374 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.942 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.1 t -123.96 170.19 14.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.446 -0.784 . . . . 0.0 108.977 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.602 ' H ' HG12 ' A' ' 6' ' ' VAL . 14.6 p -121.43 162.89 19.65 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.477 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.43 -8.38 13.26 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 120.872 -1.142 . . . . 0.0 109.051 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 4.5 t70 -110.25 -6.06 15.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.114 -0.991 . . . . 0.0 110.316 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.41 -31.75 5.67 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.266 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.768 HG22 ' NH1' ' A' ' 13' ' ' ARG . 54.1 m -49.71 114.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.043 -1.269 . . . . 0.0 109.486 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 18.3 ptt180 -130.78 126.05 35.33 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.596 -0.69 . . . . 0.0 109.694 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 1.041 ' NH2' HG21 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -104.24 125.96 50.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.949 . . . . 0.0 108.714 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -85.83 157.37 20.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.122 -0.986 . . . . 0.0 110.567 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.1 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -167.4 -177.32 3.57 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.698 0.761 . . . . 0.0 109.334 179.153 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.41 106.23 8.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.714 -0.616 . . . . 0.0 109.574 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.961 HG21 HD23 ' A' ' 23' ' ' LEU . 78.5 t -81.05 108.71 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.404 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.614 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -46.31 172.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.548 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 75.1 m-20 -83.27 125.19 31.33 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.327 -0.858 . . . . 0.0 109.137 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.81 29.31 8.74 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.908 ' O ' HG23 ' A' ' 89' ' ' ILE . 2.1 t -130.58 170.96 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.342 -1.093 . . . . 0.0 109.378 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.509 ' HB2' ' CD1' ' A' ' 89' ' ' ILE . 13.2 t -115.92 146.43 42.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 108.926 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.961 HD23 HG21 ' A' ' 17' ' ' VAL . 16.2 mt -47.53 -25.48 1.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.961 -1.087 . . . . 0.0 108.478 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.579 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 24.2 ptt? -71.6 -46.3 59.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.847 . . . . 0.0 108.832 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 1.049 ' O ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -55.14 -56.54 18.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.144 -0.972 . . . . 0.0 108.805 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 30' ' ' ASN . . . -60.17 -19.25 53.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.3 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 24' ' ' MET . . . -70.76 -40.07 72.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.847 . . . . 0.0 110.127 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.049 HG22 ' O ' ' A' ' 25' ' ' GLN . 32.6 m -45.65 -33.05 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.181 -0.95 . . . . 0.0 110.366 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 31' ' ' GLY . 3.7 t -107.39 -59.64 1.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 109.815 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.842 ' OD1' HD13 ' A' ' 15' ' ' LEU . 7.5 m120 -38.8 -27.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.342 0.592 . . . . 0.0 109.989 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 107.63 -9.69 38.04 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.161 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -68.29 -13.15 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -1.223 . . . . 0.0 107.913 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.554 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -49.51 -28.72 5.77 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 178.284 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -92.15 -30.16 16.1 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.065 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.041 HG21 ' NH2' ' A' ' 13' ' ' ARG . 3.0 mt -105.83 40.66 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.128 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.832 HG13 ' N ' ' A' ' 37' ' ' GLY . 1.3 p -143.16 -151.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.832 ' N ' HG13 ' A' ' 36' ' ' VAL . . . -72.0 -159.91 4.39 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -141.5 -53.95 0.46 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.974 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 42' ' ' SER . 15.1 p -63.7 -11.1 23.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.079 -1.013 . . . . 0.0 109.695 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 86' ' ' CYS . . . 85.19 -164.99 39.0 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.513 ' CA ' ' HB2' ' A' ' 86' ' ' CYS . . . -42.56 -27.43 0.5 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 67.8 p -59.91 168.86 1.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -1.15 . . . . 0.0 109.37 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HA ' ' S1 ' ' A' ' 107' ' ' FES . . . -128.68 71.04 1.39 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -124.71 -10.81 7.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.791 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.522 ' O ' ' CE ' ' A' ' 70' ' ' MET . 1.8 p -111.83 -178.92 3.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.662 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.736 ' HB3' ' NE1' ' A' ' 106' ' ' TRP . . . -133.03 12.89 4.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.181 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.856 HG22 ' CB ' ' A' ' 106' ' ' TRP . 5.6 p -75.57 -16.15 60.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.448 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.502 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 25.6 p -86.72 41.61 0.96 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.289 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.04 ' CE1' HD12 ' A' ' 78' ' ' LEU . 26.7 t60 -82.25 64.16 6.78 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 83' ' ' ARG . 12.5 m -80.68 147.22 6.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.55 -1.344 . . . . 0.0 110.076 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.639 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 8.0 m-85 -107.86 106.41 16.68 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.695 ' HB ' HG23 ' A' ' 57' ' ' THR . 4.5 t -89.78 166.79 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.791 0.805 . . . . 0.0 112.151 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.483 ' N ' HG12 ' A' ' 52' ' ' VAL . 1.2 m-20 -64.61 -176.79 0.27 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -100.64 -6.6 24.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 110.28 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.5 1.53 18.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.965 -1.084 . . . . 0.0 110.463 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.634 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 49.5 m-85 -115.14 -20.96 10.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.93 -1.106 . . . . 0.0 110.087 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.695 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -78.36 1.44 21.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.991 -1.068 . . . . 0.0 109.523 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -85.08 -58.62 2.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.673 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.831 ' CB ' HD11 ' A' ' 94' ' ' LEU . 3.4 mptt -49.98 -39.93 42.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.569 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -56.68 164.36 2.19 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.136 -0.977 . . . . 0.0 109.412 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 4.8 Cg_exo -59.16 172.14 1.93 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.149 1.899 . . . . 0.0 110.261 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.14 59.39 0.61 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.379 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.05 111.27 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.523 -0.736 . . . . 0.0 109.56 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 63' ' ' ALA . 5.8 m-20 -57.11 -160.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.665 ' HA ' HD12 ' A' ' 68' ' ' ILE . 21.1 tt0 -85.07 -10.36 56.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -48.28 -67.62 0.26 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -65.63 -12.94 57.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.503 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 65' ' ' GLU . 14.5 mt -73.89 -31.92 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.75 -58.58 4.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.672 ' HE1' ' S1 ' ' A' ' 107' ' ' FES . 6.1 ptm -67.95 -27.04 66.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -1.141 . . . . 0.0 109.298 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.062 HD13 HG11 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -89.99 6.41 42.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.332 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 68' ' ' ILE . 9.7 tp10 -94.62 -30.34 14.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.249 -0.907 . . . . 0.0 109.16 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 74' ' ' VAL . 77.4 m -98.64 15.79 24.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.886 . . . . 0.0 109.233 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.062 HG11 HD13 ' A' ' 71' ' ' LEU . 17.1 m -46.27 171.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.474 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.568 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 62.2 m -73.77 -2.14 22.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.739 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.782 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -126.43 -152.52 0.52 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.004 -1.06 . . . . 0.0 109.812 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.653 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.6 pt-20 -112.57 155.72 23.89 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.04 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -129.54 152.45 49.05 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 117.779 -1.568 . . . . 0.0 111.989 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.56 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 2.5 mmtm -132.67 166.32 29.92 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.56 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 6.2 Cg_exo -54.94 -17.25 13.62 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.254 1.969 . . . . 0.0 110.717 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.42 -31.44 22.88 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 110.644 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.576 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.3 m -60.45 159.55 10.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.889 -1.132 . . . . 0.0 109.578 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.528 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -162.04 139.67 8.65 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.819 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.91 HD21 HD23 ' A' ' 71' ' ' LEU . 1.3 mp -63.0 107.75 1.07 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -43.02 -26.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.878 -179.438 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 28.6 p -86.83 31.76 0.69 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 110.24 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 86' ' ' CYS . 12.3 mt-30 -153.36 24.24 0.54 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.872 -1.143 . . . . 0.0 110.492 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.447 HD13 ' HB3' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -140.63 131.31 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 0.0 109.649 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.908 HG23 ' O ' ' A' ' 21' ' ' VAL . 31.1 mm -110.0 148.44 13.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.362 -0.837 . . . . 0.0 109.436 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.548 ' HE2' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -103.69 84.95 2.35 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.169 -0.957 . . . . 0.0 109.132 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.685 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -78.03 171.69 11.81 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.685 ' HD2' HG22 ' A' ' 91' ' ' THR . 5.5 Cg_exo -59.14 -14.06 22.13 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.104 1.869 . . . . 0.0 110.117 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -69.54 -50.9 40.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 0.0 109.336 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.831 HD11 ' CB ' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -83.46 138.96 33.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 109.378 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -145.31 132.14 20.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 0.0 109.632 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.433 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 70.69 37.39 67.22 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.714 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -71.92 147.89 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.408 -1.054 . . . . 0.0 109.522 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.531 ' N ' HD13 ' A' ' 97' ' ' ILE . 5.5 t -114.09 106.68 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.239 -0.913 . . . . 0.0 109.8 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.797 HG21 HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -98.0 152.22 4.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.533 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -128.07 176.05 7.93 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.922 -1.111 . . . . 0.0 109.807 -179.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 6' ' ' VAL . 21.5 t -106.42 146.48 33.09 Favored Pre-proline 0 C--N 1.296 -1.735 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.527 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.879 ' HD2' HG13 ' A' ' 101' ' ' VAL . 11.6 Cg_exo -52.99 177.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.428 2.086 . . . . 0.0 110.303 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 21.8 t0 -74.77 -22.62 58.67 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.551 ' HD3' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -130.87 -167.51 1.85 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.655 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 106' ' ' TRP . 50.3 tp60 -139.01 28.19 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.939 -1.101 . . . . 0.0 109.657 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.856 ' CB ' HG22 ' A' ' 47' ' ' THR . 8.9 m95 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.515 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.817 ' S1 ' HD23 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.311 0.577 . . . . 0.0 109.581 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.81 161.62 37.11 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.871 . . . . 0.0 109.116 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.604 HG11 ' CD2' ' A' ' 23' ' ' LEU . 1.4 t -150.75 128.43 2.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.27 -0.894 . . . . 0.0 109.683 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.935 HG22 ' HB3' ' A' ' 14' ' ' GLN . 42.6 t -132.04 164.5 34.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.901 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -137.72 159.56 41.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.073 . . . . 0.0 109.903 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 101' ' ' VAL . 4.0 t -131.2 137.24 56.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.554 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 35.2 t -93.19 171.15 9.12 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.494 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -66.98 -6.05 15.3 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.028 -1.045 . . . . 0.0 109.156 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.35 -2.99 16.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.977 . . . . 0.0 110.219 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.66 17.34 15.12 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.215 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.529 ' OG1' ' CB ' ' A' ' 7' ' ' SER . 69.5 m -49.82 112.97 0.74 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.037 -1.272 . . . . 0.0 109.1 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.07 105.71 16.48 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.564 -0.71 . . . . 0.0 110.325 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.422 ' O ' HG13 ' A' ' 4' ' ' VAL . 22.8 ttm180 -148.33 133.86 18.71 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.935 ' HB3' HG22 ' A' ' 4' ' ' VAL . 3.5 mp0 -120.03 179.4 4.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.004 -1.06 . . . . 0.0 110.986 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.901 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -176.12 -176.03 0.76 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.27 100.0 5.89 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.545 -0.722 . . . . 0.0 109.53 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.998 HG11 ' HB3' ' A' ' 90' ' ' MET . 39.5 t -65.51 108.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.352 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.886 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -46.55 172.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.424 ' OD2' ' HG3' ' A' ' 92' ' ' PRO . 52.8 m-20 -82.2 125.03 30.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.259 -0.901 . . . . 0.0 109.151 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.04 41.13 6.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.886 HG21 ' HB3' ' A' ' 18' ' ' ALA . 1.9 t -133.79 162.37 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -1.165 . . . . 0.0 109.414 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.462 ' OG ' ' CD1' ' A' ' 89' ' ' ILE . 46.6 m -98.09 137.08 37.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 108.854 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.739 HD23 HG21 ' A' ' 17' ' ' VAL . 6.5 mt -46.29 -26.36 0.79 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.012 -1.055 . . . . 0.0 108.613 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.26 -47.09 45.91 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.788 ' HB3' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -51.96 -51.22 58.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.038 179.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.494 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -60.84 -29.59 69.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 108.821 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.997 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -73.02 -25.2 60.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.552 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.579 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 88.4 t -57.07 -42.13 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.069 -1.019 . . . . 0.0 109.385 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.2 t -84.56 -55.08 4.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.401 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.811 ' CG ' HD22 ' A' ' 15' ' ' LEU . 24.5 m-80 -52.92 -18.53 2.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.376 -0.828 . . . . 0.0 109.606 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.89 23.61 57.22 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.986 HG23 HD12 ' A' ' 35' ' ' ILE . 1.1 mt -101.33 -25.55 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.272 . . . . 0.0 108.286 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.997 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 2.3 p90 -48.74 -47.17 41.66 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.632 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 34.0 t70 -69.46 -33.08 72.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.986 HD12 HG23 ' A' ' 32' ' ' ILE . 53.5 mt -57.72 -19.28 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.182 -0.949 . . . . 0.0 108.936 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -170.03 133.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.442 -0.786 . . . . 0.0 109.377 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' OD1' ' A' ' 38' ' ' ASP . . . 133.86 169.06 11.97 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.932 ' CG ' HG21 ' A' ' 47' ' ' THR . 0.2 OUTLIER -161.73 -89.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -1.201 . . . . 0.0 109.824 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 40' ' ' GLY . 13.1 p -50.97 -41.97 59.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.568 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.513 ' N ' ' SG ' ' A' ' 39' ' ' CYS . . . 71.05 -83.9 0.4 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 43' ' ' ALA . . . -70.92 -79.1 0.39 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.461 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 59.8 p -59.71 88.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -1.139 . . . . 0.0 109.813 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.6 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -60.29 99.68 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.481 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.458 ' HA ' ' HG2' ' A' ' 70' ' ' MET . 2.3 m -160.03 22.06 0.17 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.713 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 7.8 p -116.05 -157.89 0.66 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 109.432 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.793 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -147.81 12.8 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.098 -1.001 . . . . 0.0 109.877 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.953 HG22 ' CB ' ' A' ' 106' ' ' TRP . 5.0 p -77.93 -23.74 48.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.997 . . . . 0.0 109.496 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 27.1 p -86.66 42.66 1.02 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 110.312 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.734 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 69.8 t60 -77.85 67.03 3.64 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 83' ' ' ARG . 11.4 m -87.16 147.71 5.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.471 -1.393 . . . . 0.0 110.862 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.734 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 6.8 m-30 -107.26 106.31 16.71 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 122.159 0.981 . . . . 0.0 108.393 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.801 HG22 HG12 ' A' ' 99' ' ' VAL . 9.6 t -90.0 164.46 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.852 0.834 . . . . 0.0 112.431 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.488 ' N ' HG12 ' A' ' 52' ' ' VAL . 1.4 t-20 -69.0 152.49 45.19 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.58 ' HA ' HD22 ' A' ' 81' ' ' ASN . 3.3 pm0 -77.27 7.49 5.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -0.877 . . . . 0.0 110.619 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.33 -12.52 14.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.778 -1.202 . . . . 0.0 110.046 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 1.098 ' CB ' HD13 ' A' ' 97' ' ' ILE . 80.2 m-85 -111.36 -19.71 12.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 0.0 109.587 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.598 HG21 ' OD1' ' A' ' 81' ' ' ASN . 1.9 p -68.78 -12.17 61.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.241 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -88.97 -37.95 14.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.568 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.681 ' HB2' HD21 ' A' ' 94' ' ' LEU . 1.2 mptm? -71.44 -33.14 69.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.165 -0.96 . . . . 0.0 109.487 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -51.91 164.21 0.58 Allowed Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.223 -0.923 . . . . 0.0 109.218 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 5.7 Cg_exo -56.33 -166.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.044 1.829 . . . . 0.0 110.234 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.39 58.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -43.41 107.46 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.455 -0.778 . . . . 0.0 109.355 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' ALA . 4.3 m-20 -56.86 -160.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.613 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.532 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 62.1 tt0 -100.09 -16.95 17.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.489 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 65' ' ' GLU . 2.1 mtp180 -44.74 -61.12 1.7 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.457 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.6 ' OE1' ' HB3' ' A' ' 43' ' ' ALA . 1.2 mt-10 -66.86 -23.63 66.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.532 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 32.2 mm -63.65 -31.87 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.503 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.59 -50.76 47.36 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.458 ' HG2' ' HA ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -65.9 -23.8 66.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -1.145 . . . . 0.0 109.3 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.853 ' O ' HG13 ' A' ' 74' ' ' VAL . 5.2 tp -87.76 -10.49 50.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.428 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -76.22 -35.62 58.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.355 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.99 45.07 0.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 0.0 109.363 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.882 HG23 ' H ' ' A' ' 76' ' ' ALA . 10.9 m -82.16 171.05 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 0.0 109.514 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -57.41 -16.14 8.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.604 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.882 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -124.86 -151.23 0.47 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.114 -0.991 . . . . 0.0 110.52 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.576 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 2.2 pm0 -112.59 153.01 28.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.602 HD11 HD23 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -111.22 127.36 55.58 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.803 -1.559 . . . . 0.0 111.672 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 1.9 mptp? -98.61 167.85 10.76 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 2.2 Cg_endo -60.05 -9.73 10.83 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.456 2.104 . . . . 0.0 111.37 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.598 ' OD1' HG21 ' A' ' 57' ' ' THR . 0.5 OUTLIER -107.26 4.92 27.1 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.086 -1.009 . . . . 0.0 111.836 -178.613 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.57 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -88.6 155.95 19.33 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.54 -1.35 . . . . 0.0 109.964 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.556 ' O ' HG22 ' A' ' 50' ' ' VAL . 6.5 ttt180 -162.14 158.05 24.11 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.731 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.885 HD23 ' S1 ' ' A' ' 107' ' ' FES . 4.1 mp -78.84 106.28 10.74 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 108.648 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 48' ' ' CYS . 20.2 p -48.72 -22.11 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.596 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 26.6 p -81.3 -38.65 26.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.19 -0.944 . . . . 0.0 110.245 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.518 ' OE1' ' CB ' ' A' ' 43' ' ' ALA . 4.0 tp60 -89.47 42.85 1.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.084 -1.01 . . . . 0.0 110.865 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -149.31 146.64 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.889 -1.132 . . . . 0.0 109.534 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.619 HG22 ' N ' ' A' ' 90' ' ' MET . 11.4 mm -115.26 166.98 8.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.391 -0.818 . . . . 0.0 109.229 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.998 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -130.13 97.59 4.49 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.213 -0.929 . . . . 0.0 109.462 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.673 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -90.13 172.17 7.46 Favored Pre-proline 0 C--N 1.298 -1.666 0 O-C-N 121.56 -0.713 . . . . 0.0 109.146 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.673 ' HD2' HG22 ' A' ' 91' ' ' THR . 3.8 Cg_exo -60.79 -11.03 16.02 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.161 1.907 . . . . 0.0 110.481 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -68.23 -51.1 49.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -0.999 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.79 HD23 ' HD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -78.49 127.45 32.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 109.37 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.31 126.46 33.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.918 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.577 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 78.23 35.28 34.36 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.098 HD13 ' CB ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -71.54 133.21 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -1.087 . . . . 0.0 109.541 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.097 ' N ' HD12 ' A' ' 97' ' ' ILE . 3.7 t -107.02 108.49 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.801 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -99.08 153.55 4.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.544 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -126.58 174.07 8.96 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.072 -1.018 . . . . 0.0 109.284 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.916 HG13 ' HD2' ' A' ' 102' ' ' PRO . 28.8 t -107.59 147.09 34.67 Favored Pre-proline 0 N--CA 1.494 1.725 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.95 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.916 ' HD2' HG13 ' A' ' 101' ' ' VAL . 8.2 Cg_exo -53.76 -171.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.32 2.013 . . . . 0.0 110.458 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.402 ' CB ' HH21 ' A' ' 104' ' ' ARG . 13.7 m-20 -89.45 -26.66 20.84 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.521 ' HB3' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -120.86 -157.96 0.74 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 105' ' ' GLN . 44.4 tt0 -154.97 24.4 0.43 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.001 -1.062 . . . . 0.0 109.586 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.953 ' CB ' HG22 ' A' ' 47' ' ' THR . 24.4 m95 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.715 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.885 ' S1 ' HD23 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.513 ' HB2' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.5 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -137.59 165.57 26.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.284 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.88 HG11 HD22 ' A' ' 23' ' ' LEU . 6.7 t -154.32 161.64 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.159 -0.963 . . . . 0.0 109.052 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.739 HG13 ' O ' ' A' ' 13' ' ' ARG . 51.9 t -159.46 148.68 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.075 -1.016 . . . . 0.0 109.202 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.108 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -124.68 154.08 41.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.097 -1.002 . . . . 0.0 109.498 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.723 HG22 ' HB3' ' A' ' 12' ' ' ARG . 3.0 t -136.71 141.4 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.438 -0.789 . . . . 0.0 110.177 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.515 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 1.5 p -81.52 169.52 17.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -41.87 -89.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.872 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.23 74.95 0.89 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.789 -1.194 . . . . 0.0 109.267 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.23 -105.08 0.37 Allowed Glycine 0 N--CA 1.489 2.208 0 C-N-CA 118.465 -1.826 . . . . 0.0 110.918 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.2 m -130.5 -176.09 3.86 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.544 -0.974 . . . . 0.0 109.57 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.723 ' HB3' HG22 ' A' ' 6' ' ' VAL . 5.0 ptp180 -150.98 124.35 8.91 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.291 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.739 ' O ' HG13 ' A' ' 4' ' ' VAL . 50.4 mtt180 -89.27 175.52 7.31 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.63 ' CB ' HG22 ' A' ' 4' ' ' VAL . 9.7 pt20 -134.97 141.11 46.17 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.974 -1.079 . . . . 0.0 110.324 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.108 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -136.69 -176.52 4.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.365 -0.834 . . . . 0.0 109.353 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -126.72 71.43 1.3 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.677 -0.639 . . . . 0.0 109.484 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.098 HG21 HD23 ' A' ' 23' ' ' LEU . 61.7 t -54.41 112.9 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.541 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.814 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -47.15 174.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 0.0 109.549 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.449 ' OD2' ' HB3' ' A' ' 92' ' ' PRO . 80.9 m-20 -83.66 125.3 31.7 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.359 -0.838 . . . . 0.0 109.192 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.46 19.01 31.2 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.814 HG21 ' HB3' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -118.13 155.75 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -1.135 . . . . 0.0 109.293 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 23' ' ' LEU . 2.0 m -92.4 135.04 34.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.231 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.098 HD23 HG21 ' A' ' 17' ' ' VAL . 16.7 mt -45.27 -35.28 3.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.001 . . . . 0.0 108.968 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.495 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 1.8 tmt? -65.61 -46.24 80.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.263 -0.898 . . . . 0.0 108.976 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.613 ' O ' HG13 ' A' ' 28' ' ' VAL . 4.5 tp-100 -53.75 -52.08 61.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 109.206 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.69 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -63.2 -23.39 67.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.915 . . . . 0.0 109.171 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.893 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -68.11 -26.33 65.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.358 -0.839 . . . . 0.0 109.712 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 25' ' ' GLN . 2.7 m -57.52 -43.62 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.996 -1.065 . . . . 0.0 109.368 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 2.7 t -81.63 -56.26 4.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.329 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.642 ' ND2' ' HB3' ' A' ' 15' ' ' LEU . 9.5 m120 -50.06 -20.8 1.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.446 -0.784 . . . . 0.0 109.372 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 83.55 22.21 56.67 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.789 HG23 HD11 ' A' ' 35' ' ' ILE . 1.4 mt -98.63 -31.3 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.208 -1.172 . . . . 0.0 108.848 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.893 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -51.64 -36.69 47.12 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.586 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 20.9 t70 -72.22 -35.62 68.93 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.857 ' O ' HG13 ' A' ' 36' ' ' VAL . 3.7 pt -83.09 5.08 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.958 -1.089 . . . . 0.0 109.423 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 35' ' ' ILE . 0.3 OUTLIER -169.53 120.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.36 170.01 12.61 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB2' ' CG2' ' A' ' 47' ' ' THR . 5.0 m-20 -162.31 -59.93 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -1.158 . . . . 0.0 109.795 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 41' ' ' GLY . 8.1 p -82.86 9.43 9.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' GLY . . . 57.64 -89.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 40' ' ' GLY . . . -60.63 -124.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.565 ' O ' ' HE1' ' A' ' 70' ' ' MET . 52.7 p -138.48 48.67 1.93 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.16 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.78 -93.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.522 ' HA ' ' CB ' ' A' ' 70' ' ' MET . 37.2 t -160.4 60.08 0.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.059 -1.026 . . . . 0.0 109.936 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 70' ' ' MET . 1.7 p -107.5 -171.71 1.93 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.085 -1.01 . . . . 0.0 109.21 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.838 ' HB1' ' N ' ' A' ' 74' ' ' VAL . . . -146.92 20.49 1.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 0.0 109.516 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.517 ' CG2' ' HB2' ' A' ' 38' ' ' ASP . 7.9 t -90.3 -21.94 21.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.765 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.484 ' SG ' HD23 ' A' ' 84' ' ' LEU . 21.8 p -87.18 42.55 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.145 -0.972 . . . . 0.0 110.398 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.144 ' CD2' HD12 ' A' ' 78' ' ' LEU . 44.8 t-80 -81.56 60.92 4.76 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 85' ' ' CYS . 14.1 m -76.28 149.09 6.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 120.752 -1.218 . . . . 0.0 110.912 -177.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.512 ' CE2' ' CE1' ' A' ' 49' ' ' HIS . 7.7 m-85 -108.21 103.09 12.2 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.907 HG22 HG12 ' A' ' 99' ' ' VAL . 4.3 t -89.15 174.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 121.662 0.744 . . . . 0.0 111.941 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.723 ' O ' HG23 ' A' ' 57' ' ' THR . 0.3 OUTLIER -70.41 -175.78 1.09 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -101.3 4.59 41.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.915 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.37 -25.54 10.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.081 -1.012 . . . . 0.0 110.258 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.871 ' CD2' HG22 ' A' ' 97' ' ' ILE . 73.8 m-85 -99.69 -17.05 17.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.068 -1.02 . . . . 0.0 109.816 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 53' ' ' ASN . 25.1 p -63.87 -43.63 95.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 109.612 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -55.72 -51.77 66.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.904 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.037 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -49.86 -41.8 46.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 109.623 -179.686 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.761 HG13 ' HD2' ' A' ' 61' ' ' PRO . 54.6 t -54.22 142.83 47.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.998 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.761 ' HD2' HG13 ' A' ' 60' ' ' VAL . 5.2 Cg_exo -55.79 173.43 0.39 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.076 1.851 . . . . 0.0 110.519 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.72 62.52 0.61 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -0.818 . . . . 0.0 109.373 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -38.92 126.52 1.57 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.72 -0.612 . . . . 0.0 109.849 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.458 ' O ' ' O ' ' A' ' 63' ' ' ALA . 1.2 p30 -51.39 -174.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.896 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.555 ' CD ' HD12 ' A' ' 68' ' ' ILE . 3.9 tp10 -76.86 -10.19 59.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.357 -0.839 . . . . 0.0 109.548 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -58.82 -51.25 70.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.336 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.496 ' HG2' ' HE3' ' A' ' 70' ' ' MET . 86.3 mt-10 -72.73 -7.06 48.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.403 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.555 HD12 ' CD ' ' A' ' 65' ' ' GLU . 15.2 mt -76.65 -36.93 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 0.0 109.556 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.23 -54.1 24.89 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.565 ' HE1' ' O ' ' A' ' 42' ' ' SER . 0.0 OUTLIER -68.45 -27.06 65.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.287 -1.125 . . . . 0.0 108.779 179.591 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.037 HD11 HD13 ' A' ' 78' ' ' LEU . 3.7 tt -83.34 8.13 14.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.144 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 4.0 tp10 -100.51 -10.58 20.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.61 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -82.24 -13.49 56.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.186 -0.946 . . . . 0.0 109.85 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.993 HG21 ' CD2' ' A' ' 49' ' ' HIS . 4.1 m -40.02 137.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.472 -0.768 . . . . 0.0 109.736 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.615 HG21 ' CB ' ' A' ' 104' ' ' ARG . 5.5 m -44.58 -25.3 0.26 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.243 -0.911 . . . . 0.0 109.289 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.709 ' O ' HG23 ' A' ' 74' ' ' VAL . . . -116.94 -148.94 0.43 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.629 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.6 OUTLIER -114.51 150.18 35.26 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.144 HD12 ' CD2' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -104.13 130.59 51.86 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 117.232 -1.787 . . . . 0.0 111.269 179.359 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.574 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 0.5 OUTLIER -104.76 166.1 12.09 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.574 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 5.0 Cg_exo -53.79 -26.37 38.59 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.937 1.758 . . . . 0.0 109.931 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.574 ' HA ' HG21 ' A' ' 57' ' ' THR . 1.9 t30 -75.41 -35.06 61.08 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 110.128 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.724 ' O ' HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -87.07 165.52 15.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.006 -1.059 . . . . 0.0 109.471 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.548 ' HB3' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -162.33 -162.34 0.81 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.449 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.822 HD21 ' HB2' ' A' ' 71' ' ' LEU . 1.5 mt -98.04 108.28 20.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.666 ' HB2' HG11 ' A' ' 50' ' ' VAL . 23.3 t -42.81 -25.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.108 -0.995 . . . . 0.0 110.034 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' LEU . 29.1 p -82.9 -39.35 21.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.987 . . . . 0.0 110.607 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.416 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 0.7 OUTLIER -88.91 27.0 1.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 111.192 -178.524 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.71 ' O ' HD13 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -106.68 149.39 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.654 -1.279 . . . . 0.0 108.902 178.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 88' ' ' ILE . 28.7 mm -128.24 161.61 36.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.93 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.658 ' HE2' HG23 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -130.33 95.91 4.02 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.451 -0.781 . . . . 0.0 109.12 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.446 ' OG1' ' CD1' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -82.38 164.93 45.38 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.545 -0.722 . . . . 0.0 109.586 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.449 ' HB3' ' OD2' ' A' ' 19' ' ' ASP . 4.0 Cg_exo -60.87 -28.49 86.45 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.138 1.892 . . . . 0.0 110.057 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.68 -37.74 85.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.037 HD21 ' CB ' ' A' ' 59' ' ' LYS . 4.2 mp -77.41 143.93 38.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.395 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.12 124.35 8.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 109.538 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.573 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 76.53 48.98 8.47 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.871 HG22 ' CD2' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -77.07 145.75 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -1.188 . . . . 0.0 108.549 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.491 ' N ' HD12 ' A' ' 97' ' ' ILE . 1.8 t -119.17 113.24 40.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 120.849 -1.157 . . . . 0.0 109.869 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -106.77 144.81 15.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 51' ' ' TYR . 9.2 m-20 -122.28 174.09 7.21 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.113 -0.992 . . . . 0.0 109.527 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.94 HG13 ' HD2' ' A' ' 102' ' ' PRO . 12.0 t -103.63 147.39 34.16 Favored Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.462 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.94 ' HD2' HG13 ' A' ' 101' ' ' VAL . 12.8 Cg_exo -52.59 163.48 1.82 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.413 2.075 . . . . 0.0 110.05 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 3.2 m-20 -57.99 -27.37 63.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.013 -1.054 . . . . 0.0 108.751 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.615 ' CB ' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -130.67 -163.45 1.32 Allowed 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -152.2 23.38 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.487 ' NE1' ' N ' ' A' ' 75' ' ' THR . 38.0 m95 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.642 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.487 ' S1 ' HD22 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.59 135.64 21.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.274 -0.891 . . . . 0.0 109.177 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.977 HG21 HD21 ' A' ' 23' ' ' LEU . 1.1 t -133.24 123.79 47.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.923 HG11 ' HD3' ' A' ' 12' ' ' ARG . 65.9 t -121.82 128.81 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.128 -0.982 . . . . 0.0 108.636 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.073 ' CE1' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -98.21 153.8 18.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.953 -1.092 . . . . 0.0 109.478 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.938 ' O ' HG23 ' A' ' 101' ' ' VAL . 12.0 t -121.52 168.87 13.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.59 ' N ' HG12 ' A' ' 6' ' ' VAL . 41.0 t -122.99 161.52 24.09 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.496 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.55 -8.13 12.81 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.089 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -110.66 -3.33 15.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.079 -1.013 . . . . 0.0 110.643 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.68 -23.63 13.12 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.173 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.538 ' HB ' ' CB ' ' A' ' 7' ' ' SER . 74.6 m -49.52 112.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.031 -1.276 . . . . 0.0 109.065 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.923 ' HD3' HG11 ' A' ' 4' ' ' VAL . 3.6 ttm180 -125.49 117.34 23.43 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.575 -0.703 . . . . 0.0 110.187 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.538 HH12 HD13 ' A' ' 35' ' ' ILE . 1.2 ptp180 -108.7 124.95 51.35 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.421 ' CB ' HG22 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -91.37 155.55 18.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.018 -1.051 . . . . 0.0 110.569 -178.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.073 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -163.02 -176.13 4.72 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.639 0.733 . . . . 0.0 109.169 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -129.37 114.63 16.43 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.5 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.856 HG11 ' HB3' ' A' ' 90' ' ' MET . 46.2 t -77.48 110.31 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.944 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -46.95 172.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 0.0 109.337 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -81.52 124.73 29.73 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.225 -0.922 . . . . 0.0 109.153 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.77 44.25 6.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.944 HG21 ' HB3' ' A' ' 18' ' ' ALA . 1.5 t -133.07 165.57 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.46 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 p -105.87 141.91 36.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.169 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.003 HD13 ' OH ' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -48.68 -23.79 1.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.137 -0.977 . . . . 0.0 108.985 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 0.1 OUTLIER -76.83 -43.88 34.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 108.657 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.611 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -56.77 -51.15 70.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.374 -0.829 . . . . 0.0 109.259 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.51 -24.51 65.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.0 109.308 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.971 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -74.64 -26.45 59.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.323 -0.861 . . . . 0.0 109.927 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 25' ' ' GLN . 1.7 m -56.57 -44.15 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.788 -1.195 . . . . 0.0 109.448 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.499 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 3.3 t -80.59 -52.7 7.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.433 -0.792 . . . . 0.0 109.527 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.5 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 25.9 m-80 -57.24 -14.58 4.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.832 . . . . 0.0 109.622 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.854 ' O ' HD12 ' A' ' 35' ' ' ILE . . . 77.33 22.78 69.74 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.479 HG12 ' HD2' ' A' ' 13' ' ' ARG . 1.1 mt -100.14 -25.85 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.208 -1.172 . . . . 0.0 108.271 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.971 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 2.1 p90 -48.63 -46.95 40.55 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.617 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 12.5 t70 -66.44 -35.5 80.45 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.854 HD12 ' O ' ' A' ' 31' ' ' GLY . 2.6 mp -92.3 40.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.197 -0.939 . . . . 0.0 108.889 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.674 HG12 ' N ' ' A' ' 37' ' ' GLY . 49.1 t -160.88 -93.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.594 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.674 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -84.18 167.82 43.94 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.688 ' OD1' HG21 ' A' ' 47' ' ' THR . 0.1 OUTLIER -129.28 -50.0 1.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -1.129 . . . . 0.0 109.689 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.521 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 16.8 p -65.15 -18.86 65.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 109.537 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 42.98 93.21 0.01 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.61 -140.76 11.06 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.7 p -60.0 161.64 6.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -1.149 . . . . 0.0 109.353 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . . . -59.91 101.3 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.412 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.521 ' HB3' ' CB ' ' A' ' 39' ' ' CYS . 4.6 t -132.93 18.72 4.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.687 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.9 p -168.08 -167.61 0.85 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.943 . . . . 0.0 109.683 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.895 ' HB3' ' NE1' ' A' ' 106' ' ' TRP . . . -135.48 5.54 3.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.331 -0.856 . . . . 0.0 109.331 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.688 HG21 ' OD1' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -63.07 -28.78 70.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.396 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.536 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 25.1 p -84.25 42.32 0.88 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.449 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.017 ' CE1' HD12 ' A' ' 78' ' ' LEU . 28.3 t60 -81.35 64.09 5.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.27 147.33 6.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.569 -1.332 . . . . 0.0 110.061 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.668 ' HH ' ' HE2' ' A' ' 49' ' ' HIS . 9.6 m-85 -107.03 104.12 13.71 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.734 HG22 HG12 ' A' ' 99' ' ' VAL . 4.6 t -89.41 172.6 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-O 121.948 0.88 . . . . 0.0 112.201 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.581 ' H ' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -77.6 157.98 30.01 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.067 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -81.88 12.57 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.233 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.29 -25.95 9.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.98 -1.075 . . . . 0.0 109.75 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.628 ' CD1' ' HA ' ' A' ' 97' ' ' ILE . 90.8 m-85 -104.49 -17.35 14.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.68 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -66.16 -34.97 79.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.814 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.15 -46.88 72.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.21 -0.931 . . . . 0.0 110.346 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.06 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -49.51 -43.99 45.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.736 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.139 HG11 HG22 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -100.45 143.24 26.16 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.892 . . . . 0.0 109.259 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.817 ' HD2' HG12 ' A' ' 60' ' ' VAL . 6.2 Cg_exo -58.15 -179.59 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.811 1.674 . . . . 0.0 109.219 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.516 ' HA ' ' HD3' ' A' ' 83' ' ' ARG . . . -110.29 -105.2 0.37 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.839 -1.163 . . . . 0.0 109.573 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.517 ' CB ' HG13 ' A' ' 68' ' ' ILE . . . -111.7 -160.14 0.7 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.071 . . . . 0.0 109.894 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.687 ' O ' HD12 ' A' ' 68' ' ' ILE . 12.3 m-20 -137.62 -145.43 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.87 -34.75 9.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.912 -1.117 . . . . 0.0 109.463 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -84.06 -48.37 9.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.903 . . . . 0.0 109.595 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 15.2 pt-20 -68.79 -27.0 65.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.564 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.687 HD12 ' O ' ' A' ' 64' ' ' ASN . 1.3 mt -66.34 -43.25 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.105 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.83 -55.8 21.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -25.61 65.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -1.16 . . . . 0.0 109.398 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.62 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -87.86 -3.63 58.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.247 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 68' ' ' ILE . 15.0 tp10 -82.47 -26.05 32.99 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.22 -0.925 . . . . 0.0 109.211 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.74 75.77 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.391 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.815 HG23 ' H ' ' A' ' 76' ' ' ALA . 4.9 m -97.75 174.66 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.925 . . . . 0.0 109.633 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.571 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 18.2 m -74.13 -11.95 60.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.852 . . . . 0.0 109.934 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.85 ' HB2' ' HG2' ' A' ' 104' ' ' ARG . . . -122.42 -151.41 0.48 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.029 -1.045 . . . . 0.0 109.874 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.628 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -112.26 156.13 22.89 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.017 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -128.62 152.79 47.95 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 117.596 -1.641 . . . . 0.0 112.096 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.589 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 13.7 mmtt -137.52 167.26 21.3 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.589 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 5.8 Cg_exo -54.41 -17.99 13.68 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.17 1.913 . . . . 0.0 110.589 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.458 ' OD1' HG21 ' A' ' 57' ' ' THR . 6.1 t-20 -82.62 -33.75 27.81 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.375 -0.828 . . . . 0.0 110.45 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.6 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.1 m -61.7 159.68 13.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.951 -1.093 . . . . 0.0 109.595 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.581 HH12 HG23 ' A' ' 88' ' ' ILE . 6.9 mmm-85 -160.4 167.96 26.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.737 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.58 HD11 ' HG ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -88.44 112.37 22.86 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' MET . 0.3 OUTLIER -65.35 -6.99 11.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.286 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.3 p -105.89 13.23 29.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.961 -1.087 . . . . 0.0 110.305 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.515 ' NE2' HD13 ' A' ' 84' ' ' LEU . 2.9 pt20 -139.06 3.28 2.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.796 -1.19 . . . . 0.0 110.399 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.139 HG22 HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -105.08 146.88 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.946 -1.097 . . . . 0.0 109.201 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 90' ' ' MET . 12.1 mm -116.32 158.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.27 -0.894 . . . . 0.0 109.505 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.856 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -127.89 95.24 4.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.292 -0.88 . . . . 0.0 109.271 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.664 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -87.62 171.23 10.05 Favored Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.589 -0.694 . . . . 0.0 109.533 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.664 ' HD2' HG22 ' A' ' 91' ' ' THR . 3.9 Cg_exo -60.34 -15.17 33.65 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.189 1.926 . . . . 0.0 110.33 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.781 ' HG3' HD12 ' A' ' 94' ' ' LEU . 22.3 pt-20 -66.29 -47.88 72.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.234 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.06 HD21 ' CB ' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -86.38 152.18 22.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.886 . . . . 0.0 109.23 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.417 ' HB3' ' HA ' ' A' ' 1' ' ' SER . 1.3 p30 -161.42 133.99 6.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.98 . . . . 0.0 110.022 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.585 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 78.41 37.32 27.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.721 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -78.22 149.64 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.178 -1.189 . . . . 0.0 109.047 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.455 ' N ' HD13 ' A' ' 97' ' ' ILE . 3.7 t -114.18 110.35 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.061 -1.024 . . . . 0.0 109.884 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.734 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -102.75 148.72 7.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.516 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -126.15 176.63 6.92 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.74 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 6' ' ' VAL . 21.6 t -106.02 146.32 32.68 Favored Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.685 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.888 ' HD2' HG13 ' A' ' 101' ' ' VAL . 10.5 Cg_exo -54.06 -173.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.458 2.105 . . . . 0.0 110.656 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -92.21 -18.01 24.05 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.222 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.85 ' HG2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -130.29 -162.36 1.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.478 ' O ' HG23 ' A' ' 47' ' ' THR . 4.8 tm0? -151.36 22.56 0.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.838 -1.163 . . . . 0.0 109.895 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.895 ' NE1' ' HB3' ' A' ' 46' ' ' ALA . 6.5 m95 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.533 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.562 ' S1 ' HD23 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.511 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -138.17 159.52 41.82 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.261 -0.899 . . . . 0.0 109.167 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.6 HG21 ' HG3' ' A' ' 90' ' ' MET . 0.9 OUTLIER -157.28 130.54 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.23 -0.919 . . . . 0.0 109.659 -179.215 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.988 HG13 ' O ' ' A' ' 13' ' ' ARG . 75.5 t -129.02 140.93 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 109.023 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.109 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -109.24 156.87 19.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 109.252 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.7 t -133.28 132.97 58.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.547 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -78.91 -177.37 5.5 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.771 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -48.59 162.95 0.08 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.513 ' C ' ' O ' ' A' ' 8' ' ' HIS . 5.1 t0 -29.75 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.032 0.444 . . . . 0.0 110.78 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 8' ' ' HIS . . . -168.47 -95.39 0.1 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.476 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.4 m -125.37 -175.87 3.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -1.156 . . . . 0.0 109.666 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.716 ' H ' HG22 ' A' ' 11' ' ' THR . 11.5 ptt180 -156.69 141.09 16.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.631 -0.668 . . . . 0.0 109.904 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.988 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -100.41 174.63 6.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.21 -0.931 . . . . 0.0 108.718 179.266 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.417 ' CB ' HG22 ' A' ' 4' ' ' VAL . 9.1 pm0 -130.38 162.91 28.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.029 -1.044 . . . . 0.0 110.788 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.109 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -175.84 -176.53 0.85 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.627 0.727 . . . . 0.0 109.193 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 1' ' ' SER . 7.3 t0 -132.24 88.59 2.56 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.059 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.732 HG21 HD22 ' A' ' 23' ' ' LEU . 49.4 t -54.24 145.61 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 108.918 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 1.016 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -86.42 172.98 9.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 109.662 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.412 ' OD2' ' HG3' ' A' ' 92' ' ' PRO . 78.8 m-20 -80.92 125.75 30.51 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.354 -0.841 . . . . 0.0 108.927 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.38 22.44 34.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.016 HG21 ' HB3' ' A' ' 18' ' ' ALA . 1.9 t -117.16 162.86 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -1.086 . . . . 0.0 108.918 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -100.62 134.92 42.86 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.981 -1.074 . . . . 0.0 108.568 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.958 HD13 ' OH ' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -46.64 -25.27 0.68 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.016 -1.052 . . . . 0.0 108.699 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.602 ' HE2' ' HB2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -74.44 -46.69 38.32 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.66 ' HB2' HG12 ' A' ' 21' ' ' VAL . 2.7 mm-40 -52.23 -54.29 32.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 108.95 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.473 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -57.22 -29.08 63.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 0.0 108.677 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.952 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -67.93 -34.15 76.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -0.809 . . . . 0.0 109.145 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.572 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 88.4 t -52.8 -40.49 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 109.399 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 t -79.95 -48.85 12.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.848 . . . . 0.0 109.402 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.732 ' CG ' HD22 ' A' ' 15' ' ' LEU . 29.1 m-80 -65.62 -6.19 10.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.795 . . . . 0.0 109.68 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.483 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 72.09 17.6 77.32 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.476 HG13 ' CB ' ' A' ' 30' ' ' ASN . 1.0 OUTLIER -95.56 -27.18 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -1.157 . . . . 0.0 108.538 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.952 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 1.2 p90 -46.96 -45.11 20.59 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.557 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 10.9 t70 -77.31 -29.06 53.46 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 35' ' ' ILE . 20.0 mm -64.86 -10.03 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.681 HG21 HG12 ' A' ' 50' ' ' VAL . 2.5 p -160.12 -51.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.134 -0.979 . . . . 0.0 109.826 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' H ' HG13 ' A' ' 36' ' ' VAL . . . -42.9 166.29 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.494 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 13.7 t0 -154.15 -93.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -1.203 . . . . 0.0 109.863 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 42' ' ' SER . 20.8 p -65.49 -9.5 26.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.131 -0.98 . . . . 0.0 109.765 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 86' ' ' CYS . . . 89.59 -167.47 33.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -42.01 -27.09 0.37 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.457 ' O ' ' SG ' ' A' ' 86' ' ' CYS . 19.3 m -59.68 159.57 8.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.136 -1.214 . . . . 0.0 109.286 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.596 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -124.57 74.45 1.33 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.356 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 m -129.6 -2.33 4.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 109.735 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 38' ' ' ASP . 1.4 p -120.96 -169.24 1.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.085 -1.009 . . . . 0.0 109.613 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.788 ' HB3' ' NE1' ' A' ' 106' ' ' TRP . . . -141.83 11.44 2.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.297 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 105' ' ' GLN . 9.5 m -71.54 -21.0 61.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.51 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.536 ' HB2' ' CB ' ' A' ' 85' ' ' CYS . 23.5 p -86.75 42.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.02 ' CE1' HD12 ' A' ' 78' ' ' LEU . 21.6 t60 -74.47 72.65 1.88 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.681 HG12 HG21 ' A' ' 36' ' ' VAL . 10.1 m -81.64 145.41 8.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.285 -1.509 . . . . 0.0 110.728 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 6.1 m-85 -107.26 99.97 9.46 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.709 HG22 HG12 ' A' ' 99' ' ' VAL . 3.8 t -89.93 172.08 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-O 122.053 0.93 . . . . 0.0 112.461 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.581 ' H ' HG12 ' A' ' 52' ' ' VAL . 1.3 m-20 -77.39 159.34 29.54 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.18 11.71 5.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.38 -0.825 . . . . 0.0 110.103 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.29 -29.91 7.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.015 -1.053 . . . . 0.0 109.755 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.757 ' HD2' HD23 ' A' ' 94' ' ' LEU . 47.2 m-85 -99.53 -18.47 17.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.174 -0.954 . . . . 0.0 109.4 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.685 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -64.16 -14.33 54.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.073 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.85 -36.06 17.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.767 ' HB2' HD21 ' A' ' 94' ' ' LEU . 1.9 mptp? -72.88 -32.92 65.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.462 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.582 ' HB ' HG22 ' A' ' 88' ' ' ILE . 1.3 m -56.18 163.05 2.55 Favored Pre-proline 0 C--N 1.305 -1.344 0 O-C-N 121.222 -0.924 . . . . 0.0 109.455 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.663 ' HD2' HG22 ' A' ' 88' ' ' ILE . 5.8 Cg_exo -58.16 166.47 5.7 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.166 1.911 . . . . 0.0 110.179 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -110.25 60.21 0.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -41.86 164.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.53 -0.731 . . . . 0.0 109.611 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.434 ' O ' HG12 ' A' ' 68' ' ' ILE . 1.5 p30 -94.15 -175.23 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 0.0 109.695 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.527 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 38.2 tt0 -88.13 -17.98 29.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 0.0 109.521 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -46.54 -64.53 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.713 ' O ' HD12 ' A' ' 71' ' ' LEU . 4.7 mt-10 -65.56 -21.29 66.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.433 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.527 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 23.5 mm -65.37 -31.7 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -45.12 -56.42 6.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 57.2 mtt -68.21 -26.79 65.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -1.176 . . . . 0.0 109.106 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.109 ' CD1' HD11 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -88.11 2.78 51.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.346 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 68' ' ' ILE . 55.7 tt0 -88.15 -30.53 19.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.85 . . . . 0.0 109.008 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -101.95 29.86 4.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.168 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.91 HG23 ' H ' ' A' ' 76' ' ' ALA . 5.3 m -46.07 171.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.593 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.567 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 83.4 m -75.2 -4.22 37.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.786 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.91 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -123.76 -150.71 0.45 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.063 -1.023 . . . . 0.0 109.651 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.645 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -111.85 156.64 21.7 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 179.333 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.02 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -130.71 153.91 48.49 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.964 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.539 ' CE ' ' HD2' ' A' ' 80' ' ' PRO . 4.5 mmmt -136.88 166.85 24.22 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.539 ' HD2' ' CE ' ' A' ' 79' ' ' LYS . 6.0 Cg_exo -54.68 -17.41 13.19 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.246 1.964 . . . . 0.0 110.697 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -84.78 -31.66 23.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.615 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.606 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.4 m -61.6 162.83 7.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.965 -1.084 . . . . 0.0 110.307 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.514 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -161.03 -159.08 0.63 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.369 -0.832 . . . . 0.0 109.278 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.109 HD11 ' CD1' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -110.93 118.54 36.37 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.285 -0.885 . . . . 0.0 108.97 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.609 ' SG ' HG11 ' A' ' 50' ' ' VAL . 1.8 t -60.79 -19.62 59.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.125 -0.984 . . . . 0.0 108.991 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 17.2 p -110.66 30.16 7.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.426 -0.796 . . . . 0.0 109.973 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -143.26 9.55 1.66 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.019 -1.051 . . . . 0.0 110.048 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.663 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -123.35 131.27 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.072 -1.017 . . . . 0.0 109.287 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.597 HG22 ' N ' ' A' ' 90' ' ' MET . 13.8 mm -96.29 166.39 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.342 -0.849 . . . . 0.0 109.622 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.666 ' CB ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.87 90.33 3.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.375 -0.828 . . . . 0.0 109.417 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.423 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -88.2 167.51 19.34 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.382 -0.824 . . . . 0.0 109.336 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 3.5 Cg_exo -60.09 -12.84 20.79 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.138 1.892 . . . . 0.0 110.353 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.59 ' CG ' HD12 ' A' ' 94' ' ' LEU . 24.9 pt-20 -69.83 -45.87 66.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.589 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' A' ' 59' ' ' LYS . 1.3 mp -75.98 136.02 40.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.924 . . . . 0.0 109.556 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -139.8 119.89 13.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.59 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 72.78 46.82 28.63 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.01 HD11 HG22 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -74.96 148.77 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.375 -1.074 . . . . 0.0 109.101 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.88 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.9 t -116.23 106.34 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.11 -0.994 . . . . 0.0 109.443 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.01 HG22 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -104.84 147.14 11.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -126.38 174.27 8.73 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.722 -179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.892 HG13 ' HD2' ' A' ' 102' ' ' PRO . 40.1 t -108.3 145.79 32.24 Favored Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.093 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.892 ' HD2' HG13 ' A' ' 101' ' ' VAL . 8.6 Cg_exo -50.24 177.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.304 2.003 . . . . 0.0 111.031 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.07 -22.87 33.36 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 0.0 OUTLIER -119.61 -157.03 0.69 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.644 ' O ' HG23 ' A' ' 47' ' ' THR . 20.0 mt-30 -153.36 23.99 0.54 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.953 -1.092 . . . . 0.0 109.728 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.788 ' NE1' ' HB3' ' A' ' 46' ' ' ALA . 5.0 m95 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.589 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.403 ' S1 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.361 0.6 . . . . 0.0 109.526 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -134.41 162.99 30.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 109.075 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.782 HG21 HD21 ' A' ' 23' ' ' LEU . 23.9 t -152.28 157.32 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.061 -1.025 . . . . 0.0 109.742 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -158.57 119.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 108.879 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.085 ' CE1' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -95.19 157.17 16.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 109.682 -179.381 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.935 ' O ' HG23 ' A' ' 101' ' ' VAL . 9.4 t -123.26 169.6 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.447 -0.783 . . . . 0.0 109.096 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.58 ' N ' HG12 ' A' ' 6' ' ' VAL . 84.5 p -123.12 162.69 22.0 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.477 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -65.31 -6.53 10.09 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.828 -1.17 . . . . 0.0 109.203 179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -110.07 -5.6 15.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.062 -1.024 . . . . 0.0 110.319 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' HD2' ' A' ' 12' ' ' ARG . . . 115.65 -33.39 5.25 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.689 -1.244 . . . . 0.0 110.282 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.6 m -49.61 114.09 0.98 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.974 -1.31 . . . . 0.0 109.48 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.488 ' HB3' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -133.83 122.77 23.72 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.648 -0.657 . . . . 0.0 109.695 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.726 ' NH1' HD11 ' A' ' 35' ' ' ILE . 1.3 mtt180 -97.95 173.78 6.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.121 -0.987 . . . . 0.0 108.544 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.556 ' HB3' HG13 ' A' ' 4' ' ' VAL . 10.9 pt20 -131.96 134.66 45.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.051 -1.031 . . . . 0.0 110.212 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.085 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -134.28 -176.84 4.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.269 -0.895 . . . . 0.0 109.471 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.68 80.97 1.97 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.732 -0.605 . . . . 0.0 109.505 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.008 HG21 HD23 ' A' ' 23' ' ' LEU . 85.8 t -68.88 114.32 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.52 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -52.62 175.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.882 . . . . 0.0 109.817 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 92' ' ' PRO . 67.8 m-20 -83.05 126.29 32.39 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.477 -0.764 . . . . 0.0 109.076 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.12 10.67 44.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.652 HG12 ' HB3' ' A' ' 25' ' ' GLN . 0.7 OUTLIER -115.52 155.48 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -1.144 . . . . 0.0 109.199 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 7.2 t -93.6 133.01 37.36 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.403 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.008 HD23 HG21 ' A' ' 17' ' ' VAL . 10.8 mt -42.64 -29.41 0.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.556 ' HE1' ' H ' ' A' ' 41' ' ' GLY . 1.9 tmt? -70.81 -50.52 34.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 108.811 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.652 ' HB3' HG12 ' A' ' 21' ' ' VAL . 5.5 tp-100 -49.22 -50.86 36.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.262 -0.899 . . . . 0.0 108.751 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.957 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -63.23 -32.06 73.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -0.844 . . . . 0.0 108.757 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.93 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -62.25 -25.45 67.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.351 -0.843 . . . . 0.0 109.213 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.584 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 47.0 t -57.43 -42.97 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.135 -0.978 . . . . 0.0 109.172 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 t -82.51 -53.11 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 0.0 109.284 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.625 ' ND2' ' HB3' ' A' ' 15' ' ' LEU . 11.0 m120 -54.81 -16.72 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.461 -0.775 . . . . 0.0 109.406 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 35' ' ' ILE . . . 79.14 21.82 66.88 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.809 ' HA ' HD12 ' A' ' 35' ' ' ILE . 1.1 mt -99.2 -28.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.175 -1.191 . . . . 0.0 108.535 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.93 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 1.6 p90 -47.45 -46.35 26.66 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.605 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 19.3 t70 -74.44 -30.49 61.91 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.809 HD12 ' HA ' ' A' ' 32' ' ' ILE . 60.0 mt -58.98 -17.28 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.09 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.715 ' O ' HG13 ' A' ' 36' ' ' VAL . 8.0 p -170.13 81.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.843 . . . . 0.0 109.47 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.496 ' C ' ' HG1' ' A' ' 47' ' ' THR . . . -163.62 179.55 38.6 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.566 ' CG ' HG21 ' A' ' 47' ' ' THR . 3.2 t0 -163.96 -69.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 109.667 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 42' ' ' SER . 16.3 p -83.3 10.05 9.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.698 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.04 -162.6 46.02 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.556 ' H ' ' HE1' ' A' ' 24' ' ' MET . . . -47.34 -23.98 2.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.447 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -59.89 177.49 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -1.165 . . . . 0.0 109.368 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.467 ' HA ' ' S1 ' ' A' ' 107' ' ' FES . . . -137.69 91.15 2.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.471 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.8 t -160.05 22.03 0.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 9.1 p -130.17 -151.55 0.48 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.958 . . . . 0.0 109.461 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.514 ' HB3' ' NE1' ' A' ' 106' ' ' TRP . . . -157.82 19.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.141 -0.975 . . . . 0.0 109.999 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.566 HG21 ' CG ' ' A' ' 38' ' ' ASP . 1.6 p -89.94 -19.39 24.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.113 -0.992 . . . . 0.0 109.455 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.499 ' HA ' HG22 ' A' ' 36' ' ' VAL . 23.4 p -86.62 43.36 1.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 110.073 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.717 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 67.5 t60 -76.93 65.41 2.6 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 82' ' ' SER . 12.6 m -87.14 147.89 4.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.345 -1.472 . . . . 0.0 110.384 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.717 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 6.2 m-30 -107.16 111.4 23.81 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.694 HG22 HG12 ' A' ' 99' ' ' VAL . 5.3 t -94.85 170.14 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.937 0.875 . . . . 0.0 112.306 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.568 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -74.24 144.51 44.63 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.261 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -4.84 13.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.17 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -94.96 -30.07 14.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.214 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.816 ' CD2' HG22 ' A' ' 97' ' ' ILE . 61.6 m-85 -97.98 -17.79 18.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.007 -1.058 . . . . 0.0 109.878 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.627 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -64.59 -37.21 86.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.97 . . . . 0.0 109.429 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -62.14 1.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.542 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.842 ' HB2' HD21 ' A' ' 94' ' ' LEU . 13.8 mptt -49.93 -38.57 36.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.909 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -51.24 161.17 0.79 Allowed Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.901 . . . . 0.0 109.049 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.909 ' HD2' HG22 ' A' ' 60' ' ' VAL . 4.3 Cg_exo -59.96 159.22 26.28 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.18 1.92 . . . . 0.0 110.22 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.15 58.89 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.883 . . . . 0.0 109.439 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.89 132.85 3.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.415 -0.803 . . . . 0.0 109.557 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -51.79 -174.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 109.63 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.591 ' HA ' HD12 ' A' ' 68' ' ' ILE . 31.0 tt0 -89.47 -16.43 30.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.415 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.438 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . 5.2 tpp180 -44.57 -61.79 1.43 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.477 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.438 ' OE1' ' HB3' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -66.23 -23.84 66.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.431 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 65' ' ' GLU . 18.9 mt -63.12 -32.48 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.99 -51.6 39.54 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.7 mtt -66.69 -23.36 66.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -1.152 . . . . 0.0 109.372 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.696 ' O ' HG13 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -89.72 -7.06 55.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.497 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -82.17 -36.79 27.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 109.367 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.87 57.62 4.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.398 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.903 HG23 ' H ' ' A' ' 76' ' ' ALA . 8.9 m -93.94 172.02 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.527 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 25.5 m -64.94 -10.23 27.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.518 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.903 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -128.22 -155.85 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.149 -0.97 . . . . 0.0 109.969 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.571 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -111.82 150.39 30.43 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.641 ' HG ' ' HB2' ' A' ' 82' ' ' SER . 0.4 OUTLIER -106.54 169.1 8.72 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.397 -1.321 . . . . 0.0 111.203 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.549 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -153.22 170.78 7.68 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.159 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 3.4 Cg_exo -57.83 -13.45 14.75 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.037 1.824 . . . . 0.0 109.905 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.505 ' HA ' HG21 ' A' ' 57' ' ' THR . 1.3 m-20 -95.35 -25.0 16.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 110.836 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.641 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -85.79 155.9 20.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.818 -1.176 . . . . 0.0 110.477 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.403 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -161.53 -157.68 0.51 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 179.729 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.904 HD12 ' CB ' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -104.29 95.19 5.78 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.226 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.541 ' HA ' ' CG1' ' A' ' 88' ' ' ILE . 1.9 t -42.57 -25.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 84' ' ' LEU . 13.0 p -75.72 -43.53 46.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.098 -1.001 . . . . 0.0 110.544 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.904 ' CB ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -89.62 8.87 29.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.002 -1.061 . . . . 0.0 111.334 -178.557 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.689 ' O ' HD13 ' A' ' 89' ' ' ILE . 2.9 mm -79.98 154.66 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.552 -1.342 . . . . 0.0 108.913 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 88' ' ' ILE . 30.1 mm -128.98 165.47 28.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.716 ' HE3' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -127.3 96.32 4.54 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.725 ' OG1' HD12 ' A' ' 94' ' ' LEU . 16.3 p -82.52 157.19 67.83 Favored Pre-proline 0 C--N 1.297 -1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 109.262 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.456 ' HB3' ' OD2' ' A' ' 19' ' ' ASP . 5.8 Cg_exo -59.77 -13.35 21.79 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.02 1.813 . . . . 0.0 110.264 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -80.3 -31.79 38.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.412 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.842 HD21 ' HB2' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -83.35 127.41 33.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.634 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -135.82 125.51 25.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.204 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.576 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 70.86 50.57 23.4 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.035 HD11 HG22 ' A' ' 99' ' ' VAL . 0.5 OUTLIER -74.82 159.1 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.331 -1.099 . . . . 0.0 108.868 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.006 ' N ' HD12 ' A' ' 97' ' ' ILE . 5.2 t -125.82 103.53 11.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.021 -1.049 . . . . 0.0 110.186 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.035 HG22 HD11 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -95.44 156.65 3.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 51' ' ' TYR . 12.0 m-20 -131.91 178.35 6.84 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.059 -1.025 . . . . 0.0 109.401 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 6' ' ' VAL . 27.6 t -110.45 146.84 35.14 Favored Pre-proline 0 C--N 1.297 -1.715 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.95 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.897 ' HD2' HG13 ' A' ' 101' ' ' VAL . 8.4 Cg_exo -53.95 -173.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.391 2.061 . . . . 0.0 110.369 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 19.3 t0 -102.68 -22.71 13.91 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.614 ' HD2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -131.09 -168.68 2.04 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.578 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -128.99 -82.63 0.57 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.024 -1.048 . . . . 0.0 109.186 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.578 ' CD1' ' O ' ' A' ' 105' ' ' GLN . 2.1 m95 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.38 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.467 ' S1 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -136.61 161.46 35.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.277 -0.889 . . . . 0.0 109.175 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.717 HG21 ' CG ' ' A' ' 90' ' ' MET . 1.1 t -160.7 133.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 109.531 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.9 p -136.98 161.39 35.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.123 -0.985 . . . . 0.0 108.648 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.084 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -129.04 157.99 40.17 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.185 -0.947 . . . . 0.0 109.786 -178.543 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 12' ' ' ARG . 3.4 t -126.9 143.39 40.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.552 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 5.1 p -75.98 -158.7 0.1 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.684 ' N ' HG12 ' A' ' 101' ' ' VAL . 55.8 m80 -59.2 -103.43 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.26 77.71 1.06 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.4 -1.437 . . . . 0.0 109.239 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.99 -101.31 0.2 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 118.958 -1.591 . . . . 0.0 111.053 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -121.46 -170.55 2.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -1.1 . . . . 0.0 109.954 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.767 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -149.31 139.59 22.29 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.656 -0.652 . . . . 0.0 110.32 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.517 ' C ' HG23 ' A' ' 4' ' ' VAL . 18.0 mtt180 -104.25 119.31 38.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.351 -0.843 . . . . 0.0 108.958 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.619 ' HA ' HG23 ' A' ' 4' ' ' VAL . 4.9 pt20 -79.78 171.43 15.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.973 . . . . 0.0 110.554 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.084 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -173.48 -177.98 1.58 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.611 0.72 . . . . 0.0 109.059 178.542 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -135.24 93.17 2.95 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.66 -0.65 . . . . 0.0 109.685 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.976 HG21 ' CD2' ' A' ' 23' ' ' LEU . 21.1 t -69.13 149.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 109.305 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.873 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -83.22 173.38 11.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.397 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -79.97 124.67 28.91 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.274 -0.891 . . . . 0.0 109.067 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.8 18.06 39.05 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.873 HG21 ' HB3' ' A' ' 18' ' ' ALA . 2.2 t -115.1 170.3 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -1.123 . . . . 0.0 109.27 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.496 ' OG ' ' CD1' ' A' ' 89' ' ' ILE . 70.6 m -111.76 138.79 47.87 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 108.677 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.976 ' CD2' HG21 ' A' ' 17' ' ' VAL . 1.5 mt -48.31 -23.6 0.96 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.945 -1.097 . . . . 0.0 108.709 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.478 ' HB2' ' HA ' ' A' ' 86' ' ' CYS . 13.2 ttp -73.07 -46.84 49.3 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.692 ' HB2' HG12 ' A' ' 21' ' ' VAL . 2.0 mt-30 -54.14 -59.61 4.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.363 -0.835 . . . . 0.0 109.004 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.432 ' C ' ' OD1' ' A' ' 30' ' ' ASN . . . -53.22 -46.48 69.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 108.945 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.526 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -45.37 -37.39 4.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.865 . . . . 0.0 109.885 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.538 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 58.7 t -43.57 -50.12 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.098 -1.001 . . . . 0.0 109.858 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 31' ' ' GLY . 6.1 t -87.02 -51.33 6.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.303 -0.873 . . . . 0.0 109.591 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 1.037 ' OD1' HD13 ' A' ' 15' ' ' LEU . 4.8 m120 -40.31 -25.86 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.462 0.649 . . . . 0.0 109.731 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 95.24 -5.17 67.9 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.735 HG22 ' CG2' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -79.61 -28.35 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.056 -1.261 . . . . 0.0 107.962 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -48.7 -31.45 6.85 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.046 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.619 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 13.1 t0 -93.08 -25.38 17.94 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.663 -0.648 . . . . 0.0 109.295 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.93 ' CG2' HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -60.11 -31.83 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.0 109.194 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.93 HG22 ' CG2' ' A' ' 35' ' ' ILE . 3.4 m -163.75 -171.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.404 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.08 166.05 12.06 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 12.3 t70 -154.16 -92.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -1.146 . . . . 0.0 109.716 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 40' ' ' GLY . 14.6 p -81.87 -9.87 59.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 109.625 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.76 77.15 0.1 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 87' ' ' GLN . . . 171.28 -157.17 27.65 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.2 p -60.83 171.83 1.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -1.137 . . . . 0.0 109.486 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.888 ' HB3' ' CG ' ' A' ' 67' ' ' GLU . . . -61.93 99.59 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.89 . . . . 0.0 109.41 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.81 5.84 2.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 0.0 109.636 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 13.2 p -144.33 -152.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 0.0 109.615 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 1.004 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -156.09 19.2 0.37 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.634 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -90.4 -28.78 18.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.583 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.686 ' O ' HG13 ' A' ' 50' ' ' VAL . 22.0 p -86.5 42.3 1.0 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.953 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.733 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 68.1 t60 -58.71 79.95 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.113 HG11 ' CB ' ' A' ' 85' ' ' CYS . 7.6 m -90.59 146.71 5.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.055 -1.653 . . . . 0.0 111.987 -177.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.733 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 4.1 m-30 -112.63 113.09 25.05 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.823 HG22 HG12 ' A' ' 99' ' ' VAL . 6.4 t -101.45 171.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.877 0.846 . . . . 0.0 112.209 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.582 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -73.23 155.36 39.63 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.012 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.418 ' HB3' HD22 ' A' ' 81' ' ' ASN . 1.7 pp20? -81.43 11.63 4.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.148 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.48 -28.89 8.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.95 -1.094 . . . . 0.0 110.121 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.856 ' CD2' HG22 ' A' ' 97' ' ' ILE . 43.0 m-85 -100.14 -19.34 16.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.08 -1.012 . . . . 0.0 109.695 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.612 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -61.55 -22.71 65.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.205 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -85.71 -25.69 26.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.891 . . . . 0.0 109.475 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.767 ' HB2' HD21 ' A' ' 94' ' ' LEU . 13.6 mmtm -76.83 -10.54 59.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 0.0 109.443 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.785 HG11 ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -95.68 170.39 7.79 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.276 -0.89 . . . . 0.0 108.785 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.706 ' HD2' HG12 ' A' ' 60' ' ' VAL . 5.7 Cg_exo -59.43 167.84 5.83 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.03 1.82 . . . . 0.0 110.394 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.18 59.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.865 . . . . 0.0 109.375 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -41.6 121.64 1.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.593 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.822 ' O ' HD13 ' A' ' 68' ' ' ILE . 7.0 m-80 -57.54 -158.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.545 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 14.8 tp10 -84.11 -10.06 58.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.537 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -58.24 -54.31 48.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.456 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.888 ' CG ' ' HB3' ' A' ' 43' ' ' ALA . 2.4 mp0 -67.64 -8.21 32.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.529 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.5 mp -88.66 -34.09 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.373 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.43 -59.01 3.75 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.787 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -67.89 -26.61 66.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -1.151 . . . . 0.0 109.299 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.669 HD13 HD11 ' A' ' 84' ' ' LEU . 19.8 tp -90.83 7.24 40.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.893 . . . . 0.0 109.408 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -99.23 -24.22 14.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 109.393 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.86 31.75 0.94 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.439 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.004 HG12 ' HB1' ' A' ' 46' ' ' ALA . 3.6 m -75.9 170.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.384 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 16.3 m -75.9 -17.79 59.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.97 . . . . 0.0 109.328 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.603 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -107.62 -161.28 0.77 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.273 -0.892 . . . . 0.0 110.027 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.564 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.7 OUTLIER -111.65 151.63 28.61 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.614 ' HG ' ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -104.2 173.09 6.45 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.98 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.59 ' HE3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -158.27 170.13 9.45 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 2.6 Cg_endo -58.95 -12.51 15.43 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.284 1.989 . . . . 0.0 110.155 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.418 HD22 ' HB3' ' A' ' 54' ' ' GLU . 1.0 OUTLIER -97.23 -22.09 16.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.22 -0.925 . . . . 0.0 110.84 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.614 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -75.42 153.32 37.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.004 -1.06 . . . . 0.0 110.649 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.652 ' C ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -161.31 -159.43 0.64 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.444 -0.785 . . . . 0.0 109.356 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.79 ' N ' HD22 ' A' ' 84' ' ' LEU . 3.1 mm? -109.61 79.34 1.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.337 -0.852 . . . . 0.0 108.73 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 1.113 ' CB ' HG11 ' A' ' 50' ' ' VAL . 43.2 t -45.38 -22.5 0.14 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.39 -0.819 . . . . 0.0 110.846 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 24' ' ' MET . 28.6 p -75.73 -40.88 54.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.897 -1.127 . . . . 0.0 110.914 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.573 ' CG ' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -96.14 11.64 33.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.852 -1.155 . . . . 0.0 111.193 -178.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.785 ' CG2' HG11 ' A' ' 60' ' ' VAL . 4.4 mm -79.5 160.25 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.683 -1.26 . . . . 0.0 108.811 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 ' O ' ' A' ' 88' ' ' ILE . 16.9 mm -123.72 155.69 30.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.838 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.717 ' CG ' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -116.27 88.08 2.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.471 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.69 165.07 34.56 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 121.415 -0.803 . . . . 0.0 109.315 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.36 -12.9 22.1 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.18 1.92 . . . . 0.0 110.227 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -72.42 -51.05 22.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' A' ' 59' ' ' LYS . 1.6 mp -73.16 141.81 47.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.533 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -143.48 119.0 10.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 109.744 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.587 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 71.61 47.02 36.21 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.987 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER -74.61 156.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.209 -1.171 . . . . 0.0 108.74 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.987 ' N ' HD12 ' A' ' 97' ' ' ILE . 3.6 t -124.37 106.17 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.047 -1.033 . . . . 0.0 109.939 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.937 HG22 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -101.73 159.78 4.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 1.6 m-20 -139.33 170.03 16.69 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.236 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.895 HG22 ' HD2' ' A' ' 102' ' ' PRO . 0.7 OUTLIER -105.09 157.97 33.11 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.512 178.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.895 ' HD2' HG22 ' A' ' 101' ' ' VAL . 6.3 Cg_exo -55.86 -167.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.546 2.164 . . . . 0.0 111.585 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 13.4 t0 -106.87 -22.84 12.56 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -131.31 127.95 38.74 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.57 20.03 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.968 -1.083 . . . . 0.0 110.036 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.572 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.013 . . . . 0.0 109.467 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.522 ' S1 ' HD12 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.478 ' HB2' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.471 0.653 . . . . 0.0 109.579 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.415 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -145.63 153.43 41.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.001 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.89 HG21 HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -149.13 122.95 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.125 -0.984 . . . . 0.0 109.802 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.646 HG13 ' HG3' ' A' ' 14' ' ' GLN . 16.6 t -124.06 132.11 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.082 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -100.04 154.99 17.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.953 -1.092 . . . . 0.0 109.605 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.936 ' O ' HG23 ' A' ' 101' ' ' VAL . 11.6 t -121.79 167.78 14.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.483 -0.761 . . . . 0.0 109.011 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.586 ' N ' HG12 ' A' ' 6' ' ' VAL . 42.0 t -124.3 161.75 25.2 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.503 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.51 -7.36 9.89 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.85 -1.156 . . . . 0.0 109.149 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -110.3 -4.09 15.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.014 -1.054 . . . . 0.0 110.606 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.3 -19.03 27.46 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.303 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.2 m -59.87 111.88 1.64 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.908 -1.348 . . . . 0.0 109.252 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.75 ' HG2' HG13 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -125.58 121.93 35.04 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.515 -0.741 . . . . 0.0 110.268 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.632 ' NH1' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -102.53 126.36 49.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.646 ' HG3' HG13 ' A' ' 4' ' ' VAL . 2.4 mt-30 -88.78 157.17 18.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.099 -1.001 . . . . 0.0 110.654 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.082 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -166.81 -176.85 3.62 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.707 0.765 . . . . 0.0 109.322 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.25 116.07 17.86 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.415 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.014 HG21 HD23 ' A' ' 23' ' ' LEU . 49.2 t -93.29 106.36 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.577 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -47.07 174.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.586 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 92' ' ' PRO . 65.8 m-20 -83.51 126.26 32.61 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.317 -0.865 . . . . 0.0 109.18 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.84 21.77 20.11 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.736 HG12 ' HB2' ' A' ' 25' ' ' GLN . 1.5 t -125.01 164.65 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -1.177 . . . . 0.0 109.294 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 33.0 t -109.33 143.89 38.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 108.986 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.014 HD23 HG21 ' A' ' 17' ' ' VAL . 16.0 mt -44.61 -34.63 2.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.152 -0.968 . . . . 0.0 108.878 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -48.59 76.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.047 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.811 ' O ' HG12 ' A' ' 28' ' ' VAL . 3.3 mt-30 -52.73 -55.73 20.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.01 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.16 -21.69 66.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.199 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.94 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -76.42 -24.37 54.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.561 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 25' ' ' GLN . 5.4 p -59.93 -33.75 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.167 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 t -91.79 -52.7 4.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 109.075 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.493 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 21.0 m-80 -55.04 -17.6 4.13 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.506 -0.746 . . . . 0.0 109.22 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.36 24.64 56.43 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.655 HD11 HD22 ' A' ' 15' ' ' LEU . 1.1 mt -102.9 -27.26 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.128 -1.219 . . . . 0.0 108.738 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.94 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.7 OUTLIER -50.5 -40.44 51.23 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.695 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.478 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 45.1 t0 -73.3 -32.91 64.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.632 HD13 ' NH1' ' A' ' 13' ' ' ARG . 1.0 OUTLIER -98.42 14.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.942 -1.098 . . . . 0.0 109.448 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.608 HG12 ' SG ' ' A' ' 85' ' ' CYS . 94.6 t -160.29 69.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.435 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 48' ' ' CYS . . . 154.41 -171.93 32.92 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.889 ' CG ' HG21 ' A' ' 47' ' ' THR . 0.3 OUTLIER -165.42 -79.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.172 . . . . 0.0 109.639 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.499 ' SG ' ' N ' ' A' ' 40' ' ' GLY . 16.4 p -61.97 -40.32 95.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.562 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.499 ' N ' ' SG ' ' A' ' 39' ' ' CYS . . . 64.11 138.83 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.73 -102.68 0.86 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.452 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.4 OUTLIER -60.43 99.71 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -1.179 . . . . 0.0 109.437 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.457 ' HA ' ' S1 ' ' A' ' 107' ' ' FES . . . -63.54 109.71 1.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.505 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.3 m -152.45 17.13 0.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.654 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 12.9 p -121.26 -149.55 0.43 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.988 ' HB1' ' N ' ' A' ' 74' ' ' VAL . . . -156.13 18.71 0.36 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.033 -1.042 . . . . 0.0 109.997 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.889 HG21 ' CG ' ' A' ' 38' ' ' ASP . 1.7 p -90.11 -20.73 22.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.144 -0.973 . . . . 0.0 109.728 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.584 ' SG ' HD11 ' A' ' 71' ' ' LEU . 22.2 p -87.69 41.9 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.068 -1.02 . . . . 0.0 110.05 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.137 ' CD2' HD12 ' A' ' 78' ' ' LEU . 37.2 t-80 -81.9 61.94 5.46 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 82' ' ' SER . 12.5 m -77.35 148.09 6.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 120.588 -1.32 . . . . 0.0 110.612 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.514 ' CE2' ' CE1' ' A' ' 49' ' ' HIS . 7.0 m-85 -107.59 110.87 22.87 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.765 HG22 HG12 ' A' ' 99' ' ' VAL . 8.4 t -93.91 170.39 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 121.928 0.871 . . . . 0.0 112.251 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.566 ' N ' HG12 ' A' ' 52' ' ' VAL . 1.3 m-20 -69.16 165.3 20.7 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.17 9.3 26.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 109.869 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.32 -28.55 8.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.157 -0.964 . . . . 0.0 109.964 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.815 ' HD2' HD23 ' A' ' 94' ' ' LEU . 93.7 m-85 -97.91 -19.39 18.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 109.64 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.678 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -63.82 -23.06 67.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.4 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.03 -35.73 25.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.681 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.917 ' HB2' HD21 ' A' ' 94' ' ' LEU . 2.7 mmtm -63.74 -12.94 39.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.38 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.955 HG11 ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -97.94 161.75 24.56 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.268 -0.895 . . . . 0.0 108.969 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.832 ' HD2' HG12 ' A' ' 60' ' ' VAL . 5.0 Cg_exo -59.43 164.49 10.89 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.124 1.882 . . . . 0.0 110.371 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.19 59.35 0.61 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 109.428 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -41.98 130.19 3.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.548 -0.72 . . . . 0.0 109.593 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' ALA . 8.5 m-20 -57.08 -160.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.542 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.66 ' HA ' HD12 ' A' ' 68' ' ' ILE . 57.0 tt0 -99.25 -10.39 22.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.466 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' NE ' ' OE2' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -47.13 -72.28 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.599 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -61.04 -20.06 62.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 65' ' ' GLU . 13.6 mt -66.13 -31.93 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.69 -59.51 3.7 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.45 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -68.44 -28.1 66.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -1.116 . . . . 0.0 109.056 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.068 HD13 HD23 ' A' ' 84' ' ' LEU . 1.3 tp -85.5 4.49 35.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.324 -0.86 . . . . 0.0 109.167 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 68' ' ' ILE . 3.2 tm-20 -95.84 -12.53 25.1 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.081 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.745 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 1.3 m -59.92 -14.69 16.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.673 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.989 HG21 ' CD2' ' A' ' 49' ' ' HIS . 3.9 m -34.41 134.11 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.364 0.602 . . . . 0.0 109.941 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.549 ' HB ' ' CG ' ' A' ' 104' ' ' ARG . 88.4 m -44.69 -25.5 0.29 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 108.761 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.762 ' O ' HG23 ' A' ' 74' ' ' VAL . . . -110.1 -152.6 0.5 Allowed 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.373 -0.83 . . . . 0.0 109.834 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.634 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -114.74 148.59 38.11 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.137 HD12 ' CD2' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -104.15 130.05 51.89 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 117.406 -1.718 . . . . 0.0 111.288 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.538 ' HE2' ' CD ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -108.63 166.52 10.69 Favored Pre-proline 0 C--N 1.295 -1.801 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.538 ' CD ' ' HE2' ' A' ' 79' ' ' LYS . 3.4 Cg_exo -52.37 -27.85 32.86 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.733 1.622 . . . . 0.0 109.582 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.673 ' HA ' HG21 ' A' ' 57' ' ' THR . 1.0 OUTLIER -67.14 -42.04 85.07 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.677 -0.639 . . . . 0.0 109.449 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -83.18 168.27 16.96 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.435 -0.791 . . . . 0.0 109.671 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.541 ' HB3' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -161.57 -177.27 5.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.086 -1.009 . . . . 0.0 109.687 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.068 HD23 HD13 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -83.93 114.22 21.53 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.332 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.608 ' SG ' HG12 ' A' ' 36' ' ' VAL . 9.4 t -59.66 -14.87 15.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 0.0 109.12 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.3 p -108.54 30.21 6.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 109.76 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.819 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -152.92 13.72 0.52 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.986 -1.071 . . . . 0.0 110.377 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.955 ' CG2' HG11 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -112.39 150.2 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.923 -1.111 . . . . 0.0 108.938 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.749 HD13 ' O ' ' A' ' 88' ' ' ILE . 38.2 mm -129.45 142.27 44.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.315 -0.866 . . . . 0.0 109.881 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.81 ' SD ' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -97.95 82.15 2.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 108.936 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.57 165.85 41.58 Favored Pre-proline 0 C--N 1.294 -1.805 0 O-C-N 121.606 -0.684 . . . . 0.0 109.174 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 5.8 Cg_exo -59.25 -13.8 21.54 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.067 1.845 . . . . 0.0 110.103 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -76.96 -42.39 39.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.917 HD21 ' HB2' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -80.07 160.01 25.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.52 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -173.98 125.24 0.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.613 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 75.34 40.34 33.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.736 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -79.83 149.11 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -1.082 . . . . 0.0 109.165 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.417 ' N ' HD13 ' A' ' 97' ' ' ILE . 2.3 t -113.73 108.54 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.227 -0.92 . . . . 0.0 109.759 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.765 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -99.71 153.18 4.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -129.93 179.34 5.92 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.049 -1.032 . . . . 0.0 109.939 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 6' ' ' VAL . 25.4 t -109.01 146.59 34.16 Favored Pre-proline 0 C--N 1.296 -1.757 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.544 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.887 ' HD2' HG13 ' A' ' 101' ' ' VAL . 12.1 Cg_exo -53.72 137.8 67.38 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.223 1.949 . . . . 0.0 109.762 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.58 ' CB ' ' HD2' ' A' ' 104' ' ' ARG . 1.3 m-20 -47.14 -26.28 1.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.884 -1.135 . . . . 0.0 108.417 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -117.4 -167.34 1.3 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.18 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 106' ' ' TRP . 11.8 pt20 -160.07 27.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.056 . . . . 0.0 109.75 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.504 ' NE1' ' N ' ' A' ' 75' ' ' THR . 41.4 m95 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.67 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.457 ' S1 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.88 161.99 40.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 109.355 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.752 ' CG2' HD21 ' A' ' 23' ' ' LEU . 1.5 t -147.04 132.04 11.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.304 -0.873 . . . . 0.0 109.301 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.935 HG13 ' O ' ' A' ' 13' ' ' ARG . 72.2 t -129.32 127.7 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.782 ' CD2' HD21 ' A' ' 15' ' ' LEU . 44.5 m-85 -97.57 153.72 17.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.818 -1.176 . . . . 0.0 110.263 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.69 HG22 ' HB3' ' A' ' 12' ' ' ARG . 2.6 t -132.46 141.77 44.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -76.77 -156.78 0.08 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.258 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.685 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -58.18 -105.93 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -112.07 77.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.477 -1.389 . . . . 0.0 108.887 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.05 -100.39 0.19 Allowed Glycine 0 N--CA 1.493 2.439 0 C-N-CA 118.931 -1.605 . . . . 0.0 111.027 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.702 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.3 m -119.56 -177.27 3.34 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.333 -1.098 . . . . 0.0 110.061 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.702 ' H ' HG22 ' A' ' 11' ' ' THR . 12.8 ptt180 -153.0 147.79 26.33 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.935 ' O ' HG13 ' A' ' 4' ' ' VAL . 8.0 mtt180 -106.25 173.47 6.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 108.522 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.453 ' C ' HD23 ' A' ' 15' ' ' LEU . 11.2 pt20 -123.76 163.76 20.53 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.004 -1.06 . . . . 0.0 110.567 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.782 HD21 ' CD2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -169.71 -175.32 2.08 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -131.9 91.33 2.96 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.063 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.925 HG21 HD23 ' A' ' 23' ' ' LEU . 46.9 t -62.2 153.38 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 108.872 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 1.055 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -91.03 172.37 8.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.0 . . . . 0.0 109.496 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -78.19 125.25 29.07 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.323 -0.861 . . . . 0.0 109.029 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.79 26.89 28.15 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.055 HG21 ' HB3' ' A' ' 18' ' ' ALA . 2.1 t -120.89 163.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -1.15 . . . . 0.0 109.172 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.5 t -106.07 140.72 38.62 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 108.534 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.013 HD13 HG21 ' A' ' 99' ' ' VAL . 12.1 mt -46.38 -26.08 0.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.099 -1.001 . . . . 0.0 108.623 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.589 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 22.0 ttt -71.71 -47.96 50.44 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.873 ' HB3' HG12 ' A' ' 21' ' ' VAL . 3.2 tp-100 -51.34 -55.5 18.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 108.836 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.597 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -54.1 -31.38 51.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.904 . . . . 0.0 108.903 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.83 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -61.19 -39.51 90.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.344 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.555 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 49.0 t -46.16 -22.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.857 . . . . 0.0 110.446 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 t -110.64 -50.29 2.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.019 -1.051 . . . . 0.0 110.325 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.674 ' HB3' HD11 ' A' ' 32' ' ' ILE . 17.7 m120 -59.56 -11.64 5.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 110.123 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.425 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 98.88 -31.49 8.13 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.674 HD11 ' HB3' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -51.53 -21.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.215 -1.168 . . . . 0.0 109.178 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.83 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 1.2 p90 -43.16 -47.89 6.32 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.626 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 1.2 t0 -87.12 -21.2 26.14 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.505 ' CG1' ' HA ' ' A' ' 32' ' ' ILE . 4.5 mm -85.71 5.72 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.936 -1.102 . . . . 0.0 109.437 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 32' ' ' ILE . 10.0 p -170.52 171.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.572 ' H ' HG22 ' A' ' 36' ' ' VAL . . . 77.24 173.83 39.82 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.739 ' HB2' HG21 ' A' ' 47' ' ' THR . 6.9 t0 -169.96 -89.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -1.107 . . . . 0.0 109.542 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 44' ' ' SER . 17.7 p -65.05 -22.78 67.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.155 -0.966 . . . . 0.0 109.525 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.6 -177.18 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.55 -109.84 3.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.0 -177.16 3.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -1.152 . . . . 0.0 109.449 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -61.81 110.11 1.44 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.431 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.502 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -134.98 8.36 3.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.748 ' SG ' HG22 ' A' ' 47' ' ' THR . 9.0 p -165.46 -160.51 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.659 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.857 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -145.52 13.36 1.37 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.502 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.748 HG22 ' SG ' ' A' ' 45' ' ' CYS . 8.8 t -78.51 -18.75 54.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.585 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.503 ' HB2' ' CB ' ' A' ' 85' ' ' CYS . 21.8 p -87.54 41.9 1.01 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 0.0 109.948 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.013 ' CE1' HD12 ' A' ' 78' ' ' LEU . 14.6 t60 -70.54 76.13 0.57 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.781 HG11 ' SG ' ' A' ' 85' ' ' CYS . 8.4 m -80.02 144.74 10.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 120.214 -1.554 . . . . 0.0 110.673 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.506 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 2.0 m-85 -110.98 102.72 11.18 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.052 HG22 HG12 ' A' ' 99' ' ' VAL . 7.0 t -101.13 156.32 4.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.85 0.834 . . . . 0.0 112.859 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.749 HD22 HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -46.22 177.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.468 0.651 . . . . 0.0 109.267 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -101.68 -0.28 34.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 110.115 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.57 -22.81 11.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.97 -1.081 . . . . 0.0 110.649 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.812 ' HD1' HD23 ' A' ' 94' ' ' LEU . 65.8 m-85 -91.71 -27.08 18.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.988 -1.07 . . . . 0.0 109.747 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.854 HG21 HD22 ' A' ' 81' ' ' ASN . 5.8 p -58.07 -38.13 75.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.18 -0.95 . . . . 0.0 109.475 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 1.2 m-20 -57.46 -64.61 0.83 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.777 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.638 ' HB2' HD21 ' A' ' 94' ' ' LEU . 46.2 mmtt -49.81 -37.96 32.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.912 . . . . 0.0 109.396 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.825 ' CG2' HG22 ' A' ' 88' ' ' ILE . 1.1 t -54.91 157.37 5.71 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.951 . . . . 0.0 108.754 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.604 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.6 Cg_exo -56.13 156.83 19.08 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.087 1.858 . . . . 0.0 110.309 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.52 61.13 0.6 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.325 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.621 ' HB2' ' NH2' ' A' ' 83' ' ' ARG . . . -40.83 146.46 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.626 -0.671 . . . . 0.0 109.689 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.591 ' O ' HD13 ' A' ' 68' ' ' ILE . 1.5 p30 -51.59 -174.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.679 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.527 ' HA ' HD13 ' A' ' 68' ' ' ILE . 58.0 tt0 -96.71 -9.81 28.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.86 . . . . 0.0 109.543 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -50.3 -49.12 54.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.927 . . . . 0.0 109.516 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.469 ' CG ' ' HB2' ' A' ' 43' ' ' ALA . 28.0 mt-10 -74.59 -21.35 59.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.435 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.632 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -68.21 -35.32 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.878 . . . . 0.0 109.314 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.59 -52.6 44.24 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -66.84 -24.31 66.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -1.15 . . . . 0.0 109.273 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.891 ' O ' HD13 ' A' ' 78' ' ' LEU . 5.7 tp -88.24 -7.29 57.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.378 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -80.09 -37.64 33.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.334 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.413 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 42.6 t -104.2 38.61 1.82 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.393 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.857 HG12 ' HB1' ' A' ' 46' ' ' ALA . 16.4 m -63.17 174.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.85 . . . . 0.0 109.597 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.569 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 98.3 m -65.28 -9.37 23.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.747 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.842 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -116.5 -149.92 0.45 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 109.511 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.644 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.2 pt-20 -111.52 155.24 23.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.013 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -129.8 135.66 48.68 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 117.991 -1.483 . . . . 0.0 111.454 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.594 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -117.83 171.02 5.45 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 4.4 Cg_exo -57.52 -10.6 7.13 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 C-N-CA 122.394 2.063 . . . . 0.0 111.09 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.854 HD22 HG21 ' A' ' 57' ' ' THR . 0.0 OUTLIER -104.78 16.57 25.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 0.0 111.499 -178.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.615 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.4 m -100.26 161.09 13.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.675 -1.266 . . . . 0.0 110.029 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.621 ' NH2' ' HB2' ' A' ' 63' ' ' ALA . 1.5 mtp180 -161.62 -165.11 1.22 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 109.287 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.53 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 1.7 mp -104.95 131.09 52.89 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.314 -0.866 . . . . 0.0 108.887 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.781 ' SG ' HG11 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -67.13 -10.41 49.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.399 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.1 p -110.35 15.26 22.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.797 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -131.95 -0.55 3.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.007 . . . . 0.0 109.925 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.825 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -97.9 147.14 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.03 -1.044 . . . . 0.0 108.97 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.619 HG22 ' N ' ' A' ' 90' ' ' MET . 10.7 mm -121.3 165.68 16.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.293 -0.88 . . . . 0.0 109.775 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.638 ' CB ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -122.97 90.33 3.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.352 -0.842 . . . . 0.0 109.341 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.01 162.48 40.78 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.417 -0.802 . . . . 0.0 109.303 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.0 -13.99 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.151 1.901 . . . . 0.0 110.233 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' A' ' 94' ' ' LEU . 21.6 pt-20 -70.92 -45.92 63.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.43 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.812 HD23 ' HD1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -78.46 144.4 35.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -146.41 122.03 10.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 75.22 39.53 36.5 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.948 HD11 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -78.11 134.66 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.441 -1.035 . . . . 0.0 109.197 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.68 HG11 HH11 ' A' ' 12' ' ' ARG . 2.0 t -107.23 110.12 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.976 -1.078 . . . . 0.0 110.012 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.052 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -100.82 146.57 9.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.177 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.501 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 1.6 m-20 -122.15 174.25 7.07 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.968 -1.083 . . . . 0.0 110.256 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.897 HG13 ' HD2' ' A' ' 102' ' ' PRO . 39.7 t -108.01 145.21 30.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.897 ' HD2' HG13 ' A' ' 101' ' ' VAL . 7.2 Cg_exo -50.95 159.82 2.26 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.492 2.128 . . . . 0.0 111.548 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -14.7 60.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.596 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -119.87 -159.51 0.78 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 106' ' ' TRP . 11.4 pt20 -159.87 27.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.025 -1.047 . . . . 0.0 109.78 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.681 ' NE1' ' HB3' ' A' ' 46' ' ' ALA . 5.9 m95 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.658 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -147.48 168.39 22.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -0.863 . . . . 0.0 109.253 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.673 ' CG2' HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -153.54 129.95 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.295 -0.878 . . . . 0.0 109.677 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.974 HG13 ' O ' ' A' ' 13' ' ' ARG . 77.7 t -130.17 135.42 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 108.651 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.113 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -104.0 155.14 18.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.922 -1.111 . . . . 0.0 109.393 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.749 HG13 ' HB3' ' A' ' 12' ' ' ARG . 2.4 t -135.25 133.02 52.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.531 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -80.0 -174.27 4.36 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -50.02 161.48 0.26 Allowed 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.528 ' C ' ' O ' ' A' ' 8' ' ' HIS . 33.9 t0 -29.86 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.147 0.499 . . . . 0.0 110.72 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 8' ' ' HIS . . . -167.45 -95.51 0.1 Allowed Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.484 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.6 m -124.97 -178.53 4.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -1.186 . . . . 0.0 109.77 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.749 ' HB3' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -157.15 142.64 17.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.625 -0.672 . . . . 0.0 110.032 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.974 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -100.33 176.2 5.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.255 -0.903 . . . . 0.0 108.899 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -132.43 160.83 35.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.126 -0.984 . . . . 0.0 110.52 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.113 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -177.14 -176.04 0.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.579 0.704 . . . . 0.0 109.115 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -128.94 113.88 15.76 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.581 -0.699 . . . . 0.0 109.965 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.917 HG11 ' HB3' ' A' ' 90' ' ' MET . 28.6 t -78.12 133.37 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.046 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.936 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -69.76 171.81 8.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.498 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -78.44 125.25 29.09 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.269 -0.895 . . . . 0.0 109.084 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.16 39.59 7.86 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.936 HG21 ' HB3' ' A' ' 18' ' ' ALA . 1.5 t -131.11 160.69 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -1.117 . . . . 0.0 109.327 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -99.35 135.07 41.29 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 108.65 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.736 HD23 HG21 ' A' ' 17' ' ' VAL . 6.6 mt -46.28 -26.24 0.77 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.965 -1.085 . . . . 0.0 108.6 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.541 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -72.74 -47.45 46.86 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.639 ' HB3' HG12 ' A' ' 21' ' ' VAL . 39.6 tp60 -51.97 -55.08 22.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.36 -0.837 . . . . 0.0 108.845 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.527 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -57.67 -28.5 63.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 108.737 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.703 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -68.09 -33.89 75.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.47 -0.769 . . . . 0.0 109.451 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.585 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 53.7 t -54.58 -39.89 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.475 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 t -79.87 -51.78 8.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.858 . . . . 0.0 109.398 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.878 ' ND2' HD13 ' A' ' 15' ' ' LEU . 29.4 m-80 -58.57 -13.41 5.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.424 -0.798 . . . . 0.0 109.567 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.47 14.54 78.18 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.954 ' O ' HG22 ' A' ' 35' ' ' ILE . 1.2 mt -90.41 -34.65 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -1.146 . . . . 0.0 108.851 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.703 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -51.48 -37.06 47.12 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.624 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 5.3 t0 -82.83 -26.94 31.21 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.954 HG22 ' O ' ' A' ' 32' ' ' ILE . 4.8 tp -44.48 -26.13 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 109.325 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.582 HG13 ' H ' ' A' ' 37' ' ' GLY . 2.5 p -131.17 -52.15 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.563 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' H ' HG13 ' A' ' 36' ' ' VAL . . . 69.2 120.12 0.03 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 94.9 m-20 -136.4 -120.36 0.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -1.171 . . . . 0.0 109.53 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 1.016 ' SG ' ' HB3' ' A' ' 43' ' ' ALA . 16.7 p -109.79 -6.48 15.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.75 -1.219 . . . . 0.0 109.594 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 44.62 -168.51 0.02 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 43.89 -125.95 5.69 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.12 63.86 1.46 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -1.121 . . . . 0.0 109.543 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 1.016 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . . . -88.8 -147.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 109.431 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.516 ' CB ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -139.78 60.86 1.55 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.152 -0.968 . . . . 0.0 109.773 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.414 ' SG ' ' HB3' ' A' ' 38' ' ' ASP . 6.7 p -99.22 -164.57 1.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.033 -1.042 . . . . 0.0 109.379 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.88 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -148.92 17.74 0.98 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.525 ' CG2' ' OD1' ' A' ' 38' ' ' ASP . 58.5 m -90.02 -17.19 28.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.465 ' HB2' ' SG ' ' A' ' 85' ' ' CYS . 24.5 p -87.6 42.51 1.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 110.269 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.948 ' CE1' HD12 ' A' ' 78' ' ' LEU . 15.3 t60 -75.56 71.19 2.46 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.013 HG11 ' HB3' ' A' ' 85' ' ' CYS . 12.7 m -77.88 146.1 8.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.257 -1.527 . . . . 0.0 110.168 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.661 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -112.53 100.71 8.95 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.309 1.052 . . . . 0.0 108.182 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.797 HG22 HG12 ' A' ' 99' ' ' VAL . 4.5 t -89.76 172.88 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.803 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.579 ' H ' HG12 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -68.86 -178.36 1.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.88 -1.21 35.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 109.967 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.14 -14.38 14.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.085 -1.01 . . . . 0.0 110.187 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.723 ' HD1' HD23 ' A' ' 94' ' ' LEU . 80.3 m-85 -103.67 -21.42 13.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.975 . . . . 0.0 109.7 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.718 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -68.7 -6.47 26.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.563 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -88.08 -56.17 3.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.123 -0.986 . . . . 0.0 109.6 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.64 ' HB2' HD21 ' A' ' 94' ' ' LEU . 2.5 mptp? -52.29 -38.69 59.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -50.14 164.57 0.37 Allowed Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.17 -0.956 . . . . 0.0 109.414 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 5.8 Cg_exo -58.16 176.66 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.109 1.873 . . . . 0.0 110.353 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.25 59.37 0.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.29 120.73 1.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.483 -0.761 . . . . 0.0 109.553 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 63' ' ' ALA . 9.7 m-20 -57.0 -160.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.473 ' HG2' ' HB ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -100.05 -12.1 19.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.467 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 67' ' ' GLU . 5.1 ppt_? -54.51 -44.66 72.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' N ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -81.17 -14.51 57.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.404 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.473 ' HB ' ' HG2' ' A' ' 65' ' ' GLU . 26.0 mm -77.12 -32.17 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.476 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.13 -54.69 11.66 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.516 ' SD ' ' CB ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -67.89 -24.92 65.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -1.155 . . . . 0.0 109.257 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.036 HD23 HD21 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -90.04 0.15 57.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.872 . . . . 0.0 109.43 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -89.99 -25.47 20.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.942 . . . . 0.0 109.299 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.64 34.55 2.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.426 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.922 HG11 ' HB2' ' A' ' 49' ' ' HIS . 2.1 t -63.38 165.01 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.581 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 28.4 m -71.68 -4.25 26.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.477 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.527 ' CB ' ' OD1' ' A' ' 103' ' ' ASP . . . -115.96 -149.8 0.45 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.114 -0.991 . . . . 0.0 109.34 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.63 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.7 pt-20 -112.19 155.06 24.59 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.948 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -133.49 166.34 22.78 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.465 -1.694 . . . . 0.0 112.547 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.698 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -155.7 170.62 8.46 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 5.3 Cg_exo -56.45 -14.68 13.27 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 121.997 1.798 . . . . 0.0 109.992 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.543 ' CB ' ' HE2' ' A' ' 79' ' ' LYS . 1.3 t-20 -87.03 -30.33 21.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 0.0 110.71 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.61 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -74.62 152.87 39.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.021 -1.049 . . . . 0.0 110.354 -179.374 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 1.096 ' NH2' HG23 ' A' ' 88' ' ' ILE . 8.8 mtp180 -161.8 -175.38 4.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.036 HD21 HD23 ' A' ' 71' ' ' LEU . 4.9 mp -98.99 103.43 15.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.324 -0.86 . . . . 0.0 108.698 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 1.013 ' HB3' HG11 ' A' ' 50' ' ' VAL . 6.1 p -48.85 -21.99 0.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.142 -0.974 . . . . 0.0 109.924 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 20.7 p -76.57 -40.11 50.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.084 -1.01 . . . . 0.0 110.093 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.484 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -89.74 38.44 0.91 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.112 -0.992 . . . . 0.0 110.405 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.096 HG23 ' NH2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -140.06 149.01 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.975 -1.078 . . . . 0.0 109.312 179.294 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.629 HG22 ' N ' ' A' ' 90' ' ' MET . 12.7 mm -116.23 167.09 9.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.421 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.917 ' HB3' HG11 ' A' ' 17' ' ' VAL . 12.9 tpt -130.18 96.87 4.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.665 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -95.53 171.45 6.44 Favored Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 121.549 -0.72 . . . . 0.0 109.385 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.665 ' HD2' HG22 ' A' ' 91' ' ' THR . 5.6 Cg_exo -59.03 -14.49 23.42 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.05 1.833 . . . . 0.0 110.054 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.44 ' OE1' ' HB3' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -62.8 -37.23 85.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 109.312 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.723 HD23 ' HD1' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -95.07 139.75 30.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.234 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 11.2 p-10 -138.72 124.68 19.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.803 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.469 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 71.51 39.22 61.37 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.966 HD11 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -72.91 147.66 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -1.107 . . . . 0.0 109.302 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.509 ' N ' HD13 ' A' ' 97' ' ' ILE . 3.5 t -116.75 106.73 20.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 O-C-N 121.126 -0.983 . . . . 0.0 109.853 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.966 HG13 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -101.25 142.71 15.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.514 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 3.1 m-20 -122.97 177.44 5.5 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.967 -1.083 . . . . 0.0 110.269 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.903 HG13 ' HD2' ' A' ' 102' ' ' PRO . 44.8 t -108.49 145.07 30.8 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.903 ' HD2' HG13 ' A' ' 101' ' ' VAL . 7.7 Cg_exo -51.14 -174.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.263 1.975 . . . . 0.0 111.293 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -100.7 -27.03 13.59 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -130.07 149.7 51.67 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -122.93 41.94 3.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.044 -1.035 . . . . 0.0 109.849 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.581 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 43.6 m95 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.476 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.886 ' S1 ' HD23 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.491 ' HB2' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -138.29 169.51 17.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.215 -0.928 . . . . 0.0 109.428 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.572 HG21 ' CG2' ' A' ' 17' ' ' VAL . 11.3 t -152.34 158.64 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.272 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.672 HG12 ' O ' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -157.8 120.67 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.104 -0.998 . . . . 0.0 108.905 -179.409 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.654 ' CE2' ' CD2' ' A' ' 15' ' ' LEU . 54.9 m-85 -98.5 155.62 17.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.66 -1.275 . . . . 0.0 110.634 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.806 HG22 ' HG3' ' A' ' 12' ' ' ARG . 3.0 t -130.84 142.48 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -76.5 -158.53 0.1 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.76 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -58.31 -103.97 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.18 75.15 0.9 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.482 -1.386 . . . . 0.0 108.496 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.29 -100.42 0.24 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 118.863 -1.636 . . . . 0.0 111.453 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.71 HG22 ' H ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -114.9 -176.59 2.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.289 -1.124 . . . . 0.0 110.584 -178.287 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.806 ' HG3' HG22 ' A' ' 6' ' ' VAL . 13.7 ttp180 -149.27 134.59 18.35 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.871 ' NH2' HD11 ' A' ' 35' ' ' ILE . 6.6 mtt180 -105.11 171.51 7.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.941 -1.1 . . . . 0.0 108.774 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.481 ' CG ' HG13 ' A' ' 4' ' ' VAL . 1.7 mt-30 -127.08 163.47 23.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.949 -1.094 . . . . 0.0 111.141 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.046 HD13 ' OD1' ' A' ' 30' ' ' ASN . 0.4 OUTLIER -161.65 -172.96 3.53 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.671 0.748 . . . . 0.0 109.019 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 17' ' ' VAL . 46.4 t0 -131.22 69.96 1.47 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.627 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.918 HG21 HD23 ' A' ' 23' ' ' LEU . 26.6 t -43.81 163.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.185 -0.947 . . . . 0.0 109.068 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 1.027 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -105.07 173.1 6.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.959 . . . . 0.0 109.744 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -81.99 125.81 31.22 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.371 -0.831 . . . . 0.0 108.898 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.11 23.3 38.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.027 HG21 ' HB3' ' A' ' 18' ' ' ALA . 3.0 t -118.04 167.34 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.43 -1.041 . . . . 0.0 109.113 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 23' ' ' LEU . 10.4 t -105.89 137.45 43.75 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.918 HD23 HG21 ' A' ' 17' ' ' VAL . 8.3 mt -44.9 -26.69 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.051 . . . . 0.0 108.794 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.622 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 3.3 ttm -75.03 -47.53 28.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.546 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -49.8 -54.77 17.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 108.803 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.767 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -52.24 -35.81 50.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.263 -0.898 . . . . 0.0 108.971 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.69 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -42.15 -42.38 2.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.849 . . . . 0.0 110.076 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.581 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 63.6 t -39.65 -50.41 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.19 -0.944 . . . . 0.0 110.588 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -90.8 -45.36 8.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.876 . . . . 0.0 110.017 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 1.046 ' OD1' HD13 ' A' ' 15' ' ' LEU . 2.4 m120 -50.13 -17.19 0.38 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.725 -0.609 . . . . 0.0 109.774 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.31 -21.64 36.78 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.65 HG13 ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -66.62 -22.17 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.254 -1.144 . . . . 0.0 108.554 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.69 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -48.02 -28.74 2.96 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 179.076 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -100.17 -23.39 14.85 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.925 HG22 HG13 ' A' ' 36' ' ' VAL . 18.6 mm -60.36 -51.14 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.089 -1.007 . . . . 0.0 109.405 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.925 HG13 HG22 ' A' ' 35' ' ' ILE . 11.8 m -134.06 -153.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.935 . . . . 0.0 109.538 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.492 ' HA2' ' HE1' ' A' ' 24' ' ' MET . . . 112.83 150.89 10.99 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.516 ' OD1' ' CB ' ' A' ' 45' ' ' CYS . 6.8 t70 -152.17 -92.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.178 -1.19 . . . . 0.0 109.714 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.513 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 15.6 p -85.27 -33.28 22.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.987 . . . . 0.0 109.603 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 56.57 162.23 0.03 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.01 -103.67 2.26 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.26 169.4 8.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -1.159 . . . . 0.0 109.488 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.981 ' HB1' HD21 ' A' ' 71' ' ' LEU . . . -65.5 111.95 3.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.508 ' HB2' ' CB ' ' A' ' 39' ' ' CYS . 44.3 m -140.73 11.3 2.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.652 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.516 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . 8.9 p -157.32 -157.41 0.67 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 109.626 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.728 ' HB1' ' HA ' ' A' ' 74' ' ' VAL . . . -150.0 15.22 0.83 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.687 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.779 HG23 ' CB ' ' A' ' 105' ' ' GLN . 22.0 m -82.05 -18.41 43.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.355 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.54 ' SG ' HD12 ' A' ' 84' ' ' LEU . 23.4 p -86.34 43.13 1.04 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 110.112 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.89 ' CE1' HD12 ' A' ' 78' ' ' LEU . 48.0 t60 -77.36 65.56 2.94 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.59 HG11 ' HB3' ' A' ' 85' ' ' CYS . 8.8 m -74.94 143.33 13.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.284 -1.51 . . . . 0.0 110.449 -177.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.645 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 1.0 OUTLIER -109.46 109.55 20.41 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.094 HG22 HG12 ' A' ' 99' ' ' VAL . 7.1 t -97.28 171.42 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-O 122.005 0.907 . . . . 0.0 112.531 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.565 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -65.33 176.8 1.26 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.298 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.75 7.72 45.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.151 -0.968 . . . . 0.0 109.626 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.33 -27.96 8.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.883 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.611 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 88.1 m-85 -98.27 -18.54 18.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.739 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.941 HG21 ' HA ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER -62.5 -39.01 92.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.611 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.38 -41.18 94.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 109.776 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.856 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -54.41 -42.65 70.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.907 . . . . 0.0 109.579 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.889 HG11 HG23 ' A' ' 88' ' ' ILE . 62.3 t -62.54 142.38 96.57 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.084 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.747 ' HD2' HG13 ' A' ' 60' ' ' VAL . 5.7 Cg_exo -56.36 168.8 1.89 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.075 1.85 . . . . 0.0 110.468 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.48 63.51 0.61 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.366 -0.834 . . . . 0.0 109.125 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -36.52 139.66 0.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.275 0.56 . . . . 0.0 110.068 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -50.52 -177.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.347 -0.846 . . . . 0.0 109.804 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.534 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 23.9 tt0 -97.07 -12.77 22.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 109.507 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -50.07 -67.18 0.28 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.463 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -66.09 -10.22 38.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.534 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 26.5 mm -76.38 -31.93 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.521 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.77 -54.91 8.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.3 mtt -68.25 -26.28 65.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -1.15 . . . . 0.0 108.987 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.981 HD21 ' HB1' ' A' ' 43' ' ' ALA . 38.3 mt -84.21 -2.96 57.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.35 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.415 ' C ' ' OE1' ' A' ' 72' ' ' GLU . 0.6 OUTLIER -91.13 -10.11 43.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.289 -0.882 . . . . 0.0 109.353 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -86.24 51.37 2.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.418 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.728 ' HA ' ' HB1' ' A' ' 46' ' ' ALA . 6.2 m -92.76 169.1 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 109.295 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.825 HG21 ' CB ' ' A' ' 104' ' ' ARG . 5.4 t -66.36 -34.56 78.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.797 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.405 ' N ' ' CG2' ' A' ' 75' ' ' THR . . . -106.62 -151.23 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.387 -0.821 . . . . 0.0 110.633 -178.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.558 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -112.51 149.9 32.03 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.89 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -108.29 165.44 11.5 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.609 -1.236 . . . . 0.0 110.465 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.543 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -158.97 172.87 5.57 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.579 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 6.0 Cg_exo -54.38 -18.77 15.43 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 121.309 1.339 . . . . 0.0 108.803 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.941 ' HA ' HG21 ' A' ' 57' ' ' THR . 1.6 m-20 -83.18 -35.93 25.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.712 -0.617 . . . . 0.0 109.739 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.565 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -95.48 159.22 15.1 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.19 -0.944 . . . . 0.0 110.398 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.605 ' HD2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -161.69 -164.22 1.08 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.343 -0.848 . . . . 0.0 109.03 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.865 ' N ' HD22 ' A' ' 84' ' ' LEU . 1.3 mm? -104.19 123.53 47.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.59 ' HB3' HG11 ' A' ' 50' ' ' VAL . 13.9 p -64.13 -10.75 24.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.014 -1.054 . . . . 0.0 109.553 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 22.6 p -100.21 14.7 29.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.276 -0.89 . . . . 0.0 109.914 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -143.3 0.34 1.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.013 -1.054 . . . . 0.0 110.694 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.889 HG23 HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -96.9 151.69 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.764 -1.21 . . . . 0.0 108.911 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 88' ' ' ILE . 18.0 mm -124.23 158.66 30.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.165 -0.959 . . . . 0.0 109.927 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.652 ' CB ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.93 90.33 3.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 109.176 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.413 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -82.0 167.07 33.38 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.399 -0.813 . . . . 0.0 109.456 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 3.3 Cg_exo -60.49 -13.33 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.115 1.877 . . . . 0.0 110.097 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.05 -39.99 65.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.856 HD21 ' CB ' ' A' ' 59' ' ' LYS . 4.6 mp -81.99 135.25 35.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.43 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.4 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 11.4 p-10 -135.67 124.24 23.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 68.25 49.28 47.14 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.975 HD11 HG22 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -75.9 151.11 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.187 -1.184 . . . . 0.0 108.455 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.944 ' N ' HD12 ' A' ' 97' ' ' ILE . 5.6 t -121.81 102.62 12.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.947 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.094 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -96.08 154.23 3.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.74 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -130.5 172.79 11.52 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.036 -1.04 . . . . 0.0 109.225 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.86 HG13 ' HD2' ' A' ' 102' ' ' PRO . 55.5 t -107.38 144.31 28.94 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.282 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.86 ' HD2' HG13 ' A' ' 101' ' ' VAL . 5.8 Cg_exo -57.26 -178.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.326 2.017 . . . . 0.0 110.364 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.595 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 6.9 t0 -90.2 -32.89 16.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 108.503 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.825 ' CB ' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.17 -161.19 1.12 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.779 ' CB ' HG23 ' A' ' 47' ' ' THR . 7.8 pt20 -159.45 27.76 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.956 . . . . 0.0 109.535 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 73' ' ' CYS . 10.9 m95 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.459 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.514 ' S1 ' ' CD2' ' A' ' 71' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.34 0.59 . . . . 0.0 109.513 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.499 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 3.0 ttmt -139.54 174.42 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.06 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.754 HG13 HD11 ' A' ' 23' ' ' LEU . 5.0 t -152.58 157.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.742 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 13' ' ' ARG . 67.2 t -156.93 117.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.805 . . . . 0.0 109.154 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 1.085 ' CE1' HD21 ' A' ' 15' ' ' LEU . 1.2 m-85 -95.47 154.05 17.4 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.344 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.78 HG22 ' HB3' ' A' ' 12' ' ' ARG . 2.4 t -133.87 142.44 41.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 8' ' ' HIS . 6.9 t -77.65 -158.05 0.11 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.727 ' CD2' HG12 ' A' ' 101' ' ' VAL . 17.3 m170 -58.08 -103.24 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -112.22 77.28 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.513 -1.367 . . . . 0.0 108.973 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.72 -101.06 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 118.977 -1.582 . . . . 0.0 111.093 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.697 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.3 m -120.12 -176.56 3.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.298 -1.119 . . . . 0.0 109.932 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.78 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -152.71 138.53 17.98 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.738 -0.601 . . . . 0.0 109.981 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.797 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -90.98 177.63 6.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.192 -0.943 . . . . 0.0 108.965 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 2.4 pt20 -140.5 128.18 21.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.211 -0.931 . . . . 0.0 110.37 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.085 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -139.7 -175.45 4.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.217 179.218 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.12 82.64 1.95 Allowed 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.943 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.081 HG22 ' CB ' ' A' ' 26' ' ' ALA . 42.8 t -59.72 111.92 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 109.009 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.735 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -43.56 168.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 109.925 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.433 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 57.5 m-20 -84.32 126.45 33.21 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.339 -0.851 . . . . 0.0 108.989 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.3 15.25 35.98 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.735 HG21 ' HB3' ' A' ' 18' ' ' ALA . 4.4 t -115.5 169.71 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.363 -1.081 . . . . 0.0 109.138 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.487 ' HA ' HD13 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -106.73 135.82 47.61 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.17 -0.957 . . . . 0.0 108.69 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.909 HD13 ' CZ ' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -44.35 -26.3 0.32 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.049 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.474 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -73.24 -48.68 32.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.289 -0.882 . . . . 0.0 108.74 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.504 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 1.3 tp60 -53.16 -56.11 18.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.057 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 1.081 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.54 -26.9 64.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 108.911 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -69.98 -32.39 70.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.429 -0.794 . . . . 0.0 109.215 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.575 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 59.8 t -52.95 -35.57 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.478 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -88.54 -52.26 5.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.479 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.872 ' ND2' HD13 ' A' ' 15' ' ' LEU . 24.9 m-80 -54.15 -16.21 1.92 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.656 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 35' ' ' ILE . . . 84.87 19.3 59.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.634 HG23 HD12 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -99.61 -27.64 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -1.156 . . . . 0.0 108.494 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.651 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 1.1 p90 -47.96 -44.89 30.68 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.554 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 0.9 OUTLIER -74.56 -31.4 62.09 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.634 HD12 HG23 ' A' ' 32' ' ' ILE . 56.4 mt -60.94 -20.22 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 109.098 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.514 HG11 HG22 ' A' ' 101' ' ' VAL . 2.5 p -170.1 112.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 109.515 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 38' ' ' ASP . . . 177.91 176.99 46.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.563 ' OD1' HG21 ' A' ' 47' ' ' THR . 0.3 OUTLIER -163.1 -86.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -1.182 . . . . 0.0 109.803 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 41' ' ' GLY . 12.6 p -83.49 10.07 9.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.679 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 86' ' ' CYS . . . 51.93 -90.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 39' ' ' CYS . . . -54.46 -169.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.18 99.98 12.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -1.15 . . . . 0.0 109.481 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.427 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . . . -118.07 -99.28 0.45 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 70' ' ' MET . 13.6 t -160.57 40.64 0.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.918 -1.114 . . . . 0.0 109.965 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.515 ' SG ' ' CB ' ' A' ' 38' ' ' ASP . 1.7 p -99.99 149.86 23.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.068 . . . . 0.0 109.331 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 1.044 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -105.89 23.78 13.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.563 HG21 ' OD1' ' A' ' 38' ' ' ASP . 22.0 m -90.25 -19.9 23.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.902 . . . . 0.0 109.756 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 21.9 p -91.03 42.73 1.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.099 -1.001 . . . . 0.0 110.287 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 1.008 ' CE1' HD12 ' A' ' 78' ' ' LEU . 11.7 t60 -76.29 70.27 2.89 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.582 HG11 ' SG ' ' A' ' 85' ' ' CYS . 10.3 m -77.85 144.27 11.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 120.123 -1.611 . . . . 0.0 109.755 -178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.626 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 0.9 OUTLIER -109.57 99.11 8.36 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.849 HG22 HG12 ' A' ' 99' ' ' VAL . 3.8 t -89.98 173.98 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.844 0.831 . . . . 0.0 112.124 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.617 ' H ' HG12 ' A' ' 52' ' ' VAL . 1.3 m-20 -68.88 -177.94 1.11 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.19 -1.64 33.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.139 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.3 -21.61 12.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.996 -1.065 . . . . 0.0 110.446 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.625 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 85.5 m-85 -95.18 -23.79 17.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.024 -1.047 . . . . 0.0 109.895 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.641 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -63.46 -34.1 77.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.149 -0.969 . . . . 0.0 109.39 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.61 -63.77 1.0 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.549 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.62 ' HB3' HD11 ' A' ' 94' ' ' LEU . 20.3 mmtp -49.88 -23.41 1.91 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.929 . . . . 0.0 109.385 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.877 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -57.94 162.71 5.01 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 108.994 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.877 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.5 Cg_exo -58.71 171.38 2.03 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.128 1.885 . . . . 0.0 110.243 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.22 59.65 0.61 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -0.922 . . . . 0.0 109.507 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.032 ' HB3' ' NH2' ' A' ' 83' ' ' ARG . . . -42.43 151.95 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.45 -0.781 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.72 -162.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 109.56 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.534 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 2.0 tm-20 -100.16 -22.18 15.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 109.543 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.442 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.7 mtt180 -43.9 -56.99 3.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.646 ' OE2' ' HB1' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -64.63 -30.84 71.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.534 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 36.9 mm -56.0 -43.82 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 109.528 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.76 -30.13 62.22 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.508 ' N ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -68.5 -16.08 63.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -1.131 . . . . 0.0 109.342 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.026 HD13 ' HG ' ' A' ' 84' ' ' LEU . 10.0 tp -90.89 -8.95 48.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.81 -23.0 42.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.388 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -85.32 45.14 1.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.89 . . . . 0.0 109.462 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.044 HG12 ' HB1' ' A' ' 46' ' ' ALA . 4.1 m -106.59 163.8 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.388 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 75' ' ' THR . 96.0 m -85.44 6.69 25.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.942 . . . . 0.0 109.544 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.735 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -114.47 -156.12 0.59 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.132 -0.98 . . . . 0.0 109.463 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.635 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.7 pt-20 -112.55 151.42 30.03 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.008 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -128.03 159.83 33.83 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 117.912 -1.515 . . . . 0.0 111.631 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.546 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -149.37 171.38 6.38 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 5.0 Cg_exo -56.59 -15.02 14.55 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 121.956 1.77 . . . . 0.0 109.84 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.574 ' OD1' HG21 ' A' ' 57' ' ' THR . 12.8 t30 -86.53 -30.93 21.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.392 -0.818 . . . . 0.0 110.542 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.623 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -68.59 159.25 32.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.953 -1.092 . . . . 0.0 110.481 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 1.032 ' NH2' ' HB3' ' A' ' 63' ' ' ALA . 2.6 mtp180 -161.53 166.38 27.14 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.365 -0.834 . . . . 0.0 109.124 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.026 ' HG ' HD13 ' A' ' 71' ' ' LEU . 6.2 mp -79.76 118.94 22.01 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.157 -0.965 . . . . 0.0 108.598 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.582 ' SG ' HG11 ' A' ' 50' ' ' VAL . 2.2 t -47.12 -24.35 0.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 109.475 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 30.6 p -88.19 30.88 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 0.0 109.769 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.563 ' C ' HD13 ' A' ' 88' ' ' ILE . 33.8 mm-40 -149.66 12.65 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.049 -1.032 . . . . 0.0 109.994 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.832 HG22 HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -108.87 140.52 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.082 -1.012 . . . . 0.0 108.704 179.484 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.691 HD13 ' O ' ' A' ' 88' ' ' ILE . 23.9 mm -125.91 146.03 32.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.762 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.686 ' HE3' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -98.32 83.31 3.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -0.852 . . . . 0.0 109.112 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 p -81.83 155.99 70.29 Favored Pre-proline 0 C--N 1.297 -1.686 0 O-C-N 121.486 -0.759 . . . . 0.0 109.203 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 19' ' ' ASP . 6.3 Cg_exo -58.42 -14.94 22.42 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.021 1.814 . . . . 0.0 109.905 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -73.12 -41.19 64.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.836 . . . . 0.0 109.323 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 59' ' ' LYS . 5.6 mp -86.11 142.68 28.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -138.16 126.35 22.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.703 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.591 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 68.14 49.72 44.79 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.979 HD11 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -77.79 151.71 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.224 -1.162 . . . . 0.0 108.878 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.402 ' N ' HG12 ' A' ' 97' ' ' ILE . 4.8 t -122.06 104.7 15.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.034 -1.041 . . . . 0.0 110.363 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.979 HG13 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -98.93 144.86 11.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.04 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -122.79 176.3 6.05 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.914 -1.116 . . . . 0.0 109.733 -179.288 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.88 HG13 ' HD2' ' A' ' 102' ' ' PRO . 51.0 t -108.6 144.02 28.7 Favored Pre-proline 0 C--N 1.298 -1.641 0 C-N-CA 119.671 -0.812 . . . . 0.0 108.943 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.88 ' HD2' HG13 ' A' ' 101' ' ' VAL . 4.1 Cg_exo -54.36 172.37 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.461 2.107 . . . . 0.0 111.492 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.03 -17.53 46.45 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.544 ' HG3' ' NH1' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -128.87 107.4 9.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.381 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 106' ' ' TRP . 8.3 pt20 -79.76 5.03 14.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.145 -0.972 . . . . 0.0 109.59 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.572 ' CZ2' ' OG1' ' A' ' 75' ' ' THR . 62.2 m95 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.495 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' FES . . . . . 1.004 ' S1 ' HD23 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.318 0.58 . . . . 0.0 109.504 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.408 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -151.48 159.38 44.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.187 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.839 HG11 HD22 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -147.95 125.2 3.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.211 -0.93 . . . . 0.0 109.38 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 99' ' ' VAL . 97.4 t -126.01 129.64 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 108.887 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.161 ' CD2' HG21 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -97.69 154.59 17.48 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.944 -1.097 . . . . 0.0 109.374 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.942 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.1 t -123.96 170.19 14.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.446 -0.784 . . . . 0.0 108.977 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.602 ' H ' HG12 ' A' ' 6' ' ' VAL . 14.6 p -121.43 162.89 19.65 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.477 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.43 -8.38 13.26 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 120.872 -1.142 . . . . 0.0 109.051 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 4.5 t70 -110.25 -6.06 15.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.114 -0.991 . . . . 0.0 110.316 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.41 -31.75 5.67 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.266 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.768 HG22 ' NH1' ' A' ' 13' ' ' ARG . 54.1 m -49.71 114.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.043 -1.269 . . . . 0.0 109.486 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 18.3 ptt180 -130.78 126.05 35.33 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.596 -0.69 . . . . 0.0 109.694 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 1.041 ' NH2' HG21 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -104.24 125.96 50.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.949 . . . . 0.0 108.714 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -85.83 157.37 20.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.122 -0.986 . . . . 0.0 110.567 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.1 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -167.4 -177.32 3.57 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.698 0.761 . . . . 0.0 109.334 179.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.41 106.23 8.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.714 -0.616 . . . . 0.0 109.574 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.961 HG21 HD23 ' A' ' 23' ' ' LEU . 78.5 t -81.05 108.71 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.404 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.614 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -46.31 172.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.548 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 75.1 m-20 -83.27 125.19 31.33 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.327 -0.858 . . . . 0.0 109.137 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.81 29.31 8.74 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.908 ' O ' HG23 ' A' ' 89' ' ' ILE . 2.1 t -130.58 170.96 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.342 -1.093 . . . . 0.0 109.378 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.509 ' HB2' ' CD1' ' A' ' 89' ' ' ILE . 13.2 t -115.92 146.43 42.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 108.926 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.961 HD23 HG21 ' A' ' 17' ' ' VAL . 16.2 mt -47.53 -25.48 1.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.961 -1.087 . . . . 0.0 108.478 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.579 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 24.2 ptt? -71.6 -46.3 59.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.847 . . . . 0.0 108.832 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 1.049 ' O ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -55.14 -56.54 18.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.144 -0.972 . . . . 0.0 108.805 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.588 ' HB1' ' ND2' ' A' ' 30' ' ' ASN . . . -60.17 -19.25 53.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.3 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 24' ' ' MET . . . -70.76 -40.07 72.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.847 . . . . 0.0 110.127 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.049 HG22 ' O ' ' A' ' 25' ' ' GLN . 32.6 m -45.65 -33.05 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.181 -0.95 . . . . 0.0 110.366 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 31' ' ' GLY . 3.7 t -107.39 -59.64 1.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 109.815 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.992 ' ND2' HD13 ' A' ' 15' ' ' LEU . 47.2 m-20 -38.8 -27.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.342 0.592 . . . . 0.0 109.989 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 107.63 -9.69 38.04 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.161 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -68.29 -13.15 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -1.223 . . . . 0.0 107.913 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.554 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -49.51 -28.72 5.77 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 178.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -92.15 -30.16 16.1 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.041 HG21 ' NH2' ' A' ' 13' ' ' ARG . 3.0 mt -105.83 40.66 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.128 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.832 HG13 ' N ' ' A' ' 37' ' ' GLY . 1.3 p -143.16 -151.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.832 ' N ' HG13 ' A' ' 36' ' ' VAL . . . -72.0 -159.91 4.39 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -141.5 -53.95 0.46 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.974 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 42' ' ' SER . 15.1 p -63.7 -11.1 23.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.079 -1.013 . . . . 0.0 109.695 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 86' ' ' CYS . . . 85.19 -164.99 39.0 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.513 ' CA ' ' HB2' ' A' ' 86' ' ' CYS . . . -42.56 -27.43 0.5 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 67.8 p -59.91 168.86 1.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -1.15 . . . . 0.0 109.37 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.451 ' O ' ' SD ' ' A' ' 70' ' ' MET . . . -128.68 71.04 1.39 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -124.71 -10.81 7.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.791 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.522 ' O ' ' CE ' ' A' ' 70' ' ' MET . 1.8 p -111.83 -178.92 3.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.662 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.736 ' HB3' ' NE1' ' A' ' 106' ' ' TRP . . . -133.03 12.89 4.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.181 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.856 HG22 ' CB ' ' A' ' 106' ' ' TRP . 5.6 p -75.57 -16.15 60.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.448 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.502 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 25.6 p -86.72 41.61 0.96 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.289 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.04 ' CE1' HD12 ' A' ' 78' ' ' LEU . 26.7 t60 -82.25 64.16 6.78 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 83' ' ' ARG . 12.5 m -80.68 147.22 6.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.55 -1.344 . . . . 0.0 110.076 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.639 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 8.0 m-85 -107.86 106.41 16.68 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.695 ' HB ' HG23 ' A' ' 57' ' ' THR . 4.5 t -89.78 166.79 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.791 0.805 . . . . 0.0 112.151 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.483 ' N ' HG12 ' A' ' 52' ' ' VAL . 1.2 m-20 -64.61 -176.79 0.27 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -100.64 -6.6 24.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 110.28 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.5 1.53 18.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.965 -1.084 . . . . 0.0 110.463 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.634 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 49.5 m-85 -115.14 -20.96 10.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.93 -1.106 . . . . 0.0 110.087 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.695 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -78.36 1.44 21.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.991 -1.068 . . . . 0.0 109.523 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -85.08 -58.62 2.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.673 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.831 ' CB ' HD11 ' A' ' 94' ' ' LEU . 3.4 mptt -49.98 -39.93 42.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.569 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -56.68 164.36 2.19 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.136 -0.977 . . . . 0.0 109.412 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 4.8 Cg_exo -59.16 172.14 1.93 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.149 1.899 . . . . 0.0 110.261 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.14 59.39 0.61 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.379 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.05 111.27 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.523 -0.736 . . . . 0.0 109.56 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 63' ' ' ALA . 5.8 m-20 -57.11 -160.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.665 ' HA ' HD12 ' A' ' 68' ' ' ILE . 21.1 tt0 -85.07 -10.36 56.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -48.28 -67.62 0.26 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -65.63 -12.94 57.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.503 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 65' ' ' GLU . 14.5 mt -73.89 -31.92 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.75 -58.58 4.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.522 ' CE ' ' O ' ' A' ' 45' ' ' CYS . 6.1 ptm -67.95 -27.04 66.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -1.141 . . . . 0.0 109.298 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.062 HD13 HG11 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -89.99 6.41 42.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.332 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 68' ' ' ILE . 9.7 tp10 -94.62 -30.34 14.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.249 -0.907 . . . . 0.0 109.16 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 74' ' ' VAL . 77.4 m -98.64 15.79 24.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.886 . . . . 0.0 109.233 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.062 HG11 HD13 ' A' ' 71' ' ' LEU . 17.1 m -46.27 171.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.474 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.568 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 62.2 m -73.77 -2.14 22.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.739 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.782 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -126.43 -152.52 0.52 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.004 -1.06 . . . . 0.0 109.812 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.653 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.6 pt-20 -112.57 155.72 23.89 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.04 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -129.54 152.45 49.05 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 117.779 -1.568 . . . . 0.0 111.989 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.56 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 2.5 mmtm -132.67 166.32 29.92 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.56 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 6.2 Cg_exo -54.94 -17.25 13.62 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.254 1.969 . . . . 0.0 110.717 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.42 -31.44 22.88 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 110.644 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.576 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.3 m -60.45 159.55 10.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.889 -1.132 . . . . 0.0 109.578 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.528 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -162.04 139.67 8.65 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.819 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.91 HD21 HD23 ' A' ' 71' ' ' LEU . 1.3 mp -63.0 107.75 1.07 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -43.02 -26.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.878 -179.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 28.6 p -86.83 31.76 0.69 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 110.24 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 86' ' ' CYS . 12.3 mt-30 -153.36 24.24 0.54 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.872 -1.143 . . . . 0.0 110.492 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.447 HD13 ' HB3' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -140.63 131.31 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 0.0 109.649 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.908 HG23 ' O ' ' A' ' 21' ' ' VAL . 31.1 mm -110.0 148.44 13.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.362 -0.837 . . . . 0.0 109.436 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.548 ' HE2' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -103.69 84.95 2.35 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.169 -0.957 . . . . 0.0 109.132 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.685 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -78.03 171.69 11.81 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.685 ' HD2' HG22 ' A' ' 91' ' ' THR . 5.5 Cg_exo -59.14 -14.06 22.13 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.104 1.869 . . . . 0.0 110.117 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -69.54 -50.9 40.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 0.0 109.336 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.831 HD11 ' CB ' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -83.46 138.96 33.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 109.378 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -145.31 132.14 20.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 0.0 109.632 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.433 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 70.69 37.39 67.22 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.714 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -71.92 147.89 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.408 -1.054 . . . . 0.0 109.522 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.531 ' N ' HD13 ' A' ' 97' ' ' ILE . 5.5 t -114.09 106.68 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.239 -0.913 . . . . 0.0 109.8 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.797 HG21 HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -98.0 152.22 4.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.533 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -128.07 176.05 7.93 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.922 -1.111 . . . . 0.0 109.807 -179.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 6' ' ' VAL . 21.5 t -106.42 146.48 33.09 Favored Pre-proline 0 C--N 1.296 -1.735 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.527 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.879 ' HD2' HG13 ' A' ' 101' ' ' VAL . 11.6 Cg_exo -52.99 177.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.428 2.086 . . . . 0.0 110.303 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 21.8 t0 -74.77 -22.62 58.67 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.551 ' HD3' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -130.87 -167.51 1.85 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 106' ' ' TRP . 50.3 tp60 -139.01 28.19 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.939 -1.101 . . . . 0.0 109.657 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.856 ' CB ' HG22 ' A' ' 47' ' ' THR . 8.9 m95 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.515 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.311 0.577 . . . . 0.0 109.581 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.81 161.62 37.11 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.871 . . . . 0.0 109.116 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.604 HG11 ' CD2' ' A' ' 23' ' ' LEU . 1.4 t -150.75 128.43 2.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.27 -0.894 . . . . 0.0 109.683 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.935 HG22 ' HB3' ' A' ' 14' ' ' GLN . 42.6 t -132.04 164.5 34.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.901 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -137.72 159.56 41.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.073 . . . . 0.0 109.903 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 101' ' ' VAL . 4.0 t -131.2 137.24 56.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.554 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 35.2 t -93.19 171.15 9.12 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.494 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -66.98 -6.05 15.3 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.028 -1.045 . . . . 0.0 109.156 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.35 -2.99 16.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.977 . . . . 0.0 110.219 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.66 17.34 15.12 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.215 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.529 ' OG1' ' CB ' ' A' ' 7' ' ' SER . 69.5 m -49.82 112.97 0.74 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.037 -1.272 . . . . 0.0 109.1 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.07 105.71 16.48 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.564 -0.71 . . . . 0.0 110.325 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.422 ' O ' HG13 ' A' ' 4' ' ' VAL . 22.8 ttm180 -148.33 133.86 18.71 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.935 ' HB3' HG22 ' A' ' 4' ' ' VAL . 3.5 mp0 -120.03 179.4 4.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.004 -1.06 . . . . 0.0 110.986 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.901 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -176.12 -176.03 0.76 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.27 100.0 5.89 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.545 -0.722 . . . . 0.0 109.53 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.998 HG11 ' HB3' ' A' ' 90' ' ' MET . 39.5 t -65.51 108.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.352 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.886 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -46.55 172.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.424 ' OD2' ' HG3' ' A' ' 92' ' ' PRO . 52.8 m-20 -82.2 125.03 30.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.259 -0.901 . . . . 0.0 109.151 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.04 41.13 6.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.886 HG21 ' HB3' ' A' ' 18' ' ' ALA . 1.9 t -133.79 162.37 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -1.165 . . . . 0.0 109.414 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.462 ' OG ' ' CD1' ' A' ' 89' ' ' ILE . 46.6 m -98.09 137.08 37.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 108.854 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.739 HD23 HG21 ' A' ' 17' ' ' VAL . 6.5 mt -46.29 -26.36 0.79 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.012 -1.055 . . . . 0.0 108.613 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.26 -47.09 45.91 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.788 ' HB3' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -51.96 -51.22 58.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.038 179.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.494 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -60.84 -29.59 69.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 108.821 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.997 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -73.02 -25.2 60.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.552 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.579 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 88.4 t -57.07 -42.13 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.069 -1.019 . . . . 0.0 109.385 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.2 t -84.56 -55.08 4.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.401 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.811 ' CG ' HD22 ' A' ' 15' ' ' LEU . 24.5 m-80 -52.92 -18.53 2.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.376 -0.828 . . . . 0.0 109.606 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.89 23.61 57.22 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.986 HG23 HD12 ' A' ' 35' ' ' ILE . 1.1 mt -101.33 -25.55 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.272 . . . . 0.0 108.286 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.997 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 2.3 p90 -48.74 -47.17 41.66 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.632 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 34.0 t70 -69.46 -33.08 72.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.986 HD12 HG23 ' A' ' 32' ' ' ILE . 53.5 mt -57.72 -19.28 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.182 -0.949 . . . . 0.0 108.936 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -170.03 133.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.442 -0.786 . . . . 0.0 109.377 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' OD1' ' A' ' 38' ' ' ASP . . . 133.86 169.06 11.97 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.932 ' CG ' HG21 ' A' ' 47' ' ' THR . 0.2 OUTLIER -161.73 -89.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -1.201 . . . . 0.0 109.824 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 40' ' ' GLY . 13.1 p -50.97 -41.97 59.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.568 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.513 ' N ' ' SG ' ' A' ' 39' ' ' CYS . . . 71.05 -83.9 0.4 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 43' ' ' ALA . . . -70.92 -79.1 0.39 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.461 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 59.8 p -59.71 88.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -1.139 . . . . 0.0 109.813 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.6 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -60.29 99.68 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.481 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.458 ' HA ' ' HG2' ' A' ' 70' ' ' MET . 2.3 m -160.03 22.06 0.17 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.713 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 7.8 p -116.05 -157.89 0.66 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 109.432 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.793 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -147.81 12.8 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.098 -1.001 . . . . 0.0 109.877 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.953 HG22 ' CB ' ' A' ' 106' ' ' TRP . 5.0 p -77.93 -23.74 48.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.997 . . . . 0.0 109.496 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 27.1 p -86.66 42.66 1.02 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 110.312 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.734 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 69.8 t60 -77.85 67.03 3.64 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 83' ' ' ARG . 11.4 m -87.16 147.71 5.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.471 -1.393 . . . . 0.0 110.862 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.734 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 6.8 m-30 -107.26 106.31 16.71 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 122.159 0.981 . . . . 0.0 108.393 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.801 HG22 HG12 ' A' ' 99' ' ' VAL . 9.6 t -90.0 164.46 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.852 0.834 . . . . 0.0 112.431 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.488 ' N ' HG12 ' A' ' 52' ' ' VAL . 1.4 t-20 -69.0 152.49 45.19 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -77.27 7.49 5.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -0.877 . . . . 0.0 110.619 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.33 -12.52 14.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.778 -1.202 . . . . 0.0 110.046 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 1.098 ' CB ' HD13 ' A' ' 97' ' ' ILE . 80.2 m-85 -111.36 -19.71 12.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 0.0 109.587 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.748 HG21 ' ND2' ' A' ' 81' ' ' ASN . 1.9 p -68.78 -12.17 61.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.241 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -88.97 -37.95 14.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.568 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.681 ' HB2' HD21 ' A' ' 94' ' ' LEU . 1.2 mptm? -71.44 -33.14 69.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.165 -0.96 . . . . 0.0 109.487 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -51.91 164.21 0.58 Allowed Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.223 -0.923 . . . . 0.0 109.218 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 5.7 Cg_exo -56.33 -166.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.044 1.829 . . . . 0.0 110.234 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.39 58.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -43.41 107.46 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.455 -0.778 . . . . 0.0 109.355 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' ALA . 4.3 m-20 -56.86 -160.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.613 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.532 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 62.1 tt0 -100.09 -16.95 17.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.489 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 65' ' ' GLU . 2.1 mtp180 -44.74 -61.12 1.7 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.457 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.6 ' OE1' ' HB3' ' A' ' 43' ' ' ALA . 1.2 mt-10 -66.86 -23.63 66.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.532 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 32.2 mm -63.65 -31.87 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.503 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.59 -50.76 47.36 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.458 ' HG2' ' HA ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -65.9 -23.8 66.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -1.145 . . . . 0.0 109.3 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.853 ' O ' HG13 ' A' ' 74' ' ' VAL . 5.2 tp -87.76 -10.49 50.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.428 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -76.22 -35.62 58.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.355 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.99 45.07 0.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 0.0 109.363 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.882 HG23 ' H ' ' A' ' 76' ' ' ALA . 10.9 m -82.16 171.05 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 0.0 109.514 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -57.41 -16.14 8.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.604 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.882 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -124.86 -151.23 0.47 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.114 -0.991 . . . . 0.0 110.52 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.576 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 2.2 pm0 -112.59 153.01 28.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.602 HD11 HD23 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -111.22 127.36 55.58 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.803 -1.559 . . . . 0.0 111.672 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 1.9 mptp? -98.61 167.85 10.76 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 2.2 Cg_endo -60.05 -9.73 10.83 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.456 2.104 . . . . 0.0 111.37 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.748 ' ND2' HG21 ' A' ' 57' ' ' THR . 0.2 OUTLIER -107.26 4.92 27.1 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.086 -1.009 . . . . 0.0 111.836 -178.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.57 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -88.6 155.95 19.33 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.54 -1.35 . . . . 0.0 109.964 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.556 ' O ' HG22 ' A' ' 50' ' ' VAL . 6.5 ttt180 -162.14 158.05 24.11 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.731 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.774 HD12 ' H ' ' A' ' 84' ' ' LEU . 4.1 mp -78.84 106.28 10.74 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 108.648 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 48' ' ' CYS . 20.2 p -48.72 -22.11 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.596 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 26.6 p -81.3 -38.65 26.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.19 -0.944 . . . . 0.0 110.245 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.518 ' OE1' ' CB ' ' A' ' 43' ' ' ALA . 4.0 tp60 -89.47 42.85 1.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.084 -1.01 . . . . 0.0 110.865 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -149.31 146.64 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.889 -1.132 . . . . 0.0 109.534 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.619 HG22 ' N ' ' A' ' 90' ' ' MET . 11.4 mm -115.26 166.98 8.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.391 -0.818 . . . . 0.0 109.229 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.998 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -130.13 97.59 4.49 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.213 -0.929 . . . . 0.0 109.462 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.673 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -90.13 172.17 7.46 Favored Pre-proline 0 C--N 1.298 -1.666 0 O-C-N 121.56 -0.713 . . . . 0.0 109.146 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.673 ' HD2' HG22 ' A' ' 91' ' ' THR . 3.8 Cg_exo -60.79 -11.03 16.02 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.161 1.907 . . . . 0.0 110.481 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -68.23 -51.1 49.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -0.999 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.79 HD23 ' HD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -78.49 127.45 32.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 109.37 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.31 126.46 33.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.918 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.577 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 78.23 35.28 34.36 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.098 HD13 ' CB ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -71.54 133.21 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -1.087 . . . . 0.0 109.541 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.097 ' N ' HD12 ' A' ' 97' ' ' ILE . 3.7 t -107.02 108.49 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.801 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -99.08 153.55 4.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -126.58 174.07 8.96 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.072 -1.018 . . . . 0.0 109.284 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.916 HG13 ' HD2' ' A' ' 102' ' ' PRO . 28.8 t -107.59 147.09 34.67 Favored Pre-proline 0 N--CA 1.494 1.725 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.95 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.916 ' HD2' HG13 ' A' ' 101' ' ' VAL . 8.2 Cg_exo -53.76 -171.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.32 2.013 . . . . 0.0 110.458 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.402 ' CB ' HH21 ' A' ' 104' ' ' ARG . 13.7 m-20 -89.45 -26.66 20.84 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.521 ' HB3' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -120.86 -157.96 0.74 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 105' ' ' GLN . 9.7 tt0 -154.97 24.4 0.43 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.001 -1.062 . . . . 0.0 109.586 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.953 ' CB ' HG22 ' A' ' 47' ' ' THR . 24.4 m95 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.715 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.513 ' HB2' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.5 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -137.59 165.57 26.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.284 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.88 HG11 HD22 ' A' ' 23' ' ' LEU . 6.7 t -154.32 161.64 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.159 -0.963 . . . . 0.0 109.052 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.739 HG13 ' O ' ' A' ' 13' ' ' ARG . 51.9 t -159.46 148.68 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.075 -1.016 . . . . 0.0 109.202 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.108 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -124.68 154.08 41.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.097 -1.002 . . . . 0.0 109.498 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.723 HG22 ' HB3' ' A' ' 12' ' ' ARG . 3.0 t -136.71 141.4 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.438 -0.789 . . . . 0.0 110.177 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.515 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 1.5 p -81.52 169.52 17.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -41.87 -89.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.872 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.23 74.95 0.89 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.789 -1.194 . . . . 0.0 109.267 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.23 -105.08 0.37 Allowed Glycine 0 N--CA 1.489 2.208 0 C-N-CA 118.465 -1.826 . . . . 0.0 110.918 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.2 m -130.5 -176.09 3.86 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.544 -0.974 . . . . 0.0 109.57 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.723 ' HB3' HG22 ' A' ' 6' ' ' VAL . 5.0 ptp180 -150.98 124.35 8.91 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.291 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.739 ' O ' HG13 ' A' ' 4' ' ' VAL . 50.4 mtt180 -89.27 175.52 7.31 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.63 ' CB ' HG22 ' A' ' 4' ' ' VAL . 9.7 pt20 -134.97 141.11 46.17 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.974 -1.079 . . . . 0.0 110.324 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.108 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -136.69 -176.52 4.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.365 -0.834 . . . . 0.0 109.353 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -126.72 71.43 1.3 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.677 -0.639 . . . . 0.0 109.484 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.098 HG21 HD23 ' A' ' 23' ' ' LEU . 61.7 t -54.41 112.9 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.541 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.814 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -47.15 174.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 0.0 109.549 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.449 ' OD2' ' HB3' ' A' ' 92' ' ' PRO . 80.9 m-20 -83.66 125.3 31.7 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.359 -0.838 . . . . 0.0 109.192 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.46 19.01 31.2 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.814 HG21 ' HB3' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -118.13 155.75 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -1.135 . . . . 0.0 109.293 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 23' ' ' LEU . 2.0 m -92.4 135.04 34.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.231 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.098 HD23 HG21 ' A' ' 17' ' ' VAL . 16.7 mt -45.27 -35.28 3.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.001 . . . . 0.0 108.968 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.495 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 1.8 tmt? -65.61 -46.24 80.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.263 -0.898 . . . . 0.0 108.976 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.613 ' O ' HG13 ' A' ' 28' ' ' VAL . 4.5 tp-100 -53.75 -52.08 61.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 109.206 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.69 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -63.2 -23.39 67.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.915 . . . . 0.0 109.171 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.893 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -68.11 -26.33 65.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.358 -0.839 . . . . 0.0 109.712 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 25' ' ' GLN . 2.7 m -57.52 -43.62 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.996 -1.065 . . . . 0.0 109.368 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 2.7 t -81.63 -56.26 4.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.329 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.49 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 33.1 m-80 -50.06 -20.8 1.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.446 -0.784 . . . . 0.0 109.372 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 83.55 22.21 56.67 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.789 HG23 HD11 ' A' ' 35' ' ' ILE . 1.4 mt -98.63 -31.3 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.208 -1.172 . . . . 0.0 108.848 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.893 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -51.64 -36.69 47.12 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.586 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 20.9 t70 -72.22 -35.62 68.93 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.857 ' O ' HG13 ' A' ' 36' ' ' VAL . 3.7 pt -83.09 5.08 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.958 -1.089 . . . . 0.0 109.423 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 35' ' ' ILE . 0.3 OUTLIER -169.53 120.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.36 170.01 12.61 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB2' ' CG2' ' A' ' 47' ' ' THR . 5.0 m-20 -162.31 -59.93 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -1.158 . . . . 0.0 109.795 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 41' ' ' GLY . 8.1 p -82.86 9.43 9.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' GLY . . . 57.64 -89.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 40' ' ' GLY . . . -60.63 -124.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.565 ' O ' ' HE1' ' A' ' 70' ' ' MET . 52.7 p -138.48 48.67 1.93 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.16 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.78 -93.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.522 ' HA ' ' CB ' ' A' ' 70' ' ' MET . 37.2 t -160.4 60.08 0.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.059 -1.026 . . . . 0.0 109.936 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 70' ' ' MET . 1.7 p -107.5 -171.71 1.93 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.085 -1.01 . . . . 0.0 109.21 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.838 ' HB1' ' N ' ' A' ' 74' ' ' VAL . . . -146.92 20.49 1.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 0.0 109.516 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.517 ' CG2' ' HB2' ' A' ' 38' ' ' ASP . 7.9 t -90.3 -21.94 21.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.765 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.484 ' SG ' HD23 ' A' ' 84' ' ' LEU . 21.8 p -87.18 42.55 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.145 -0.972 . . . . 0.0 110.398 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.144 ' CD2' HD12 ' A' ' 78' ' ' LEU . 44.8 t-80 -81.56 60.92 4.76 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 85' ' ' CYS . 14.1 m -76.28 149.09 6.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 120.752 -1.218 . . . . 0.0 110.912 -177.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.512 ' CE2' ' CE1' ' A' ' 49' ' ' HIS . 7.7 m-85 -108.21 103.09 12.2 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.907 HG22 HG12 ' A' ' 99' ' ' VAL . 4.3 t -89.15 174.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 121.662 0.744 . . . . 0.0 111.941 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.723 ' O ' HG23 ' A' ' 57' ' ' THR . 0.3 OUTLIER -70.41 -175.78 1.09 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -101.3 4.59 41.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.915 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.37 -25.54 10.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.081 -1.012 . . . . 0.0 110.258 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.871 ' CD2' HG22 ' A' ' 97' ' ' ILE . 73.8 m-85 -99.69 -17.05 17.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.068 -1.02 . . . . 0.0 109.816 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 53' ' ' ASN . 25.1 p -63.87 -43.63 95.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 109.612 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -55.72 -51.77 66.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.904 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.037 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -49.86 -41.8 46.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 109.623 -179.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.761 HG13 ' HD2' ' A' ' 61' ' ' PRO . 54.6 t -54.22 142.83 47.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.998 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.761 ' HD2' HG13 ' A' ' 60' ' ' VAL . 5.2 Cg_exo -55.79 173.43 0.39 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.076 1.851 . . . . 0.0 110.519 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.72 62.52 0.61 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -0.818 . . . . 0.0 109.373 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -38.92 126.52 1.57 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.72 -0.612 . . . . 0.0 109.849 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.528 ' ND2' ' N ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -51.39 -174.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.896 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.555 ' CD ' HD12 ' A' ' 68' ' ' ILE . 3.9 tp10 -76.86 -10.19 59.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.357 -0.839 . . . . 0.0 109.548 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -58.82 -51.25 70.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.336 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.496 ' HG2' ' HE3' ' A' ' 70' ' ' MET . 86.3 mt-10 -72.73 -7.06 48.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.403 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.555 HD12 ' CD ' ' A' ' 65' ' ' GLU . 15.2 mt -76.65 -36.93 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 0.0 109.556 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.23 -54.1 24.89 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.565 ' HE1' ' O ' ' A' ' 42' ' ' SER . 0.0 OUTLIER -68.45 -27.06 65.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.287 -1.125 . . . . 0.0 108.779 179.591 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.037 HD11 HD13 ' A' ' 78' ' ' LEU . 3.7 tt -83.34 8.13 14.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.144 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 4.0 tp10 -100.51 -10.58 20.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.61 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -82.24 -13.49 56.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.186 -0.946 . . . . 0.0 109.85 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.993 HG21 ' CD2' ' A' ' 49' ' ' HIS . 4.1 m -40.02 137.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.472 -0.768 . . . . 0.0 109.736 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.615 HG21 ' CB ' ' A' ' 104' ' ' ARG . 5.5 m -44.58 -25.3 0.26 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.243 -0.911 . . . . 0.0 109.289 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.709 ' O ' HG23 ' A' ' 74' ' ' VAL . . . -116.94 -148.94 0.43 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.629 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.6 OUTLIER -114.51 150.18 35.26 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.144 HD12 ' CD2' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -104.13 130.59 51.86 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 117.232 -1.787 . . . . 0.0 111.269 179.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.574 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 0.5 OUTLIER -104.76 166.1 12.09 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.574 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 5.0 Cg_exo -53.79 -26.37 38.59 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.937 1.758 . . . . 0.0 109.931 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.574 ' HA ' HG21 ' A' ' 57' ' ' THR . 1.9 t30 -75.41 -35.06 61.08 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 110.128 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.724 ' O ' HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -87.07 165.52 15.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.006 -1.059 . . . . 0.0 109.471 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.548 ' HB3' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -162.33 -162.34 0.81 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.449 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.822 HD21 ' HB2' ' A' ' 71' ' ' LEU . 1.5 mt -98.04 108.28 20.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.666 ' HB2' HG11 ' A' ' 50' ' ' VAL . 23.3 t -42.81 -25.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.108 -0.995 . . . . 0.0 110.034 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' LEU . 29.1 p -82.9 -39.35 21.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.987 . . . . 0.0 110.607 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.416 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 0.7 OUTLIER -88.91 27.0 1.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 111.192 -178.524 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.71 ' O ' HD13 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -106.68 149.39 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.654 -1.279 . . . . 0.0 108.902 178.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 88' ' ' ILE . 28.7 mm -128.24 161.61 36.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.93 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.658 ' HE2' HG23 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -130.33 95.91 4.02 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.451 -0.781 . . . . 0.0 109.12 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.446 ' OG1' ' CD1' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -82.38 164.93 45.38 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.545 -0.722 . . . . 0.0 109.586 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.449 ' HB3' ' OD2' ' A' ' 19' ' ' ASP . 4.0 Cg_exo -60.87 -28.49 86.45 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.138 1.892 . . . . 0.0 110.057 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.68 -37.74 85.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.037 HD21 ' CB ' ' A' ' 59' ' ' LYS . 4.2 mp -77.41 143.93 38.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.395 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.12 124.35 8.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 109.538 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.573 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 76.53 48.98 8.47 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.871 HG22 ' CD2' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -77.07 145.75 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -1.188 . . . . 0.0 108.549 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.491 ' N ' HD12 ' A' ' 97' ' ' ILE . 1.8 t -119.17 113.24 40.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 120.849 -1.157 . . . . 0.0 109.869 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -106.77 144.81 15.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 51' ' ' TYR . 9.2 m-20 -122.28 174.09 7.21 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.113 -0.992 . . . . 0.0 109.527 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.94 HG13 ' HD2' ' A' ' 102' ' ' PRO . 12.0 t -103.63 147.39 34.16 Favored Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.462 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.94 ' HD2' HG13 ' A' ' 101' ' ' VAL . 12.8 Cg_exo -52.59 163.48 1.82 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.413 2.075 . . . . 0.0 110.05 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 3.2 m-20 -57.99 -27.37 63.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.013 -1.054 . . . . 0.0 108.751 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.615 ' CB ' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -130.67 -163.45 1.32 Allowed 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -152.2 23.38 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.487 ' NE1' ' N ' ' A' ' 75' ' ' THR . 38.0 m95 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.642 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.59 135.64 21.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.274 -0.891 . . . . 0.0 109.177 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.977 HG21 HD21 ' A' ' 23' ' ' LEU . 1.1 t -133.24 123.79 47.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.923 HG11 ' HD3' ' A' ' 12' ' ' ARG . 65.9 t -121.82 128.81 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.128 -0.982 . . . . 0.0 108.636 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.073 ' CE1' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -98.21 153.8 18.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.953 -1.092 . . . . 0.0 109.478 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.938 ' O ' HG23 ' A' ' 101' ' ' VAL . 12.0 t -121.52 168.87 13.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.59 ' N ' HG12 ' A' ' 6' ' ' VAL . 41.0 t -122.99 161.52 24.09 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.496 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.55 -8.13 12.81 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.089 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -110.66 -3.33 15.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.079 -1.013 . . . . 0.0 110.643 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.68 -23.63 13.12 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.173 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.538 ' HB ' ' CB ' ' A' ' 7' ' ' SER . 74.6 m -49.52 112.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.031 -1.276 . . . . 0.0 109.065 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.923 ' HD3' HG11 ' A' ' 4' ' ' VAL . 3.6 ttm180 -125.49 117.34 23.43 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.575 -0.703 . . . . 0.0 110.187 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.538 HH12 HD13 ' A' ' 35' ' ' ILE . 1.2 ptp180 -108.7 124.95 51.35 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.421 ' CB ' HG22 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -91.37 155.55 18.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.018 -1.051 . . . . 0.0 110.569 -178.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.073 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -163.02 -176.13 4.72 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.639 0.733 . . . . 0.0 109.169 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -129.37 114.63 16.43 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.5 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.856 HG11 ' HB3' ' A' ' 90' ' ' MET . 46.2 t -77.48 110.31 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.944 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -46.95 172.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 0.0 109.337 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -81.52 124.73 29.73 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.225 -0.922 . . . . 0.0 109.153 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.77 44.25 6.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.944 HG21 ' HB3' ' A' ' 18' ' ' ALA . 1.5 t -133.07 165.57 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.46 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 p -105.87 141.91 36.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.169 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.003 HD13 ' OH ' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -48.68 -23.79 1.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.137 -0.977 . . . . 0.0 108.985 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 0.1 OUTLIER -76.83 -43.88 34.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 108.657 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.611 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -56.77 -51.15 70.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.374 -0.829 . . . . 0.0 109.259 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.51 -24.51 65.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.0 109.308 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.971 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -74.64 -26.45 59.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.323 -0.861 . . . . 0.0 109.927 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 25' ' ' GLN . 1.7 m -56.57 -44.15 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.788 -1.195 . . . . 0.0 109.448 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.499 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 3.3 t -80.59 -52.7 7.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.433 -0.792 . . . . 0.0 109.527 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.5 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 25.9 m-80 -57.24 -14.58 4.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.832 . . . . 0.0 109.622 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.854 ' O ' HD12 ' A' ' 35' ' ' ILE . . . 77.33 22.78 69.74 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.479 HG12 ' HD2' ' A' ' 13' ' ' ARG . 1.1 mt -100.14 -25.85 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.208 -1.172 . . . . 0.0 108.271 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.971 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 2.1 p90 -48.63 -46.95 40.55 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.617 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 12.5 t70 -66.44 -35.5 80.45 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.854 HD12 ' O ' ' A' ' 31' ' ' GLY . 2.6 mp -92.3 40.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.197 -0.939 . . . . 0.0 108.889 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.674 HG12 ' N ' ' A' ' 37' ' ' GLY . 49.1 t -160.88 -93.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.594 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.674 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -84.18 167.82 43.94 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.688 ' OD1' HG21 ' A' ' 47' ' ' THR . 0.1 OUTLIER -129.28 -50.0 1.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -1.129 . . . . 0.0 109.689 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.521 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 16.8 p -65.15 -18.86 65.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 109.537 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 42.98 93.21 0.01 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.61 -140.76 11.06 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.7 p -60.0 161.64 6.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -1.149 . . . . 0.0 109.353 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . . . -59.91 101.3 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.412 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.521 ' HB3' ' CB ' ' A' ' 39' ' ' CYS . 4.6 t -132.93 18.72 4.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.687 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.9 p -168.08 -167.61 0.85 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.943 . . . . 0.0 109.683 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.895 ' HB3' ' NE1' ' A' ' 106' ' ' TRP . . . -135.48 5.54 3.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.331 -0.856 . . . . 0.0 109.331 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.688 HG21 ' OD1' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -63.07 -28.78 70.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.396 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.536 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 25.1 p -84.25 42.32 0.88 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.449 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.017 ' CE1' HD12 ' A' ' 78' ' ' LEU . 28.3 t60 -81.35 64.09 5.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.27 147.33 6.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.569 -1.332 . . . . 0.0 110.061 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.668 ' HH ' ' HE2' ' A' ' 49' ' ' HIS . 9.6 m-85 -107.03 104.12 13.71 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.734 HG22 HG12 ' A' ' 99' ' ' VAL . 4.6 t -89.41 172.6 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-O 121.948 0.88 . . . . 0.0 112.201 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.581 ' H ' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -77.6 157.98 30.01 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.067 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -81.88 12.57 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.233 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.29 -25.95 9.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.98 -1.075 . . . . 0.0 109.75 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.628 ' CD1' ' HA ' ' A' ' 97' ' ' ILE . 90.8 m-85 -104.49 -17.35 14.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.836 HG21 HD22 ' A' ' 81' ' ' ASN . 0.7 OUTLIER -66.16 -34.97 79.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.814 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.15 -46.88 72.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.21 -0.931 . . . . 0.0 110.346 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.06 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -49.51 -43.99 45.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.736 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.139 HG11 HG22 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -100.45 143.24 26.16 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.892 . . . . 0.0 109.259 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.817 ' HD2' HG12 ' A' ' 60' ' ' VAL . 6.2 Cg_exo -58.15 -179.59 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.811 1.674 . . . . 0.0 109.219 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.516 ' HA ' ' HD3' ' A' ' 83' ' ' ARG . . . -110.29 -105.2 0.37 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.839 -1.163 . . . . 0.0 109.573 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.517 ' CB ' HG13 ' A' ' 68' ' ' ILE . . . -111.7 -160.14 0.7 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.071 . . . . 0.0 109.894 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.687 ' O ' HD12 ' A' ' 68' ' ' ILE . 12.3 m-20 -137.62 -145.43 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.87 -34.75 9.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.912 -1.117 . . . . 0.0 109.463 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -84.06 -48.37 9.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.903 . . . . 0.0 109.595 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 15.2 pt-20 -68.79 -27.0 65.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.564 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.687 HD12 ' O ' ' A' ' 64' ' ' ASN . 1.3 mt -66.34 -43.25 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.105 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.83 -55.8 21.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -25.61 65.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -1.16 . . . . 0.0 109.398 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.62 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -87.86 -3.63 58.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.247 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 68' ' ' ILE . 15.0 tp10 -82.47 -26.05 32.99 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.22 -0.925 . . . . 0.0 109.211 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.74 75.77 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.391 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.815 HG23 ' H ' ' A' ' 76' ' ' ALA . 4.9 m -97.75 174.66 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.925 . . . . 0.0 109.633 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.571 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 18.2 m -74.13 -11.95 60.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.852 . . . . 0.0 109.934 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.85 ' HB2' ' HG2' ' A' ' 104' ' ' ARG . . . -122.42 -151.41 0.48 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.029 -1.045 . . . . 0.0 109.874 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.628 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -112.26 156.13 22.89 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.017 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -128.62 152.79 47.95 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 117.596 -1.641 . . . . 0.0 112.096 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.589 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 13.7 mmtt -137.52 167.26 21.3 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.589 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 5.8 Cg_exo -54.41 -17.99 13.68 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.17 1.913 . . . . 0.0 110.589 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.836 HD22 HG21 ' A' ' 57' ' ' THR . 0.2 OUTLIER -82.62 -33.75 27.81 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.375 -0.828 . . . . 0.0 110.45 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.6 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.1 m -61.7 159.68 13.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.951 -1.093 . . . . 0.0 109.595 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.581 HH12 HG23 ' A' ' 88' ' ' ILE . 6.9 mmm-85 -160.4 167.96 26.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.737 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.58 HD11 ' HG ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -88.44 112.37 22.86 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' MET . 0.3 OUTLIER -65.35 -6.99 11.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.286 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.3 p -105.89 13.23 29.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.961 -1.087 . . . . 0.0 110.305 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.515 ' NE2' HD13 ' A' ' 84' ' ' LEU . 2.9 pt20 -139.06 3.28 2.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.796 -1.19 . . . . 0.0 110.399 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.139 HG22 HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -105.08 146.88 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.946 -1.097 . . . . 0.0 109.201 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 90' ' ' MET . 12.1 mm -116.32 158.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.27 -0.894 . . . . 0.0 109.505 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.856 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -127.89 95.24 4.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.292 -0.88 . . . . 0.0 109.271 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.664 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -87.62 171.23 10.05 Favored Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.589 -0.694 . . . . 0.0 109.533 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.664 ' HD2' HG22 ' A' ' 91' ' ' THR . 3.9 Cg_exo -60.34 -15.17 33.65 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.189 1.926 . . . . 0.0 110.33 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.781 ' HG3' HD12 ' A' ' 94' ' ' LEU . 22.3 pt-20 -66.29 -47.88 72.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.234 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.06 HD21 ' CB ' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -86.38 152.18 22.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.886 . . . . 0.0 109.23 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.417 ' HB3' ' HA ' ' A' ' 1' ' ' SER . 1.3 p30 -161.42 133.99 6.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.98 . . . . 0.0 110.022 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.585 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 78.41 37.32 27.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.721 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -78.22 149.64 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.178 -1.189 . . . . 0.0 109.047 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.455 ' N ' HD13 ' A' ' 97' ' ' ILE . 3.7 t -114.18 110.35 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.061 -1.024 . . . . 0.0 109.884 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.734 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -102.75 148.72 7.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.516 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -126.15 176.63 6.92 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.74 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 6' ' ' VAL . 21.6 t -106.02 146.32 32.68 Favored Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.685 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.888 ' HD2' HG13 ' A' ' 101' ' ' VAL . 10.5 Cg_exo -54.06 -173.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.458 2.105 . . . . 0.0 110.656 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -92.21 -18.01 24.05 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.85 ' HG2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -130.29 -162.36 1.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.478 ' O ' HG23 ' A' ' 47' ' ' THR . 4.8 tm0? -151.36 22.56 0.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.838 -1.163 . . . . 0.0 109.895 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.895 ' NE1' ' HB3' ' A' ' 46' ' ' ALA . 6.5 m95 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.533 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.511 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -138.17 159.52 41.82 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.261 -0.899 . . . . 0.0 109.167 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.6 HG21 ' HG3' ' A' ' 90' ' ' MET . 0.9 OUTLIER -157.28 130.54 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.23 -0.919 . . . . 0.0 109.659 -179.215 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.988 HG13 ' O ' ' A' ' 13' ' ' ARG . 75.5 t -129.02 140.93 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 109.023 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.109 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -109.24 156.87 19.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 109.252 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.7 t -133.28 132.97 58.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.547 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -78.91 -177.37 5.5 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -48.59 162.95 0.08 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.513 ' C ' ' O ' ' A' ' 8' ' ' HIS . 5.1 t0 -29.75 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.032 0.444 . . . . 0.0 110.78 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 8' ' ' HIS . . . -168.47 -95.39 0.1 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.476 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.4 m -125.37 -175.87 3.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -1.156 . . . . 0.0 109.666 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.716 ' H ' HG22 ' A' ' 11' ' ' THR . 11.5 ptt180 -156.69 141.09 16.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.631 -0.668 . . . . 0.0 109.904 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.988 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -100.41 174.63 6.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.21 -0.931 . . . . 0.0 108.718 179.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.417 ' CB ' HG22 ' A' ' 4' ' ' VAL . 9.1 pm0 -130.38 162.91 28.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.029 -1.044 . . . . 0.0 110.788 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.109 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -175.84 -176.53 0.85 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.627 0.727 . . . . 0.0 109.193 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 1' ' ' SER . 7.3 t0 -132.24 88.59 2.56 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.059 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.732 HG21 HD22 ' A' ' 23' ' ' LEU . 49.4 t -54.24 145.61 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 108.918 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 1.016 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -86.42 172.98 9.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 109.662 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.412 ' OD2' ' HG3' ' A' ' 92' ' ' PRO . 78.8 m-20 -80.92 125.75 30.51 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.354 -0.841 . . . . 0.0 108.927 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.38 22.44 34.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.016 HG21 ' HB3' ' A' ' 18' ' ' ALA . 1.9 t -117.16 162.86 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -1.086 . . . . 0.0 108.918 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -100.62 134.92 42.86 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.981 -1.074 . . . . 0.0 108.568 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.958 HD13 ' OH ' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -46.64 -25.27 0.68 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.016 -1.052 . . . . 0.0 108.699 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.602 ' HE2' ' HB2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -74.44 -46.69 38.32 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.66 ' HB2' HG12 ' A' ' 21' ' ' VAL . 2.7 mm-40 -52.23 -54.29 32.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 108.95 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.473 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -57.22 -29.08 63.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 0.0 108.677 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.952 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -67.93 -34.15 76.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -0.809 . . . . 0.0 109.145 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.572 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 88.4 t -52.8 -40.49 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 109.399 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 t -79.95 -48.85 12.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.848 . . . . 0.0 109.402 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.732 ' CG ' HD22 ' A' ' 15' ' ' LEU . 29.1 m-80 -65.62 -6.19 10.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.795 . . . . 0.0 109.68 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.483 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 72.09 17.6 77.32 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.476 HG13 ' CB ' ' A' ' 30' ' ' ASN . 1.0 OUTLIER -95.56 -27.18 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -1.157 . . . . 0.0 108.538 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.952 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 1.2 p90 -46.96 -45.11 20.59 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.557 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 10.9 t70 -77.31 -29.06 53.46 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 35' ' ' ILE . 20.0 mm -64.86 -10.03 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.681 HG21 HG12 ' A' ' 50' ' ' VAL . 2.5 p -160.12 -51.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.134 -0.979 . . . . 0.0 109.826 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' H ' HG13 ' A' ' 36' ' ' VAL . . . -42.9 166.29 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.494 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 13.7 t0 -154.15 -93.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -1.203 . . . . 0.0 109.863 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 42' ' ' SER . 20.8 p -65.49 -9.5 26.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.131 -0.98 . . . . 0.0 109.765 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 86' ' ' CYS . . . 89.59 -167.47 33.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -42.01 -27.09 0.37 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.453 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 19.3 m -59.68 159.57 8.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.136 -1.214 . . . . 0.0 109.286 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.596 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -124.57 74.45 1.33 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.356 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 m -129.6 -2.33 4.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 109.735 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 38' ' ' ASP . 1.4 p -120.96 -169.24 1.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.085 -1.009 . . . . 0.0 109.613 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.788 ' HB3' ' NE1' ' A' ' 106' ' ' TRP . . . -141.83 11.44 2.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.297 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 105' ' ' GLN . 9.5 m -71.54 -21.0 61.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.51 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.536 ' HB2' ' CB ' ' A' ' 85' ' ' CYS . 23.5 p -86.75 42.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.02 ' CE1' HD12 ' A' ' 78' ' ' LEU . 21.6 t60 -74.47 72.65 1.88 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.681 HG12 HG21 ' A' ' 36' ' ' VAL . 10.1 m -81.64 145.41 8.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.285 -1.509 . . . . 0.0 110.728 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 6.1 m-85 -107.26 99.97 9.46 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.709 HG22 HG12 ' A' ' 99' ' ' VAL . 3.8 t -89.93 172.08 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-O 122.053 0.93 . . . . 0.0 112.461 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.581 ' H ' HG12 ' A' ' 52' ' ' VAL . 1.3 m-20 -77.39 159.34 29.54 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.18 11.71 5.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.38 -0.825 . . . . 0.0 110.103 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.29 -29.91 7.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.015 -1.053 . . . . 0.0 109.755 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.757 ' HD2' HD23 ' A' ' 94' ' ' LEU . 47.2 m-85 -99.53 -18.47 17.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.174 -0.954 . . . . 0.0 109.4 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.797 HG21 HD22 ' A' ' 81' ' ' ASN . 0.7 OUTLIER -64.16 -14.33 54.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.073 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.85 -36.06 17.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.767 ' HB2' HD21 ' A' ' 94' ' ' LEU . 1.9 mptp? -72.88 -32.92 65.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.462 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.582 ' HB ' HG22 ' A' ' 88' ' ' ILE . 1.3 m -56.18 163.05 2.55 Favored Pre-proline 0 C--N 1.305 -1.344 0 O-C-N 121.222 -0.924 . . . . 0.0 109.455 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.663 ' HD2' HG22 ' A' ' 88' ' ' ILE . 5.8 Cg_exo -58.16 166.47 5.7 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.166 1.911 . . . . 0.0 110.179 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -110.25 60.21 0.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -41.86 164.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.53 -0.731 . . . . 0.0 109.611 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.434 ' O ' HG12 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -94.15 -175.23 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 0.0 109.695 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.527 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 38.2 tt0 -88.13 -17.98 29.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 0.0 109.521 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -46.54 -64.53 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.713 ' O ' HD12 ' A' ' 71' ' ' LEU . 4.7 mt-10 -65.56 -21.29 66.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.433 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.527 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 23.5 mm -65.37 -31.7 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -45.12 -56.42 6.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 57.2 mtt -68.21 -26.79 65.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -1.176 . . . . 0.0 109.106 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.109 ' CD1' HD11 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -88.11 2.78 51.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.346 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 68' ' ' ILE . 55.7 tt0 -88.15 -30.53 19.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.85 . . . . 0.0 109.008 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -101.95 29.86 4.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.168 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.91 HG23 ' H ' ' A' ' 76' ' ' ALA . 5.3 m -46.07 171.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.593 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.567 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 83.4 m -75.2 -4.22 37.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.786 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.91 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -123.76 -150.71 0.45 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.063 -1.023 . . . . 0.0 109.651 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.645 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -111.85 156.64 21.7 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 179.333 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.02 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -130.71 153.91 48.49 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.964 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.539 ' CE ' ' HD2' ' A' ' 80' ' ' PRO . 4.5 mmmt -136.88 166.85 24.22 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.539 ' HD2' ' CE ' ' A' ' 79' ' ' LYS . 6.0 Cg_exo -54.68 -17.41 13.19 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.246 1.964 . . . . 0.0 110.697 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.797 HD22 HG21 ' A' ' 57' ' ' THR . 0.1 OUTLIER -84.78 -31.66 23.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.615 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.606 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.4 m -61.6 162.83 7.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.965 -1.084 . . . . 0.0 110.307 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.514 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -161.03 -159.08 0.63 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.369 -0.832 . . . . 0.0 109.278 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.109 HD11 ' CD1' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -110.93 118.54 36.37 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.285 -0.885 . . . . 0.0 108.97 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.609 ' SG ' HG11 ' A' ' 50' ' ' VAL . 1.8 t -60.79 -19.62 59.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.125 -0.984 . . . . 0.0 108.991 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 17.2 p -110.66 30.16 7.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.426 -0.796 . . . . 0.0 109.973 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -143.26 9.55 1.66 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.019 -1.051 . . . . 0.0 110.048 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.663 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -123.35 131.27 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.072 -1.017 . . . . 0.0 109.287 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.597 HG22 ' N ' ' A' ' 90' ' ' MET . 13.8 mm -96.29 166.39 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.342 -0.849 . . . . 0.0 109.622 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.666 ' CB ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.87 90.33 3.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.375 -0.828 . . . . 0.0 109.417 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.423 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -88.2 167.51 19.34 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.382 -0.824 . . . . 0.0 109.336 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 3.5 Cg_exo -60.09 -12.84 20.79 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.138 1.892 . . . . 0.0 110.353 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.59 ' CG ' HD12 ' A' ' 94' ' ' LEU . 24.9 pt-20 -69.83 -45.87 66.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.589 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' A' ' 59' ' ' LYS . 1.3 mp -75.98 136.02 40.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.924 . . . . 0.0 109.556 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -139.8 119.89 13.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.59 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 72.78 46.82 28.63 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.01 HD11 HG22 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -74.96 148.77 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.375 -1.074 . . . . 0.0 109.101 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.88 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.9 t -116.23 106.34 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.11 -0.994 . . . . 0.0 109.443 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.01 HG22 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -104.84 147.14 11.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -126.38 174.27 8.73 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.722 -179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.892 HG13 ' HD2' ' A' ' 102' ' ' PRO . 40.1 t -108.3 145.79 32.24 Favored Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.093 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.892 ' HD2' HG13 ' A' ' 101' ' ' VAL . 8.6 Cg_exo -50.24 177.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.304 2.003 . . . . 0.0 111.031 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.07 -22.87 33.36 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 0.0 OUTLIER -119.61 -157.03 0.69 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.644 ' O ' HG23 ' A' ' 47' ' ' THR . 20.0 mt-30 -153.36 23.99 0.54 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.953 -1.092 . . . . 0.0 109.728 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.788 ' NE1' ' HB3' ' A' ' 46' ' ' ALA . 5.0 m95 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.589 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.361 0.6 . . . . 0.0 109.526 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -134.41 162.99 30.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 109.075 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.782 HG21 HD21 ' A' ' 23' ' ' LEU . 23.9 t -152.28 157.32 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.061 -1.025 . . . . 0.0 109.742 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -158.57 119.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 108.879 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.085 ' CE1' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -95.19 157.17 16.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 109.682 -179.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.935 ' O ' HG23 ' A' ' 101' ' ' VAL . 9.4 t -123.26 169.6 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.447 -0.783 . . . . 0.0 109.096 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.58 ' N ' HG12 ' A' ' 6' ' ' VAL . 84.5 p -123.12 162.69 22.0 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.477 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -65.31 -6.53 10.09 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.828 -1.17 . . . . 0.0 109.203 179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -110.07 -5.6 15.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.062 -1.024 . . . . 0.0 110.319 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' HD2' ' A' ' 12' ' ' ARG . . . 115.65 -33.39 5.25 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.689 -1.244 . . . . 0.0 110.282 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.6 m -49.61 114.09 0.98 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.974 -1.31 . . . . 0.0 109.48 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.488 ' HB3' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -133.83 122.77 23.72 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.648 -0.657 . . . . 0.0 109.695 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.726 ' NH1' HD11 ' A' ' 35' ' ' ILE . 1.3 mtt180 -97.95 173.78 6.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.121 -0.987 . . . . 0.0 108.544 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.556 ' HB3' HG13 ' A' ' 4' ' ' VAL . 10.9 pt20 -131.96 134.66 45.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.051 -1.031 . . . . 0.0 110.212 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.085 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -134.28 -176.84 4.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.269 -0.895 . . . . 0.0 109.471 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.68 80.97 1.97 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.732 -0.605 . . . . 0.0 109.505 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.008 HG21 HD23 ' A' ' 23' ' ' LEU . 85.8 t -68.88 114.32 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.52 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -52.62 175.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.882 . . . . 0.0 109.817 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 92' ' ' PRO . 67.8 m-20 -83.05 126.29 32.39 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.477 -0.764 . . . . 0.0 109.076 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.12 10.67 44.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.652 HG12 ' HB3' ' A' ' 25' ' ' GLN . 0.7 OUTLIER -115.52 155.48 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -1.144 . . . . 0.0 109.199 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 7.2 t -93.6 133.01 37.36 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.403 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.008 HD23 HG21 ' A' ' 17' ' ' VAL . 10.8 mt -42.64 -29.41 0.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.556 ' HE1' ' H ' ' A' ' 41' ' ' GLY . 1.9 tmt? -70.81 -50.52 34.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 108.811 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.652 ' HB3' HG12 ' A' ' 21' ' ' VAL . 5.5 tp-100 -49.22 -50.86 36.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.262 -0.899 . . . . 0.0 108.751 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.957 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -63.23 -32.06 73.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -0.844 . . . . 0.0 108.757 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.93 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -62.25 -25.45 67.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.351 -0.843 . . . . 0.0 109.213 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.584 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 47.0 t -57.43 -42.97 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.135 -0.978 . . . . 0.0 109.172 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 t -82.51 -53.11 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 0.0 109.284 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.475 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 37.2 m-80 -54.81 -16.72 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.461 -0.775 . . . . 0.0 109.406 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 35' ' ' ILE . . . 79.14 21.82 66.88 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.809 ' HA ' HD12 ' A' ' 35' ' ' ILE . 1.1 mt -99.2 -28.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.175 -1.191 . . . . 0.0 108.535 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.93 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 1.6 p90 -47.45 -46.35 26.66 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.605 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 19.3 t70 -74.44 -30.49 61.91 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.809 HD12 ' HA ' ' A' ' 32' ' ' ILE . 60.0 mt -58.98 -17.28 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.09 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.715 ' O ' HG13 ' A' ' 36' ' ' VAL . 8.0 p -170.13 81.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.843 . . . . 0.0 109.47 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.496 ' C ' ' HG1' ' A' ' 47' ' ' THR . . . -163.62 179.55 38.6 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.566 ' CG ' HG21 ' A' ' 47' ' ' THR . 3.2 t0 -163.96 -69.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 109.667 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 42' ' ' SER . 16.3 p -83.3 10.05 9.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.698 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.04 -162.6 46.02 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.556 ' H ' ' HE1' ' A' ' 24' ' ' MET . . . -47.34 -23.98 2.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.447 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -59.89 177.49 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -1.165 . . . . 0.0 109.368 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.69 91.15 2.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.471 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.8 t -160.05 22.03 0.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 9.1 p -130.17 -151.55 0.48 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.958 . . . . 0.0 109.461 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.514 ' HB3' ' NE1' ' A' ' 106' ' ' TRP . . . -157.82 19.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.141 -0.975 . . . . 0.0 109.999 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.566 HG21 ' CG ' ' A' ' 38' ' ' ASP . 1.6 p -89.94 -19.39 24.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.113 -0.992 . . . . 0.0 109.455 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.499 ' HA ' HG22 ' A' ' 36' ' ' VAL . 23.4 p -86.62 43.36 1.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 110.073 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.717 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 67.5 t60 -76.93 65.41 2.6 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 82' ' ' SER . 12.6 m -87.14 147.89 4.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.345 -1.472 . . . . 0.0 110.384 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.717 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 6.2 m-30 -107.16 111.4 23.81 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.694 HG22 HG12 ' A' ' 99' ' ' VAL . 5.3 t -94.85 170.14 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.937 0.875 . . . . 0.0 112.306 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.568 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -74.24 144.51 44.63 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -4.84 13.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.17 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -94.96 -30.07 14.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.214 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.816 ' CD2' HG22 ' A' ' 97' ' ' ILE . 61.6 m-85 -97.98 -17.79 18.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.007 -1.058 . . . . 0.0 109.878 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.653 HG21 HD22 ' A' ' 81' ' ' ASN . 0.8 OUTLIER -64.59 -37.21 86.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.97 . . . . 0.0 109.429 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -62.14 1.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.542 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.842 ' HB2' HD21 ' A' ' 94' ' ' LEU . 13.8 mptt -49.93 -38.57 36.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.909 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -51.24 161.17 0.79 Allowed Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.901 . . . . 0.0 109.049 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.909 ' HD2' HG22 ' A' ' 60' ' ' VAL . 4.3 Cg_exo -59.96 159.22 26.28 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.18 1.92 . . . . 0.0 110.22 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.15 58.89 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.883 . . . . 0.0 109.439 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.89 132.85 3.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.415 -0.803 . . . . 0.0 109.557 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -51.79 -174.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 109.63 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.591 ' HA ' HD12 ' A' ' 68' ' ' ILE . 31.0 tt0 -89.47 -16.43 30.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.415 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.438 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . 5.2 tpp180 -44.57 -61.79 1.43 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.477 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.438 ' OE1' ' HB3' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -66.23 -23.84 66.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.431 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 65' ' ' GLU . 18.9 mt -63.12 -32.48 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.99 -51.6 39.54 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.7 mtt -66.69 -23.36 66.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -1.152 . . . . 0.0 109.372 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.696 ' O ' HG13 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -89.72 -7.06 55.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.497 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -82.17 -36.79 27.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 109.367 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.87 57.62 4.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.398 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.903 HG23 ' H ' ' A' ' 76' ' ' ALA . 8.9 m -93.94 172.02 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.527 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 25.5 m -64.94 -10.23 27.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.518 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.903 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -128.22 -155.85 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.149 -0.97 . . . . 0.0 109.969 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.571 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -111.82 150.39 30.43 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.641 ' HG ' ' HB2' ' A' ' 82' ' ' SER . 0.4 OUTLIER -106.54 169.1 8.72 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.397 -1.321 . . . . 0.0 111.203 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.549 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -153.22 170.78 7.68 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 3.4 Cg_exo -57.83 -13.45 14.75 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.037 1.824 . . . . 0.0 109.905 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.653 HD22 HG21 ' A' ' 57' ' ' THR . 0.1 OUTLIER -95.35 -25.0 16.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 110.836 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.641 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -85.79 155.9 20.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.818 -1.176 . . . . 0.0 110.477 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.403 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -161.53 -157.68 0.51 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 179.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.904 HD12 ' CB ' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -104.29 95.19 5.78 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.226 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.541 ' HA ' ' CG1' ' A' ' 88' ' ' ILE . 1.9 t -42.57 -25.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 84' ' ' LEU . 13.0 p -75.72 -43.53 46.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.098 -1.001 . . . . 0.0 110.544 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.904 ' CB ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -89.62 8.87 29.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.002 -1.061 . . . . 0.0 111.334 -178.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.689 ' O ' HD13 ' A' ' 89' ' ' ILE . 2.9 mm -79.98 154.66 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.552 -1.342 . . . . 0.0 108.913 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 88' ' ' ILE . 30.1 mm -128.98 165.47 28.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.716 ' HE3' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -127.3 96.32 4.54 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.725 ' OG1' HD12 ' A' ' 94' ' ' LEU . 16.3 p -82.52 157.19 67.83 Favored Pre-proline 0 C--N 1.297 -1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 109.262 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.456 ' HB3' ' OD2' ' A' ' 19' ' ' ASP . 5.8 Cg_exo -59.77 -13.35 21.79 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.02 1.813 . . . . 0.0 110.264 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -80.3 -31.79 38.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.412 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.842 HD21 ' HB2' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -83.35 127.41 33.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.634 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -135.82 125.51 25.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.204 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.576 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 70.86 50.57 23.4 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.035 HD11 HG22 ' A' ' 99' ' ' VAL . 0.5 OUTLIER -74.82 159.1 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.331 -1.099 . . . . 0.0 108.868 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.006 ' N ' HD12 ' A' ' 97' ' ' ILE . 5.2 t -125.82 103.53 11.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.021 -1.049 . . . . 0.0 110.186 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.035 HG22 HD11 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -95.44 156.65 3.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 51' ' ' TYR . 12.0 m-20 -131.91 178.35 6.84 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.059 -1.025 . . . . 0.0 109.401 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 6' ' ' VAL . 27.6 t -110.45 146.84 35.14 Favored Pre-proline 0 C--N 1.297 -1.715 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.95 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.897 ' HD2' HG13 ' A' ' 101' ' ' VAL . 8.4 Cg_exo -53.95 -173.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.391 2.061 . . . . 0.0 110.369 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 19.3 t0 -102.68 -22.71 13.91 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.614 ' HD2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -131.09 -168.68 2.04 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.578 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -128.99 -82.63 0.57 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.024 -1.048 . . . . 0.0 109.186 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.578 ' CD1' ' O ' ' A' ' 105' ' ' GLN . 2.1 m95 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.38 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -136.61 161.46 35.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.277 -0.889 . . . . 0.0 109.175 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.717 HG21 ' CG ' ' A' ' 90' ' ' MET . 1.1 t -160.7 133.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 109.531 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.9 p -136.98 161.39 35.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.123 -0.985 . . . . 0.0 108.648 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.084 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -129.04 157.99 40.17 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.185 -0.947 . . . . 0.0 109.786 -178.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 12' ' ' ARG . 3.4 t -126.9 143.39 40.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.552 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 5.1 p -75.98 -158.7 0.1 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.684 ' N ' HG12 ' A' ' 101' ' ' VAL . 55.8 m80 -59.2 -103.43 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.26 77.71 1.06 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.4 -1.437 . . . . 0.0 109.239 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.99 -101.31 0.2 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 118.958 -1.591 . . . . 0.0 111.053 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -121.46 -170.55 2.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -1.1 . . . . 0.0 109.954 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.767 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -149.31 139.59 22.29 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.656 -0.652 . . . . 0.0 110.32 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.517 ' C ' HG23 ' A' ' 4' ' ' VAL . 18.0 mtt180 -104.25 119.31 38.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.351 -0.843 . . . . 0.0 108.958 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.619 ' HA ' HG23 ' A' ' 4' ' ' VAL . 4.9 pt20 -79.78 171.43 15.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.973 . . . . 0.0 110.554 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.084 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -173.48 -177.98 1.58 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.611 0.72 . . . . 0.0 109.059 178.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -135.24 93.17 2.95 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.66 -0.65 . . . . 0.0 109.685 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.976 HG21 ' CD2' ' A' ' 23' ' ' LEU . 21.1 t -69.13 149.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 109.305 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.873 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -83.22 173.38 11.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.397 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -79.97 124.67 28.91 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.274 -0.891 . . . . 0.0 109.067 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.8 18.06 39.05 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.873 HG21 ' HB3' ' A' ' 18' ' ' ALA . 2.2 t -115.1 170.3 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -1.123 . . . . 0.0 109.27 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.496 ' OG ' ' CD1' ' A' ' 89' ' ' ILE . 70.6 m -111.76 138.79 47.87 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 108.677 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.976 ' CD2' HG21 ' A' ' 17' ' ' VAL . 1.5 mt -48.31 -23.6 0.96 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.945 -1.097 . . . . 0.0 108.709 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.478 ' HB2' ' HA ' ' A' ' 86' ' ' CYS . 13.2 ttp -73.07 -46.84 49.3 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.692 ' HB2' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -54.14 -59.61 4.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.363 -0.835 . . . . 0.0 109.004 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.432 ' C ' ' OD1' ' A' ' 30' ' ' ASN . . . -53.22 -46.48 69.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 108.945 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.526 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -45.37 -37.39 4.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.865 . . . . 0.0 109.885 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.538 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 58.7 t -43.57 -50.12 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.098 -1.001 . . . . 0.0 109.858 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 31' ' ' GLY . 6.1 t -87.02 -51.33 6.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.303 -0.873 . . . . 0.0 109.591 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 1.037 ' OD1' HD13 ' A' ' 15' ' ' LEU . 4.8 m120 -40.31 -25.86 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.462 0.649 . . . . 0.0 109.731 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 95.24 -5.17 67.9 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.735 HG22 ' CG2' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -79.61 -28.35 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.056 -1.261 . . . . 0.0 107.962 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -48.7 -31.45 6.85 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.619 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 13.1 t0 -93.08 -25.38 17.94 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.663 -0.648 . . . . 0.0 109.295 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.93 ' CG2' HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -60.11 -31.83 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.0 109.194 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.93 HG22 ' CG2' ' A' ' 35' ' ' ILE . 3.4 m -163.75 -171.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.404 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.08 166.05 12.06 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 12.3 t70 -154.16 -92.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -1.146 . . . . 0.0 109.716 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 40' ' ' GLY . 14.6 p -81.87 -9.87 59.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 109.625 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.76 77.15 0.1 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 87' ' ' GLN . . . 171.28 -157.17 27.65 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.2 p -60.83 171.83 1.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -1.137 . . . . 0.0 109.486 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.888 ' HB3' ' CG ' ' A' ' 67' ' ' GLU . . . -61.93 99.59 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.89 . . . . 0.0 109.41 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.81 5.84 2.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 0.0 109.636 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 13.2 p -144.33 -152.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 0.0 109.615 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 1.004 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -156.09 19.2 0.37 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.634 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -90.4 -28.78 18.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.583 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.686 ' O ' HG13 ' A' ' 50' ' ' VAL . 22.0 p -86.5 42.3 1.0 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.953 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.733 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 68.1 t60 -58.71 79.95 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.113 HG11 ' CB ' ' A' ' 85' ' ' CYS . 7.6 m -90.59 146.71 5.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.055 -1.653 . . . . 0.0 111.987 -177.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.733 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 4.1 m-30 -112.63 113.09 25.05 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.823 HG22 HG12 ' A' ' 99' ' ' VAL . 6.4 t -101.45 171.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.877 0.846 . . . . 0.0 112.209 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.582 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -73.23 155.36 39.63 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.012 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -81.43 11.63 4.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.148 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.48 -28.89 8.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.95 -1.094 . . . . 0.0 110.121 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.856 ' CD2' HG22 ' A' ' 97' ' ' ILE . 43.0 m-85 -100.14 -19.34 16.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.08 -1.012 . . . . 0.0 109.695 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.761 HG21 HD22 ' A' ' 81' ' ' ASN . 0.8 OUTLIER -61.55 -22.71 65.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.205 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -85.71 -25.69 26.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.891 . . . . 0.0 109.475 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.767 ' HB2' HD21 ' A' ' 94' ' ' LEU . 13.6 mmtm -76.83 -10.54 59.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 0.0 109.443 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.785 HG11 ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -95.68 170.39 7.79 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.276 -0.89 . . . . 0.0 108.785 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.706 ' HD2' HG12 ' A' ' 60' ' ' VAL . 5.7 Cg_exo -59.43 167.84 5.83 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.03 1.82 . . . . 0.0 110.394 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.18 59.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.865 . . . . 0.0 109.375 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -41.6 121.64 1.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.593 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.822 ' O ' HD13 ' A' ' 68' ' ' ILE . 7.0 m-80 -57.54 -158.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.545 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 14.8 tp10 -84.11 -10.06 58.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.537 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -58.24 -54.31 48.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.456 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.888 ' CG ' ' HB3' ' A' ' 43' ' ' ALA . 2.4 mp0 -67.64 -8.21 32.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.529 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.5 mp -88.66 -34.09 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.373 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.43 -59.01 3.75 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.787 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -67.89 -26.61 66.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -1.151 . . . . 0.0 109.299 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.669 HD13 HD11 ' A' ' 84' ' ' LEU . 19.8 tp -90.83 7.24 40.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.893 . . . . 0.0 109.408 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -99.23 -24.22 14.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 109.393 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.86 31.75 0.94 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.439 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.004 HG12 ' HB1' ' A' ' 46' ' ' ALA . 3.6 m -75.9 170.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.384 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 16.3 m -75.9 -17.79 59.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.97 . . . . 0.0 109.328 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.603 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -107.62 -161.28 0.77 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.273 -0.892 . . . . 0.0 110.027 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.564 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.7 OUTLIER -111.65 151.63 28.61 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.614 ' HG ' ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -104.2 173.09 6.45 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.98 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.59 ' HE3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -158.27 170.13 9.45 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 2.6 Cg_endo -58.95 -12.51 15.43 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.284 1.989 . . . . 0.0 110.155 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.761 HD22 HG21 ' A' ' 57' ' ' THR . 0.0 OUTLIER -97.23 -22.09 16.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.22 -0.925 . . . . 0.0 110.84 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.614 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -75.42 153.32 37.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.004 -1.06 . . . . 0.0 110.649 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.652 ' C ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -161.31 -159.43 0.64 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.444 -0.785 . . . . 0.0 109.356 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.79 ' N ' HD22 ' A' ' 84' ' ' LEU . 3.1 mm? -109.61 79.34 1.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.337 -0.852 . . . . 0.0 108.73 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 1.113 ' CB ' HG11 ' A' ' 50' ' ' VAL . 43.2 t -45.38 -22.5 0.14 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.39 -0.819 . . . . 0.0 110.846 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 24' ' ' MET . 28.6 p -75.73 -40.88 54.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.897 -1.127 . . . . 0.0 110.914 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.573 ' CG ' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -96.14 11.64 33.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.852 -1.155 . . . . 0.0 111.193 -178.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.785 ' CG2' HG11 ' A' ' 60' ' ' VAL . 4.4 mm -79.5 160.25 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.683 -1.26 . . . . 0.0 108.811 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 ' O ' ' A' ' 88' ' ' ILE . 16.9 mm -123.72 155.69 30.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.838 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.717 ' CG ' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -116.27 88.08 2.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.471 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.69 165.07 34.56 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 121.415 -0.803 . . . . 0.0 109.315 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.36 -12.9 22.1 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.18 1.92 . . . . 0.0 110.227 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -72.42 -51.05 22.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' A' ' 59' ' ' LYS . 1.6 mp -73.16 141.81 47.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.533 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -143.48 119.0 10.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 109.744 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.587 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 71.61 47.02 36.21 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.987 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER -74.61 156.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.209 -1.171 . . . . 0.0 108.74 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.987 ' N ' HD12 ' A' ' 97' ' ' ILE . 3.6 t -124.37 106.17 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.047 -1.033 . . . . 0.0 109.939 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.937 HG22 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -101.73 159.78 4.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 1.6 m-20 -139.33 170.03 16.69 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.236 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.895 HG22 ' HD2' ' A' ' 102' ' ' PRO . 0.7 OUTLIER -105.09 157.97 33.11 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.512 178.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.895 ' HD2' HG22 ' A' ' 101' ' ' VAL . 6.3 Cg_exo -55.86 -167.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.546 2.164 . . . . 0.0 111.585 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 13.4 t0 -106.87 -22.84 12.56 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -131.31 127.95 38.74 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.57 20.03 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.968 -1.083 . . . . 0.0 110.036 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.572 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.013 . . . . 0.0 109.467 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.478 ' HB2' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.471 0.653 . . . . 0.0 109.579 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.415 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -145.63 153.43 41.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.001 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.89 HG21 HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -149.13 122.95 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.125 -0.984 . . . . 0.0 109.802 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.646 HG13 ' HG3' ' A' ' 14' ' ' GLN . 16.6 t -124.06 132.11 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.082 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -100.04 154.99 17.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.953 -1.092 . . . . 0.0 109.605 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.936 ' O ' HG23 ' A' ' 101' ' ' VAL . 11.6 t -121.79 167.78 14.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.483 -0.761 . . . . 0.0 109.011 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.586 ' N ' HG12 ' A' ' 6' ' ' VAL . 42.0 t -124.3 161.75 25.2 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.503 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.51 -7.36 9.89 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.85 -1.156 . . . . 0.0 109.149 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -110.3 -4.09 15.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.014 -1.054 . . . . 0.0 110.606 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.3 -19.03 27.46 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.303 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.2 m -59.87 111.88 1.64 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.908 -1.348 . . . . 0.0 109.252 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.75 ' HG2' HG13 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -125.58 121.93 35.04 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.515 -0.741 . . . . 0.0 110.268 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.632 ' NH1' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -102.53 126.36 49.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.646 ' HG3' HG13 ' A' ' 4' ' ' VAL . 2.4 mt-30 -88.78 157.17 18.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.099 -1.001 . . . . 0.0 110.654 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.082 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -166.81 -176.85 3.62 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.707 0.765 . . . . 0.0 109.322 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.25 116.07 17.86 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.415 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.014 HG21 HD23 ' A' ' 23' ' ' LEU . 49.2 t -93.29 106.36 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.577 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -47.07 174.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.586 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 92' ' ' PRO . 65.8 m-20 -83.51 126.26 32.61 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.317 -0.865 . . . . 0.0 109.18 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.84 21.77 20.11 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.736 HG12 ' HB2' ' A' ' 25' ' ' GLN . 1.5 t -125.01 164.65 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -1.177 . . . . 0.0 109.294 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 33.0 t -109.33 143.89 38.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 108.986 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.014 HD23 HG21 ' A' ' 17' ' ' VAL . 16.0 mt -44.61 -34.63 2.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.152 -0.968 . . . . 0.0 108.878 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -48.59 76.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.047 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.811 ' O ' HG12 ' A' ' 28' ' ' VAL . 3.3 mt-30 -52.73 -55.73 20.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.01 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.16 -21.69 66.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.199 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.94 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -76.42 -24.37 54.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.561 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 25' ' ' GLN . 5.4 p -59.93 -33.75 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.167 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 t -91.79 -52.7 4.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 109.075 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.493 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 21.0 m-80 -55.04 -17.6 4.13 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.506 -0.746 . . . . 0.0 109.22 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.36 24.64 56.43 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.655 HD11 HD22 ' A' ' 15' ' ' LEU . 1.1 mt -102.9 -27.26 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.128 -1.219 . . . . 0.0 108.738 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.94 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.7 OUTLIER -50.5 -40.44 51.23 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.478 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 45.1 t0 -73.3 -32.91 64.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.632 HD13 ' NH1' ' A' ' 13' ' ' ARG . 1.0 OUTLIER -98.42 14.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.942 -1.098 . . . . 0.0 109.448 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.608 HG12 ' SG ' ' A' ' 85' ' ' CYS . 94.6 t -160.29 69.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.435 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 48' ' ' CYS . . . 154.41 -171.93 32.92 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.889 ' CG ' HG21 ' A' ' 47' ' ' THR . 0.3 OUTLIER -165.42 -79.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.172 . . . . 0.0 109.639 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.499 ' SG ' ' N ' ' A' ' 40' ' ' GLY . 16.4 p -61.97 -40.32 95.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.562 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.499 ' N ' ' SG ' ' A' ' 39' ' ' CYS . . . 64.11 138.83 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.73 -102.68 0.86 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.43 99.71 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -1.179 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.54 109.71 1.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.505 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.3 m -152.45 17.13 0.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.654 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 12.9 p -121.26 -149.55 0.43 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.988 ' HB1' ' N ' ' A' ' 74' ' ' VAL . . . -156.13 18.71 0.36 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.033 -1.042 . . . . 0.0 109.997 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.889 HG21 ' CG ' ' A' ' 38' ' ' ASP . 1.7 p -90.11 -20.73 22.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.144 -0.973 . . . . 0.0 109.728 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.584 ' SG ' HD11 ' A' ' 71' ' ' LEU . 22.2 p -87.69 41.9 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.068 -1.02 . . . . 0.0 110.05 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.137 ' CD2' HD12 ' A' ' 78' ' ' LEU . 37.2 t-80 -81.9 61.94 5.46 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 82' ' ' SER . 12.5 m -77.35 148.09 6.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 120.588 -1.32 . . . . 0.0 110.612 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.514 ' CE2' ' CE1' ' A' ' 49' ' ' HIS . 7.0 m-85 -107.59 110.87 22.87 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.765 HG22 HG12 ' A' ' 99' ' ' VAL . 8.4 t -93.91 170.39 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 121.928 0.871 . . . . 0.0 112.251 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.566 ' N ' HG12 ' A' ' 52' ' ' VAL . 1.3 m-20 -69.16 165.3 20.7 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.17 9.3 26.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 109.869 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.32 -28.55 8.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.157 -0.964 . . . . 0.0 109.964 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.815 ' HD2' HD23 ' A' ' 94' ' ' LEU . 93.7 m-85 -97.91 -19.39 18.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 109.64 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.678 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -63.82 -23.06 67.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.4 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.03 -35.73 25.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.681 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.917 ' HB2' HD21 ' A' ' 94' ' ' LEU . 2.7 mmtm -63.74 -12.94 39.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.38 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.955 HG11 ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -97.94 161.75 24.56 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.268 -0.895 . . . . 0.0 108.969 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.832 ' HD2' HG12 ' A' ' 60' ' ' VAL . 5.0 Cg_exo -59.43 164.49 10.89 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.124 1.882 . . . . 0.0 110.371 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.19 59.35 0.61 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 109.428 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -41.98 130.19 3.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.548 -0.72 . . . . 0.0 109.593 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' ALA . 8.5 m-20 -57.08 -160.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.542 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.66 ' HA ' HD12 ' A' ' 68' ' ' ILE . 57.0 tt0 -99.25 -10.39 22.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.466 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' NE ' ' OE2' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -47.13 -72.28 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.599 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -61.04 -20.06 62.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 65' ' ' GLU . 13.6 mt -66.13 -31.93 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.69 -59.51 3.7 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.45 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -68.44 -28.1 66.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -1.116 . . . . 0.0 109.056 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.068 HD13 HD23 ' A' ' 84' ' ' LEU . 1.3 tp -85.5 4.49 35.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.324 -0.86 . . . . 0.0 109.167 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 68' ' ' ILE . 3.2 tm-20 -95.84 -12.53 25.1 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.081 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.745 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 1.3 m -59.92 -14.69 16.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.673 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.989 HG21 ' CD2' ' A' ' 49' ' ' HIS . 3.9 m -34.41 134.11 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.364 0.602 . . . . 0.0 109.941 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.549 ' HB ' ' CG ' ' A' ' 104' ' ' ARG . 88.4 m -44.69 -25.5 0.29 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 108.761 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.762 ' O ' HG23 ' A' ' 74' ' ' VAL . . . -110.1 -152.6 0.5 Allowed 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.373 -0.83 . . . . 0.0 109.834 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.634 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -114.74 148.59 38.11 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.137 HD12 ' CD2' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -104.15 130.05 51.89 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 117.406 -1.718 . . . . 0.0 111.288 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.538 ' HE2' ' CD ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -108.63 166.52 10.69 Favored Pre-proline 0 C--N 1.295 -1.801 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.538 ' CD ' ' HE2' ' A' ' 79' ' ' LYS . 3.4 Cg_exo -52.37 -27.85 32.86 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.733 1.622 . . . . 0.0 109.582 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.673 ' HA ' HG21 ' A' ' 57' ' ' THR . 0.0 OUTLIER -67.14 -42.04 85.07 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.677 -0.639 . . . . 0.0 109.449 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -83.18 168.27 16.96 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.435 -0.791 . . . . 0.0 109.671 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.541 ' HB3' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -161.57 -177.27 5.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.086 -1.009 . . . . 0.0 109.687 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.068 HD23 HD13 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -83.93 114.22 21.53 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.332 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.608 ' SG ' HG12 ' A' ' 36' ' ' VAL . 9.4 t -59.66 -14.87 15.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 0.0 109.12 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.3 p -108.54 30.21 6.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 109.76 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.819 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -152.92 13.72 0.52 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.986 -1.071 . . . . 0.0 110.377 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.955 ' CG2' HG11 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -112.39 150.2 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.923 -1.111 . . . . 0.0 108.938 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.749 HD13 ' O ' ' A' ' 88' ' ' ILE . 38.2 mm -129.45 142.27 44.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.315 -0.866 . . . . 0.0 109.881 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.81 ' SD ' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -97.95 82.15 2.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 108.936 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.57 165.85 41.58 Favored Pre-proline 0 C--N 1.294 -1.805 0 O-C-N 121.606 -0.684 . . . . 0.0 109.174 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 5.8 Cg_exo -59.25 -13.8 21.54 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.067 1.845 . . . . 0.0 110.103 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -76.96 -42.39 39.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.917 HD21 ' HB2' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -80.07 160.01 25.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.52 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -173.98 125.24 0.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.613 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 75.34 40.34 33.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.736 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -79.83 149.11 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -1.082 . . . . 0.0 109.165 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.417 ' N ' HD13 ' A' ' 97' ' ' ILE . 2.3 t -113.73 108.54 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.227 -0.92 . . . . 0.0 109.759 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.765 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -99.71 153.18 4.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -129.93 179.34 5.92 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.049 -1.032 . . . . 0.0 109.939 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 6' ' ' VAL . 25.4 t -109.01 146.59 34.16 Favored Pre-proline 0 C--N 1.296 -1.757 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.544 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.887 ' HD2' HG13 ' A' ' 101' ' ' VAL . 12.1 Cg_exo -53.72 137.8 67.38 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.223 1.949 . . . . 0.0 109.762 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.58 ' CB ' ' HD2' ' A' ' 104' ' ' ARG . 1.3 m-20 -47.14 -26.28 1.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.884 -1.135 . . . . 0.0 108.417 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -117.4 -167.34 1.3 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 106' ' ' TRP . 11.8 pt20 -160.07 27.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.056 . . . . 0.0 109.75 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.504 ' NE1' ' N ' ' A' ' 75' ' ' THR . 41.4 m95 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.67 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.88 161.99 40.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 109.355 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.752 ' CG2' HD21 ' A' ' 23' ' ' LEU . 1.5 t -147.04 132.04 11.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.304 -0.873 . . . . 0.0 109.301 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.935 HG13 ' O ' ' A' ' 13' ' ' ARG . 72.2 t -129.32 127.7 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.782 ' CD2' HD21 ' A' ' 15' ' ' LEU . 44.5 m-85 -97.57 153.72 17.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.818 -1.176 . . . . 0.0 110.263 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.69 HG22 ' HB3' ' A' ' 12' ' ' ARG . 2.6 t -132.46 141.77 44.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -76.77 -156.78 0.08 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.258 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.685 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -58.18 -105.93 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -112.07 77.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.477 -1.389 . . . . 0.0 108.887 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.05 -100.39 0.19 Allowed Glycine 0 N--CA 1.493 2.439 0 C-N-CA 118.931 -1.605 . . . . 0.0 111.027 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.702 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.3 m -119.56 -177.27 3.34 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.333 -1.098 . . . . 0.0 110.061 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.702 ' H ' HG22 ' A' ' 11' ' ' THR . 12.8 ptt180 -153.0 147.79 26.33 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.935 ' O ' HG13 ' A' ' 4' ' ' VAL . 8.0 mtt180 -106.25 173.47 6.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 108.522 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.453 ' C ' HD23 ' A' ' 15' ' ' LEU . 4.0 pt20 -123.76 163.76 20.53 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.004 -1.06 . . . . 0.0 110.567 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.782 HD21 ' CD2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -169.71 -175.32 2.08 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -131.9 91.33 2.96 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.063 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.925 HG21 HD23 ' A' ' 23' ' ' LEU . 46.9 t -62.2 153.38 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 108.872 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 1.055 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -91.03 172.37 8.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.0 . . . . 0.0 109.496 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -78.19 125.25 29.07 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.323 -0.861 . . . . 0.0 109.029 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.79 26.89 28.15 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.055 HG21 ' HB3' ' A' ' 18' ' ' ALA . 2.1 t -120.89 163.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -1.15 . . . . 0.0 109.172 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.5 t -106.07 140.72 38.62 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 108.534 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.013 HD13 HG21 ' A' ' 99' ' ' VAL . 12.1 mt -46.38 -26.08 0.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.099 -1.001 . . . . 0.0 108.623 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.589 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 22.0 ttt -71.71 -47.96 50.44 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.873 ' HB3' HG12 ' A' ' 21' ' ' VAL . 3.2 tp-100 -51.34 -55.5 18.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 108.836 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.597 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -54.1 -31.38 51.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.904 . . . . 0.0 108.903 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.83 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -61.19 -39.51 90.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.344 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.555 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 49.0 t -46.16 -22.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.857 . . . . 0.0 110.446 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 t -110.64 -50.29 2.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.019 -1.051 . . . . 0.0 110.325 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.674 ' HB3' HD11 ' A' ' 32' ' ' ILE . 56.1 m-80 -59.56 -11.64 5.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 110.123 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.425 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 98.88 -31.49 8.13 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.674 HD11 ' HB3' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -51.53 -21.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.215 -1.168 . . . . 0.0 109.178 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.83 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 1.2 p90 -43.16 -47.89 6.32 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.626 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 1.2 t0 -87.12 -21.2 26.14 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.505 ' CG1' ' HA ' ' A' ' 32' ' ' ILE . 4.5 mm -85.71 5.72 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.936 -1.102 . . . . 0.0 109.437 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 32' ' ' ILE . 10.0 p -170.52 171.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.572 ' H ' HG22 ' A' ' 36' ' ' VAL . . . 77.24 173.83 39.82 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.739 ' HB2' HG21 ' A' ' 47' ' ' THR . 6.9 t0 -169.96 -89.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -1.107 . . . . 0.0 109.542 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 44' ' ' SER . 17.7 p -65.05 -22.78 67.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.155 -0.966 . . . . 0.0 109.525 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.6 -177.18 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.55 -109.84 3.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.0 -177.16 3.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -1.152 . . . . 0.0 109.449 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -61.81 110.11 1.44 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.431 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.502 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -134.98 8.36 3.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.748 ' SG ' HG22 ' A' ' 47' ' ' THR . 9.0 p -165.46 -160.51 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.659 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.857 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -145.52 13.36 1.37 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.502 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.748 HG22 ' SG ' ' A' ' 45' ' ' CYS . 8.8 t -78.51 -18.75 54.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.585 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.503 ' HB2' ' CB ' ' A' ' 85' ' ' CYS . 21.8 p -87.54 41.9 1.01 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 0.0 109.948 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.013 ' CE1' HD12 ' A' ' 78' ' ' LEU . 14.6 t60 -70.54 76.13 0.57 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.781 HG11 ' SG ' ' A' ' 85' ' ' CYS . 8.4 m -80.02 144.74 10.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 120.214 -1.554 . . . . 0.0 110.673 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.506 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 2.0 m-85 -110.98 102.72 11.18 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.052 HG22 HG12 ' A' ' 99' ' ' VAL . 7.0 t -101.13 156.32 4.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.85 0.834 . . . . 0.0 112.859 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.749 HD22 HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -46.22 177.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.468 0.651 . . . . 0.0 109.267 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -101.68 -0.28 34.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 110.115 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.57 -22.81 11.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.97 -1.081 . . . . 0.0 110.649 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.812 ' HD1' HD23 ' A' ' 94' ' ' LEU . 65.8 m-85 -91.71 -27.08 18.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.988 -1.07 . . . . 0.0 109.747 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.854 HG21 HD22 ' A' ' 81' ' ' ASN . 5.8 p -58.07 -38.13 75.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.18 -0.95 . . . . 0.0 109.475 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 1.2 m-20 -57.46 -64.61 0.83 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.777 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.638 ' HB2' HD21 ' A' ' 94' ' ' LEU . 46.2 mmtt -49.81 -37.96 32.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.912 . . . . 0.0 109.396 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.825 ' CG2' HG22 ' A' ' 88' ' ' ILE . 1.1 t -54.91 157.37 5.71 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.951 . . . . 0.0 108.754 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.604 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.6 Cg_exo -56.13 156.83 19.08 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.087 1.858 . . . . 0.0 110.309 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.52 61.13 0.6 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.325 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.621 ' HB2' ' NH2' ' A' ' 83' ' ' ARG . . . -40.83 146.46 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.626 -0.671 . . . . 0.0 109.689 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.591 ' O ' HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -51.59 -174.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.679 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.527 ' HA ' HD13 ' A' ' 68' ' ' ILE . 58.0 tt0 -96.71 -9.81 28.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.86 . . . . 0.0 109.543 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -50.3 -49.12 54.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.927 . . . . 0.0 109.516 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.469 ' CG ' ' HB2' ' A' ' 43' ' ' ALA . 28.0 mt-10 -74.59 -21.35 59.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.435 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.632 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -68.21 -35.32 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.878 . . . . 0.0 109.314 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.59 -52.6 44.24 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -66.84 -24.31 66.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -1.15 . . . . 0.0 109.273 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.891 ' O ' HD13 ' A' ' 78' ' ' LEU . 5.7 tp -88.24 -7.29 57.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.378 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -80.09 -37.64 33.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.334 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.413 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 42.6 t -104.2 38.61 1.82 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.393 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.857 HG12 ' HB1' ' A' ' 46' ' ' ALA . 16.4 m -63.17 174.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.85 . . . . 0.0 109.597 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.569 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 98.3 m -65.28 -9.37 23.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.747 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.842 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -116.5 -149.92 0.45 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 109.511 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.644 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.2 pt-20 -111.52 155.24 23.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.013 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -129.8 135.66 48.68 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 117.991 -1.483 . . . . 0.0 111.454 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.594 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -117.83 171.02 5.45 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 4.4 Cg_exo -57.52 -10.6 7.13 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 C-N-CA 122.394 2.063 . . . . 0.0 111.09 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.854 HD22 HG21 ' A' ' 57' ' ' THR . 0.0 OUTLIER -104.78 16.57 25.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 0.0 111.499 -178.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.615 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.4 m -100.26 161.09 13.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.675 -1.266 . . . . 0.0 110.029 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.621 ' NH2' ' HB2' ' A' ' 63' ' ' ALA . 1.5 mtp180 -161.62 -165.11 1.22 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 109.287 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.53 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 1.7 mp -104.95 131.09 52.89 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.314 -0.866 . . . . 0.0 108.887 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.781 ' SG ' HG11 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -67.13 -10.41 49.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.399 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.1 p -110.35 15.26 22.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.797 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -131.95 -0.55 3.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.007 . . . . 0.0 109.925 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.825 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -97.9 147.14 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.03 -1.044 . . . . 0.0 108.97 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.619 HG22 ' N ' ' A' ' 90' ' ' MET . 10.7 mm -121.3 165.68 16.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.293 -0.88 . . . . 0.0 109.775 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.638 ' CB ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -122.97 90.33 3.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.352 -0.842 . . . . 0.0 109.341 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.01 162.48 40.78 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.417 -0.802 . . . . 0.0 109.303 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.0 -13.99 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.151 1.901 . . . . 0.0 110.233 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' A' ' 94' ' ' LEU . 21.6 pt-20 -70.92 -45.92 63.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.43 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.812 HD23 ' HD1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -78.46 144.4 35.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -146.41 122.03 10.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 75.22 39.53 36.5 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.948 HD11 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -78.11 134.66 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.441 -1.035 . . . . 0.0 109.197 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.68 HG11 HH11 ' A' ' 12' ' ' ARG . 2.0 t -107.23 110.12 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.976 -1.078 . . . . 0.0 110.012 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.052 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -100.82 146.57 9.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.501 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 1.6 m-20 -122.15 174.25 7.07 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.968 -1.083 . . . . 0.0 110.256 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.897 HG13 ' HD2' ' A' ' 102' ' ' PRO . 39.7 t -108.01 145.21 30.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.897 ' HD2' HG13 ' A' ' 101' ' ' VAL . 7.2 Cg_exo -50.95 159.82 2.26 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.492 2.128 . . . . 0.0 111.548 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -14.7 60.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.596 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -119.87 -159.51 0.78 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 106' ' ' TRP . 3.8 pt20 -159.87 27.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.025 -1.047 . . . . 0.0 109.78 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.681 ' NE1' ' HB3' ' A' ' 46' ' ' ALA . 5.9 m95 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.658 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -147.48 168.39 22.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -0.863 . . . . 0.0 109.253 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.673 ' CG2' HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -153.54 129.95 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.295 -0.878 . . . . 0.0 109.677 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.974 HG13 ' O ' ' A' ' 13' ' ' ARG . 77.7 t -130.17 135.42 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 108.651 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.113 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -104.0 155.14 18.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.922 -1.111 . . . . 0.0 109.393 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.749 HG13 ' HB3' ' A' ' 12' ' ' ARG . 2.4 t -135.25 133.02 52.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.531 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -80.0 -174.27 4.36 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -50.02 161.48 0.26 Allowed 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.528 ' C ' ' O ' ' A' ' 8' ' ' HIS . 33.9 t0 -29.86 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.147 0.499 . . . . 0.0 110.72 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 8' ' ' HIS . . . -167.45 -95.51 0.1 Allowed Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.484 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.6 m -124.97 -178.53 4.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -1.186 . . . . 0.0 109.77 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.749 ' HB3' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -157.15 142.64 17.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.625 -0.672 . . . . 0.0 110.032 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.974 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -100.33 176.2 5.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.255 -0.903 . . . . 0.0 108.899 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -132.43 160.83 35.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.126 -0.984 . . . . 0.0 110.52 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.113 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -177.14 -176.04 0.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.579 0.704 . . . . 0.0 109.115 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -128.94 113.88 15.76 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.581 -0.699 . . . . 0.0 109.965 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.917 HG11 ' HB3' ' A' ' 90' ' ' MET . 28.6 t -78.12 133.37 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.046 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.936 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -69.76 171.81 8.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.498 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -78.44 125.25 29.09 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.269 -0.895 . . . . 0.0 109.084 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.16 39.59 7.86 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.936 HG21 ' HB3' ' A' ' 18' ' ' ALA . 1.5 t -131.11 160.69 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -1.117 . . . . 0.0 109.327 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -99.35 135.07 41.29 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 108.65 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.736 HD23 HG21 ' A' ' 17' ' ' VAL . 6.6 mt -46.28 -26.24 0.77 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.965 -1.085 . . . . 0.0 108.6 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.541 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -72.74 -47.45 46.86 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.639 ' HB3' HG12 ' A' ' 21' ' ' VAL . 39.6 tp60 -51.97 -55.08 22.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.36 -0.837 . . . . 0.0 108.845 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.527 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -57.67 -28.5 63.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 108.737 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.703 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -68.09 -33.89 75.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.47 -0.769 . . . . 0.0 109.451 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.585 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 53.7 t -54.58 -39.89 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.475 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 t -79.87 -51.78 8.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.858 . . . . 0.0 109.398 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.878 ' ND2' HD13 ' A' ' 15' ' ' LEU . 29.4 m-80 -58.57 -13.41 5.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.424 -0.798 . . . . 0.0 109.567 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.47 14.54 78.18 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.954 ' O ' HG22 ' A' ' 35' ' ' ILE . 1.2 mt -90.41 -34.65 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -1.146 . . . . 0.0 108.851 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.703 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -51.48 -37.06 47.12 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.624 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 5.3 t0 -82.83 -26.94 31.21 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.954 HG22 ' O ' ' A' ' 32' ' ' ILE . 4.8 tp -44.48 -26.13 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 109.325 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.582 HG13 ' H ' ' A' ' 37' ' ' GLY . 2.5 p -131.17 -52.15 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.563 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' H ' HG13 ' A' ' 36' ' ' VAL . . . 69.2 120.12 0.03 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 94.9 m-20 -136.4 -120.36 0.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -1.171 . . . . 0.0 109.53 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 1.016 ' SG ' ' HB3' ' A' ' 43' ' ' ALA . 16.7 p -109.79 -6.48 15.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.75 -1.219 . . . . 0.0 109.594 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 44.62 -168.51 0.02 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 43.89 -125.95 5.69 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.12 63.86 1.46 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -1.121 . . . . 0.0 109.543 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 1.016 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . . . -88.8 -147.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 109.431 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.516 ' CB ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -139.78 60.86 1.55 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.152 -0.968 . . . . 0.0 109.773 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.414 ' SG ' ' HB3' ' A' ' 38' ' ' ASP . 6.7 p -99.22 -164.57 1.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.033 -1.042 . . . . 0.0 109.379 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.88 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -148.92 17.74 0.98 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.525 ' CG2' ' OD1' ' A' ' 38' ' ' ASP . 58.5 m -90.02 -17.19 28.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.465 ' HB2' ' SG ' ' A' ' 85' ' ' CYS . 24.5 p -87.6 42.51 1.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 110.269 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.948 ' CE1' HD12 ' A' ' 78' ' ' LEU . 15.3 t60 -75.56 71.19 2.46 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.013 HG11 ' HB3' ' A' ' 85' ' ' CYS . 12.7 m -77.88 146.1 8.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.257 -1.527 . . . . 0.0 110.168 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.661 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -112.53 100.71 8.95 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.309 1.052 . . . . 0.0 108.182 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.797 HG22 HG12 ' A' ' 99' ' ' VAL . 4.5 t -89.76 172.88 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.803 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.579 ' H ' HG12 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -68.86 -178.36 1.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.88 -1.21 35.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 109.967 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.14 -14.38 14.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.085 -1.01 . . . . 0.0 110.187 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.723 ' HD1' HD23 ' A' ' 94' ' ' LEU . 80.3 m-85 -103.67 -21.42 13.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.975 . . . . 0.0 109.7 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.827 HG21 HD22 ' A' ' 81' ' ' ASN . 0.7 OUTLIER -68.7 -6.47 26.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.563 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -88.08 -56.17 3.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.123 -0.986 . . . . 0.0 109.6 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.64 ' HB2' HD21 ' A' ' 94' ' ' LEU . 2.5 mptp? -52.29 -38.69 59.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -50.14 164.57 0.37 Allowed Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.17 -0.956 . . . . 0.0 109.414 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 5.8 Cg_exo -58.16 176.66 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.109 1.873 . . . . 0.0 110.353 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.25 59.37 0.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.29 120.73 1.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.483 -0.761 . . . . 0.0 109.553 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 63' ' ' ALA . 9.7 m-20 -57.0 -160.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.473 ' HG2' ' HB ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -100.05 -12.1 19.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.467 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 67' ' ' GLU . 5.1 ppt_? -54.51 -44.66 72.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.476 ' N ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -81.17 -14.51 57.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.404 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.473 ' HB ' ' HG2' ' A' ' 65' ' ' GLU . 26.0 mm -77.12 -32.17 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.476 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.13 -54.69 11.66 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.516 ' SD ' ' CB ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -67.89 -24.92 65.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -1.155 . . . . 0.0 109.257 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.036 HD23 HD21 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -90.04 0.15 57.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.872 . . . . 0.0 109.43 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -89.99 -25.47 20.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.942 . . . . 0.0 109.299 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.64 34.55 2.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.426 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.922 HG11 ' HB2' ' A' ' 49' ' ' HIS . 2.1 t -63.38 165.01 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.581 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 28.4 m -71.68 -4.25 26.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.477 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.527 ' CB ' ' OD1' ' A' ' 103' ' ' ASP . . . -115.96 -149.8 0.45 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.114 -0.991 . . . . 0.0 109.34 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.63 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.7 pt-20 -112.19 155.06 24.59 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.948 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -133.49 166.34 22.78 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.465 -1.694 . . . . 0.0 112.547 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.698 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -155.7 170.62 8.46 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 5.3 Cg_exo -56.45 -14.68 13.27 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 121.997 1.798 . . . . 0.0 109.992 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.827 HD22 HG21 ' A' ' 57' ' ' THR . 0.0 OUTLIER -87.03 -30.33 21.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 0.0 110.71 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.61 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -74.62 152.87 39.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.021 -1.049 . . . . 0.0 110.354 -179.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 1.096 ' NH2' HG23 ' A' ' 88' ' ' ILE . 8.8 mtp180 -161.8 -175.38 4.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.036 HD21 HD23 ' A' ' 71' ' ' LEU . 4.9 mp -98.99 103.43 15.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.324 -0.86 . . . . 0.0 108.698 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 1.013 ' HB3' HG11 ' A' ' 50' ' ' VAL . 6.1 p -48.85 -21.99 0.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.142 -0.974 . . . . 0.0 109.924 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 20.7 p -76.57 -40.11 50.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.084 -1.01 . . . . 0.0 110.093 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.484 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -89.74 38.44 0.91 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.112 -0.992 . . . . 0.0 110.405 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.096 HG23 ' NH2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -140.06 149.01 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.975 -1.078 . . . . 0.0 109.312 179.294 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.629 HG22 ' N ' ' A' ' 90' ' ' MET . 12.7 mm -116.23 167.09 9.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.421 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.917 ' HB3' HG11 ' A' ' 17' ' ' VAL . 12.9 tpt -130.18 96.87 4.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.665 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -95.53 171.45 6.44 Favored Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 121.549 -0.72 . . . . 0.0 109.385 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.665 ' HD2' HG22 ' A' ' 91' ' ' THR . 5.6 Cg_exo -59.03 -14.49 23.42 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.05 1.833 . . . . 0.0 110.054 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.44 ' OE1' ' HB3' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -62.8 -37.23 85.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 109.312 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.723 HD23 ' HD1' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -95.07 139.75 30.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.234 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 11.2 p-10 -138.72 124.68 19.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.803 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.469 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 71.51 39.22 61.37 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.966 HD11 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -72.91 147.66 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -1.107 . . . . 0.0 109.302 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.509 ' N ' HD13 ' A' ' 97' ' ' ILE . 3.5 t -116.75 106.73 20.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 O-C-N 121.126 -0.983 . . . . 0.0 109.853 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.966 HG13 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -101.25 142.71 15.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.514 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 3.1 m-20 -122.97 177.44 5.5 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.967 -1.083 . . . . 0.0 110.269 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.903 HG13 ' HD2' ' A' ' 102' ' ' PRO . 44.8 t -108.49 145.07 30.8 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.903 ' HD2' HG13 ' A' ' 101' ' ' VAL . 7.7 Cg_exo -51.14 -174.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.263 1.975 . . . . 0.0 111.293 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -100.7 -27.03 13.59 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -130.07 149.7 51.67 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -122.93 41.94 3.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.044 -1.035 . . . . 0.0 109.849 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.581 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 43.6 m95 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.476 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.491 ' HB2' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -138.29 169.51 17.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.215 -0.928 . . . . 0.0 109.428 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.572 HG21 ' CG2' ' A' ' 17' ' ' VAL . 11.3 t -152.34 158.64 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.272 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.672 HG12 ' O ' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -157.8 120.67 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.104 -0.998 . . . . 0.0 108.905 -179.409 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.654 ' CE2' ' CD2' ' A' ' 15' ' ' LEU . 54.9 m-85 -98.5 155.62 17.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.66 -1.275 . . . . 0.0 110.634 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.806 HG22 ' HG3' ' A' ' 12' ' ' ARG . 3.0 t -130.84 142.48 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -76.5 -158.53 0.1 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.76 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -58.31 -103.97 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.18 75.15 0.9 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.482 -1.386 . . . . 0.0 108.496 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.29 -100.42 0.24 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 118.863 -1.636 . . . . 0.0 111.453 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.71 HG22 ' H ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -114.9 -176.59 2.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.289 -1.124 . . . . 0.0 110.584 -178.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.806 ' HG3' HG22 ' A' ' 6' ' ' VAL . 13.7 ttp180 -149.27 134.59 18.35 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.871 ' NH2' HD11 ' A' ' 35' ' ' ILE . 6.6 mtt180 -105.11 171.51 7.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.941 -1.1 . . . . 0.0 108.774 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.481 ' CG ' HG13 ' A' ' 4' ' ' VAL . 1.7 mt-30 -127.08 163.47 23.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.949 -1.094 . . . . 0.0 111.141 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.046 HD13 ' OD1' ' A' ' 30' ' ' ASN . 0.4 OUTLIER -161.65 -172.96 3.53 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.671 0.748 . . . . 0.0 109.019 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 17' ' ' VAL . 46.4 t0 -131.22 69.96 1.47 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.627 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.918 HG21 HD23 ' A' ' 23' ' ' LEU . 26.6 t -43.81 163.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.185 -0.947 . . . . 0.0 109.068 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 1.027 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -105.07 173.1 6.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.959 . . . . 0.0 109.744 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -81.99 125.81 31.22 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.371 -0.831 . . . . 0.0 108.898 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.11 23.3 38.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.027 HG21 ' HB3' ' A' ' 18' ' ' ALA . 3.0 t -118.04 167.34 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.43 -1.041 . . . . 0.0 109.113 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 23' ' ' LEU . 10.4 t -105.89 137.45 43.75 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.918 HD23 HG21 ' A' ' 17' ' ' VAL . 8.3 mt -44.9 -26.69 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.051 . . . . 0.0 108.794 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.622 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 3.3 ttm -75.03 -47.53 28.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.546 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -49.8 -54.77 17.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 108.803 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.767 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -52.24 -35.81 50.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.263 -0.898 . . . . 0.0 108.971 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.69 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -42.15 -42.38 2.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.849 . . . . 0.0 110.076 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.581 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 63.6 t -39.65 -50.41 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.19 -0.944 . . . . 0.0 110.588 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -90.8 -45.36 8.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.876 . . . . 0.0 110.017 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 1.046 ' OD1' HD13 ' A' ' 15' ' ' LEU . 2.4 m120 -50.13 -17.19 0.38 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.725 -0.609 . . . . 0.0 109.774 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.31 -21.64 36.78 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.65 HG13 ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -66.62 -22.17 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.254 -1.144 . . . . 0.0 108.554 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.69 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -48.02 -28.74 2.96 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 179.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -100.17 -23.39 14.85 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.925 HG22 HG13 ' A' ' 36' ' ' VAL . 18.6 mm -60.36 -51.14 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.089 -1.007 . . . . 0.0 109.405 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.925 HG13 HG22 ' A' ' 35' ' ' ILE . 11.8 m -134.06 -153.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.935 . . . . 0.0 109.538 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.492 ' HA2' ' HE1' ' A' ' 24' ' ' MET . . . 112.83 150.89 10.99 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.516 ' OD1' ' CB ' ' A' ' 45' ' ' CYS . 6.8 t70 -152.17 -92.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.178 -1.19 . . . . 0.0 109.714 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.513 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 15.6 p -85.27 -33.28 22.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.987 . . . . 0.0 109.603 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 56.57 162.23 0.03 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.01 -103.67 2.26 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.26 169.4 8.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -1.159 . . . . 0.0 109.488 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.981 ' HB1' HD21 ' A' ' 71' ' ' LEU . . . -65.5 111.95 3.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.508 ' HB2' ' CB ' ' A' ' 39' ' ' CYS . 44.3 m -140.73 11.3 2.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.652 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.516 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . 8.9 p -157.32 -157.41 0.67 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 109.626 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.728 ' HB1' ' HA ' ' A' ' 74' ' ' VAL . . . -150.0 15.22 0.83 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.687 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.779 HG23 ' CB ' ' A' ' 105' ' ' GLN . 22.0 m -82.05 -18.41 43.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.355 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.54 ' SG ' HD12 ' A' ' 84' ' ' LEU . 23.4 p -86.34 43.13 1.04 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 110.112 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.89 ' CE1' HD12 ' A' ' 78' ' ' LEU . 48.0 t60 -77.36 65.56 2.94 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.59 HG11 ' HB3' ' A' ' 85' ' ' CYS . 8.8 m -74.94 143.33 13.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.284 -1.51 . . . . 0.0 110.449 -177.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.645 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 1.0 OUTLIER -109.46 109.55 20.41 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.094 HG22 HG12 ' A' ' 99' ' ' VAL . 7.1 t -97.28 171.42 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-O 122.005 0.907 . . . . 0.0 112.531 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.565 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -65.33 176.8 1.26 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.298 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.75 7.72 45.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.151 -0.968 . . . . 0.0 109.626 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.33 -27.96 8.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.883 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.611 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 88.1 m-85 -98.27 -18.54 18.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.739 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.941 HG21 ' HA ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER -62.5 -39.01 92.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.611 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.38 -41.18 94.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 109.776 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.856 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -54.41 -42.65 70.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.907 . . . . 0.0 109.579 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.889 HG11 HG23 ' A' ' 88' ' ' ILE . 62.3 t -62.54 142.38 96.57 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.084 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.747 ' HD2' HG13 ' A' ' 60' ' ' VAL . 5.7 Cg_exo -56.36 168.8 1.89 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.075 1.85 . . . . 0.0 110.468 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.48 63.51 0.61 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.366 -0.834 . . . . 0.0 109.125 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -36.52 139.66 0.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.275 0.56 . . . . 0.0 110.068 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -50.52 -177.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.347 -0.846 . . . . 0.0 109.804 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.534 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 23.9 tt0 -97.07 -12.77 22.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 109.507 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -50.07 -67.18 0.28 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.463 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -66.09 -10.22 38.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.534 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 26.5 mm -76.38 -31.93 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.521 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.77 -54.91 8.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.3 mtt -68.25 -26.28 65.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -1.15 . . . . 0.0 108.987 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.981 HD21 ' HB1' ' A' ' 43' ' ' ALA . 38.3 mt -84.21 -2.96 57.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.35 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.415 ' C ' ' OE1' ' A' ' 72' ' ' GLU . 0.6 OUTLIER -91.13 -10.11 43.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.289 -0.882 . . . . 0.0 109.353 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -86.24 51.37 2.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.418 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.728 ' HA ' ' HB1' ' A' ' 46' ' ' ALA . 6.2 m -92.76 169.1 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 109.295 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.825 HG21 ' CB ' ' A' ' 104' ' ' ARG . 5.4 t -66.36 -34.56 78.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.797 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.405 ' N ' ' CG2' ' A' ' 75' ' ' THR . . . -106.62 -151.23 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.387 -0.821 . . . . 0.0 110.633 -178.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.558 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -112.51 149.9 32.03 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.89 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -108.29 165.44 11.5 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.609 -1.236 . . . . 0.0 110.465 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.543 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -158.97 172.87 5.57 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 6.0 Cg_exo -54.38 -18.77 15.43 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 121.309 1.339 . . . . 0.0 108.803 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.941 ' HA ' HG21 ' A' ' 57' ' ' THR . 0.2 OUTLIER -83.18 -35.93 25.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.712 -0.617 . . . . 0.0 109.739 179.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.565 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -95.48 159.22 15.1 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.19 -0.944 . . . . 0.0 110.398 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.605 ' HD2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -161.69 -164.22 1.08 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.343 -0.848 . . . . 0.0 109.03 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.865 ' N ' HD22 ' A' ' 84' ' ' LEU . 1.3 mm? -104.19 123.53 47.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.59 ' HB3' HG11 ' A' ' 50' ' ' VAL . 13.9 p -64.13 -10.75 24.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.014 -1.054 . . . . 0.0 109.553 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 22.6 p -100.21 14.7 29.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.276 -0.89 . . . . 0.0 109.914 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -143.3 0.34 1.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.013 -1.054 . . . . 0.0 110.694 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.889 HG23 HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -96.9 151.69 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.764 -1.21 . . . . 0.0 108.911 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 88' ' ' ILE . 18.0 mm -124.23 158.66 30.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.165 -0.959 . . . . 0.0 109.927 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.652 ' CB ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.93 90.33 3.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 109.176 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.413 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -82.0 167.07 33.38 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.399 -0.813 . . . . 0.0 109.456 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 3.3 Cg_exo -60.49 -13.33 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.115 1.877 . . . . 0.0 110.097 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.05 -39.99 65.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.856 HD21 ' CB ' ' A' ' 59' ' ' LYS . 4.6 mp -81.99 135.25 35.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.43 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.4 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 11.4 p-10 -135.67 124.24 23.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 68.25 49.28 47.14 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.975 HD11 HG22 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -75.9 151.11 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.187 -1.184 . . . . 0.0 108.455 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.944 ' N ' HD12 ' A' ' 97' ' ' ILE . 5.6 t -121.81 102.62 12.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.947 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.094 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -96.08 154.23 3.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -130.5 172.79 11.52 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.036 -1.04 . . . . 0.0 109.225 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.86 HG13 ' HD2' ' A' ' 102' ' ' PRO . 55.5 t -107.38 144.31 28.94 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.282 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.86 ' HD2' HG13 ' A' ' 101' ' ' VAL . 5.8 Cg_exo -57.26 -178.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.326 2.017 . . . . 0.0 110.364 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.595 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 6.9 t0 -90.2 -32.89 16.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 108.503 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.825 ' CB ' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.17 -161.19 1.12 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.779 ' CB ' HG23 ' A' ' 47' ' ' THR . 7.8 pt20 -159.45 27.76 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.956 . . . . 0.0 109.535 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 73' ' ' CYS . 10.9 m95 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.459 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.34 0.59 . . . . 0.0 109.513 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.499 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 3.0 ttmt -139.54 174.42 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.06 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.754 HG13 HD11 ' A' ' 23' ' ' LEU . 5.0 t -152.58 157.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.742 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 13' ' ' ARG . 67.2 t -156.93 117.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.805 . . . . 0.0 109.154 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 1.085 ' CE1' HD21 ' A' ' 15' ' ' LEU . 1.2 m-85 -95.47 154.05 17.4 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.344 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.78 HG22 ' HB3' ' A' ' 12' ' ' ARG . 2.4 t -133.87 142.44 41.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 8' ' ' HIS . 6.9 t -77.65 -158.05 0.11 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.714 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -58.08 -103.24 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -112.22 77.28 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.513 -1.367 . . . . 0.0 108.973 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.72 -101.06 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 118.977 -1.582 . . . . 0.0 111.093 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.697 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.3 m -120.12 -176.56 3.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.298 -1.119 . . . . 0.0 109.932 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.78 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -152.71 138.53 17.98 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.738 -0.601 . . . . 0.0 109.981 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.797 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -90.98 177.63 6.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.192 -0.943 . . . . 0.0 108.965 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 2.4 pt20 -140.5 128.18 21.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.211 -0.931 . . . . 0.0 110.37 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.085 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -139.7 -175.45 4.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.217 179.218 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.12 82.64 1.95 Allowed 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.943 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.081 HG22 ' CB ' ' A' ' 26' ' ' ALA . 42.8 t -59.72 111.92 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 109.009 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.735 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -43.56 168.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 109.925 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.433 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 57.5 m-20 -84.32 126.45 33.21 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.339 -0.851 . . . . 0.0 108.989 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.3 15.25 35.98 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.735 HG21 ' HB3' ' A' ' 18' ' ' ALA . 4.4 t -115.5 169.71 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.363 -1.081 . . . . 0.0 109.138 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.487 ' HA ' HD13 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -106.73 135.82 47.61 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.17 -0.957 . . . . 0.0 108.69 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.909 HD13 ' CZ ' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -44.35 -26.3 0.32 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.049 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.474 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -73.24 -48.68 32.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.289 -0.882 . . . . 0.0 108.74 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.504 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 1.3 tp60 -53.16 -56.11 18.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.057 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 1.081 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.54 -26.9 64.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 108.911 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -69.98 -32.39 70.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.429 -0.794 . . . . 0.0 109.215 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.575 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 59.8 t -52.95 -35.57 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.478 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -88.54 -52.26 5.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.479 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.872 ' ND2' HD13 ' A' ' 15' ' ' LEU . 24.9 m-80 -54.15 -16.21 1.92 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.656 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 35' ' ' ILE . . . 84.87 19.3 59.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.634 HG23 HD12 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -99.61 -27.64 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -1.156 . . . . 0.0 108.494 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.651 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 1.1 p90 -47.96 -44.89 30.68 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.554 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 0.9 OUTLIER -74.56 -31.4 62.09 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.634 HD12 HG23 ' A' ' 32' ' ' ILE . 56.4 mt -60.94 -20.22 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 109.098 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.514 HG11 HG22 ' A' ' 101' ' ' VAL . 2.5 p -170.1 112.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 109.515 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 38' ' ' ASP . . . 177.91 176.99 46.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.563 ' OD1' HG21 ' A' ' 47' ' ' THR . 0.3 OUTLIER -163.1 -86.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -1.182 . . . . 0.0 109.803 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 41' ' ' GLY . 12.6 p -83.49 10.07 9.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.679 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 86' ' ' CYS . . . 51.93 -90.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 39' ' ' CYS . . . -54.46 -169.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.18 99.98 12.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -1.15 . . . . 0.0 109.481 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.427 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . . . -118.07 -99.28 0.45 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 70' ' ' MET . 13.6 t -160.57 40.64 0.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.918 -1.114 . . . . 0.0 109.965 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.515 ' SG ' ' CB ' ' A' ' 38' ' ' ASP . 1.7 p -99.99 149.86 23.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.068 . . . . 0.0 109.331 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 1.044 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -105.89 23.78 13.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.563 HG21 ' OD1' ' A' ' 38' ' ' ASP . 22.0 m -90.25 -19.9 23.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.902 . . . . 0.0 109.756 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 21.9 p -91.03 42.73 1.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.099 -1.001 . . . . 0.0 110.287 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 1.008 ' CE1' HD12 ' A' ' 78' ' ' LEU . 11.7 t60 -76.29 70.27 2.89 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.582 HG11 ' SG ' ' A' ' 85' ' ' CYS . 10.3 m -77.85 144.27 11.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 120.123 -1.611 . . . . 0.0 109.755 -178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.626 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 0.9 OUTLIER -109.57 99.11 8.36 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.849 HG22 HG12 ' A' ' 99' ' ' VAL . 3.8 t -89.98 173.98 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.844 0.831 . . . . 0.0 112.124 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.617 ' H ' HG12 ' A' ' 52' ' ' VAL . 1.3 m-20 -68.88 -177.94 1.11 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.19 -1.64 33.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.139 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.3 -21.61 12.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.996 -1.065 . . . . 0.0 110.446 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.625 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 85.5 m-85 -95.18 -23.79 17.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.024 -1.047 . . . . 0.0 109.895 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.785 HG21 HD22 ' A' ' 81' ' ' ASN . 0.8 OUTLIER -63.46 -34.1 77.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.149 -0.969 . . . . 0.0 109.39 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.61 -63.77 1.0 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.549 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.62 ' HB3' HD11 ' A' ' 94' ' ' LEU . 20.3 mmtp -49.88 -23.41 1.91 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.929 . . . . 0.0 109.385 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.877 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -57.94 162.71 5.01 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 108.994 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.877 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.5 Cg_exo -58.71 171.38 2.03 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.128 1.885 . . . . 0.0 110.243 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.22 59.65 0.61 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -0.922 . . . . 0.0 109.507 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.032 ' HB3' ' NH2' ' A' ' 83' ' ' ARG . . . -42.43 151.95 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.45 -0.781 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -61.72 -162.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 109.56 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.534 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 2.0 tm-20 -100.16 -22.18 15.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 109.543 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.442 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.7 mtt180 -43.9 -56.99 3.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.646 ' OE2' ' HB1' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -64.63 -30.84 71.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.534 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 36.9 mm -56.0 -43.82 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 109.528 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.76 -30.13 62.22 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.508 ' N ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -68.5 -16.08 63.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -1.131 . . . . 0.0 109.342 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.026 HD13 ' HG ' ' A' ' 84' ' ' LEU . 10.0 tp -90.89 -8.95 48.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.81 -23.0 42.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.388 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -85.32 45.14 1.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.89 . . . . 0.0 109.462 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.044 HG12 ' HB1' ' A' ' 46' ' ' ALA . 4.1 m -106.59 163.8 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.388 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 75' ' ' THR . 96.0 m -85.44 6.69 25.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.942 . . . . 0.0 109.544 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.735 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -114.47 -156.12 0.59 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.132 -0.98 . . . . 0.0 109.463 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.635 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.7 pt-20 -112.55 151.42 30.03 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.008 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -128.03 159.83 33.83 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 117.912 -1.515 . . . . 0.0 111.631 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.546 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -149.37 171.38 6.38 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 5.0 Cg_exo -56.59 -15.02 14.55 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 121.956 1.77 . . . . 0.0 109.84 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.785 HD22 HG21 ' A' ' 57' ' ' THR . 2.7 t-20 -86.53 -30.93 21.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.392 -0.818 . . . . 0.0 110.542 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.623 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -68.59 159.25 32.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.953 -1.092 . . . . 0.0 110.481 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 1.032 ' NH2' ' HB3' ' A' ' 63' ' ' ALA . 2.6 mtp180 -161.53 166.38 27.14 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.365 -0.834 . . . . 0.0 109.124 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.026 ' HG ' HD13 ' A' ' 71' ' ' LEU . 6.2 mp -79.76 118.94 22.01 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.157 -0.965 . . . . 0.0 108.598 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.582 ' SG ' HG11 ' A' ' 50' ' ' VAL . 2.2 t -47.12 -24.35 0.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 109.475 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 30.6 p -88.19 30.88 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 0.0 109.769 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.654 HE21 ' HB2' ' A' ' 63' ' ' ALA . 7.8 mm100 -149.66 12.65 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.049 -1.032 . . . . 0.0 109.994 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.832 HG22 HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -108.87 140.52 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.082 -1.012 . . . . 0.0 108.704 179.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.691 HD13 ' O ' ' A' ' 88' ' ' ILE . 23.9 mm -125.91 146.03 32.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.762 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.686 ' HE3' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -98.32 83.31 3.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -0.852 . . . . 0.0 109.112 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 p -81.83 155.99 70.29 Favored Pre-proline 0 C--N 1.297 -1.686 0 O-C-N 121.486 -0.759 . . . . 0.0 109.203 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 19' ' ' ASP . 6.3 Cg_exo -58.42 -14.94 22.42 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.021 1.814 . . . . 0.0 109.905 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -73.12 -41.19 64.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.836 . . . . 0.0 109.323 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 59' ' ' LYS . 5.6 mp -86.11 142.68 28.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -138.16 126.35 22.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.703 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.591 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 68.14 49.72 44.79 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.979 HD11 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -77.79 151.71 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.224 -1.162 . . . . 0.0 108.878 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.402 ' N ' HG12 ' A' ' 97' ' ' ILE . 4.8 t -122.06 104.7 15.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.034 -1.041 . . . . 0.0 110.363 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.979 HG13 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -98.93 144.86 11.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.04 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -122.79 176.3 6.05 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.914 -1.116 . . . . 0.0 109.733 -179.288 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.88 HG13 ' HD2' ' A' ' 102' ' ' PRO . 51.0 t -108.6 144.02 28.7 Favored Pre-proline 0 C--N 1.298 -1.641 0 C-N-CA 119.671 -0.812 . . . . 0.0 108.943 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.88 ' HD2' HG13 ' A' ' 101' ' ' VAL . 4.1 Cg_exo -54.36 172.37 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.461 2.107 . . . . 0.0 111.492 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.421 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -82.03 -17.53 46.45 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.544 ' HG3' ' NH1' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -128.87 107.4 9.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.381 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 106' ' ' TRP . 8.3 pt20 -79.76 5.03 14.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.145 -0.972 . . . . 0.0 109.59 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.572 ' CZ2' ' OG1' ' A' ' 75' ' ' THR . 62.2 m95 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.495 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.318 0.58 . . . . 0.0 109.504 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.408 ' O ' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -151.48 159.38 44.2 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.268 -0.895 . . . . 0.0 109.187 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.839 HG11 HD22 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -147.95 125.2 3.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.211 -0.93 . . . . 0.0 109.38 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 99' ' ' VAL . 97.4 t -126.01 129.64 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -0.918 . . . . 0.0 108.887 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.161 ' CD2' HG21 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -97.69 154.59 17.48 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.944 -1.097 . . . . 0.0 109.374 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.942 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.1 t -123.96 170.19 14.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.446 -0.784 . . . . 0.0 108.977 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.602 ' H ' HG12 ' A' ' 6' ' ' VAL . 14.6 p -121.43 162.89 19.65 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.477 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.43 -8.38 13.26 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 120.872 -1.142 . . . . 0.0 109.051 179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 9' ' ' ASP . 4.5 t70 -110.25 -6.06 15.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.114 -0.991 . . . . 0.0 110.316 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.41 -31.75 5.67 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.266 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.768 HG22 ' NH1' ' A' ' 13' ' ' ARG . 54.1 m -49.71 114.0 0.96 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.043 -1.269 . . . . 0.0 109.486 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 5' ' ' TYR . 18.3 ptt180 -130.78 126.05 35.33 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.596 -0.69 . . . . 0.0 109.694 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 1.041 ' NH2' HG21 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -104.24 125.96 50.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.182 -0.949 . . . . 0.0 108.714 179.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -85.83 157.37 20.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.122 -0.986 . . . . 0.0 110.567 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.1 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -167.4 -177.32 3.57 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.698 0.761 . . . . 0.0 109.334 179.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.41 106.23 8.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.714 -0.616 . . . . 0.0 109.574 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.961 HG21 HD23 ' A' ' 23' ' ' LEU . 78.5 t -81.05 108.71 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.404 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.614 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -46.31 172.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.548 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 75.1 m-20 -83.27 125.19 31.33 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.327 -0.858 . . . . 0.0 109.137 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.81 29.31 8.74 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.908 ' O ' HG23 ' A' ' 89' ' ' ILE . 2.1 t -130.58 170.96 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.342 -1.093 . . . . 0.0 109.378 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.509 ' HB2' ' CD1' ' A' ' 89' ' ' ILE . 13.2 t -115.92 146.43 42.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.26 -0.9 . . . . 0.0 108.926 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.961 HD23 HG21 ' A' ' 17' ' ' VAL . 16.2 mt -47.53 -25.48 1.13 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.961 -1.087 . . . . 0.0 108.478 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.579 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 24.2 ptt? -71.6 -46.3 59.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.847 . . . . 0.0 108.832 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 1.049 ' O ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -55.14 -56.54 18.76 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.144 -0.972 . . . . 0.0 108.805 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.588 ' HB1' ' ND2' ' A' ' 30' ' ' ASN . . . -60.17 -19.25 53.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.3 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 24' ' ' MET . . . -70.76 -40.07 72.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.346 -0.847 . . . . 0.0 110.127 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.049 HG22 ' O ' ' A' ' 25' ' ' GLN . 32.6 m -45.65 -33.05 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.181 -0.95 . . . . 0.0 110.366 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 31' ' ' GLY . 3.7 t -107.39 -59.64 1.8 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.956 . . . . 0.0 109.815 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.992 ' ND2' HD13 ' A' ' 15' ' ' LEU . 47.2 m-20 -38.8 -27.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.342 0.592 . . . . 0.0 109.989 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 107.63 -9.69 38.04 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.161 HG21 ' CD2' ' A' ' 5' ' ' TYR . 0.9 OUTLIER -68.29 -13.15 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -1.223 . . . . 0.0 107.913 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.554 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -49.51 -28.72 5.77 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 178.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' N ' ' C ' ' A' ' 32' ' ' ILE . 0.3 OUTLIER -92.15 -30.16 16.1 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.041 HG21 ' NH2' ' A' ' 13' ' ' ARG . 3.0 mt -105.83 40.66 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.128 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.832 HG13 ' N ' ' A' ' 37' ' ' GLY . 1.3 p -143.16 -151.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.832 ' N ' HG13 ' A' ' 36' ' ' VAL . . . -72.0 -159.91 4.39 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -141.5 -53.95 0.46 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.974 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 42' ' ' SER . 15.1 p -63.7 -11.1 23.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.079 -1.013 . . . . 0.0 109.695 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 86' ' ' CYS . . . 85.19 -164.99 39.0 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.513 ' CA ' ' HB2' ' A' ' 86' ' ' CYS . . . -42.56 -27.43 0.5 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.458 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 67.8 p -59.91 168.86 1.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -1.15 . . . . 0.0 109.37 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HA ' ' S1 ' ' A' ' 107' ' ' FES . . . -128.68 71.04 1.39 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.288 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -124.71 -10.81 7.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.791 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.522 ' O ' ' CE ' ' A' ' 70' ' ' MET . 1.8 p -111.83 -178.92 3.55 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.662 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.736 ' HB3' ' NE1' ' A' ' 106' ' ' TRP . . . -133.03 12.89 4.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.181 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.856 HG22 ' CB ' ' A' ' 106' ' ' TRP . 5.6 p -75.57 -16.15 60.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.448 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.502 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 25.6 p -86.72 41.61 0.96 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.289 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.04 ' CE1' HD12 ' A' ' 78' ' ' LEU . 26.7 t60 -82.25 64.16 6.78 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 83' ' ' ARG . 12.5 m -80.68 147.22 6.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.55 -1.344 . . . . 0.0 110.076 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.639 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 8.0 m-85 -107.86 106.41 16.68 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.695 ' HB ' HG23 ' A' ' 57' ' ' THR . 4.5 t -89.78 166.79 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 CA-C-O 121.791 0.805 . . . . 0.0 112.151 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.483 ' N ' HG12 ' A' ' 52' ' ' VAL . 1.2 m-20 -64.61 -176.79 0.27 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -100.64 -6.6 24.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.236 -0.915 . . . . 0.0 110.28 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.5 1.53 18.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.965 -1.084 . . . . 0.0 110.463 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.634 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 49.5 m-85 -115.14 -20.96 10.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.93 -1.106 . . . . 0.0 110.087 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.695 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -78.36 1.44 21.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.991 -1.068 . . . . 0.0 109.523 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -85.08 -58.62 2.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.673 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.831 ' CB ' HD11 ' A' ' 94' ' ' LEU . 3.4 mptt -49.98 -39.93 42.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.569 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -56.68 164.36 2.19 Favored Pre-proline 0 C--N 1.306 -1.309 0 O-C-N 121.136 -0.977 . . . . 0.0 109.412 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 4.8 Cg_exo -59.16 172.14 1.93 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.149 1.899 . . . . 0.0 110.261 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.423 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.14 59.39 0.61 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.379 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.05 111.27 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.523 -0.736 . . . . 0.0 109.56 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 63' ' ' ALA . 5.8 m-20 -57.11 -160.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.549 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.665 ' HA ' HD12 ' A' ' 68' ' ' ILE . 21.1 tt0 -85.07 -10.36 56.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -48.28 -67.62 0.26 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -65.63 -12.94 57.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.503 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.665 HD12 ' HA ' ' A' ' 65' ' ' GLU . 14.5 mt -73.89 -31.92 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.75 -58.58 4.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.672 ' HE1' ' S1 ' ' A' ' 107' ' ' FES . 6.1 ptm -67.95 -27.04 66.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -1.141 . . . . 0.0 109.298 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.062 HD13 HG11 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -89.99 6.41 42.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.332 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 68' ' ' ILE . 9.7 tp10 -94.62 -30.34 14.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.249 -0.907 . . . . 0.0 109.16 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 74' ' ' VAL . 77.4 m -98.64 15.79 24.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.886 . . . . 0.0 109.233 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.062 HG11 HD13 ' A' ' 71' ' ' LEU . 17.1 m -46.27 171.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.474 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.568 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 62.2 m -73.77 -2.14 22.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.739 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.782 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -126.43 -152.52 0.52 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.004 -1.06 . . . . 0.0 109.812 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.653 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.6 pt-20 -112.57 155.72 23.89 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.04 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -129.54 152.45 49.05 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 117.779 -1.568 . . . . 0.0 111.989 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.56 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 2.5 mmtm -132.67 166.32 29.92 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.56 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 6.2 Cg_exo -54.94 -17.25 13.62 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.254 1.969 . . . . 0.0 110.717 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.42 -31.44 22.88 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.396 -0.815 . . . . 0.0 110.644 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.576 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.3 m -60.45 159.55 10.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.889 -1.132 . . . . 0.0 109.578 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.528 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -162.04 139.67 8.65 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.819 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.91 HD21 HD23 ' A' ' 71' ' ' LEU . 1.3 mp -63.0 107.75 1.07 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -43.02 -26.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.878 -179.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 28.6 p -86.83 31.76 0.69 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 110.24 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 86' ' ' CYS . 12.3 mt-30 -153.36 24.24 0.54 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.872 -1.143 . . . . 0.0 110.492 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.447 HD13 ' HB3' ' A' ' 83' ' ' ARG . 0.4 OUTLIER -140.63 131.31 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 0.0 109.649 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.908 HG23 ' O ' ' A' ' 21' ' ' VAL . 31.1 mm -110.0 148.44 13.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.362 -0.837 . . . . 0.0 109.436 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.548 ' HE2' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -103.69 84.95 2.35 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.169 -0.957 . . . . 0.0 109.132 179.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.685 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -78.03 171.69 11.81 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.685 ' HD2' HG22 ' A' ' 91' ' ' THR . 5.5 Cg_exo -59.14 -14.06 22.13 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.104 1.869 . . . . 0.0 110.117 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -69.54 -50.9 40.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 0.0 109.336 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.831 HD11 ' CB ' ' A' ' 59' ' ' LYS . 0.9 OUTLIER -83.46 138.96 33.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.242 -0.911 . . . . 0.0 109.378 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -145.31 132.14 20.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 0.0 109.632 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.433 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 70.69 37.39 67.22 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.714 ' CG2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -71.92 147.89 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.408 -1.054 . . . . 0.0 109.522 -179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.531 ' N ' HD13 ' A' ' 97' ' ' ILE . 5.5 t -114.09 106.68 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.239 -0.913 . . . . 0.0 109.8 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.797 HG21 HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -98.0 152.22 4.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.533 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 0.4 OUTLIER -128.07 176.05 7.93 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.922 -1.111 . . . . 0.0 109.807 -179.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 6' ' ' VAL . 21.5 t -106.42 146.48 33.09 Favored Pre-proline 0 C--N 1.296 -1.735 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.527 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.879 ' HD2' HG13 ' A' ' 101' ' ' VAL . 11.6 Cg_exo -52.99 177.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.428 2.086 . . . . 0.0 110.303 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 21.8 t0 -74.77 -22.62 58.67 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.551 ' HD3' HG22 ' A' ' 75' ' ' THR . 0.0 OUTLIER -130.87 -167.51 1.85 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 106' ' ' TRP . 50.3 tp60 -139.01 28.19 2.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.939 -1.101 . . . . 0.0 109.657 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.856 ' CB ' HG22 ' A' ' 47' ' ' THR . 8.9 m95 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.515 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.817 ' S1 ' HD23 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.311 0.577 . . . . 0.0 109.581 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.81 161.62 37.11 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.306 -0.871 . . . . 0.0 109.116 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.604 HG11 ' CD2' ' A' ' 23' ' ' LEU . 1.4 t -150.75 128.43 2.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.27 -0.894 . . . . 0.0 109.683 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.935 HG22 ' HB3' ' A' ' 14' ' ' GLN . 42.6 t -132.04 164.5 34.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.901 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -137.72 159.56 41.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.073 . . . . 0.0 109.903 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 101' ' ' VAL . 4.0 t -131.2 137.24 56.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.554 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 35.2 t -93.19 171.15 9.12 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.494 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -66.98 -6.05 15.3 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.028 -1.045 . . . . 0.0 109.156 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.35 -2.99 16.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.136 -0.977 . . . . 0.0 110.219 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.66 17.34 15.12 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.215 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.529 ' OG1' ' CB ' ' A' ' 7' ' ' SER . 69.5 m -49.82 112.97 0.74 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.037 -1.272 . . . . 0.0 109.1 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.07 105.71 16.48 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.564 -0.71 . . . . 0.0 110.325 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.422 ' O ' HG13 ' A' ' 4' ' ' VAL . 22.8 ttm180 -148.33 133.86 18.71 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.935 ' HB3' HG22 ' A' ' 4' ' ' VAL . 3.5 mp0 -120.03 179.4 4.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.004 -1.06 . . . . 0.0 110.986 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.901 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -176.12 -176.03 0.76 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.27 100.0 5.89 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.545 -0.722 . . . . 0.0 109.53 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.998 HG11 ' HB3' ' A' ' 90' ' ' MET . 39.5 t -65.51 108.62 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.352 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.886 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -46.55 172.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.424 ' OD2' ' HG3' ' A' ' 92' ' ' PRO . 52.8 m-20 -82.2 125.03 30.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.259 -0.901 . . . . 0.0 109.151 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.04 41.13 6.36 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.886 HG21 ' HB3' ' A' ' 18' ' ' ALA . 1.9 t -133.79 162.37 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -1.165 . . . . 0.0 109.414 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.462 ' OG ' ' CD1' ' A' ' 89' ' ' ILE . 46.6 m -98.09 137.08 37.4 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 108.854 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.739 HD23 HG21 ' A' ' 17' ' ' VAL . 6.5 mt -46.29 -26.36 0.79 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.012 -1.055 . . . . 0.0 108.613 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.26 -47.09 45.91 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.788 ' HB3' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -51.96 -51.22 58.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.038 179.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.494 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -60.84 -29.59 69.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 108.821 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.997 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -73.02 -25.2 60.87 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.44 -0.787 . . . . 0.0 109.552 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.579 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 88.4 t -57.07 -42.13 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.069 -1.019 . . . . 0.0 109.385 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.2 t -84.56 -55.08 4.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.401 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.811 ' CG ' HD22 ' A' ' 15' ' ' LEU . 24.5 m-80 -52.92 -18.53 2.0 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.376 -0.828 . . . . 0.0 109.606 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.89 23.61 57.22 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.986 HG23 HD12 ' A' ' 35' ' ' ILE . 1.1 mt -101.33 -25.55 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.038 -1.272 . . . . 0.0 108.286 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.997 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 2.3 p90 -48.74 -47.17 41.66 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.632 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 34.0 t70 -69.46 -33.08 72.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.986 HD12 HG23 ' A' ' 32' ' ' ILE . 53.5 mt -57.72 -19.28 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.182 -0.949 . . . . 0.0 108.936 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.874 HG13 ' O ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -170.03 133.73 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.442 -0.786 . . . . 0.0 109.377 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' ' OD1' ' A' ' 38' ' ' ASP . . . 133.86 169.06 11.97 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.932 ' CG ' HG21 ' A' ' 47' ' ' THR . 0.2 OUTLIER -161.73 -89.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.158 -1.201 . . . . 0.0 109.824 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.513 ' SG ' ' N ' ' A' ' 40' ' ' GLY . 13.1 p -50.97 -41.97 59.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 109.568 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.513 ' N ' ' SG ' ' A' ' 39' ' ' CYS . . . 71.05 -83.9 0.4 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 43' ' ' ALA . . . -70.92 -79.1 0.39 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.461 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 59.8 p -59.71 88.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.264 -1.139 . . . . 0.0 109.813 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.6 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -60.29 99.68 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.481 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.458 ' HA ' ' HG2' ' A' ' 70' ' ' MET . 2.3 m -160.03 22.06 0.17 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.713 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 7.8 p -116.05 -157.89 0.66 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 109.432 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.793 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -147.81 12.8 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.098 -1.001 . . . . 0.0 109.877 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.953 HG22 ' CB ' ' A' ' 106' ' ' TRP . 5.0 p -77.93 -23.74 48.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.104 -0.997 . . . . 0.0 109.496 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 27.1 p -86.66 42.66 1.02 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 110.312 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.734 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 69.8 t60 -77.85 67.03 3.64 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 83' ' ' ARG . 11.4 m -87.16 147.71 5.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.471 -1.393 . . . . 0.0 110.862 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.734 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 6.8 m-30 -107.26 106.31 16.71 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 122.159 0.981 . . . . 0.0 108.393 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.801 HG22 HG12 ' A' ' 99' ' ' VAL . 9.6 t -90.0 164.46 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.852 0.834 . . . . 0.0 112.431 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.488 ' N ' HG12 ' A' ' 52' ' ' VAL . 1.4 t-20 -69.0 152.49 45.19 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -77.27 7.49 5.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.297 -0.877 . . . . 0.0 110.619 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.33 -12.52 14.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.778 -1.202 . . . . 0.0 110.046 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 1.098 ' CB ' HD13 ' A' ' 97' ' ' ILE . 80.2 m-85 -111.36 -19.71 12.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 0.0 109.587 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.748 HG21 ' ND2' ' A' ' 81' ' ' ASN . 1.9 p -68.78 -12.17 61.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 109.241 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -88.97 -37.95 14.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.918 . . . . 0.0 109.568 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.681 ' HB2' HD21 ' A' ' 94' ' ' LEU . 1.2 mptm? -71.44 -33.14 69.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.165 -0.96 . . . . 0.0 109.487 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 57' ' ' THR . 0.2 OUTLIER -51.91 164.21 0.58 Allowed Pre-proline 0 C--N 1.305 -1.326 0 O-C-N 121.223 -0.923 . . . . 0.0 109.218 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 5.7 Cg_exo -56.33 -166.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.044 1.829 . . . . 0.0 110.234 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.39 58.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.628 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -43.41 107.46 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.455 -0.778 . . . . 0.0 109.355 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' ALA . 4.3 m-20 -56.86 -160.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.613 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.532 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 62.1 tt0 -100.09 -16.95 17.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.489 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 65' ' ' GLU . 2.1 mtp180 -44.74 -61.12 1.7 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.238 -0.914 . . . . 0.0 109.457 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.6 ' OE1' ' HB3' ' A' ' 43' ' ' ALA . 1.2 mt-10 -66.86 -23.63 66.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.917 . . . . 0.0 109.425 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.532 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 32.2 mm -63.65 -31.87 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.503 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.59 -50.76 47.36 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.458 ' HG2' ' HA ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -65.9 -23.8 66.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -1.145 . . . . 0.0 109.3 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.853 ' O ' HG13 ' A' ' 74' ' ' VAL . 5.2 tp -87.76 -10.49 50.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.428 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -76.22 -35.62 58.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.355 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.99 45.07 0.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 0.0 109.363 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.882 HG23 ' H ' ' A' ' 76' ' ' ALA . 10.9 m -82.16 171.05 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 0.0 109.514 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -57.41 -16.14 8.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.883 . . . . 0.0 109.604 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.882 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -124.86 -151.23 0.47 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.114 -0.991 . . . . 0.0 110.52 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.576 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 2.2 pm0 -112.59 153.01 28.22 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.602 HD11 HD23 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -111.22 127.36 55.58 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.803 -1.559 . . . . 0.0 111.672 179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 1.9 mptp? -98.61 167.85 10.76 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 2.2 Cg_endo -60.05 -9.73 10.83 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 C-N-CA 122.456 2.104 . . . . 0.0 111.37 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.748 ' ND2' HG21 ' A' ' 57' ' ' THR . 0.2 OUTLIER -107.26 4.92 27.1 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.086 -1.009 . . . . 0.0 111.836 -178.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.57 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -88.6 155.95 19.33 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.54 -1.35 . . . . 0.0 109.964 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.556 ' O ' HG22 ' A' ' 50' ' ' VAL . 6.5 ttt180 -162.14 158.05 24.11 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.731 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.885 HD23 ' S1 ' ' A' ' 107' ' ' FES . 4.1 mp -78.84 106.28 10.74 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 108.648 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 48' ' ' CYS . 20.2 p -48.72 -22.11 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.22 -0.925 . . . . 0.0 109.596 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 26.6 p -81.3 -38.65 26.44 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.19 -0.944 . . . . 0.0 110.245 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.518 ' OE1' ' CB ' ' A' ' 43' ' ' ALA . 4.0 tp60 -89.47 42.85 1.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.084 -1.01 . . . . 0.0 110.865 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -149.31 146.64 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.889 -1.132 . . . . 0.0 109.534 178.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.619 HG22 ' N ' ' A' ' 90' ' ' MET . 11.4 mm -115.26 166.98 8.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.391 -0.818 . . . . 0.0 109.229 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.998 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -130.13 97.59 4.49 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.213 -0.929 . . . . 0.0 109.462 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.673 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -90.13 172.17 7.46 Favored Pre-proline 0 C--N 1.298 -1.666 0 O-C-N 121.56 -0.713 . . . . 0.0 109.146 179.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.673 ' HD2' HG22 ' A' ' 91' ' ' THR . 3.8 Cg_exo -60.79 -11.03 16.02 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.161 1.907 . . . . 0.0 110.481 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -68.23 -51.1 49.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -0.999 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.79 HD23 ' HD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -78.49 127.45 32.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 109.37 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.31 126.46 33.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.174 -0.954 . . . . 0.0 109.918 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.577 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 78.23 35.28 34.36 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.098 HD13 ' CB ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -71.54 133.21 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.351 -1.087 . . . . 0.0 109.541 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.097 ' N ' HD12 ' A' ' 97' ' ' ILE . 3.7 t -107.02 108.49 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.345 -0.847 . . . . 0.0 109.63 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.801 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -99.08 153.55 4.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.5 OUTLIER -126.58 174.07 8.96 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.072 -1.018 . . . . 0.0 109.284 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.916 HG13 ' HD2' ' A' ' 102' ' ' PRO . 28.8 t -107.59 147.09 34.67 Favored Pre-proline 0 N--CA 1.494 1.725 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.95 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.916 ' HD2' HG13 ' A' ' 101' ' ' VAL . 8.2 Cg_exo -53.76 -171.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.32 2.013 . . . . 0.0 110.458 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.402 ' CB ' HH21 ' A' ' 104' ' ' ARG . 13.7 m-20 -89.45 -26.66 20.84 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.521 ' HB3' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -120.86 -157.96 0.74 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 105' ' ' GLN . 9.7 tt0 -154.97 24.4 0.43 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.001 -1.062 . . . . 0.0 109.586 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.953 ' CB ' HG22 ' A' ' 47' ' ' THR . 24.4 m95 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.715 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.885 ' S1 ' HD23 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.513 ' HB2' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.5 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -137.59 165.57 26.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 109.284 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.88 HG11 HD22 ' A' ' 23' ' ' LEU . 6.7 t -154.32 161.64 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.159 -0.963 . . . . 0.0 109.052 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.739 HG13 ' O ' ' A' ' 13' ' ' ARG . 51.9 t -159.46 148.68 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.075 -1.016 . . . . 0.0 109.202 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.108 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -124.68 154.08 41.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.097 -1.002 . . . . 0.0 109.498 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.723 HG22 ' HB3' ' A' ' 12' ' ' ARG . 3.0 t -136.71 141.4 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.438 -0.789 . . . . 0.0 110.177 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.515 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 1.5 p -81.52 169.52 17.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -41.87 -89.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.872 -179.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.23 74.95 0.89 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.789 -1.194 . . . . 0.0 109.267 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.23 -105.08 0.37 Allowed Glycine 0 N--CA 1.489 2.208 0 C-N-CA 118.465 -1.826 . . . . 0.0 110.918 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.2 m -130.5 -176.09 3.86 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.544 -0.974 . . . . 0.0 109.57 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.723 ' HB3' HG22 ' A' ' 6' ' ' VAL . 5.0 ptp180 -150.98 124.35 8.91 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.291 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.739 ' O ' HG13 ' A' ' 4' ' ' VAL . 50.4 mtt180 -89.27 175.52 7.31 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.63 ' CB ' HG22 ' A' ' 4' ' ' VAL . 9.7 pt20 -134.97 141.11 46.17 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.974 -1.079 . . . . 0.0 110.324 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.108 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -136.69 -176.52 4.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.365 -0.834 . . . . 0.0 109.353 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -126.72 71.43 1.3 Allowed 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.677 -0.639 . . . . 0.0 109.484 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.098 HG21 HD23 ' A' ' 23' ' ' LEU . 61.7 t -54.41 112.9 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.541 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.814 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -47.15 174.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 0.0 109.549 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.449 ' OD2' ' HB3' ' A' ' 92' ' ' PRO . 80.9 m-20 -83.66 125.3 31.7 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.359 -0.838 . . . . 0.0 109.192 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.46 19.01 31.2 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.814 HG21 ' HB3' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -118.13 155.75 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -1.135 . . . . 0.0 109.293 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 23' ' ' LEU . 2.0 m -92.4 135.04 34.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.231 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.098 HD23 HG21 ' A' ' 17' ' ' VAL . 16.7 mt -45.27 -35.28 3.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.001 . . . . 0.0 108.968 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.495 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 1.8 tmt? -65.61 -46.24 80.03 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.263 -0.898 . . . . 0.0 108.976 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.613 ' O ' HG13 ' A' ' 28' ' ' VAL . 4.5 tp-100 -53.75 -52.08 61.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 109.206 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.69 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -63.2 -23.39 67.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.915 . . . . 0.0 109.171 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.893 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -68.11 -26.33 65.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.358 -0.839 . . . . 0.0 109.712 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 25' ' ' GLN . 2.7 m -57.52 -43.62 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.996 -1.065 . . . . 0.0 109.368 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.509 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 2.7 t -81.63 -56.26 4.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.329 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.49 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 33.1 m-80 -50.06 -20.8 1.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.446 -0.784 . . . . 0.0 109.372 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 83.55 22.21 56.67 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.789 HG23 HD11 ' A' ' 35' ' ' ILE . 1.4 mt -98.63 -31.3 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.208 -1.172 . . . . 0.0 108.848 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.893 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -51.64 -36.69 47.12 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.586 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 20.9 t70 -72.22 -35.62 68.93 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.857 ' O ' HG13 ' A' ' 36' ' ' VAL . 3.7 pt -83.09 5.08 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.958 -1.089 . . . . 0.0 109.423 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 35' ' ' ILE . 0.3 OUTLIER -169.53 120.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 109.414 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.36 170.01 12.61 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB2' ' CG2' ' A' ' 47' ' ' THR . 5.0 m-20 -162.31 -59.93 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -1.158 . . . . 0.0 109.795 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 41' ' ' GLY . 8.1 p -82.86 9.43 9.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.163 -0.961 . . . . 0.0 109.751 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 41' ' ' GLY . . . 57.64 -89.04 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 40' ' ' GLY . . . -60.63 -124.64 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.565 ' O ' ' HE1' ' A' ' 70' ' ' MET . 52.7 p -138.48 48.67 1.93 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.16 . . . . 0.0 109.511 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.78 -93.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.522 ' HA ' ' CB ' ' A' ' 70' ' ' MET . 37.2 t -160.4 60.08 0.33 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.059 -1.026 . . . . 0.0 109.936 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 70' ' ' MET . 1.7 p -107.5 -171.71 1.93 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.085 -1.01 . . . . 0.0 109.21 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.838 ' HB1' ' N ' ' A' ' 74' ' ' VAL . . . -146.92 20.49 1.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 0.0 109.516 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.517 ' CG2' ' HB2' ' A' ' 38' ' ' ASP . 7.9 t -90.3 -21.94 21.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.765 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.484 ' SG ' HD23 ' A' ' 84' ' ' LEU . 21.8 p -87.18 42.55 1.04 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.145 -0.972 . . . . 0.0 110.398 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.144 ' CD2' HD12 ' A' ' 78' ' ' LEU . 44.8 t-80 -81.56 60.92 4.76 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 85' ' ' CYS . 14.1 m -76.28 149.09 6.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 120.752 -1.218 . . . . 0.0 110.912 -177.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.512 ' CE2' ' CE1' ' A' ' 49' ' ' HIS . 7.7 m-85 -108.21 103.09 12.2 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.907 HG22 HG12 ' A' ' 99' ' ' VAL . 4.3 t -89.15 174.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-O 121.662 0.744 . . . . 0.0 111.941 -176.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.723 ' O ' HG23 ' A' ' 57' ' ' THR . 0.3 OUTLIER -70.41 -175.78 1.09 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -101.3 4.59 41.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.915 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.37 -25.54 10.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.081 -1.012 . . . . 0.0 110.258 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.871 ' CD2' HG22 ' A' ' 97' ' ' ILE . 73.8 m-85 -99.69 -17.05 17.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.068 -1.02 . . . . 0.0 109.816 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 53' ' ' ASN . 25.1 p -63.87 -43.63 95.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 109.612 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -55.72 -51.77 66.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.904 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.037 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -49.86 -41.8 46.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.152 -0.967 . . . . 0.0 109.623 -179.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.761 HG13 ' HD2' ' A' ' 61' ' ' PRO . 54.6 t -54.22 142.83 47.09 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.998 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.761 ' HD2' HG13 ' A' ' 60' ' ' VAL . 5.2 Cg_exo -55.79 173.43 0.39 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.076 1.851 . . . . 0.0 110.519 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.72 62.52 0.61 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.391 -0.818 . . . . 0.0 109.373 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -38.92 126.52 1.57 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.72 -0.612 . . . . 0.0 109.849 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.528 ' ND2' ' N ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -51.39 -174.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.896 -179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.555 ' CD ' HD12 ' A' ' 68' ' ' ILE . 3.9 tp10 -76.86 -10.19 59.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.357 -0.839 . . . . 0.0 109.548 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 ttp180 -58.82 -51.25 70.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.123 -0.986 . . . . 0.0 109.336 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.496 ' HG2' ' HE3' ' A' ' 70' ' ' MET . 86.3 mt-10 -72.73 -7.06 48.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.403 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.555 HD12 ' CD ' ' A' ' 65' ' ' GLU . 15.2 mt -76.65 -36.93 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.159 -0.963 . . . . 0.0 109.556 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.23 -54.1 24.89 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.565 ' HE1' ' O ' ' A' ' 42' ' ' SER . 0.0 OUTLIER -68.45 -27.06 65.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.287 -1.125 . . . . 0.0 108.779 179.591 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.037 HD11 HD13 ' A' ' 78' ' ' LEU . 3.7 tt -83.34 8.13 14.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.454 -0.779 . . . . 0.0 109.144 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 4.0 tp10 -100.51 -10.58 20.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.247 -0.908 . . . . 0.0 109.321 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.61 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 0.7 OUTLIER -82.24 -13.49 56.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.186 -0.946 . . . . 0.0 109.85 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.993 HG21 ' CD2' ' A' ' 49' ' ' HIS . 4.1 m -40.02 137.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.472 -0.768 . . . . 0.0 109.736 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.615 HG21 ' CB ' ' A' ' 104' ' ' ARG . 5.5 m -44.58 -25.3 0.26 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.243 -0.911 . . . . 0.0 109.289 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.709 ' O ' HG23 ' A' ' 74' ' ' VAL . . . -116.94 -148.94 0.43 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.254 -0.904 . . . . 0.0 110.164 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.629 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.6 OUTLIER -114.51 150.18 35.26 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.144 HD12 ' CD2' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -104.13 130.59 51.86 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 117.232 -1.787 . . . . 0.0 111.269 179.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.574 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 0.5 OUTLIER -104.76 166.1 12.09 Favored Pre-proline 0 C--N 1.296 -1.736 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.574 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 5.0 Cg_exo -53.79 -26.37 38.59 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 121.937 1.758 . . . . 0.0 109.931 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.574 ' HA ' HG21 ' A' ' 57' ' ' THR . 1.9 t30 -75.41 -35.06 61.08 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.587 -0.696 . . . . 0.0 110.128 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.724 ' O ' HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -87.07 165.52 15.72 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.006 -1.059 . . . . 0.0 109.471 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.548 ' HB3' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -162.33 -162.34 0.81 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.084 -1.01 . . . . 0.0 109.449 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.822 HD21 ' HB2' ' A' ' 71' ' ' LEU . 1.5 mt -98.04 108.28 20.95 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.666 ' HB2' HG11 ' A' ' 50' ' ' VAL . 23.3 t -42.81 -25.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.108 -0.995 . . . . 0.0 110.034 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 84' ' ' LEU . 29.1 p -82.9 -39.35 21.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.987 . . . . 0.0 110.607 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.416 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 0.7 OUTLIER -88.91 27.0 1.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.044 -1.035 . . . . 0.0 111.192 -178.524 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.71 ' O ' HD13 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -106.68 149.39 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.654 -1.279 . . . . 0.0 108.902 178.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 88' ' ' ILE . 28.7 mm -128.24 161.61 36.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.93 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.658 ' HE2' HG23 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -130.33 95.91 4.02 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.451 -0.781 . . . . 0.0 109.12 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.446 ' OG1' ' CD1' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -82.38 164.93 45.38 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.545 -0.722 . . . . 0.0 109.586 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.449 ' HB3' ' OD2' ' A' ' 19' ' ' ASP . 4.0 Cg_exo -60.87 -28.49 86.45 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.138 1.892 . . . . 0.0 110.057 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.68 -37.74 85.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.297 -0.877 . . . . 0.0 109.32 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.037 HD21 ' CB ' ' A' ' 59' ' ' LYS . 4.2 mp -77.41 143.93 38.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.395 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.12 124.35 8.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 109.538 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.573 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 76.53 48.98 8.47 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.871 HG22 ' CD2' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -77.07 145.75 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -1.188 . . . . 0.0 108.549 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.491 ' N ' HD12 ' A' ' 97' ' ' ILE . 1.8 t -119.17 113.24 40.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 120.849 -1.157 . . . . 0.0 109.869 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.907 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -106.77 144.81 15.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 51' ' ' TYR . 9.2 m-20 -122.28 174.09 7.21 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.113 -0.992 . . . . 0.0 109.527 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.94 HG13 ' HD2' ' A' ' 102' ' ' PRO . 12.0 t -103.63 147.39 34.16 Favored Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.462 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.94 ' HD2' HG13 ' A' ' 101' ' ' VAL . 12.8 Cg_exo -52.59 163.48 1.82 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.413 2.075 . . . . 0.0 110.05 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 3.2 m-20 -57.99 -27.37 63.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.013 -1.054 . . . . 0.0 108.751 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.615 ' CB ' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -130.67 -163.45 1.32 Allowed 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -152.2 23.38 0.64 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.487 ' NE1' ' N ' ' A' ' 75' ' ' THR . 38.0 m95 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.642 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.487 ' S1 ' HD22 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.59 135.64 21.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.274 -0.891 . . . . 0.0 109.177 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.977 HG21 HD21 ' A' ' 23' ' ' LEU . 1.1 t -133.24 123.79 47.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.923 HG11 ' HD3' ' A' ' 12' ' ' ARG . 65.9 t -121.82 128.81 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.128 -0.982 . . . . 0.0 108.636 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.073 ' CE1' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -98.21 153.8 18.22 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.953 -1.092 . . . . 0.0 109.478 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.938 ' O ' HG23 ' A' ' 101' ' ' VAL . 12.0 t -121.52 168.87 13.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.59 ' N ' HG12 ' A' ' 6' ' ' VAL . 41.0 t -122.99 161.52 24.09 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.496 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.55 -8.13 12.81 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 118.959 -1.096 . . . . 0.0 109.089 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -110.66 -3.33 15.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.079 -1.013 . . . . 0.0 110.643 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.68 -23.63 13.12 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.173 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.538 ' HB ' ' CB ' ' A' ' 7' ' ' SER . 74.6 m -49.52 112.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.031 -1.276 . . . . 0.0 109.065 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.923 ' HD3' HG11 ' A' ' 4' ' ' VAL . 3.6 ttm180 -125.49 117.34 23.43 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.575 -0.703 . . . . 0.0 110.187 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.538 HH12 HD13 ' A' ' 35' ' ' ILE . 1.2 ptp180 -108.7 124.95 51.35 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.421 ' CB ' HG22 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -91.37 155.55 18.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.018 -1.051 . . . . 0.0 110.569 -178.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.073 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -163.02 -176.13 4.72 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.639 0.733 . . . . 0.0 109.169 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -129.37 114.63 16.43 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.5 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.856 HG11 ' HB3' ' A' ' 90' ' ' MET . 46.2 t -77.48 110.31 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.944 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -46.95 172.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 0.0 109.337 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -81.52 124.73 29.73 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.225 -0.922 . . . . 0.0 109.153 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.77 44.25 6.48 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.944 HG21 ' HB3' ' A' ' 18' ' ' ALA . 1.5 t -133.07 165.57 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.46 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.4 p -105.87 141.91 36.48 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.169 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.003 HD13 ' OH ' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -48.68 -23.79 1.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.137 -0.977 . . . . 0.0 108.985 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 85' ' ' CYS . 0.1 OUTLIER -76.83 -43.88 34.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 108.657 179.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.611 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -56.77 -51.15 70.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.374 -0.829 . . . . 0.0 109.259 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.51 -24.51 65.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.0 109.308 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.971 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -74.64 -26.45 59.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.323 -0.861 . . . . 0.0 109.927 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 25' ' ' GLN . 1.7 m -56.57 -44.15 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.788 -1.195 . . . . 0.0 109.448 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.499 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 3.3 t -80.59 -52.7 7.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.433 -0.792 . . . . 0.0 109.527 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.5 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 25.9 m-80 -57.24 -14.58 4.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.832 . . . . 0.0 109.622 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.854 ' O ' HD12 ' A' ' 35' ' ' ILE . . . 77.33 22.78 69.74 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.479 HG12 ' HD2' ' A' ' 13' ' ' ARG . 1.1 mt -100.14 -25.85 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.208 -1.172 . . . . 0.0 108.271 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.971 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 2.1 p90 -48.63 -46.95 40.55 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.617 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 12.5 t70 -66.44 -35.5 80.45 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.854 HD12 ' O ' ' A' ' 31' ' ' GLY . 2.6 mp -92.3 40.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.197 -0.939 . . . . 0.0 108.889 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.674 HG12 ' N ' ' A' ' 37' ' ' GLY . 49.1 t -160.88 -93.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.594 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.674 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -84.18 167.82 43.94 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.688 ' OD1' HG21 ' A' ' 47' ' ' THR . 0.1 OUTLIER -129.28 -50.0 1.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -1.129 . . . . 0.0 109.689 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.521 ' CB ' ' HB3' ' A' ' 44' ' ' SER . 16.8 p -65.15 -18.86 65.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 109.537 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 42.98 93.21 0.01 OUTLIER Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 139.61 -140.76 11.06 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 55.7 p -60.0 161.64 6.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -1.149 . . . . 0.0 109.353 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . . . -59.91 101.3 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.412 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.521 ' HB3' ' CB ' ' A' ' 39' ' ' CYS . 4.6 t -132.93 18.72 4.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.687 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.9 p -168.08 -167.61 0.85 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.943 . . . . 0.0 109.683 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.895 ' HB3' ' NE1' ' A' ' 106' ' ' TRP . . . -135.48 5.54 3.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.331 -0.856 . . . . 0.0 109.331 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.688 HG21 ' OD1' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -63.07 -28.78 70.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.396 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.536 ' HB3' ' CA ' ' A' ' 37' ' ' GLY . 25.1 p -84.25 42.32 0.88 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 110.449 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.017 ' CE1' HD12 ' A' ' 78' ' ' LEU . 28.3 t60 -81.35 64.09 5.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 m -80.27 147.33 6.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.569 -1.332 . . . . 0.0 110.061 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.668 ' HH ' ' HE2' ' A' ' 49' ' ' HIS . 9.6 m-85 -107.03 104.12 13.71 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.734 HG22 HG12 ' A' ' 99' ' ' VAL . 4.6 t -89.41 172.6 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-O 121.948 0.88 . . . . 0.0 112.201 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.581 ' H ' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -77.6 157.98 30.01 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.067 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -81.88 12.57 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.207 -0.933 . . . . 0.0 110.233 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.29 -25.95 9.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.98 -1.075 . . . . 0.0 109.75 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.628 ' CD1' ' HA ' ' A' ' 97' ' ' ILE . 90.8 m-85 -104.49 -17.35 14.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.836 HG21 HD22 ' A' ' 81' ' ' ASN . 0.7 OUTLIER -66.16 -34.97 79.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.814 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.15 -46.88 72.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.21 -0.931 . . . . 0.0 110.346 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.06 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -49.51 -43.99 45.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.736 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.139 HG11 HG22 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -100.45 143.24 26.16 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.272 -0.892 . . . . 0.0 109.259 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.817 ' HD2' HG12 ' A' ' 60' ' ' VAL . 6.2 Cg_exo -58.15 -179.59 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 121.811 1.674 . . . . 0.0 109.219 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.516 ' HA ' ' HD3' ' A' ' 83' ' ' ARG . . . -110.29 -105.2 0.37 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.839 -1.163 . . . . 0.0 109.573 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.517 ' CB ' HG13 ' A' ' 68' ' ' ILE . . . -111.7 -160.14 0.7 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.071 . . . . 0.0 109.894 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.687 ' O ' HD12 ' A' ' 68' ' ' ILE . 12.3 m-20 -137.62 -145.43 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.87 -34.75 9.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.912 -1.117 . . . . 0.0 109.463 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -84.06 -48.37 9.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.254 -0.903 . . . . 0.0 109.595 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 15.2 pt-20 -68.79 -27.0 65.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.234 -0.916 . . . . 0.0 109.564 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.687 HD12 ' O ' ' A' ' 64' ' ' ASN . 1.3 mt -66.34 -43.25 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.105 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -52.83 -55.8 21.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -25.61 65.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -1.16 . . . . 0.0 109.398 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.62 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -87.86 -3.63 58.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 0.0 109.247 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 68' ' ' ILE . 15.0 tp10 -82.47 -26.05 32.99 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.22 -0.925 . . . . 0.0 109.211 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.74 75.77 0.95 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.391 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.815 HG23 ' H ' ' A' ' 76' ' ' ALA . 4.9 m -97.75 174.66 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.925 . . . . 0.0 109.633 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.571 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 18.2 m -74.13 -11.95 60.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.852 . . . . 0.0 109.934 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.85 ' HB2' ' HG2' ' A' ' 104' ' ' ARG . . . -122.42 -151.41 0.48 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.029 -1.045 . . . . 0.0 109.874 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.628 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -112.26 156.13 22.89 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.017 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -128.62 152.79 47.95 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 117.596 -1.641 . . . . 0.0 112.096 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.589 ' CD ' ' HD2' ' A' ' 80' ' ' PRO . 13.7 mmtt -137.52 167.26 21.3 Favored Pre-proline 0 C--N 1.298 -1.645 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.589 ' HD2' ' CD ' ' A' ' 79' ' ' LYS . 5.8 Cg_exo -54.41 -17.99 13.68 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 C-N-CA 122.17 1.913 . . . . 0.0 110.589 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.836 HD22 HG21 ' A' ' 57' ' ' THR . 0.2 OUTLIER -82.62 -33.75 27.81 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.375 -0.828 . . . . 0.0 110.45 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.6 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.1 m -61.7 159.68 13.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.951 -1.093 . . . . 0.0 109.595 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.581 HH12 HG23 ' A' ' 88' ' ' ILE . 6.9 mmm-85 -160.4 167.96 26.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.737 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.58 HD11 ' HG ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -88.44 112.37 22.86 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' MET . 0.3 OUTLIER -65.35 -6.99 11.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.286 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.3 p -105.89 13.23 29.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.961 -1.087 . . . . 0.0 110.305 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.515 ' NE2' HD13 ' A' ' 84' ' ' LEU . 2.9 pt20 -139.06 3.28 2.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.796 -1.19 . . . . 0.0 110.399 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.139 HG22 HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -105.08 146.88 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.946 -1.097 . . . . 0.0 109.201 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 90' ' ' MET . 12.1 mm -116.32 158.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.27 -0.894 . . . . 0.0 109.505 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.856 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -127.89 95.24 4.15 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.292 -0.88 . . . . 0.0 109.271 179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.664 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -87.62 171.23 10.05 Favored Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.589 -0.694 . . . . 0.0 109.533 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.664 ' HD2' HG22 ' A' ' 91' ' ' THR . 3.9 Cg_exo -60.34 -15.17 33.65 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.189 1.926 . . . . 0.0 110.33 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.781 ' HG3' HD12 ' A' ' 94' ' ' LEU . 22.3 pt-20 -66.29 -47.88 72.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.234 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.06 HD21 ' CB ' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -86.38 152.18 22.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.886 . . . . 0.0 109.23 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.417 ' HB3' ' HA ' ' A' ' 1' ' ' SER . 1.3 p30 -161.42 133.99 6.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.98 . . . . 0.0 110.022 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.585 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 78.41 37.32 27.97 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.721 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -78.22 149.64 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.178 -1.189 . . . . 0.0 109.047 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.455 ' N ' HD13 ' A' ' 97' ' ' ILE . 3.7 t -114.18 110.35 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.061 -1.024 . . . . 0.0 109.884 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.734 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -102.75 148.72 7.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.516 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -126.15 176.63 6.92 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.74 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 6' ' ' VAL . 21.6 t -106.02 146.32 32.68 Favored Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.685 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.888 ' HD2' HG13 ' A' ' 101' ' ' VAL . 10.5 Cg_exo -54.06 -173.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.458 2.105 . . . . 0.0 110.656 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 0.4 OUTLIER -92.21 -18.01 24.05 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.85 ' HG2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -130.29 -162.36 1.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.478 ' O ' HG23 ' A' ' 47' ' ' THR . 4.8 tm0? -151.36 22.56 0.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.838 -1.163 . . . . 0.0 109.895 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.895 ' NE1' ' HB3' ' A' ' 46' ' ' ALA . 6.5 m95 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.533 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.562 ' S1 ' HD23 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.511 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -138.17 159.52 41.82 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.261 -0.899 . . . . 0.0 109.167 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.6 HG21 ' HG3' ' A' ' 90' ' ' MET . 0.9 OUTLIER -157.28 130.54 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.23 -0.919 . . . . 0.0 109.659 -179.215 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.988 HG13 ' O ' ' A' ' 13' ' ' ARG . 75.5 t -129.02 140.93 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 109.023 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.109 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -109.24 156.87 19.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 109.252 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 99' ' ' VAL . 2.7 t -133.28 132.97 58.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.547 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -78.91 -177.37 5.5 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -48.59 162.95 0.08 Allowed 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.513 ' C ' ' O ' ' A' ' 8' ' ' HIS . 5.1 t0 -29.75 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.032 0.444 . . . . 0.0 110.78 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 8' ' ' HIS . . . -168.47 -95.39 0.1 Allowed Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.61 -1.281 . . . . 0.0 110.476 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.4 m -125.37 -175.87 3.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -1.156 . . . . 0.0 109.666 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.716 ' H ' HG22 ' A' ' 11' ' ' THR . 11.5 ptt180 -156.69 141.09 16.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.631 -0.668 . . . . 0.0 109.904 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.988 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -100.41 174.63 6.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.21 -0.931 . . . . 0.0 108.718 179.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.417 ' CB ' HG22 ' A' ' 4' ' ' VAL . 9.1 pm0 -130.38 162.91 28.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.029 -1.044 . . . . 0.0 110.788 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.109 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -175.84 -176.53 0.85 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.627 0.727 . . . . 0.0 109.193 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.449 ' OD2' ' O ' ' A' ' 1' ' ' SER . 7.3 t0 -132.24 88.59 2.56 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.984 -0.687 . . . . 0.0 110.059 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.732 HG21 HD22 ' A' ' 23' ' ' LEU . 49.4 t -54.24 145.61 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.174 -0.954 . . . . 0.0 108.918 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 1.016 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -86.42 172.98 9.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 109.662 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.412 ' OD2' ' HG3' ' A' ' 92' ' ' PRO . 78.8 m-20 -80.92 125.75 30.51 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.354 -0.841 . . . . 0.0 108.927 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.38 22.44 34.65 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.016 HG21 ' HB3' ' A' ' 18' ' ' ALA . 1.9 t -117.16 162.86 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -1.086 . . . . 0.0 108.918 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -100.62 134.92 42.86 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.981 -1.074 . . . . 0.0 108.568 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.958 HD13 ' OH ' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -46.64 -25.27 0.68 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.016 -1.052 . . . . 0.0 108.699 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.602 ' HE2' ' HB2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -74.44 -46.69 38.32 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.66 ' HB2' HG12 ' A' ' 21' ' ' VAL . 2.7 mm-40 -52.23 -54.29 32.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 108.95 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.473 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -57.22 -29.08 63.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -0.966 . . . . 0.0 108.677 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.952 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -67.93 -34.15 76.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.405 -0.809 . . . . 0.0 109.145 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.572 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 88.4 t -52.8 -40.49 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 0.0 109.399 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.2 t -79.95 -48.85 12.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.848 . . . . 0.0 109.402 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.732 ' CG ' HD22 ' A' ' 15' ' ' LEU . 29.1 m-80 -65.62 -6.19 10.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.427 -0.795 . . . . 0.0 109.68 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.483 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 72.09 17.6 77.32 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.476 HG13 ' CB ' ' A' ' 30' ' ' ASN . 1.0 OUTLIER -95.56 -27.18 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -1.157 . . . . 0.0 108.538 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.952 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 1.2 p90 -46.96 -45.11 20.59 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.557 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 10.9 t70 -77.31 -29.06 53.46 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 35' ' ' ILE . 20.0 mm -64.86 -10.03 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.681 HG21 HG12 ' A' ' 50' ' ' VAL . 2.5 p -160.12 -51.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.134 -0.979 . . . . 0.0 109.826 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' H ' HG13 ' A' ' 36' ' ' VAL . . . -42.9 166.29 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.494 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 13.7 t0 -154.15 -93.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -1.203 . . . . 0.0 109.863 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 42' ' ' SER . 20.8 p -65.49 -9.5 26.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.131 -0.98 . . . . 0.0 109.765 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 86' ' ' CYS . . . 89.59 -167.47 33.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 86' ' ' CYS . . . -42.01 -27.09 0.37 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.457 ' O ' ' SG ' ' A' ' 86' ' ' CYS . 19.3 m -59.68 159.57 8.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.136 -1.214 . . . . 0.0 109.286 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.596 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . . . -124.57 74.45 1.33 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 109.356 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 m -129.6 -2.33 4.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 109.735 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 38' ' ' ASP . 1.4 p -120.96 -169.24 1.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.085 -1.009 . . . . 0.0 109.613 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.788 ' HB3' ' NE1' ' A' ' 106' ' ' TRP . . . -141.83 11.44 2.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 109.297 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.644 HG23 ' O ' ' A' ' 105' ' ' GLN . 9.5 m -71.54 -21.0 61.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.51 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.536 ' HB2' ' CB ' ' A' ' 85' ' ' CYS . 23.5 p -86.75 42.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 110.249 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.02 ' CE1' HD12 ' A' ' 78' ' ' LEU . 21.6 t60 -74.47 72.65 1.88 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.681 HG12 HG21 ' A' ' 36' ' ' VAL . 10.1 m -81.64 145.41 8.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.285 -1.509 . . . . 0.0 110.728 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.632 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 6.1 m-85 -107.26 99.97 9.46 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.709 HG22 HG12 ' A' ' 99' ' ' VAL . 3.8 t -89.93 172.08 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-O 122.053 0.93 . . . . 0.0 112.461 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.581 ' H ' HG12 ' A' ' 52' ' ' VAL . 1.3 m-20 -77.39 159.34 29.54 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.18 11.71 5.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.38 -0.825 . . . . 0.0 110.103 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.29 -29.91 7.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.015 -1.053 . . . . 0.0 109.755 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.757 ' HD2' HD23 ' A' ' 94' ' ' LEU . 47.2 m-85 -99.53 -18.47 17.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.174 -0.954 . . . . 0.0 109.4 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.797 HG21 HD22 ' A' ' 81' ' ' ASN . 0.7 OUTLIER -64.16 -14.33 54.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.073 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.85 -36.06 17.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.767 ' HB2' HD21 ' A' ' 94' ' ' LEU . 1.9 mptp? -72.88 -32.92 65.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.242 -0.911 . . . . 0.0 109.462 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.582 ' HB ' HG22 ' A' ' 88' ' ' ILE . 1.3 m -56.18 163.05 2.55 Favored Pre-proline 0 C--N 1.305 -1.344 0 O-C-N 121.222 -0.924 . . . . 0.0 109.455 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.663 ' HD2' HG22 ' A' ' 88' ' ' ILE . 5.8 Cg_exo -58.16 166.47 5.7 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.166 1.911 . . . . 0.0 110.179 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 63' ' ' ALA . . . -110.25 60.21 0.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 62' ' ' ALA . . . -41.86 164.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.53 -0.731 . . . . 0.0 109.611 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.434 ' O ' HG12 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -94.15 -175.23 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 0.0 109.695 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.527 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 38.2 tt0 -88.13 -17.98 29.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.409 -0.807 . . . . 0.0 109.521 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -46.54 -64.53 0.74 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.713 ' O ' HD12 ' A' ' 71' ' ' LEU . 4.7 mt-10 -65.56 -21.29 66.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.433 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.527 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 23.5 mm -65.37 -31.7 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -45.12 -56.42 6.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 57.2 mtt -68.21 -26.79 65.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.2 -1.176 . . . . 0.0 109.106 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.109 ' CD1' HD11 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -88.11 2.78 51.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.369 -0.832 . . . . 0.0 109.346 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 68' ' ' ILE . 55.7 tt0 -88.15 -30.53 19.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.85 . . . . 0.0 109.008 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -101.95 29.86 4.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.168 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.91 HG23 ' H ' ' A' ' 76' ' ' ALA . 5.3 m -46.07 171.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.593 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.567 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 83.4 m -75.2 -4.22 37.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.786 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.91 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -123.76 -150.71 0.45 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.063 -1.023 . . . . 0.0 109.651 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.645 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -111.85 156.64 21.7 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 179.333 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.02 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -130.71 153.91 48.49 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 117.772 -1.571 . . . . 0.0 111.964 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.539 ' CE ' ' HD2' ' A' ' 80' ' ' PRO . 4.5 mmmt -136.88 166.85 24.22 Favored Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.539 ' HD2' ' CE ' ' A' ' 79' ' ' LYS . 6.0 Cg_exo -54.68 -17.41 13.19 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 C-N-CA 122.246 1.964 . . . . 0.0 110.697 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.797 HD22 HG21 ' A' ' 57' ' ' THR . 0.1 OUTLIER -84.78 -31.66 23.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 0.0 110.615 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.606 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.4 m -61.6 162.83 7.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.965 -1.084 . . . . 0.0 110.307 -179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.514 ' HG3' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -161.03 -159.08 0.63 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.369 -0.832 . . . . 0.0 109.278 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.109 HD11 ' CD1' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -110.93 118.54 36.37 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.285 -0.885 . . . . 0.0 108.97 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.609 ' SG ' HG11 ' A' ' 50' ' ' VAL . 1.8 t -60.79 -19.62 59.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.125 -0.984 . . . . 0.0 108.991 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 40' ' ' GLY . 17.2 p -110.66 30.16 7.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.426 -0.796 . . . . 0.0 109.973 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -143.26 9.55 1.66 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.019 -1.051 . . . . 0.0 110.048 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.663 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -123.35 131.27 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.072 -1.017 . . . . 0.0 109.287 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.597 HG22 ' N ' ' A' ' 90' ' ' MET . 13.8 mm -96.29 166.39 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.342 -0.849 . . . . 0.0 109.622 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.666 ' CB ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.87 90.33 3.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.375 -0.828 . . . . 0.0 109.417 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.423 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -88.2 167.51 19.34 Favored Pre-proline 0 C--N 1.299 -1.602 0 O-C-N 121.382 -0.824 . . . . 0.0 109.336 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 3.5 Cg_exo -60.09 -12.84 20.79 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.138 1.892 . . . . 0.0 110.353 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.59 ' CG ' HD12 ' A' ' 94' ' ' LEU . 24.9 pt-20 -69.83 -45.87 66.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.589 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' A' ' 59' ' ' LYS . 1.3 mp -75.98 136.02 40.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.222 -0.924 . . . . 0.0 109.556 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -139.8 119.89 13.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.59 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 72.78 46.82 28.63 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.01 HD11 HG22 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -74.96 148.77 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.375 -1.074 . . . . 0.0 109.101 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.88 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.9 t -116.23 106.34 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.11 -0.994 . . . . 0.0 109.443 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.01 HG22 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -104.84 147.14 11.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -126.38 174.27 8.73 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.722 -179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.892 HG13 ' HD2' ' A' ' 102' ' ' PRO . 40.1 t -108.3 145.79 32.24 Favored Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.093 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.892 ' HD2' HG13 ' A' ' 101' ' ' VAL . 8.6 Cg_exo -50.24 177.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.304 2.003 . . . . 0.0 111.031 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.07 -22.87 33.36 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 0.0 OUTLIER -119.61 -157.03 0.69 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.644 ' O ' HG23 ' A' ' 47' ' ' THR . 20.0 mt-30 -153.36 23.99 0.54 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.953 -1.092 . . . . 0.0 109.728 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.788 ' NE1' ' HB3' ' A' ' 46' ' ' ALA . 5.0 m95 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.589 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.403 ' S1 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.361 0.6 . . . . 0.0 109.526 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -134.41 162.99 30.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 109.075 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.782 HG21 HD21 ' A' ' 23' ' ' LEU . 23.9 t -152.28 157.32 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.061 -1.025 . . . . 0.0 109.742 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -158.57 119.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.232 -0.918 . . . . 0.0 108.879 179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.085 ' CE1' HD21 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -95.19 157.17 16.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 109.682 -179.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.935 ' O ' HG23 ' A' ' 101' ' ' VAL . 9.4 t -123.26 169.6 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.447 -0.783 . . . . 0.0 109.096 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.58 ' N ' HG12 ' A' ' 6' ' ' VAL . 84.5 p -123.12 162.69 22.0 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.477 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -65.31 -6.53 10.09 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.828 -1.17 . . . . 0.0 109.203 179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -110.07 -5.6 15.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.062 -1.024 . . . . 0.0 110.319 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' HD2' ' A' ' 12' ' ' ARG . . . 115.65 -33.39 5.25 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.689 -1.244 . . . . 0.0 110.282 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.6 m -49.61 114.09 0.98 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.974 -1.31 . . . . 0.0 109.48 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.488 ' HB3' ' HA ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -133.83 122.77 23.72 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.648 -0.657 . . . . 0.0 109.695 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.726 ' NH1' HD11 ' A' ' 35' ' ' ILE . 1.3 mtt180 -97.95 173.78 6.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.121 -0.987 . . . . 0.0 108.544 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.556 ' HB3' HG13 ' A' ' 4' ' ' VAL . 10.9 pt20 -131.96 134.66 45.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.051 -1.031 . . . . 0.0 110.212 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.085 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -134.28 -176.84 4.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.269 -0.895 . . . . 0.0 109.471 179.26 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.68 80.97 1.97 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.732 -0.605 . . . . 0.0 109.505 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.008 HG21 HD23 ' A' ' 23' ' ' LEU . 85.8 t -68.88 114.32 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.52 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -52.62 175.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.882 . . . . 0.0 109.817 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' A' ' 92' ' ' PRO . 67.8 m-20 -83.05 126.29 32.39 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.477 -0.764 . . . . 0.0 109.076 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.12 10.67 44.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.652 HG12 ' HB3' ' A' ' 25' ' ' GLN . 0.7 OUTLIER -115.52 155.48 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -1.144 . . . . 0.0 109.199 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 89' ' ' ILE . 7.2 t -93.6 133.01 37.36 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.403 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.008 HD23 HG21 ' A' ' 17' ' ' VAL . 10.8 mt -42.64 -29.41 0.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.556 ' HE1' ' H ' ' A' ' 41' ' ' GLY . 1.9 tmt? -70.81 -50.52 34.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 108.811 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.652 ' HB3' HG12 ' A' ' 21' ' ' VAL . 5.5 tp-100 -49.22 -50.86 36.51 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.262 -0.899 . . . . 0.0 108.751 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.957 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -63.23 -32.06 73.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.35 -0.844 . . . . 0.0 108.757 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.93 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -62.25 -25.45 67.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.351 -0.843 . . . . 0.0 109.213 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.584 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 47.0 t -57.43 -42.97 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.135 -0.978 . . . . 0.0 109.172 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 t -82.51 -53.11 6.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 0.0 109.284 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.475 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 37.2 m-80 -54.81 -16.72 2.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.461 -0.775 . . . . 0.0 109.406 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 35' ' ' ILE . . . 79.14 21.82 66.88 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.809 ' HA ' HD12 ' A' ' 35' ' ' ILE . 1.1 mt -99.2 -28.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.175 -1.191 . . . . 0.0 108.535 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.93 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 1.6 p90 -47.45 -46.35 26.66 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.605 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 19.3 t70 -74.44 -30.49 61.91 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.809 HD12 ' HA ' ' A' ' 32' ' ' ILE . 60.0 mt -58.98 -17.28 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.09 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.715 ' O ' HG13 ' A' ' 36' ' ' VAL . 8.0 p -170.13 81.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.843 . . . . 0.0 109.47 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.496 ' C ' ' HG1' ' A' ' 47' ' ' THR . . . -163.62 179.55 38.6 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.566 ' CG ' HG21 ' A' ' 47' ' ' THR . 3.2 t0 -163.96 -69.28 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 109.667 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 42' ' ' SER . 16.3 p -83.3 10.05 9.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.698 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.04 -162.6 46.02 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.556 ' H ' ' HE1' ' A' ' 24' ' ' MET . . . -47.34 -23.98 2.2 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.447 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -59.89 177.49 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -1.165 . . . . 0.0 109.368 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.467 ' HA ' ' S1 ' ' A' ' 107' ' ' FES . . . -137.69 91.15 2.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.471 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.8 t -160.05 22.03 0.16 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 9.1 p -130.17 -151.55 0.48 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.958 . . . . 0.0 109.461 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.514 ' HB3' ' NE1' ' A' ' 106' ' ' TRP . . . -157.82 19.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.141 -0.975 . . . . 0.0 109.999 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.566 HG21 ' CG ' ' A' ' 38' ' ' ASP . 1.6 p -89.94 -19.39 24.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.113 -0.992 . . . . 0.0 109.455 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.499 ' HA ' HG22 ' A' ' 36' ' ' VAL . 23.4 p -86.62 43.36 1.07 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 110.073 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.717 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 67.5 t60 -76.93 65.41 2.6 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 82' ' ' SER . 12.6 m -87.14 147.89 4.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.345 -1.472 . . . . 0.0 110.384 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.717 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 6.2 m-30 -107.16 111.4 23.81 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.694 HG22 HG12 ' A' ' 99' ' ' VAL . 5.3 t -94.85 170.14 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.937 0.875 . . . . 0.0 112.306 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.568 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -74.24 144.51 44.63 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -4.84 13.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.338 -0.851 . . . . 0.0 110.17 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -94.96 -30.07 14.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.994 -1.066 . . . . 0.0 110.214 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.816 ' CD2' HG22 ' A' ' 97' ' ' ILE . 61.6 m-85 -97.98 -17.79 18.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.007 -1.058 . . . . 0.0 109.878 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.653 HG21 HD22 ' A' ' 81' ' ' ASN . 0.8 OUTLIER -64.59 -37.21 86.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.97 . . . . 0.0 109.429 179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.98 -62.14 1.82 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.542 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.842 ' HB2' HD21 ' A' ' 94' ' ' LEU . 13.8 mptt -49.93 -38.57 36.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.909 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -51.24 161.17 0.79 Allowed Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.901 . . . . 0.0 109.049 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.909 ' HD2' HG22 ' A' ' 60' ' ' VAL . 4.3 Cg_exo -59.96 159.22 26.28 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.18 1.92 . . . . 0.0 110.22 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.15 58.89 0.61 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.883 . . . . 0.0 109.439 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.89 132.85 3.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.415 -0.803 . . . . 0.0 109.557 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.464 ' O ' ' O ' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -51.79 -174.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 109.63 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.591 ' HA ' HD12 ' A' ' 68' ' ' ILE . 31.0 tt0 -89.47 -16.43 30.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.415 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.438 ' HB3' ' OE1' ' A' ' 67' ' ' GLU . 5.2 tpp180 -44.57 -61.79 1.43 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.477 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.438 ' OE1' ' HB3' ' A' ' 66' ' ' ARG . 1.0 OUTLIER -66.23 -23.84 66.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.202 -0.936 . . . . 0.0 109.431 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 65' ' ' GLU . 18.9 mt -63.12 -32.48 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.99 -51.6 39.54 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.7 mtt -66.69 -23.36 66.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -1.152 . . . . 0.0 109.372 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.696 ' O ' HG13 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -89.72 -7.06 55.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.497 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -82.17 -36.79 27.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.232 -0.917 . . . . 0.0 109.367 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.87 57.62 4.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.398 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.903 HG23 ' H ' ' A' ' 76' ' ' ALA . 8.9 m -93.94 172.02 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.527 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.576 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 25.5 m -64.94 -10.23 27.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.518 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.903 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -128.22 -155.85 0.72 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.149 -0.97 . . . . 0.0 109.969 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.571 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -111.82 150.39 30.43 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.641 ' HG ' ' HB2' ' A' ' 82' ' ' SER . 0.4 OUTLIER -106.54 169.1 8.72 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 118.397 -1.321 . . . . 0.0 111.203 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.549 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -153.22 170.78 7.68 Favored Pre-proline 0 C--N 1.3 -1.567 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 3.4 Cg_exo -57.83 -13.45 14.75 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 C-N-CA 122.037 1.824 . . . . 0.0 109.905 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.653 HD22 HG21 ' A' ' 57' ' ' THR . 0.1 OUTLIER -95.35 -25.0 16.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 110.836 -179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.641 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -85.79 155.9 20.81 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.818 -1.176 . . . . 0.0 110.477 -179.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.403 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -161.53 -157.68 0.51 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 179.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.904 HD12 ' CB ' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -104.29 95.19 5.78 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.226 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.541 ' HA ' ' CG1' ' A' ' 88' ' ' ILE . 1.9 t -42.57 -25.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 84' ' ' LEU . 13.0 p -75.72 -43.53 46.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.098 -1.001 . . . . 0.0 110.544 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.904 ' CB ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -89.62 8.87 29.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.002 -1.061 . . . . 0.0 111.334 -178.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.689 ' O ' HD13 ' A' ' 89' ' ' ILE . 2.9 mm -79.98 154.66 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.552 -1.342 . . . . 0.0 108.913 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 88' ' ' ILE . 30.1 mm -128.98 165.47 28.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 110.366 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.716 ' HE3' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -127.3 96.32 4.54 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.725 ' OG1' HD12 ' A' ' 94' ' ' LEU . 16.3 p -82.52 157.19 67.83 Favored Pre-proline 0 C--N 1.297 -1.713 0 O-C-N 121.575 -0.703 . . . . 0.0 109.262 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.456 ' HB3' ' OD2' ' A' ' 19' ' ' ASP . 5.8 Cg_exo -59.77 -13.35 21.79 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.02 1.813 . . . . 0.0 110.264 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -80.3 -31.79 38.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.246 -0.909 . . . . 0.0 109.412 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.842 HD21 ' HB2' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -83.35 127.41 33.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.634 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -135.82 125.51 25.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -0.882 . . . . 0.0 109.204 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.576 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 70.86 50.57 23.4 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.035 HD11 HG22 ' A' ' 99' ' ' VAL . 0.5 OUTLIER -74.82 159.1 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.331 -1.099 . . . . 0.0 108.868 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.006 ' N ' HD12 ' A' ' 97' ' ' ILE . 5.2 t -125.82 103.53 11.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.021 -1.049 . . . . 0.0 110.186 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.035 HG22 HD11 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -95.44 156.65 3.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 51' ' ' TYR . 12.0 m-20 -131.91 178.35 6.84 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.059 -1.025 . . . . 0.0 109.401 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.935 HG23 ' O ' ' A' ' 6' ' ' VAL . 27.6 t -110.45 146.84 35.14 Favored Pre-proline 0 C--N 1.297 -1.715 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.95 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.897 ' HD2' HG13 ' A' ' 101' ' ' VAL . 8.4 Cg_exo -53.95 -173.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.391 2.061 . . . . 0.0 110.369 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 19.3 t0 -102.68 -22.71 13.91 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.614 ' HD2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -131.09 -168.68 2.04 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.578 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 0.0 OUTLIER -128.99 -82.63 0.57 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.024 -1.048 . . . . 0.0 109.186 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.578 ' CD1' ' O ' ' A' ' 105' ' ' GLN . 2.1 m95 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.38 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.467 ' S1 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -136.61 161.46 35.83 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.277 -0.889 . . . . 0.0 109.175 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.717 HG21 ' CG ' ' A' ' 90' ' ' MET . 1.1 t -160.7 133.31 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 109.531 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 99' ' ' VAL . 2.9 p -136.98 161.39 35.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.123 -0.985 . . . . 0.0 108.648 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.084 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -129.04 157.99 40.17 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.185 -0.947 . . . . 0.0 109.786 -178.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 12' ' ' ARG . 3.4 t -126.9 143.39 40.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.552 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . 5.1 p -75.98 -158.7 0.1 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.684 ' N ' HG12 ' A' ' 101' ' ' VAL . 55.8 m80 -59.2 -103.43 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.26 77.71 1.06 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.4 -1.437 . . . . 0.0 109.239 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.99 -101.31 0.2 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 118.958 -1.591 . . . . 0.0 111.053 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 t -121.46 -170.55 2.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -1.1 . . . . 0.0 109.954 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.767 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -149.31 139.59 22.29 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.656 -0.652 . . . . 0.0 110.32 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.517 ' C ' HG23 ' A' ' 4' ' ' VAL . 18.0 mtt180 -104.25 119.31 38.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.351 -0.843 . . . . 0.0 108.958 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.619 ' HA ' HG23 ' A' ' 4' ' ' VAL . 4.9 pt20 -79.78 171.43 15.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.973 . . . . 0.0 110.554 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.084 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -173.48 -177.98 1.58 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.611 0.72 . . . . 0.0 109.059 178.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -135.24 93.17 2.95 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.66 -0.65 . . . . 0.0 109.685 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.976 HG21 ' CD2' ' A' ' 23' ' ' LEU . 21.1 t -69.13 149.2 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 109.305 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.873 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -83.22 173.38 11.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.397 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -79.97 124.67 28.91 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.274 -0.891 . . . . 0.0 109.067 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.8 18.06 39.05 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.873 HG21 ' HB3' ' A' ' 18' ' ' ALA . 2.2 t -115.1 170.3 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -1.123 . . . . 0.0 109.27 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.496 ' OG ' ' CD1' ' A' ' 89' ' ' ILE . 70.6 m -111.76 138.79 47.87 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 108.677 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.976 ' CD2' HG21 ' A' ' 17' ' ' VAL . 1.5 mt -48.31 -23.6 0.96 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.945 -1.097 . . . . 0.0 108.709 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.478 ' HB2' ' HA ' ' A' ' 86' ' ' CYS . 13.2 ttp -73.07 -46.84 49.3 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.692 ' HB2' HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -54.14 -59.61 4.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.363 -0.835 . . . . 0.0 109.004 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.432 ' C ' ' OD1' ' A' ' 30' ' ' ASN . . . -53.22 -46.48 69.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 108.945 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.526 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -45.37 -37.39 4.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.315 -0.865 . . . . 0.0 109.885 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.538 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 58.7 t -43.57 -50.12 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.098 -1.001 . . . . 0.0 109.858 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 31' ' ' GLY . 6.1 t -87.02 -51.33 6.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.303 -0.873 . . . . 0.0 109.591 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 1.037 ' OD1' HD13 ' A' ' 15' ' ' LEU . 4.8 m120 -40.31 -25.86 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.462 0.649 . . . . 0.0 109.731 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 95.24 -5.17 67.9 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.735 HG22 ' CG2' ' A' ' 35' ' ' ILE . 0.8 OUTLIER -79.61 -28.35 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.056 -1.261 . . . . 0.0 107.962 179.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 34' ' ' ASP . 0.0 OUTLIER -48.7 -31.45 6.85 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.619 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 13.1 t0 -93.08 -25.38 17.94 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.663 -0.648 . . . . 0.0 109.295 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.93 ' CG2' HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -60.11 -31.83 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.0 109.194 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.93 HG22 ' CG2' ' A' ' 35' ' ' ILE . 3.4 m -163.75 -171.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.404 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.08 166.05 12.06 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB2' ' HB ' ' A' ' 47' ' ' THR . 12.3 t70 -154.16 -92.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -1.146 . . . . 0.0 109.716 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.425 ' O ' ' C ' ' A' ' 40' ' ' GLY . 14.6 p -81.87 -9.87 59.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 109.625 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 39' ' ' CYS . . . 43.76 77.15 0.1 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 87' ' ' GLN . . . 171.28 -157.17 27.65 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.2 p -60.83 171.83 1.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -1.137 . . . . 0.0 109.486 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.888 ' HB3' ' CG ' ' A' ' 67' ' ' GLU . . . -61.93 99.59 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.89 . . . . 0.0 109.41 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.81 5.84 2.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 0.0 109.636 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 13.2 p -144.33 -152.65 0.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 0.0 109.615 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 1.004 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -156.09 19.2 0.37 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.634 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -90.4 -28.78 18.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.958 . . . . 0.0 109.583 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.686 ' O ' HG13 ' A' ' 50' ' ' VAL . 22.0 p -86.5 42.3 1.0 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.245 -0.909 . . . . 0.0 109.953 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.733 ' NE2' ' CE1' ' A' ' 51' ' ' TYR . 68.1 t60 -58.71 79.95 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.113 HG11 ' CB ' ' A' ' 85' ' ' CYS . 7.6 m -90.59 146.71 5.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.055 -1.653 . . . . 0.0 111.987 -177.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.733 ' CE1' ' NE2' ' A' ' 49' ' ' HIS . 4.1 m-30 -112.63 113.09 25.05 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.823 HG22 HG12 ' A' ' 99' ' ' VAL . 6.4 t -101.45 171.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.877 0.846 . . . . 0.0 112.209 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.582 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -73.23 155.36 39.63 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.012 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -81.43 11.63 4.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.889 . . . . 0.0 110.148 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.48 -28.89 8.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.95 -1.094 . . . . 0.0 110.121 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.856 ' CD2' HG22 ' A' ' 97' ' ' ILE . 43.0 m-85 -100.14 -19.34 16.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.08 -1.012 . . . . 0.0 109.695 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.761 HG21 HD22 ' A' ' 81' ' ' ASN . 0.8 OUTLIER -61.55 -22.71 65.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.205 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -85.71 -25.69 26.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.891 . . . . 0.0 109.475 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.767 ' HB2' HD21 ' A' ' 94' ' ' LEU . 13.6 mmtm -76.83 -10.54 59.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 0.0 109.443 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.785 HG11 ' CG2' ' A' ' 88' ' ' ILE . 0.1 OUTLIER -95.68 170.39 7.79 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.276 -0.89 . . . . 0.0 108.785 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.706 ' HD2' HG12 ' A' ' 60' ' ' VAL . 5.7 Cg_exo -59.43 167.84 5.83 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.03 1.82 . . . . 0.0 110.394 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.18 59.69 0.61 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.865 . . . . 0.0 109.375 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -41.6 121.64 1.75 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.593 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.822 ' O ' HD13 ' A' ' 68' ' ' ILE . 7.0 m-80 -57.54 -158.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.545 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 14.8 tp10 -84.11 -10.06 58.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.537 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -58.24 -54.31 48.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 109.456 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.888 ' CG ' ' HB3' ' A' ' 43' ' ' ALA . 2.4 mp0 -67.64 -8.21 32.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.529 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.822 HD13 ' O ' ' A' ' 64' ' ' ASN . 1.5 mp -88.66 -34.09 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.373 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.43 -59.01 3.75 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.787 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -67.89 -26.61 66.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -1.151 . . . . 0.0 109.299 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.669 HD13 HD11 ' A' ' 84' ' ' LEU . 19.8 tp -90.83 7.24 40.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.893 . . . . 0.0 109.408 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -99.23 -24.22 14.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.211 -0.931 . . . . 0.0 109.393 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.86 31.75 0.94 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.439 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.004 HG12 ' HB1' ' A' ' 46' ' ' ALA . 3.6 m -75.9 170.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.384 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 16.3 m -75.9 -17.79 59.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.147 -0.97 . . . . 0.0 109.328 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.603 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -107.62 -161.28 0.77 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.273 -0.892 . . . . 0.0 110.027 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.564 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.7 OUTLIER -111.65 151.63 28.61 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.614 ' HG ' ' CB ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -104.2 173.09 6.45 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.98 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.59 ' HE3' ' CZ ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -158.27 170.13 9.45 Favored Pre-proline 0 C--N 1.301 -1.521 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 2.6 Cg_endo -58.95 -12.51 15.43 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.284 1.989 . . . . 0.0 110.155 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.761 HD22 HG21 ' A' ' 57' ' ' THR . 0.0 OUTLIER -97.23 -22.09 16.9 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.22 -0.925 . . . . 0.0 110.84 -179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.614 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -75.42 153.32 37.74 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.004 -1.06 . . . . 0.0 110.649 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.652 ' C ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -161.31 -159.43 0.64 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.444 -0.785 . . . . 0.0 109.356 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.79 ' N ' HD22 ' A' ' 84' ' ' LEU . 3.1 mm? -109.61 79.34 1.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.337 -0.852 . . . . 0.0 108.73 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 1.113 ' CB ' HG11 ' A' ' 50' ' ' VAL . 43.2 t -45.38 -22.5 0.14 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.39 -0.819 . . . . 0.0 110.846 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 24' ' ' MET . 28.6 p -75.73 -40.88 54.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.897 -1.127 . . . . 0.0 110.914 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.573 ' CG ' ' HB2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -96.14 11.64 33.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.852 -1.155 . . . . 0.0 111.193 -178.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.785 ' CG2' HG11 ' A' ' 60' ' ' VAL . 4.4 mm -79.5 160.25 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.683 -1.26 . . . . 0.0 108.811 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 ' O ' ' A' ' 88' ' ' ILE . 16.9 mm -123.72 155.69 30.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.838 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.717 ' CG ' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -116.27 88.08 2.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.471 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.69 165.07 34.56 Favored Pre-proline 0 C--N 1.298 -1.637 0 O-C-N 121.415 -0.803 . . . . 0.0 109.315 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.36 -12.9 22.1 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.18 1.92 . . . . 0.0 110.227 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -72.42 -51.05 22.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.537 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' A' ' 59' ' ' LYS . 1.6 mp -73.16 141.81 47.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 0.0 109.533 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -143.48 119.0 10.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 109.744 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.587 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 71.61 47.02 36.21 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.987 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER -74.61 156.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.209 -1.171 . . . . 0.0 108.74 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.987 ' N ' HD12 ' A' ' 97' ' ' ILE . 3.6 t -124.37 106.17 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.047 -1.033 . . . . 0.0 109.939 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.937 HG22 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -101.73 159.78 4.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 51' ' ' TYR . 1.6 m-20 -139.33 170.03 16.69 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.172 -0.955 . . . . 0.0 109.236 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.895 HG22 ' HD2' ' A' ' 102' ' ' PRO . 0.7 OUTLIER -105.09 157.97 33.11 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 118.999 -1.08 . . . . 0.0 108.512 178.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.895 ' HD2' HG22 ' A' ' 101' ' ' VAL . 6.3 Cg_exo -55.86 -167.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.546 2.164 . . . . 0.0 111.585 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 13.4 t0 -106.87 -22.84 12.56 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -131.31 127.95 38.74 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.57 20.03 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.968 -1.083 . . . . 0.0 110.036 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.572 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.013 . . . . 0.0 109.467 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.522 ' S1 ' HD12 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.478 ' HB2' ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.471 0.653 . . . . 0.0 109.579 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.415 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -145.63 153.43 41.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 0.0 109.001 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.89 HG21 HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -149.13 122.95 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.125 -0.984 . . . . 0.0 109.802 -179.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.646 HG13 ' HG3' ' A' ' 14' ' ' GLN . 16.6 t -124.06 132.11 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.082 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -100.04 154.99 17.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.953 -1.092 . . . . 0.0 109.605 -179.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.936 ' O ' HG23 ' A' ' 101' ' ' VAL . 11.6 t -121.79 167.78 14.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.483 -0.761 . . . . 0.0 109.011 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.586 ' N ' HG12 ' A' ' 6' ' ' VAL . 42.0 t -124.3 161.75 25.2 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.503 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -64.51 -7.36 9.89 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.85 -1.156 . . . . 0.0 109.149 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -110.3 -4.09 15.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.014 -1.054 . . . . 0.0 110.606 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 12' ' ' ARG . . . 110.3 -19.03 27.46 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.303 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.2 m -59.87 111.88 1.64 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.908 -1.348 . . . . 0.0 109.252 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.75 ' HG2' HG13 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -125.58 121.93 35.04 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.515 -0.741 . . . . 0.0 110.268 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.632 ' NH1' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -102.53 126.36 49.57 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.646 ' HG3' HG13 ' A' ' 4' ' ' VAL . 2.4 mt-30 -88.78 157.17 18.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.099 -1.001 . . . . 0.0 110.654 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.082 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -166.81 -176.85 3.62 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.707 0.765 . . . . 0.0 109.322 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.25 116.07 17.86 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.415 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.014 HG21 HD23 ' A' ' 23' ' ' LEU . 49.2 t -93.29 106.36 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.577 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -47.07 174.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.324 -0.86 . . . . 0.0 109.586 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 92' ' ' PRO . 65.8 m-20 -83.51 126.26 32.61 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.317 -0.865 . . . . 0.0 109.18 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.84 21.77 20.11 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.736 HG12 ' HB2' ' A' ' 25' ' ' GLN . 1.5 t -125.01 164.65 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -1.177 . . . . 0.0 109.294 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 88' ' ' ILE . 33.0 t -109.33 143.89 38.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 108.986 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.014 HD23 HG21 ' A' ' 17' ' ' VAL . 16.0 mt -44.61 -34.63 2.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.152 -0.968 . . . . 0.0 108.878 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -48.59 76.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.047 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.811 ' O ' HG12 ' A' ' 28' ' ' VAL . 3.3 mt-30 -52.73 -55.73 20.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 109.01 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.16 -21.69 66.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.199 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.94 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -76.42 -24.37 54.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 109.561 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.811 HG12 ' O ' ' A' ' 25' ' ' GLN . 5.4 p -59.93 -33.75 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 0.0 109.167 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 t -91.79 -52.7 4.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 109.075 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.493 ' OD1' ' HB3' ' A' ' 15' ' ' LEU . 21.0 m-80 -55.04 -17.6 4.13 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.506 -0.746 . . . . 0.0 109.22 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.36 24.64 56.43 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.655 HD11 HD22 ' A' ' 15' ' ' LEU . 1.1 mt -102.9 -27.26 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.128 -1.219 . . . . 0.0 108.738 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.94 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.7 OUTLIER -50.5 -40.44 51.23 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.478 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 45.1 t0 -73.3 -32.91 64.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.632 HD13 ' NH1' ' A' ' 13' ' ' ARG . 1.0 OUTLIER -98.42 14.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.942 -1.098 . . . . 0.0 109.448 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.608 HG12 ' SG ' ' A' ' 85' ' ' CYS . 94.6 t -160.29 69.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.435 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 48' ' ' CYS . . . 154.41 -171.93 32.92 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.889 ' CG ' HG21 ' A' ' 47' ' ' THR . 0.3 OUTLIER -165.42 -79.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.172 . . . . 0.0 109.639 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.499 ' SG ' ' N ' ' A' ' 40' ' ' GLY . 16.4 p -61.97 -40.32 95.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 109.562 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.499 ' N ' ' SG ' ' A' ' 39' ' ' CYS . . . 64.11 138.83 0.02 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.73 -102.68 0.86 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.452 ' O ' ' SG ' ' A' ' 39' ' ' CYS . 0.4 OUTLIER -60.43 99.71 0.09 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -1.179 . . . . 0.0 109.437 -179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.457 ' HA ' ' S1 ' ' A' ' 107' ' ' FES . . . -63.54 109.71 1.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.505 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.3 m -152.45 17.13 0.62 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.654 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 12.9 p -121.26 -149.55 0.43 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.988 ' HB1' ' N ' ' A' ' 74' ' ' VAL . . . -156.13 18.71 0.36 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.033 -1.042 . . . . 0.0 109.997 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.889 HG21 ' CG ' ' A' ' 38' ' ' ASP . 1.7 p -90.11 -20.73 22.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.144 -0.973 . . . . 0.0 109.728 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.584 ' SG ' HD11 ' A' ' 71' ' ' LEU . 22.2 p -87.69 41.9 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.068 -1.02 . . . . 0.0 110.05 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.137 ' CD2' HD12 ' A' ' 78' ' ' LEU . 37.2 t-80 -81.9 61.94 5.46 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 82' ' ' SER . 12.5 m -77.35 148.09 6.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 120.588 -1.32 . . . . 0.0 110.612 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.514 ' CE2' ' CE1' ' A' ' 49' ' ' HIS . 7.0 m-85 -107.59 110.87 22.87 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.765 HG22 HG12 ' A' ' 99' ' ' VAL . 8.4 t -93.91 170.39 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 121.928 0.871 . . . . 0.0 112.251 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.566 ' N ' HG12 ' A' ' 52' ' ' VAL . 1.3 m-20 -69.16 165.3 20.7 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.17 9.3 26.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.158 -0.964 . . . . 0.0 109.869 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.32 -28.55 8.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.157 -0.964 . . . . 0.0 109.964 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.815 ' HD2' HD23 ' A' ' 94' ' ' LEU . 93.7 m-85 -97.91 -19.39 18.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.149 -0.969 . . . . 0.0 109.64 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.678 HG23 ' HB ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -63.82 -23.06 67.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.4 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.03 -35.73 25.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.681 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.917 ' HB2' HD21 ' A' ' 94' ' ' LEU . 2.7 mmtm -63.74 -12.94 39.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.38 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.955 HG11 ' CG2' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -97.94 161.75 24.56 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.268 -0.895 . . . . 0.0 108.969 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.832 ' HD2' HG12 ' A' ' 60' ' ' VAL . 5.0 Cg_exo -59.43 164.49 10.89 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.124 1.882 . . . . 0.0 110.371 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.19 59.35 0.61 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 109.428 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -41.98 130.19 3.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.548 -0.72 . . . . 0.0 109.593 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' ALA . 8.5 m-20 -57.08 -160.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.542 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.66 ' HA ' HD12 ' A' ' 68' ' ' ILE . 57.0 tt0 -99.25 -10.39 22.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.466 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' NE ' ' OE2' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -47.13 -72.28 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.599 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -61.04 -20.06 62.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 65' ' ' GLU . 13.6 mt -66.13 -31.93 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 68' ' ' ILE . . . -43.69 -59.51 3.7 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.45 ' O ' ' O ' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -68.44 -28.1 66.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -1.116 . . . . 0.0 109.056 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.068 HD13 HD23 ' A' ' 84' ' ' LEU . 1.3 tp -85.5 4.49 35.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.324 -0.86 . . . . 0.0 109.167 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 68' ' ' ILE . 3.2 tm-20 -95.84 -12.53 25.1 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.081 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.745 ' HB2' ' HB2' ' A' ' 46' ' ' ALA . 1.3 m -59.92 -14.69 16.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.673 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.989 HG21 ' CD2' ' A' ' 49' ' ' HIS . 3.9 m -34.41 134.11 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 121.364 0.602 . . . . 0.0 109.941 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.549 ' HB ' ' CG ' ' A' ' 104' ' ' ARG . 88.4 m -44.69 -25.5 0.29 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 108.761 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.762 ' O ' HG23 ' A' ' 74' ' ' VAL . . . -110.1 -152.6 0.5 Allowed 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.373 -0.83 . . . . 0.0 109.834 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.634 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -114.74 148.59 38.11 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.137 HD12 ' CD2' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -104.15 130.05 51.89 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 117.406 -1.718 . . . . 0.0 111.288 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.538 ' HE2' ' CD ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -108.63 166.52 10.69 Favored Pre-proline 0 C--N 1.295 -1.801 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.538 ' CD ' ' HE2' ' A' ' 79' ' ' LYS . 3.4 Cg_exo -52.37 -27.85 32.86 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 C-N-CA 121.733 1.622 . . . . 0.0 109.582 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.673 ' HA ' HG21 ' A' ' 57' ' ' THR . 0.0 OUTLIER -67.14 -42.04 85.07 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.677 -0.639 . . . . 0.0 109.449 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -83.18 168.27 16.96 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.435 -0.791 . . . . 0.0 109.671 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.541 ' HB3' ' CD1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -161.57 -177.27 5.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.086 -1.009 . . . . 0.0 109.687 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.068 HD23 HD13 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -83.93 114.22 21.53 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.714 -0.846 . . . . 0.0 108.714 179.332 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.608 ' SG ' HG12 ' A' ' 36' ' ' VAL . 9.4 t -59.66 -14.87 15.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 0.0 109.12 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.3 p -108.54 30.21 6.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 109.76 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.819 ' HB3' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -152.92 13.72 0.52 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.986 -1.071 . . . . 0.0 110.377 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.955 ' CG2' HG11 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -112.39 150.2 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.923 -1.111 . . . . 0.0 108.938 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.749 HD13 ' O ' ' A' ' 88' ' ' ILE . 38.2 mm -129.45 142.27 44.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.315 -0.866 . . . . 0.0 109.881 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.81 ' SD ' HG23 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -97.95 82.15 2.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -0.888 . . . . 0.0 108.936 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.57 165.85 41.58 Favored Pre-proline 0 C--N 1.294 -1.805 0 O-C-N 121.606 -0.684 . . . . 0.0 109.174 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.508 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 5.8 Cg_exo -59.25 -13.8 21.54 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.067 1.845 . . . . 0.0 110.103 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -76.96 -42.39 39.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.917 HD21 ' HB2' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -80.07 160.01 25.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.52 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -173.98 125.24 0.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.613 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.57 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 75.34 40.34 33.71 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.736 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -79.83 149.11 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -1.082 . . . . 0.0 109.165 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.417 ' N ' HD13 ' A' ' 97' ' ' ILE . 2.3 t -113.73 108.54 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.227 -0.92 . . . . 0.0 109.759 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.765 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -99.71 153.18 4.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -129.93 179.34 5.92 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.049 -1.032 . . . . 0.0 109.939 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 6' ' ' VAL . 25.4 t -109.01 146.59 34.16 Favored Pre-proline 0 C--N 1.296 -1.757 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.544 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.887 ' HD2' HG13 ' A' ' 101' ' ' VAL . 12.1 Cg_exo -53.72 137.8 67.38 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.223 1.949 . . . . 0.0 109.762 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.58 ' CB ' ' HD2' ' A' ' 104' ' ' ARG . 1.3 m-20 -47.14 -26.28 1.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.884 -1.135 . . . . 0.0 108.417 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -117.4 -167.34 1.3 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 106' ' ' TRP . 11.8 pt20 -160.07 27.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.056 . . . . 0.0 109.75 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.504 ' NE1' ' N ' ' A' ' 75' ' ' THR . 41.4 m95 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.67 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.457 ' S1 ' ' HA ' ' A' ' 43' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.88 161.99 40.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 109.355 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.752 ' CG2' HD21 ' A' ' 23' ' ' LEU . 1.5 t -147.04 132.04 11.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.304 -0.873 . . . . 0.0 109.301 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.935 HG13 ' O ' ' A' ' 13' ' ' ARG . 72.2 t -129.32 127.7 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.782 ' CD2' HD21 ' A' ' 15' ' ' LEU . 44.5 m-85 -97.57 153.72 17.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.818 -1.176 . . . . 0.0 110.263 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.69 HG22 ' HB3' ' A' ' 12' ' ' ARG . 2.6 t -132.46 141.77 44.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -76.77 -156.78 0.08 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.258 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.685 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -58.18 -105.93 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -112.07 77.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.477 -1.389 . . . . 0.0 108.887 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.05 -100.39 0.19 Allowed Glycine 0 N--CA 1.493 2.439 0 C-N-CA 118.931 -1.605 . . . . 0.0 111.027 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.702 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.3 m -119.56 -177.27 3.34 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.333 -1.098 . . . . 0.0 110.061 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.702 ' H ' HG22 ' A' ' 11' ' ' THR . 12.8 ptt180 -153.0 147.79 26.33 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.935 ' O ' HG13 ' A' ' 4' ' ' VAL . 8.0 mtt180 -106.25 173.47 6.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 108.522 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.453 ' C ' HD23 ' A' ' 15' ' ' LEU . 4.0 pt20 -123.76 163.76 20.53 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.004 -1.06 . . . . 0.0 110.567 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.782 HD21 ' CD2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -169.71 -175.32 2.08 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -131.9 91.33 2.96 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.063 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.925 HG21 HD23 ' A' ' 23' ' ' LEU . 46.9 t -62.2 153.38 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 108.872 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 1.055 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -91.03 172.37 8.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.0 . . . . 0.0 109.496 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -78.19 125.25 29.07 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.323 -0.861 . . . . 0.0 109.029 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.79 26.89 28.15 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.055 HG21 ' HB3' ' A' ' 18' ' ' ALA . 2.1 t -120.89 163.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -1.15 . . . . 0.0 109.172 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 23' ' ' LEU . 1.5 t -106.07 140.72 38.62 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 108.534 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.013 HD13 HG21 ' A' ' 99' ' ' VAL . 12.1 mt -46.38 -26.08 0.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.099 -1.001 . . . . 0.0 108.623 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.589 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 22.0 ttt -71.71 -47.96 50.44 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.873 ' HB3' HG12 ' A' ' 21' ' ' VAL . 3.2 tp-100 -51.34 -55.5 18.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.314 -0.866 . . . . 0.0 108.836 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.597 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -54.1 -31.38 51.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.253 -0.904 . . . . 0.0 108.903 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.83 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -61.19 -39.51 90.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.344 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.555 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 49.0 t -46.16 -22.71 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.328 -0.857 . . . . 0.0 110.446 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 t -110.64 -50.29 2.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.019 -1.051 . . . . 0.0 110.325 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.674 ' HB3' HD11 ' A' ' 32' ' ' ILE . 56.1 m-80 -59.56 -11.64 5.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 110.123 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.425 ' O ' HG12 ' A' ' 35' ' ' ILE . . . 98.88 -31.49 8.13 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.674 HD11 ' HB3' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -51.53 -21.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.215 -1.168 . . . . 0.0 109.178 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.83 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 1.2 p90 -43.16 -47.89 6.32 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.626 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 1.2 t0 -87.12 -21.2 26.14 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.505 ' CG1' ' HA ' ' A' ' 32' ' ' ILE . 4.5 mm -85.71 5.72 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.936 -1.102 . . . . 0.0 109.437 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.663 HG12 ' O ' ' A' ' 32' ' ' ILE . 10.0 p -170.52 171.47 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.572 ' H ' HG22 ' A' ' 36' ' ' VAL . . . 77.24 173.83 39.82 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.739 ' HB2' HG21 ' A' ' 47' ' ' THR . 6.9 t0 -169.96 -89.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -1.107 . . . . 0.0 109.542 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 44' ' ' SER . 17.7 p -65.05 -22.78 67.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.155 -0.966 . . . . 0.0 109.525 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.6 -177.18 0.08 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.55 -109.84 3.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.0 -177.16 3.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -1.152 . . . . 0.0 109.449 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -61.81 110.11 1.44 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.431 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.502 ' HB3' ' HB2' ' A' ' 39' ' ' CYS . 0.3 OUTLIER -134.98 8.36 3.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.748 ' SG ' HG22 ' A' ' 47' ' ' THR . 9.0 p -165.46 -160.51 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.659 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.857 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -145.52 13.36 1.37 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.502 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.748 HG22 ' SG ' ' A' ' 45' ' ' CYS . 8.8 t -78.51 -18.75 54.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.585 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.503 ' HB2' ' CB ' ' A' ' 85' ' ' CYS . 21.8 p -87.54 41.9 1.01 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 0.0 109.948 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.013 ' CE1' HD12 ' A' ' 78' ' ' LEU . 14.6 t60 -70.54 76.13 0.57 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.781 HG11 ' SG ' ' A' ' 85' ' ' CYS . 8.4 m -80.02 144.74 10.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 120.214 -1.554 . . . . 0.0 110.673 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.506 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 2.0 m-85 -110.98 102.72 11.18 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.052 HG22 HG12 ' A' ' 99' ' ' VAL . 7.0 t -101.13 156.32 4.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-O 121.85 0.834 . . . . 0.0 112.859 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.749 HD22 HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -46.22 177.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.468 0.651 . . . . 0.0 109.267 178.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . 0.3 OUTLIER -101.68 -0.28 34.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 110.115 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.57 -22.81 11.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.97 -1.081 . . . . 0.0 110.649 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.812 ' HD1' HD23 ' A' ' 94' ' ' LEU . 65.8 m-85 -91.71 -27.08 18.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.988 -1.07 . . . . 0.0 109.747 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.854 HG21 HD22 ' A' ' 81' ' ' ASN . 5.8 p -58.07 -38.13 75.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.18 -0.95 . . . . 0.0 109.475 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 1.2 m-20 -57.46 -64.61 0.83 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.777 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.638 ' HB2' HD21 ' A' ' 94' ' ' LEU . 46.2 mmtt -49.81 -37.96 32.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.912 . . . . 0.0 109.396 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.825 ' CG2' HG22 ' A' ' 88' ' ' ILE . 1.1 t -54.91 157.37 5.71 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.179 -0.951 . . . . 0.0 108.754 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.604 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.6 Cg_exo -56.13 156.83 19.08 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.087 1.858 . . . . 0.0 110.309 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.52 61.13 0.6 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.34 -0.85 . . . . 0.0 109.325 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.621 ' HB2' ' NH2' ' A' ' 83' ' ' ARG . . . -40.83 146.46 0.15 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.626 -0.671 . . . . 0.0 109.689 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.591 ' O ' HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -51.59 -174.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.679 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.527 ' HA ' HD13 ' A' ' 68' ' ' ILE . 58.0 tt0 -96.71 -9.81 28.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.86 . . . . 0.0 109.543 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -50.3 -49.12 54.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.927 . . . . 0.0 109.516 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.469 ' CG ' ' HB2' ' A' ' 43' ' ' ALA . 28.0 mt-10 -74.59 -21.35 59.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.435 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.632 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -68.21 -35.32 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.878 . . . . 0.0 109.314 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.59 -52.6 44.24 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -66.84 -24.31 66.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -1.15 . . . . 0.0 109.273 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.891 ' O ' HD13 ' A' ' 78' ' ' LEU . 5.7 tp -88.24 -7.29 57.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.378 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -80.09 -37.64 33.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.334 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.413 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 42.6 t -104.2 38.61 1.82 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.393 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.857 HG12 ' HB1' ' A' ' 46' ' ' ALA . 16.4 m -63.17 174.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.85 . . . . 0.0 109.597 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.569 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 98.3 m -65.28 -9.37 23.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.747 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.842 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -116.5 -149.92 0.45 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.081 -1.012 . . . . 0.0 109.511 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.644 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.2 pt-20 -111.52 155.24 23.58 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.013 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -129.8 135.66 48.68 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 117.991 -1.483 . . . . 0.0 111.454 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.594 ' HB3' ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -117.83 171.02 5.45 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 79' ' ' LYS . 4.4 Cg_exo -57.52 -10.6 7.13 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 C-N-CA 122.394 2.063 . . . . 0.0 111.09 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.854 HD22 HG21 ' A' ' 57' ' ' THR . 0.0 OUTLIER -104.78 16.57 25.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 0.0 111.499 -178.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.615 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 1.4 m -100.26 161.09 13.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.675 -1.266 . . . . 0.0 110.029 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.621 ' NH2' ' HB2' ' A' ' 63' ' ' ALA . 1.5 mtp180 -161.62 -165.11 1.22 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.351 -0.843 . . . . 0.0 109.287 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.53 ' O ' ' CG1' ' A' ' 88' ' ' ILE . 1.7 mp -104.95 131.09 52.89 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.314 -0.866 . . . . 0.0 108.887 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.781 ' SG ' HG11 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -67.13 -10.41 49.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.399 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 24.1 p -110.35 15.26 22.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.797 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -131.95 -0.55 3.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.088 -1.007 . . . . 0.0 109.925 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.825 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -97.9 147.14 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.03 -1.044 . . . . 0.0 108.97 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.619 HG22 ' N ' ' A' ' 90' ' ' MET . 10.7 mm -121.3 165.68 16.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.293 -0.88 . . . . 0.0 109.775 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.638 ' CB ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -122.97 90.33 3.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.352 -0.842 . . . . 0.0 109.341 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.01 162.48 40.78 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.417 -0.802 . . . . 0.0 109.303 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.0 -13.99 21.18 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.151 1.901 . . . . 0.0 110.233 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.507 ' CG ' ' N ' ' A' ' 94' ' ' LEU . 21.6 pt-20 -70.92 -45.92 63.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.43 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.812 HD23 ' HD1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -78.46 144.4 35.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -146.41 122.03 10.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.637 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 75.22 39.53 36.5 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.948 HD11 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -78.11 134.66 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.441 -1.035 . . . . 0.0 109.197 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.68 HG11 HH11 ' A' ' 12' ' ' ARG . 2.0 t -107.23 110.12 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.976 -1.078 . . . . 0.0 110.012 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.052 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -100.82 146.57 9.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.501 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 1.6 m-20 -122.15 174.25 7.07 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.968 -1.083 . . . . 0.0 110.256 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.897 HG13 ' HD2' ' A' ' 102' ' ' PRO . 39.7 t -108.01 145.21 30.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.897 ' HD2' HG13 ' A' ' 101' ' ' VAL . 7.2 Cg_exo -50.95 159.82 2.26 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.492 2.128 . . . . 0.0 111.548 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -14.7 60.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 108.596 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -119.87 -159.51 0.78 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 106' ' ' TRP . 3.8 pt20 -159.87 27.36 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.025 -1.047 . . . . 0.0 109.78 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.681 ' NE1' ' HB3' ' A' ' 46' ' ' ALA . 5.9 m95 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.658 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -147.48 168.39 22.02 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -0.863 . . . . 0.0 109.253 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.673 ' CG2' HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -153.54 129.95 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.295 -0.878 . . . . 0.0 109.677 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.974 HG13 ' O ' ' A' ' 13' ' ' ARG . 77.7 t -130.17 135.42 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.872 . . . . 0.0 108.651 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.113 ' CE1' HD21 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -104.0 155.14 18.9 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.922 -1.111 . . . . 0.0 109.393 -179.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.749 HG13 ' HB3' ' A' ' 12' ' ' ARG . 2.4 t -135.25 133.02 52.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.531 ' HA ' ' CG2' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -80.0 -174.27 4.36 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 177.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.544 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -50.02 161.48 0.26 Allowed 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.528 ' C ' ' O ' ' A' ' 8' ' ' HIS . 33.9 t0 -29.86 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.147 0.499 . . . . 0.0 110.72 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 8' ' ' HIS . . . -167.45 -95.51 0.1 Allowed Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.484 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.6 m -124.97 -178.53 4.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -1.186 . . . . 0.0 109.77 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.749 ' HB3' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -157.15 142.64 17.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.625 -0.672 . . . . 0.0 110.032 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.974 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -100.33 176.2 5.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.255 -0.903 . . . . 0.0 108.899 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -132.43 160.83 35.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.126 -0.984 . . . . 0.0 110.52 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.113 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.5 OUTLIER -177.14 -176.04 0.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.579 0.704 . . . . 0.0 109.115 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -128.94 113.88 15.76 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.581 -0.699 . . . . 0.0 109.965 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.917 HG11 ' HB3' ' A' ' 90' ' ' MET . 28.6 t -78.12 133.37 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.046 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.936 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -69.76 171.81 8.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.498 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -78.44 125.25 29.09 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.269 -0.895 . . . . 0.0 109.084 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.16 39.59 7.86 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.936 HG21 ' HB3' ' A' ' 18' ' ' ALA . 1.5 t -131.11 160.69 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -1.117 . . . . 0.0 109.327 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -99.35 135.07 41.29 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.26 -0.9 . . . . 0.0 108.65 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.736 HD23 HG21 ' A' ' 17' ' ' VAL . 6.6 mt -46.28 -26.24 0.77 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.965 -1.085 . . . . 0.0 108.6 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.541 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -72.74 -47.45 46.86 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.639 ' HB3' HG12 ' A' ' 21' ' ' VAL . 39.6 tp60 -51.97 -55.08 22.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.36 -0.837 . . . . 0.0 108.845 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.527 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -57.67 -28.5 63.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.178 -0.951 . . . . 0.0 108.737 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.703 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -68.09 -33.89 75.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.47 -0.769 . . . . 0.0 109.451 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.585 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 53.7 t -54.58 -39.89 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.475 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 t -79.87 -51.78 8.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.858 . . . . 0.0 109.398 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.878 ' ND2' HD13 ' A' ' 15' ' ' LEU . 29.4 m-80 -58.57 -13.41 5.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.424 -0.798 . . . . 0.0 109.567 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.47 14.54 78.18 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.954 ' O ' HG22 ' A' ' 35' ' ' ILE . 1.2 mt -90.41 -34.65 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.252 -1.146 . . . . 0.0 108.851 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.703 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -51.48 -37.06 47.12 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.624 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 5.3 t0 -82.83 -26.94 31.21 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.954 HG22 ' O ' ' A' ' 32' ' ' ILE . 4.8 tp -44.48 -26.13 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 109.325 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.582 HG13 ' H ' ' A' ' 37' ' ' GLY . 2.5 p -131.17 -52.15 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.563 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' H ' HG13 ' A' ' 36' ' ' VAL . . . 69.2 120.12 0.03 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 94.9 m-20 -136.4 -120.36 0.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -1.171 . . . . 0.0 109.53 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 1.016 ' SG ' ' HB3' ' A' ' 43' ' ' ALA . 16.7 p -109.79 -6.48 15.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.75 -1.219 . . . . 0.0 109.594 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 44.62 -168.51 0.02 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 43.89 -125.95 5.69 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.12 63.86 1.46 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -1.121 . . . . 0.0 109.543 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 1.016 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . . . -88.8 -147.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 109.431 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.516 ' CB ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -139.78 60.86 1.55 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.152 -0.968 . . . . 0.0 109.773 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.414 ' SG ' ' HB3' ' A' ' 38' ' ' ASP . 6.7 p -99.22 -164.57 1.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.033 -1.042 . . . . 0.0 109.379 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.88 ' O ' HG13 ' A' ' 74' ' ' VAL . . . -148.92 17.74 0.98 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.525 ' CG2' ' OD1' ' A' ' 38' ' ' ASP . 58.5 m -90.02 -17.19 28.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.44 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.465 ' HB2' ' SG ' ' A' ' 85' ' ' CYS . 24.5 p -87.6 42.51 1.05 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 110.269 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.948 ' CE1' HD12 ' A' ' 78' ' ' LEU . 15.3 t60 -75.56 71.19 2.46 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.013 HG11 ' HB3' ' A' ' 85' ' ' CYS . 12.7 m -77.88 146.1 8.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.257 -1.527 . . . . 0.0 110.168 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.661 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -112.53 100.71 8.95 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.309 1.052 . . . . 0.0 108.182 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.797 HG22 HG12 ' A' ' 99' ' ' VAL . 4.5 t -89.76 172.88 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.803 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.579 ' H ' HG12 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -68.86 -178.36 1.19 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -100.88 -1.21 35.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 109.967 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.14 -14.38 14.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.085 -1.01 . . . . 0.0 110.187 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.723 ' HD1' HD23 ' A' ' 94' ' ' LEU . 80.3 m-85 -103.67 -21.42 13.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.141 -0.975 . . . . 0.0 109.7 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.827 HG21 HD22 ' A' ' 81' ' ' ASN . 0.7 OUTLIER -68.7 -6.47 26.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.563 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -88.08 -56.17 3.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.123 -0.986 . . . . 0.0 109.6 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.64 ' HB2' HD21 ' A' ' 94' ' ' LEU . 2.5 mptp? -52.29 -38.69 59.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 57' ' ' THR . 0.1 OUTLIER -50.14 164.57 0.37 Allowed Pre-proline 0 C--N 1.306 -1.303 0 O-C-N 121.17 -0.956 . . . . 0.0 109.414 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 60' ' ' VAL . 5.8 Cg_exo -58.16 176.66 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.109 1.873 . . . . 0.0 110.353 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.431 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.25 59.37 0.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 64' ' ' ASN . . . -42.29 120.73 1.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.483 -0.761 . . . . 0.0 109.553 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 63' ' ' ALA . 9.7 m-20 -57.0 -160.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.473 ' HG2' ' HB ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -100.05 -12.1 19.98 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.882 . . . . 0.0 109.467 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 67' ' ' GLU . 5.1 ppt_? -54.51 -44.66 72.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' N ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -81.17 -14.51 57.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.404 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.473 ' HB ' ' HG2' ' A' ' 65' ' ' GLU . 26.0 mm -77.12 -32.17 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.476 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.13 -54.69 11.66 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.516 ' SD ' ' CB ' ' A' ' 44' ' ' SER . 0.2 OUTLIER -67.89 -24.92 65.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -1.155 . . . . 0.0 109.257 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.036 HD23 HD21 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -90.04 0.15 57.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -0.872 . . . . 0.0 109.43 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -89.99 -25.47 20.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.942 . . . . 0.0 109.299 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.64 34.55 2.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.426 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.922 HG11 ' HB2' ' A' ' 49' ' ' HIS . 2.1 t -63.38 165.01 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.581 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 28.4 m -71.68 -4.25 26.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.477 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.527 ' CB ' ' OD1' ' A' ' 103' ' ' ASP . . . -115.96 -149.8 0.45 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.114 -0.991 . . . . 0.0 109.34 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.63 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.7 pt-20 -112.19 155.06 24.59 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.948 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.4 OUTLIER -133.49 166.34 22.78 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 117.465 -1.694 . . . . 0.0 112.547 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.698 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -155.7 170.62 8.46 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 5.3 Cg_exo -56.45 -14.68 13.27 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 121.997 1.798 . . . . 0.0 109.992 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.827 HD22 HG21 ' A' ' 57' ' ' THR . 0.0 OUTLIER -87.03 -30.33 21.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 0.0 110.71 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.61 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -74.62 152.87 39.17 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.021 -1.049 . . . . 0.0 110.354 -179.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 1.096 ' NH2' HG23 ' A' ' 88' ' ' ILE . 8.8 mtp180 -161.8 -175.38 4.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.211 -0.931 . . . . 0.0 109.488 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.036 HD21 HD23 ' A' ' 71' ' ' LEU . 4.9 mp -98.99 103.43 15.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.324 -0.86 . . . . 0.0 108.698 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 1.013 ' HB3' HG11 ' A' ' 50' ' ' VAL . 6.1 p -48.85 -21.99 0.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.142 -0.974 . . . . 0.0 109.924 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 20.7 p -76.57 -40.11 50.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.084 -1.01 . . . . 0.0 110.093 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.484 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 0.2 OUTLIER -89.74 38.44 0.91 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.112 -0.992 . . . . 0.0 110.405 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.096 HG23 ' NH2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -140.06 149.01 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.975 -1.078 . . . . 0.0 109.312 179.294 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.629 HG22 ' N ' ' A' ' 90' ' ' MET . 12.7 mm -116.23 167.09 9.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.421 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.917 ' HB3' HG11 ' A' ' 17' ' ' VAL . 12.9 tpt -130.18 96.87 4.28 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.665 HG22 ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -95.53 171.45 6.44 Favored Pre-proline 0 C--N 1.298 -1.662 0 O-C-N 121.549 -0.72 . . . . 0.0 109.385 -179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.665 ' HD2' HG22 ' A' ' 91' ' ' THR . 5.6 Cg_exo -59.03 -14.49 23.42 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.05 1.833 . . . . 0.0 110.054 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.44 ' OE1' ' HB3' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -62.8 -37.23 85.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 109.312 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.723 HD23 ' HD1' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -95.07 139.75 30.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.234 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 11.2 p-10 -138.72 124.68 19.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.803 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.469 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 71.51 39.22 61.37 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.966 HD11 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -72.91 147.66 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.317 -1.107 . . . . 0.0 109.302 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.509 ' N ' HD13 ' A' ' 97' ' ' ILE . 3.5 t -116.75 106.73 20.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 O-C-N 121.126 -0.983 . . . . 0.0 109.853 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.966 HG13 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -101.25 142.71 15.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.514 ' HA ' ' HB ' ' A' ' 6' ' ' VAL . 3.1 m-20 -122.97 177.44 5.5 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.967 -1.083 . . . . 0.0 110.269 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.903 HG13 ' HD2' ' A' ' 102' ' ' PRO . 44.8 t -108.49 145.07 30.8 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.903 ' HD2' HG13 ' A' ' 101' ' ' VAL . 7.7 Cg_exo -51.14 -174.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.263 1.975 . . . . 0.0 111.293 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.527 ' OD1' ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -100.7 -27.03 13.59 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' A' ' 103' ' ' ASP . 0.0 OUTLIER -130.07 149.7 51.67 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -122.93 41.94 3.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.044 -1.035 . . . . 0.0 109.849 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.581 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 43.6 m95 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.476 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.886 ' S1 ' HD23 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.491 ' HB2' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -138.29 169.51 17.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.215 -0.928 . . . . 0.0 109.428 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.572 HG21 ' CG2' ' A' ' 17' ' ' VAL . 11.3 t -152.34 158.64 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.272 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.672 HG12 ' O ' ' A' ' 13' ' ' ARG . 0.2 OUTLIER -157.8 120.67 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.104 -0.998 . . . . 0.0 108.905 -179.409 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.654 ' CE2' ' CD2' ' A' ' 15' ' ' LEU . 54.9 m-85 -98.5 155.62 17.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.66 -1.275 . . . . 0.0 110.634 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.806 HG22 ' HG3' ' A' ' 12' ' ' ARG . 3.0 t -130.84 142.48 43.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -76.5 -158.53 0.1 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.76 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -58.31 -103.97 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.18 75.15 0.9 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.482 -1.386 . . . . 0.0 108.496 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.29 -100.42 0.24 Allowed Glycine 0 N--CA 1.492 2.425 0 C-N-CA 118.863 -1.636 . . . . 0.0 111.453 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.71 HG22 ' H ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER -114.9 -176.59 2.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.289 -1.124 . . . . 0.0 110.584 -178.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.806 ' HG3' HG22 ' A' ' 6' ' ' VAL . 13.7 ttp180 -149.27 134.59 18.35 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.871 ' NH2' HD11 ' A' ' 35' ' ' ILE . 6.6 mtt180 -105.11 171.51 7.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.941 -1.1 . . . . 0.0 108.774 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.481 ' CG ' HG13 ' A' ' 4' ' ' VAL . 1.7 mt-30 -127.08 163.47 23.7 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.949 -1.094 . . . . 0.0 111.141 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.046 HD13 ' OD1' ' A' ' 30' ' ' ASN . 0.4 OUTLIER -161.65 -172.96 3.53 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.671 0.748 . . . . 0.0 109.019 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 17' ' ' VAL . 46.4 t0 -131.22 69.96 1.47 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.627 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.918 HG21 HD23 ' A' ' 23' ' ' LEU . 26.6 t -43.81 163.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.185 -0.947 . . . . 0.0 109.068 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 1.027 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -105.07 173.1 6.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.959 . . . . 0.0 109.744 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -81.99 125.81 31.22 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.371 -0.831 . . . . 0.0 108.898 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.11 23.3 38.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.027 HG21 ' HB3' ' A' ' 18' ' ' ALA . 3.0 t -118.04 167.34 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.43 -1.041 . . . . 0.0 109.113 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 23' ' ' LEU . 10.4 t -105.89 137.45 43.75 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.918 HD23 HG21 ' A' ' 17' ' ' VAL . 8.3 mt -44.9 -26.69 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.018 -1.051 . . . . 0.0 108.794 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.622 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 3.3 ttm -75.03 -47.53 28.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.546 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -49.8 -54.77 17.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 108.803 179.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.767 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -52.24 -35.81 50.67 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.263 -0.898 . . . . 0.0 108.971 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.69 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -42.15 -42.38 2.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -0.849 . . . . 0.0 110.076 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.581 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 63.6 t -39.65 -50.41 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.19 -0.944 . . . . 0.0 110.588 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 t -90.8 -45.36 8.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.299 -0.876 . . . . 0.0 110.017 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 1.046 ' OD1' HD13 ' A' ' 15' ' ' LEU . 2.4 m120 -50.13 -17.19 0.38 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.725 -0.609 . . . . 0.0 109.774 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.31 -21.64 36.78 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.65 HG13 ' CE2' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -66.62 -22.17 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.254 -1.144 . . . . 0.0 108.554 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.69 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -48.02 -28.74 2.96 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 179.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -100.17 -23.39 14.85 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.925 HG22 HG13 ' A' ' 36' ' ' VAL . 18.6 mm -60.36 -51.14 76.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.089 -1.007 . . . . 0.0 109.405 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.925 HG13 HG22 ' A' ' 35' ' ' ILE . 11.8 m -134.06 -153.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.935 . . . . 0.0 109.538 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.492 ' HA2' ' HE1' ' A' ' 24' ' ' MET . . . 112.83 150.89 10.99 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.516 ' OD1' ' CB ' ' A' ' 45' ' ' CYS . 6.8 t70 -152.17 -92.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.178 -1.19 . . . . 0.0 109.714 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.513 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 15.6 p -85.27 -33.28 22.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.987 . . . . 0.0 109.603 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 39' ' ' CYS . . . 56.57 162.23 0.03 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.01 -103.67 2.26 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.26 169.4 8.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -1.159 . . . . 0.0 109.488 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.981 ' HB1' HD21 ' A' ' 71' ' ' LEU . . . -65.5 111.95 3.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.508 ' HB2' ' CB ' ' A' ' 39' ' ' CYS . 44.3 m -140.73 11.3 2.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.652 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.516 ' CB ' ' OD1' ' A' ' 38' ' ' ASP . 8.9 p -157.32 -157.41 0.67 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 109.626 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.728 ' HB1' ' HA ' ' A' ' 74' ' ' VAL . . . -150.0 15.22 0.83 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.687 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.779 HG23 ' CB ' ' A' ' 105' ' ' GLN . 22.0 m -82.05 -18.41 43.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.355 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.54 ' SG ' HD12 ' A' ' 84' ' ' LEU . 23.4 p -86.34 43.13 1.04 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 110.112 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.89 ' CE1' HD12 ' A' ' 78' ' ' LEU . 48.0 t60 -77.36 65.56 2.94 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.59 HG11 ' HB3' ' A' ' 85' ' ' CYS . 8.8 m -74.94 143.33 13.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.284 -1.51 . . . . 0.0 110.449 -177.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.645 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 1.0 OUTLIER -109.46 109.55 20.41 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.094 HG22 HG12 ' A' ' 99' ' ' VAL . 7.1 t -97.28 171.42 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-O 122.005 0.907 . . . . 0.0 112.531 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.565 ' N ' HG12 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -65.33 176.8 1.26 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.298 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.75 7.72 45.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.151 -0.968 . . . . 0.0 109.626 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.33 -27.96 8.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.883 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.611 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 88.1 m-85 -98.27 -18.54 18.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.739 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.941 HG21 ' HA ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER -62.5 -39.01 92.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.611 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.38 -41.18 94.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 109.776 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.856 ' CB ' HD21 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -54.41 -42.65 70.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.907 . . . . 0.0 109.579 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.889 HG11 HG23 ' A' ' 88' ' ' ILE . 62.3 t -62.54 142.38 96.57 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.084 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.747 ' HD2' HG13 ' A' ' 60' ' ' VAL . 5.7 Cg_exo -56.36 168.8 1.89 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.075 1.85 . . . . 0.0 110.468 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.48 63.51 0.61 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.366 -0.834 . . . . 0.0 109.125 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 62' ' ' ALA . . . -36.52 139.66 0.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.275 0.56 . . . . 0.0 110.068 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -50.52 -177.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.347 -0.846 . . . . 0.0 109.804 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.534 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 23.9 tt0 -97.07 -12.77 22.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 109.507 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -50.07 -67.18 0.28 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.463 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -66.09 -10.22 38.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.534 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 26.5 mm -76.38 -31.93 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.521 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.77 -54.91 8.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.3 mtt -68.25 -26.28 65.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -1.15 . . . . 0.0 108.987 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.981 HD21 ' HB1' ' A' ' 43' ' ' ALA . 38.3 mt -84.21 -2.96 57.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.35 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.415 ' C ' ' OE1' ' A' ' 72' ' ' GLU . 0.6 OUTLIER -91.13 -10.11 43.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.289 -0.882 . . . . 0.0 109.353 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.581 ' O ' ' CD1' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -86.24 51.37 2.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.418 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.728 ' HA ' ' HB1' ' A' ' 46' ' ' ALA . 6.2 m -92.76 169.1 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 0.0 109.295 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.825 HG21 ' CB ' ' A' ' 104' ' ' ARG . 5.4 t -66.36 -34.56 78.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.084 -1.01 . . . . 0.0 109.797 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.405 ' N ' ' CG2' ' A' ' 75' ' ' THR . . . -106.62 -151.23 0.45 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.387 -0.821 . . . . 0.0 110.633 -178.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.558 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -112.51 149.9 32.03 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.89 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -108.29 165.44 11.5 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 118.609 -1.236 . . . . 0.0 110.465 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.543 ' HB2' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -158.97 172.87 5.57 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -178.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 79' ' ' LYS . 6.0 Cg_exo -54.38 -18.77 15.43 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 121.309 1.339 . . . . 0.0 108.803 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.941 ' HA ' HG21 ' A' ' 57' ' ' THR . 0.2 OUTLIER -83.18 -35.93 25.09 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.712 -0.617 . . . . 0.0 109.739 179.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.565 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -95.48 159.22 15.1 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.19 -0.944 . . . . 0.0 110.398 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.605 ' HD2' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -161.69 -164.22 1.08 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.343 -0.848 . . . . 0.0 109.03 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.865 ' N ' HD22 ' A' ' 84' ' ' LEU . 1.3 mm? -104.19 123.53 47.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.59 ' HB3' HG11 ' A' ' 50' ' ' VAL . 13.9 p -64.13 -10.75 24.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.014 -1.054 . . . . 0.0 109.553 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 22.6 p -100.21 14.7 29.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.276 -0.89 . . . . 0.0 109.914 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -143.3 0.34 1.16 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.013 -1.054 . . . . 0.0 110.694 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.889 HG23 HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -96.9 151.69 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.764 -1.21 . . . . 0.0 108.911 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.654 HD13 ' O ' ' A' ' 88' ' ' ILE . 18.0 mm -124.23 158.66 30.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.165 -0.959 . . . . 0.0 109.927 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.652 ' CB ' HG11 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -120.93 90.33 3.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.4 -0.812 . . . . 0.0 109.176 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.413 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -82.0 167.07 33.38 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.399 -0.813 . . . . 0.0 109.456 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 3.3 Cg_exo -60.49 -13.33 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.115 1.877 . . . . 0.0 110.097 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.05 -39.99 65.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.434 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.856 HD21 ' CB ' ' A' ' 59' ' ' LYS . 4.6 mp -81.99 135.25 35.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.43 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.4 ' O ' ' CE2' ' A' ' 56' ' ' PHE . 11.4 p-10 -135.67 124.24 23.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.223 -0.923 . . . . 0.0 109.55 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.574 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 68.25 49.28 47.14 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.975 HD11 HG22 ' A' ' 99' ' ' VAL . 0.4 OUTLIER -75.9 151.11 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.187 -1.184 . . . . 0.0 108.455 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.944 ' N ' HD12 ' A' ' 97' ' ' ILE . 5.6 t -121.81 102.62 12.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 118.889 -1.124 . . . . 0.0 109.947 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.094 HG12 HG22 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -96.08 154.23 3.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -130.5 172.79 11.52 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.036 -1.04 . . . . 0.0 109.225 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.86 HG13 ' HD2' ' A' ' 102' ' ' PRO . 55.5 t -107.38 144.31 28.94 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 119.461 -0.896 . . . . 0.0 109.282 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.86 ' HD2' HG13 ' A' ' 101' ' ' VAL . 5.8 Cg_exo -57.26 -178.4 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.326 2.017 . . . . 0.0 110.364 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.595 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 6.9 t0 -90.2 -32.89 16.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.122 -0.986 . . . . 0.0 108.503 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.825 ' CB ' HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -133.17 -161.19 1.12 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.779 ' CB ' HG23 ' A' ' 47' ' ' THR . 7.8 pt20 -159.45 27.76 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.171 -0.956 . . . . 0.0 109.535 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 73' ' ' CYS . 10.9 m95 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.459 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.514 ' S1 ' ' CD2' ' A' ' 71' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.34 0.59 . . . . 0.0 109.513 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.499 ' HB3' ' HA2' ' A' ' 96' ' ' GLY . 3.0 ttmt -139.54 174.42 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.356 -0.84 . . . . 0.0 109.06 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.754 HG13 HD11 ' A' ' 23' ' ' LEU . 5.0 t -152.58 157.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.193 -0.942 . . . . 0.0 109.742 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 13' ' ' ARG . 67.2 t -156.93 117.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.411 -0.805 . . . . 0.0 109.154 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 1.085 ' CE1' HD21 ' A' ' 15' ' ' LEU . 1.2 m-85 -95.47 154.05 17.4 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.344 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.78 HG22 ' HB3' ' A' ' 12' ' ' ARG . 2.4 t -133.87 142.44 41.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 8' ' ' HIS . 6.9 t -77.65 -158.05 0.11 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.714 ' CE1' HG12 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -58.08 -103.24 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -112.22 77.28 1.03 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.513 -1.367 . . . . 0.0 108.973 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.72 -101.06 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 118.977 -1.582 . . . . 0.0 111.093 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.697 HG22 ' H ' ' A' ' 12' ' ' ARG . 1.3 m -120.12 -176.56 3.23 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.298 -1.119 . . . . 0.0 109.932 -178.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.78 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -152.71 138.53 17.98 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.738 -0.601 . . . . 0.0 109.981 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.797 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -90.98 177.63 6.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.192 -0.943 . . . . 0.0 108.965 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 4' ' ' VAL . 2.4 pt20 -140.5 128.18 21.65 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.211 -0.931 . . . . 0.0 110.37 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.085 HD21 ' CE1' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -139.7 -175.45 4.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 109.217 179.218 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -121.12 82.64 1.95 Allowed 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.943 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.081 HG22 ' CB ' ' A' ' 26' ' ' ALA . 42.8 t -59.72 111.92 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.097 -1.002 . . . . 0.0 109.009 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.735 ' HB3' HG21 ' A' ' 21' ' ' VAL . . . -43.56 168.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.0 109.925 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.433 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 57.5 m-20 -84.32 126.45 33.21 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.339 -0.851 . . . . 0.0 108.989 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.3 15.25 35.98 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.735 HG21 ' HB3' ' A' ' 18' ' ' ALA . 4.4 t -115.5 169.71 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.363 -1.081 . . . . 0.0 109.138 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.487 ' HA ' HD13 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -106.73 135.82 47.61 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.17 -0.957 . . . . 0.0 108.69 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.909 HD13 ' CZ ' ' A' ' 5' ' ' TYR . 0.4 OUTLIER -44.35 -26.3 0.32 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.049 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.474 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -73.24 -48.68 32.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.289 -0.882 . . . . 0.0 108.74 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.504 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 1.3 tp60 -53.16 -56.11 18.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.057 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 1.081 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.54 -26.9 64.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 108.911 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.651 ' HB1' ' N ' ' A' ' 33' ' ' TYR . . . -69.98 -32.39 70.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.429 -0.794 . . . . 0.0 109.215 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.575 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 59.8 t -52.95 -35.57 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.478 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 t -88.54 -52.26 5.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.479 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.872 ' ND2' HD13 ' A' ' 15' ' ' LEU . 24.9 m-80 -54.15 -16.21 1.92 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.656 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 35' ' ' ILE . . . 84.87 19.3 59.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.634 HG23 HD12 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -99.61 -27.64 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -1.156 . . . . 0.0 108.494 179.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.651 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 1.1 p90 -47.96 -44.89 30.68 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.554 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 0.9 OUTLIER -74.56 -31.4 62.09 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.634 HD12 HG23 ' A' ' 32' ' ' ILE . 56.4 mt -60.94 -20.22 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 0.0 109.098 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.514 HG11 HG22 ' A' ' 101' ' ' VAL . 2.5 p -170.1 112.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 109.515 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 38' ' ' ASP . . . 177.91 176.99 46.35 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.563 ' OD1' HG21 ' A' ' 47' ' ' THR . 0.3 OUTLIER -163.1 -86.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -1.182 . . . . 0.0 109.803 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 41' ' ' GLY . 12.6 p -83.49 10.07 9.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.679 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 86' ' ' CYS . . . 51.93 -90.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 39' ' ' CYS . . . -54.46 -169.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.18 99.98 12.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -1.15 . . . . 0.0 109.481 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.427 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . . . -118.07 -99.28 0.45 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 109.444 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.484 ' HA ' ' HG2' ' A' ' 70' ' ' MET . 13.6 t -160.57 40.64 0.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.918 -1.114 . . . . 0.0 109.965 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.515 ' SG ' ' CB ' ' A' ' 38' ' ' ASP . 1.7 p -99.99 149.86 23.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.992 -1.068 . . . . 0.0 109.331 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 1.044 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -105.89 23.78 13.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.563 HG21 ' OD1' ' A' ' 38' ' ' ASP . 22.0 m -90.25 -19.9 23.59 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.902 . . . . 0.0 109.756 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.468 ' SG ' ' HA ' ' A' ' 84' ' ' LEU . 21.9 p -91.03 42.73 1.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.099 -1.001 . . . . 0.0 110.287 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 1.008 ' CE1' HD12 ' A' ' 78' ' ' LEU . 11.7 t60 -76.29 70.27 2.89 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.582 HG11 ' SG ' ' A' ' 85' ' ' CYS . 10.3 m -77.85 144.27 11.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 120.123 -1.611 . . . . 0.0 109.755 -178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.626 ' CE2' ' NE2' ' A' ' 49' ' ' HIS . 0.9 OUTLIER -109.57 99.11 8.36 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.849 HG22 HG12 ' A' ' 99' ' ' VAL . 3.8 t -89.98 173.98 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-O 121.844 0.831 . . . . 0.0 112.124 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.617 ' H ' HG12 ' A' ' 52' ' ' VAL . 1.3 m-20 -68.88 -177.94 1.11 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -101.19 -1.64 33.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.159 -0.963 . . . . 0.0 110.139 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.3 -21.61 12.13 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.996 -1.065 . . . . 0.0 110.446 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.625 ' CG ' ' HA ' ' A' ' 97' ' ' ILE . 85.5 m-85 -95.18 -23.79 17.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.024 -1.047 . . . . 0.0 109.895 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.785 HG21 HD22 ' A' ' 81' ' ' ASN . 0.8 OUTLIER -63.46 -34.1 77.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.149 -0.969 . . . . 0.0 109.39 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -66.61 -63.77 1.0 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 109.549 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.62 ' HB3' HD11 ' A' ' 94' ' ' LEU . 20.3 mmtp -49.88 -23.41 1.91 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.929 . . . . 0.0 109.385 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.877 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -57.94 162.71 5.01 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.274 -0.891 . . . . 0.0 108.994 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.877 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.5 Cg_exo -58.71 171.38 2.03 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.128 1.885 . . . . 0.0 110.243 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 63' ' ' ALA . . . -110.22 59.65 0.61 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -0.922 . . . . 0.0 109.507 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.032 ' HB3' ' NH2' ' A' ' 83' ' ' ARG . . . -42.43 151.95 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.45 -0.781 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -61.72 -162.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.936 . . . . 0.0 109.56 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.534 ' HA ' ' CG1' ' A' ' 68' ' ' ILE . 2.0 tm-20 -100.16 -22.18 15.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.338 -0.851 . . . . 0.0 109.543 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.442 ' O ' ' SD ' ' A' ' 70' ' ' MET . 3.7 mtt180 -43.9 -56.99 3.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.646 ' OE2' ' HB1' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -64.63 -30.84 71.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.534 ' CG1' ' HA ' ' A' ' 65' ' ' GLU . 36.9 mm -56.0 -43.82 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 109.528 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.76 -30.13 62.22 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.508 ' N ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -68.5 -16.08 63.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -1.131 . . . . 0.0 109.342 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.026 HD13 ' HG ' ' A' ' 84' ' ' LEU . 10.0 tp -90.89 -8.95 48.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -79.81 -23.0 42.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.922 . . . . 0.0 109.388 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -85.32 45.14 1.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.89 . . . . 0.0 109.462 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.044 HG12 ' HB1' ' A' ' 46' ' ' ALA . 4.1 m -106.59 163.8 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.388 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 75' ' ' THR . 96.0 m -85.44 6.69 25.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.942 . . . . 0.0 109.544 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.735 ' H ' HG23 ' A' ' 74' ' ' VAL . . . -114.47 -156.12 0.59 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.132 -0.98 . . . . 0.0 109.463 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.635 ' O ' ' CE1' ' A' ' 49' ' ' HIS . 1.7 pt-20 -112.55 151.42 30.03 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.008 HD12 ' CE1' ' A' ' 49' ' ' HIS . 0.3 OUTLIER -128.03 159.83 33.83 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 117.912 -1.515 . . . . 0.0 111.631 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.546 ' CB ' ' HD2' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -149.37 171.38 6.38 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 79' ' ' LYS . 5.0 Cg_exo -56.59 -15.02 14.55 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 121.956 1.77 . . . . 0.0 109.84 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.785 HD22 HG21 ' A' ' 57' ' ' THR . 2.7 t-20 -86.53 -30.93 21.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.392 -0.818 . . . . 0.0 110.542 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.623 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -68.59 159.25 32.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.953 -1.092 . . . . 0.0 110.481 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 1.032 ' NH2' ' HB3' ' A' ' 63' ' ' ALA . 2.6 mtp180 -161.53 166.38 27.14 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.365 -0.834 . . . . 0.0 109.124 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.026 ' HG ' HD13 ' A' ' 71' ' ' LEU . 6.2 mp -79.76 118.94 22.01 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.157 -0.965 . . . . 0.0 108.598 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.582 ' SG ' HG11 ' A' ' 50' ' ' VAL . 2.2 t -47.12 -24.35 0.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.158 -0.964 . . . . 0.0 109.475 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 40' ' ' GLY . 30.6 p -88.19 30.88 0.83 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 0.0 109.769 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.654 HE21 ' HB2' ' A' ' 63' ' ' ALA . 7.8 mm100 -149.66 12.65 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.049 -1.032 . . . . 0.0 109.994 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.832 HG22 HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -108.87 140.52 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.082 -1.012 . . . . 0.0 108.704 179.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.691 HD13 ' O ' ' A' ' 88' ' ' ILE . 23.9 mm -125.91 146.03 32.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 109.762 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.686 ' HE3' HG22 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -98.32 83.31 3.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -0.852 . . . . 0.0 109.112 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 p -81.83 155.99 70.29 Favored Pre-proline 0 C--N 1.297 -1.686 0 O-C-N 121.486 -0.759 . . . . 0.0 109.203 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 19' ' ' ASP . 6.3 Cg_exo -58.42 -14.94 22.42 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.021 1.814 . . . . 0.0 109.905 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -73.12 -41.19 64.27 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.836 . . . . 0.0 109.323 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 59' ' ' LYS . 5.6 mp -86.11 142.68 28.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -138.16 126.35 22.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.153 -0.967 . . . . 0.0 109.703 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.591 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . . . 68.14 49.72 44.79 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.979 HD11 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -77.79 151.71 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.224 -1.162 . . . . 0.0 108.878 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.402 ' N ' HG12 ' A' ' 97' ' ' ILE . 4.8 t -122.06 104.7 15.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.034 -1.041 . . . . 0.0 110.363 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.979 HG13 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -98.93 144.86 11.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 178.04 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.4 OUTLIER -122.79 176.3 6.05 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.914 -1.116 . . . . 0.0 109.733 -179.288 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.88 HG13 ' HD2' ' A' ' 102' ' ' PRO . 51.0 t -108.6 144.02 28.7 Favored Pre-proline 0 C--N 1.298 -1.641 0 C-N-CA 119.671 -0.812 . . . . 0.0 108.943 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.88 ' HD2' HG13 ' A' ' 101' ' ' VAL . 4.1 Cg_exo -54.36 172.37 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.461 2.107 . . . . 0.0 111.492 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.421 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -82.03 -17.53 46.45 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.544 ' HG3' ' NH1' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -128.87 107.4 9.61 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.381 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 106' ' ' TRP . 8.3 pt20 -79.76 5.03 14.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.145 -0.972 . . . . 0.0 109.59 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.572 ' CZ2' ' OG1' ' A' ' 75' ' ' THR . 62.2 m95 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.495 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 1.004 ' S1 ' HD23 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_